10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

___________________________________________________________________________ 

FORM 10-Q

(Mark One) 

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the quarterly period ended September 30, 2020

or 

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                              to                             

Commission File Number: 1-13991

MFA FINANCIAL, INC.

(Exact name of registrant as specified in its charter)

__________________________________________________________________ 

Maryland		13-3974868
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
350 Park Avenue, 20th Floor
New York	New York	10022
(Address of principal executive offices)		(Zip Code)

 (212) 207-6400

(Registrant’s telephone number, including area code)

_____________________________________________

Not Applicable 

(Former name, former address and former fiscal year, if changed since last period)

____________________________________________________________________ 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share	MFA	New York Stock Exchange
7.50% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share	MFA/PB	New York Stock Exchange
6.50% Series C Cumulative Redeemable Preferred Stock, par value $0.01 per share	MFA/PC	New York Stock Exchange
8.00% Senior Notes due 2042	MFO	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No x

453,333,220 shares of the registrant’s common stock, $0.01 par value, were outstanding as of October 29, 2020.

MFA FINANCIAL, INC.

TABLE OF CONTENTS

		Page
PART I
FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Balance Sheets as of September 30, 2020 (Unaudited) and December 31, 2019	1
	Consolidated Statements of Operations (Unaudited) for the Three and Nine Months Ended September 30, 2020 and September 30, 2019	2
	Consolidated Statements of Comprehensive Income/(Loss) (Unaudited) for the Three and Nine Months Ended September 30, 2020 and September 30, 2019	3
	Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) for the Nine Months Ended September 30, 2020 and September 30, 2019	4
	Consolidated Statements of Cash Flows (Unaudited) for the Nine Months Ended September 30, 2020 and September 30, 2019	6
	Notes to the Unaudited Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	62
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	90
Item 4.	Controls and Procedures	95
PART II
OTHER INFORMATION
Item 1.	Legal Proceedings	96
Item 1A.	Risk Factors	96
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	96
Item 3.	Defaults Upon Senior Securities	96
Item 4.	Mine Safety Disclosures	96
Item 5.	Other Information	97
Item 6.	Exhibits	97
Signatures		98

MFA FINANCIAL, INC. CONSOLIDATED BALANCE SHEETS
(In Thousands Except Per Share Amounts)	September 30, 2020		December 31, 2019
	(Unaudited)
Assets:
Residential whole loans:
Residential whole loans, at carrying value ($3,843,153 and $4,847,782 pledged as collateral, respectively) (1)	$	4,493,805	$	6,069,370
Residential whole loans, at fair value ($705,666 and $794,684 pledged as collateral, respectively) (1)	1,229,664		1,381,583
Allowance for credit losses on residential whole loans held at carrying value	(106,246)		(3,025)
Total residential whole loans, net	5,617,223		7,447,928
Residential mortgage securities, at fair value ($152,765 and $3,966,591 pledged as collateral, respectively)	152,765		3,983,519
Mortgage servicing rights (“MSR”) related assets ($252,183 and $1,217,002 pledged as collateral, respectively)	252,183		1,217,002
Cash and cash equivalents	884,171		70,629
Restricted cash	5,303		64,035
Other assets	571,614		784,251
Total Assets	$	7,483,259	$	13,567,364
Liabilities:
Financing agreements ($4,080,461 and $0 held at fair value, respectively)	$	4,851,121	$	10,031,606
Other liabilities	66,482		151,806
Total Liabilities	$	4,917,603	$	10,183,412
Commitments and contingencies (See Note 10)
Stockholders’ Equity:
Preferred stock, $0.01 par value; 7.5% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)	$	80	$	80
Preferred stock, $0.01 par value; 6.5% Series C fixed-to-floating rate cumulative redeemable; 12,650 shares authorized; 11,000 shares issued and outstanding ($275,000 aggregate liquidation preference)	110		—
Common stock, $0.01 par value; 874,300 and 886,950 shares authorized; 453,333 and 452,369 shares issued   and outstanding, respectively	4,533		4,524
Additional paid-in capital, in excess of par	3,924,584		3,640,341
Accumulated deficit	(1,408,910)		(631,040)
Accumulated other comprehensive income	45,259		370,047
Total Stockholders’ Equity	$	2,565,656	$	3,383,952
Total Liabilities and Stockholders’ Equity	$	7,483,259	$	13,567,364

(1)Includes approximately $568.6 million and $186.4 million of Residential whole loans, at carrying value and $521.2 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.

The accompanying notes are an integral part of the consolidated financial statements.

1

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands, Except Per Share Amounts)	2020		2019		2020		2019
Interest Income:
Residential whole loans held at carrying value	$	54,393	$	64,226	$	207,306	$	171,725
Residential mortgage securities	2,329		60,639		51,678		211,676
MSR-related assets	6,241		15,274		30,189		38,232
Other interest-earning assets	3,017		1,679		9,089		4,272
Cash and cash equivalent investments	100		903		646		2,703
Interest Income	$	66,080	$	142,721	$	298,908	$	428,608
Interest Expense:
Asset-backed and other collateralized financing arrangements	$	50,054	$	79,932	$	209,998	$	238,773
Other interest expense	5,910		5,891		17,716		11,120
Interest Expense	$	55,964	$	85,823	$	227,714	$	249,893
Net Interest Income	$	10,116	$	56,898	$	71,194	$	178,715
Reversal/(Provision) for credit and valuation losses on residential whole loans and other financial instruments	$	27,244	$	(347)	$	(38,090)	$	(1,538)
Net Interest Income after Provision for Credit and Valuation Losses	$	37,360	$	56,551	$	33,104	$	177,177
Other Income, net:
Impairment and other losses on securities available-for-sale and other assets	$	(221)	$	—	$	(424,966)	$	—
Net realized gain/(loss) on sales of residential mortgage securities and residential whole loans	48		17,708		(188,847)		50,027
Net unrealized gain/(loss) on residential mortgage securities measured at fair value through earnings	91		(695)		(13,432)		7,977
Net gain on residential whole loans measured at fair value through earnings	76,871		40,175		44,431		116,915
Loss on terminated swaps previously designated as hedges for accounting purposes	(7,177)		—		(57,034)		—
Other, net	7,498		5,241		2,370		(4,459)
Other Income/(Loss), net	$	77,110	$	62,429	$	(637,478)	$	170,460
Operating and Other Expense:
Compensation and benefits	$	11,657	$	7,920	$	29,134	$	24,315
Other general and administrative expense	6,611		5,022		18,656		15,601
Loan servicing, financing and other related costs	8,992		10,439		28,609		30,225
Costs associated with restructuring/forbearance agreement	—		—		44,434		$	—
Operating and Other Expense	$	27,260	$	23,381	$	120,833	$	70,141
Net Income/(Loss)	$	87,210	$	95,599	$	(725,207)	$	277,496
Less Preferred Stock Dividend Requirement	$	8,219	$	3,750	$	21,578	11,250
Net Income/(Loss) Available to Common Stock and Participating Securities	$	78,991	$	91,849	$	(746,785)	$	266,246
Basic Earnings/(Loss) per Common Share	$	0.17	$	0.20	$	(1.65)	$	0.59
Diluted Earnings/(Loss) per Common Share	$	0.17	$	0.20	$	(1.65)	$	0.58

The accompanying notes are an integral part of the consolidated financial statements.

2

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) (UNAUDITED)
	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Net income/(loss)	$	87,210	$	95,599	$	(725,207)	$	277,496
Other Comprehensive Income/(Loss):
Unrealized gains on securities available-for-sale	15,082		5,483		408,585		50,085
Reclassification adjustment for MBS sales included in net income	(60)		(14,499)		(389,127)		(36,370)
Reclassification adjustment for impairments included in net income	—		—		(344,269)		—
Derivative hedging instrument fair value changes, net	—		(233)		(50,127)		(30,384)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk	(22,652)		—		(22,652)		—
Reclassification adjustment for losses/(gains) related to hedging instruments included in net income	7,176		(685)		72,802		(1,769)
Other Comprehensive Income/(Loss)	(454)		(9,934)		(324,788)		(18,438)
Comprehensive income before preferred stock dividends	$	86,756	$	85,665	$	(1,049,995)	$	259,058
Dividends required on preferred stock	(8,219)		(3,750)		(21,578)		(11,250)
Comprehensive Income/(Loss) Available to Common Stock and Participating Securities	$	78,537	$	81,915	$	(1,071,573)	$	247,808

The accompanying notes are an integral part of the consolidated financial statements.

3

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
	Nine Months Ended September 30, 2020
(In Thousands,  Except Per Share Amounts)	Preferred Stock 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable - Liquidation Preference $25.00 per Share			Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock			Additional Paid-in Capital		Accumulated Deficit		Accumulated Other Comprehensive Income		Total
	Shares	Amount		Shares	Amount		Shares	Amount
Balance at December 31, 2019	—	$	—	8,000	$	80	452,369	$	4,524	$	3,640,341	$	(631,040)	$	370,047	$	3,383,952
Cumulative effect adjustment on adoption of new accounting standard ASU 2016-13	—	—		—	—		—	—		—		(8,326)		—		(8,326)
Net loss	—	—		—	—		—	—		—		(908,995)		—		(908,995)
Issuance of Series C Preferred Stock, net of expenses	11,000	110		—	—		—	—		265,919		—		—		266,029
Issuance of common stock, net of expenses	—	—		—	—		1,106	7		680		—		—		687
Repurchase of shares of common stock (1)	—	—		—	—		(337)	—		(2,652)		—		—		(2,652)
Equity based compensation expense	—	—		—	—		—	—		1,266		—		—		1,266
Accrued dividends attributable to stock-based awards	—	—		—	—		—	—		1,059		—		—		1,059
Change in unrealized gains on MBS, net	—	—		—	—		—	—		—		—		(243,812)		(243,812)
Derivative hedging instrument fair value changes and amortization, net	—	—		—	—		—	—		—		—		(48,533)		(48,533)
Balance at March 31, 2020	11,000	$	110	8,000	$	80	453,138	$	4,531	$	3,906,613	$	(1,548,361)	$	77,702	$	2,440,675
Net income	—	—		—	—		—	—		—		96,578		—		96,578
Issuance of common stock, net of expenses	—	—		—	—		106	1		36		—		—		37
Equity based compensation expense	—	—		—	—		—	—		1,709		—		—		1,709
Change in unrealized gains on MBS, net	—	—		—	—		—	—		—		—		(96,021)		(96,021)
Derivative hedging instrument fair value changes and amortization, net	—	—		—	—		—	—		—		—		64,032		64,032
Warrants Issued	—	—		—	—		—	—		14,041		—		—		14,041
Balance at June 30, 2020	11,000	$	110	8,000	$	80	453,244	$	4,532	$	3,922,399	$	(1,451,783)	$	45,713	$	2,521,051
Net income	—	—		—	—		—	—		—		87,210		—		87,210
Issuance of common stock, net of expenses	—	—		—	—		89	1		—		—		—		1
Repurchase of shares of common stock (1)	—	—		—	—		—	—		—		—		—		—
Equity based compensation expense	—	—		—	—		—	—		2,266		—		—		2,266
Accrued dividends attributable to stock-based awards	—	—		—	—		—	—		(81)		—		—		(81)
Dividends declared on common stock ($0.05 per share)	—	—		—	—		—	—		—		(22,667)		—		(22,667)
Dividends declared on Series B Preferred Stock ($1.40625 per share) (2)	—	—		—	—		—	—		—		(11,250)		—		(11,250)
Dividends declared on Series C Preferred Stock ($0.93889 per share) (2)	—	—		—	—		—	—		—		(10,328)		—		(10,328)
Dividends attributable to dividend equivalents	—	—		—	—		—	—		—		(92)		—		(92)
Change in unrealized gains on MBS, net	—	—		—	—		—	—		—		—		15,022		15,022
Derivative hedging instrument fair value changes and amortization, net	—	—		—	—		—	—		—		—		7,176		7,176
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk	—	—		—	—		—	—		—		—		(22,652)		(22,652)
Balance at September 30, 2020	11,000	$	110	8,000	$	80	453,333	$	4,533	$	3,924,584	$	(1,408,910)	$	45,259	$	2,565,656

(1)  For the nine months ended September 30, 2020 includes approximately $2.7 million (337,026 shares) surrendered for tax purposes related to equity-based compensation awards.

(2) Includes reinstated dividends that were unpaid through June 30, 2020, and were paid during the three months ended September 30, 2020 (see Note11(a)).

The accompanying notes are an integral part of the consolidated financial statements.

4

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
	Nine Months Ended September 30, 2019
(In Thousands,  Except Per Share Amounts)	Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock			Additional Paid-in Capital		Accumulated Deficit		Accumulated Other Comprehensive Income		Total
	Shares	Amount		Shares	Amount
Balance at December 31, 2018	8,000	$	80	449,787	$	4,498	$	3,623,275	$	(632,040)	$	420,288	$	3,416,101
Net income	—	—		—	—		—		88,857		—		88,857
Issuance of common stock, net of expenses	—	—		1,066	7		544		—		—		551
Repurchase of shares of common stock (1)	—	—		(370)	—		(2,610)		—		—		(2,610)
Equity based compensation expense	—	—		—	—		992		—		—		992
Accrued dividends attributable to stock-based awards	—	—		—	—		435		—		—		435
Dividends declared on common stock ($0.20 per share)	—	—		—	—		—		(90,097)		—		(90,097)
Dividends declared on preferred stock ($0.46875 per share)	—	—		—	—		—		(3,750)		—		(3,750)
Dividends attributable to dividend equivalents	—	—		—	—		—		(256)		—		(256)
Change in unrealized losses on MBS, net	—	—		—	—		—		—		5,094		5,094
Derivative hedging instruments fair value changes, net	—	—		—	—		—		—		(10,786)		(10,786)
Balance at March 31, 2019	8,000	$	80	450,483	$	4,505	$	3,622,636	$	(637,286)	$	414,596	$	3,404,531
Net income	—	—		—	—		—		93,040		—		93,040
Issuance of common stock, net of expenses	—	—		139	1		585		—		—		586
Repurchase of shares of common stock (1)	—	—		—	—		—		—		—		—
Equity based compensation expense	—	—		—	—		2,438		—		—		2,438
Accrued dividends attributable to stock-based awards	—	—		—	—		(260)		—		—		(260)
Dividends declared on common stock ($0.20 per share)	—	—		—	—		—		(90,124)		—		(90,124)
Dividends declared on preferred stock ($0.46875 per share)	—	—		—	—		—		(3,750)		—		(3,750)
Dividends attributable to dividend equivalents	—	—		—	—		—		(276)		—		(276)
Change in unrealized losses on MBS, net	—	—		—	—		—		—		17,637		17,637
Derivative hedging instruments fair value changes, net	—	—		—	—		—		—		(20,449)		(20,449)
Balance at June 30, 2019	8,000	$	80	450,622	$	4,506	$	3,625,399	$	(638,396)	$	411,784	$	3,403,373
Net income	—	—		—	—		—		95,599		—		95,599
Issuance of common stock, net of expenses	—	—		1,070	11		7,713		—		—		7,724
Repurchase of shares of common stock (1)	—	—		—	—		—		—		—		—
Equity based compensation expense	—	—		—	—		1,288		—		—		1,288
Accrued dividends attributable to stock-based awards	—	—		—	—		(260)		—		—		(260)
Dividends declared on common stock ($0.20 per share)	—	—		—	—		—		(90,338)		—		(90,338)
Dividends declared on preferred stock ($0.46875 per share)	—	—		—	—		—		(3,750)		—		(3,750)
Dividends attributable to dividend equivalents	—	—		—	—		—		(276)		—		(276)
Change in unrealized losses on MBS, net	—	—		—	—		—		—		(9,016)		(9,016)
Derivative hedging instruments fair value changes, net	—	—		—	—		—		—		(918)		(918)
Balance at September 30, 2019	8,000	$	80	451,692	$	4,517	$	3,634,140	$	(637,161)	$	401,850	$	3,403,426

(1)  For the nine months ended September 30, 2019, includes approximately $2.6 million (370,244 shares) surrendered for tax purposes related to equity-based compensation awards.

The accompanying notes are an integral part of the consolidated financial statements.

5

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
	Nine Months Ended September 30,
(In Thousands)	2020		2019
Cash Flows From Operating Activities:
Net (loss)/income	$	(725,207)	$	277,496
Adjustments to reconcile net income to net cash provided by operating activities:
Losses/(gains) on residential whole loans and real estate owned, net	280,142		(61,125)
Gains on residential mortgage securities and MSR related assets, net	(71,569)		(58,005)
Impairment and other losses on securities available-for-sale and other assets	424,966		—
Losses on terminated swaps previously designated as hedges and other	57,034		—
Accretion of purchase discounts on residential mortgage securities, residential whole loans and MSR-related assets	(27,585)		(45,990)
Amortization of purchase premiums on residential mortgage securities and residential whole loans, and amortization of terminated hedging instruments	40,952		32,085
Provision for credit and valuation losses on residential whole loans and other financial instruments	38,090		—
Net valuation and other non-cash losses included in net income	16,388		22,026
Decrease/(increase) in other assets	459		(24,647)
(Decrease)/increase in other liabilities	(16,919)		11,756
Net cash provided by operating activities	$	16,751	$	153,596
Cash Flows From Investing Activities:
Purchases of residential whole loans, loan related investments and capitalized advances	$	(1,345,422)	$	(2,988,229)
Proceeds from sales of residential whole loans	1,521,060		—
Principal payments on residential whole loans	1,261,319		906,072
Principal payments on residential mortgage securities and MSR-related assets	609,758		1,555,449
Proceeds from sales of residential mortgage securities, MSR-related assets, and other assets	3,790,148		735,768
Purchases of residential mortgage securities and MSR-related assets	(163,748)		(837,591)
Proceeds from sales of real estate owned	203,603		81,206
Purchases of real estate owned and capital improvements	(9,334)		(15,671)
Additions to leasehold improvements, furniture and fixtures	(1,425)		(1,351)
Net cash provided by/(used in) investing activities	$	5,865,959	$	(564,347)
Cash Flows From Financing Activities:
Principal payments on financing agreements with mark-to-market collateral provisions	$	(21,401,578)	$	(54,103,776)
Proceeds from borrowings under financing agreements with mark-to-market collateral provisions	13,749,720		54,796,010
Principal payments on financing agreements with non-mark-to-market collateral provisions	(312,638)		—
Proceeds from borrowings under financing agreements with non-mark-to-market collateral provisions	2,036,597		—
Principal payments made on senior secured credit agreement	(18,750)		—
Proceeds from issuance of senior secured credit agreement	480,959		—
Principal payments on securitized debt	(133,450)		(79,350)
Proceeds from issuance of securitized debt	391,154		—
Proceeds from issuance of convertible senior notes	—		223,311
Payments made for settlements and unwinds of Swaps	(88,405)		(47,622)
Proceeds from issuance of series C preferred stock	275,000		—
Payments made for costs related to series C preferred stock issuance	(8,948)		—
Proceeds from issuances of common stock	725		8,861
Proceeds from the issuance of warrants	14,041		—
Dividends paid on preferred stock	(21,578)		(11,250)
Dividends paid on common stock and dividend equivalents	(90,749)		(270,951)
Net cash (used in)/provided by financing activities	$	(5,127,900)	$	515,233
Net increase in cash, cash equivalents and restricted cash	$	754,810	$	104,482
Cash, cash equivalents and restricted cash at beginning of period	$	134,664	$	88,709
Cash, cash equivalents and restricted cash at end of period	$	889,474	$	193,191

6

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Supplemental Disclosure of Cash Flow Information
Interest Paid	$	213,318	$	237,644
Non-cash Investing and Financing Activities:
Transfer from residential whole loans to real estate owned	$	74,891	$	193,531
Dividends and dividend equivalents declared and unpaid	$	22,758	$	90,614
Payable for unsettled residential whole loan purchases	$	—	$	59,524

The accompanying notes are an integral part of the consolidated financial statements.

7

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

1.   Organization

MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as taxable REIT subsidiaries (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Note 2(n))

2.   Summary of Significant Accounting Policies

(a)  Basis of Presentation and Consolidation

The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted in accordance with these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2020 and results of operations for all periods presented have been made.  The results of operations for the three and nine months ended September 30, 2020 should not be construed as indicative of the results to be expected for the full year.

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including impairment, valuation allowances and loss allowances on residential whole loans (see Note 3), mortgage-backed securities (“MBS”) (see Note 4) and Other Assets (see Note 5), valuation of MBS, CRT securities and MSR-related assets (see Notes 4 and 14), income recognition and valuation of residential whole loans (see Notes 3 and 14), valuation of derivative instruments (see Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount (see Note 4).  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (see Note 2(n)).  Actual results could differ from those estimates.

The Company has one reportable segment since it manages its business and analyzes and reports its results of operations on the basis of one operating segment: investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries. All intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.

8

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(b)  Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed- and adjustable-rate residential mortgage loans acquired through consolidated trusts in secondary market transactions. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for Purchased Credit Deteriorated Loans that are held at carrying value is typically utilized by the Company for Purchased Credit Deteriorated Loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company also acquires Purchased Performing Loans that are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required credit loss reserves (as discussed below) differ from those used for Purchased Credit Deteriorated Loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against financing agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans that are subject to an extended period of due diligence that crosses a reporting date are recorded in our balance sheet at amounts reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Residential whole loans purchased under flow arrangements with loan origination partners are generally recorded at the transaction settlement date. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any financing agreement until the closing of the purchase transaction. Interest income, credit related losses and changes in the fair value of loans held at fair value are recorded post settlement for acquired loans and until transaction settlement for sold loans (see Notes 3, 6, 7, 14 and 15).

Residential Whole Loans at Carrying Value

Purchased Performing Loans

Acquisitions of Purchased Performing Loans to date have been primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties that are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to four-family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”). Purchased Performing Loans are initially recorded at their purchase price. Interest income on Purchased Performing Loans acquired at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any amortization of premium or accretion of discount, adjusted for actual prepayment activity. For loans acquired with related servicing rights retained by the seller, interest income is reported net of related serving costs.

An allowance for credit losses is recorded at acquisition, and maintained on an ongoing basis, for all losses expected to be incurred over the life of the respective loan. Any required credit loss allowance would reduce the net carrying value of the loan with a corresponding charge to earnings, and may increase or decrease over time. Significant judgments are required in determining any allowance for credit loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended, and interest accruals are reversed against income, for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful (i.e., such loans are placed on nonaccrual status). For nonaccrual loans other than Fix and Flip loans, all payments are applied to principal under the cost recovery method. For nonaccrual Fix and Flip loans, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged. Modified loans are considered

9

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

“troubled debt restructurings” if the Company grants a concession to a borrower who is experiencing financial difficulty (including the interpretation of this definition set forth in OCC Bulletin 2020-35).

Charge-offs to the allowance for loan losses occur when losses are confirmed through the receipt of cash or other consideration from the completion of a sale; when a modification or restructuring takes place in which we grant a concession to a borrower or agree to a discount in full or partial satisfaction of the loan; when we take ownership and control of the underlying collateral in full satisfaction of the loan; when loans are reclassified as other investments; or when significant collection efforts have ceased and it is highly likely that a loss has been realized.

The aggregate allowance for credit losses is equal to the sum of the losses expected to be incurred over the life of each respective loan. These losses were estimated by projecting each loan’s expected cash flows based on their contractual terms, expected prepayments, and estimated default and loss severity rates. The default and severity rates were estimated based on the following steps: (i) obtained the Company’s historical experience through an entire economic cycle for each loan type or, to the extent the Company did not have sufficient historical loss experience for a given loan type, publicly available data derived from the historical loss experience of certain banks, which data the Company believes is generally representative of its portfolio, (ii) obtained historical economic data (U.S. unemployment rates and home price appreciation) over the same period, and (iii) estimated default and severity rates during three distinct future periods based on historical default and severity rates during periods when economic conditions similar to those forecasted were experienced. The three periods were as follows: (i) a one-year forecast of economic conditions based on U.S. unemployment rates and home price appreciation, followed by (ii) a two-year “reversion” period during which economic conditions (U.S. unemployment rates and home price appreciation) are projected to revert to historical averages on a straight line basis, followed by (iii) the remaining life of each loan, during which period economic conditions (U.S. unemployment rates and home price appreciation) are projected to equal historical averages. In addition, a liability is established (and recorded in Other Liabilities) each period using a similar methodology for committed but undrawn loan amounts. This methodology has not changed from the calculation of the allowance for credit losses on January 1, 2020 pursuant to the transition to ASU 2016-13 as described below under “New Accounting Standards and Interpretations,” other than a change in the reversion period from one year to two years to reflect the expected ongoing impact of current conditions (see Note 3).

Purchased Credit Deteriorated Loans

The Company has elected to account for these loans as credit impaired as they have experienced a more-than-insignificant deterioration in credit quality since origination and were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price on a net basis, after establishing an initial allowance for credit losses (their initial cost basis is equal to their purchase price plus the initial allowance for credit losses). Subsequent to acquisition, the gross recorded amount for these loans reflects the initial cost basis, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded cost basis reduced by any allowance for credit losses. Interest income on such loans purchased is recorded each period based on the contractual coupon net of amortization of the difference between their cost basis and unpaid principal balance (“UPB”), subject to the Company’s nonaccrual policy.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

10

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Cash received (or accrued) representing coupon interest payments on residential whole loans held at fair value is not included in Interest Income, but rather is included in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in unrealized gains or losses reported each period.

(c)  Residential Mortgage Securities

Prior to the quarter ended June 30, 2020, the Company had invested in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). The Company disposed of its investments in Agency MBS during the quarter and has substantially reduced its investments in Non-Agency MBS. In addition, the Company has investments in CRT securities that are issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the issuer and the principal payments received are dependent on the performance of loans in either a reference pool or an actual pool of loans. As the loans in the underlying pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company.

Designation

MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an allowance for losses is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company had elected the fair value option for certain of its previously held Agency MBS that it did not intend to hold to maturity. These securities were carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk-sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on their outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Determination of Fair Value for Residential Mortgage Securities

In determining the fair value of the Company’s residential mortgage securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity (see Note 14).

11

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Allowance for credit losses

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities, as well as securities for which a credit loss allowance had been previously recorded, on at least a quarterly basis and determines whether any changes to the allowance for credit losses are required.  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize a write-down through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an impaired security, only the portion of the impairment related to credit losses is recognized through a loss allowance charged to earnings with the remainder recognized through AOCI on the Company’s consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Credit loss allowances are subject to reversal through earnings resulting from improvements in expected cash flows. The determination as to whether to record (or reverse) a credit loss allowance is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of future performance and cash flow projections.  As a result, the timing and amount of losses constitute material estimates that are susceptible to significant change (see Note 4).

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the allowance related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s residential mortgage securities pledged as collateral against financing agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(d) MSR-Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR-related assets, are discussed in more detail below. The Company’s MSR-related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR-related assets are recorded on the trade date (see Notes 4, 6, 7 and 14).

Term Notes Backed by MSR-Related Collateral

The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

12

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The Company’s term notes backed by MSR-related collateral are treated as AFS securities and reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI, subject to impairment and loss allowances. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes is similar to that used for residential mortgage securities and considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral, as applicable, and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations, subject to loss allowances. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

(e)  Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its financing counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at September 30, 2020 and December 31, 2019. At September 30, 2020 and December 31, 2019, the Company had cash and cash equivalents of $884.2 million and $70.6 million, respectively. At September 30, 2020, the Company had $837.6 million of investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation (“FDIC”) or any other government agency. As of December 31, 2019, the Company had $39.6 million worth of investments in overnight money market funds. In addition, deposits in FDIC insured accounts generally exceed insured limits (see Notes 7 and 14).

(f)  Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s Swaps and/or financing agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to financing agreement and/or Swap counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap and/or financing agreements.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its financing agreements and/or Swaps of $5.3 million and $64.0 million at September 30, 2020 and December 31, 2019, respectively (see Notes 5(c), 6, 7 and 14).

(g) Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on

13

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

the Company’s consolidated statements of operations. The Company has acquired certain properties that it holds for investment purposes, including rentals to third parties. These properties are held at their historical basis less depreciation, and are subject to impairment. Related rental income and expenses are recorded in Other Income, net (see Note 5).

(h)  Depreciation

Leasehold Improvements, Real estate and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. The building component of real estate held-for-investment is depreciated over 27.5 years.

(i)  Loan Securitization and Other Debt Issuance Costs

Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing its 6.25% Convertible Senior Notes due 2024 (“Convertible Senior Notes”) and its 8% Senior Notes due 2042 (“Senior Notes”). These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges (unless the debt is recorded at fair value, as discussed below), are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For the Convertible Senior Notes and Senior Notes, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and, in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

(j)  Financing Agreements

The Company finances the majority of its residential mortgage assets with financing agreements that include repurchase agreements and other forms of collateralized financing.  Under repurchase agreements, the Company sells assets to a lender and agrees to repurchase the same assets in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements and other forms of collateralized financing, the Company pledges its assets as collateral to secure the borrowing, in an amount which is equal to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional assets or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the assets pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings collateralized by residential mortgage securities and MSR-related assets typically have terms ranging from one month to six months at inception, while the majority of our financing arrangements collateralized by residential whole loans have terms of twelve months or longer.  Should a counterparty decide not to renew a financing arrangement at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable on such collateral (see Notes 6, 7 and 14).

The Company has elected the fair value option on certain of its financing agreements. These agreements are reported at their fair value, with changes in fair value being recorded in earnings each period (or other comprehensive income, to the extent

14

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

the change results from a change in instrument specific credit risk), as further detailed in Note 6. Financing costs, including “up front” fees paid at inception related to financing agreements at fair value are expensed as incurred. Interest expense is recorded based on the current interest rate in effect for the related agreement.

(k)  Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. 

The Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period, subject only to continued employment, and others of which cliff vest after a three-year period, subject to both continued employment and the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total shareholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total shareholder return over a specified period constitute a “market condition,” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.

The Company makes dividend equivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company (see Notes 2(l) and 13).

(l)  Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s dividend equivalents attached to/associated with RSUs, to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of RSUs outstanding that are unvested and have dividends that are subject to forfeiture, and for the effect of outstanding warrants, using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments (if any), are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  In addition, the Company’s Convertible Senior Notes are included in the calculation of diluted EPS if the assumed conversion into common shares is dilutive, using the “if-converted” method. This involves adding back the periodic interest expense associated with the Convertible Senior Notes to the numerator and by adding the shares that would be issued in an assumed conversion (regardless of whether the conversion option is in or out of the money) to the denominator for the purposes of calculating diluted EPS (see Note 12).

(m)  Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and terminated hedging relationships, as well as the portion of unrealized gains/(losses) on its financing agreements held at fair value related to instrument-specific credit risk, and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

15

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(n)  U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”), and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business is conducted through one or more TRS, the net taxable income earned by its domestic TRS, if any, is subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of the Company’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No net deferred tax benefit was recorded by the Company for the nine months ended September 30, 2020 and 2019, related to the net taxable losses in the TRS, since a valuation allowance for the full amount of the associated deferred tax asset of approximately $75.5 million was recognized as its recovery is not considered more likely than not. The related net operating loss carryforwards generated prior to 2018 will begin to expire in 2034; those generated in 2020, 2019 and 2018 can be carried back to each of the five taxable years preceding the taxable year of such loss and thereafter can be carried forward and do not expire.

Based on its analysis of any potentially uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2020, December 31, 2019, or September 30, 2019. As of the date of this filing the Company’s tax returns for tax years 2017 through 2019 are open to examination.

(o)  Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments have generally been comprised of Swaps, the majority of which were designated as cash flow hedges against the interest rate risk associated with its borrowings.

16

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at the inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

During the first quarter of 2020, the Company terminated all of its Swaps. Prior to their termination, Swaps were carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value was positive, or in Other liabilities, if their fair value was negative.  Changes in the fair value of the Company’s Swaps previously designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense and are treated as an operating cash flow.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate (see Notes 5(c), 7 and 14).

Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statements of operations.

(p)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its financial assets and liabilities at the time of acquisition or issuance. Subsequent changes in the fair value of these financial instruments are generally reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable (see Notes 2(b), 2(c), 3, 4 and 14).

(q)  Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without the additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) the holders of the equity investment at risk have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into several financing transactions which resulted in the Company forming entities to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the

17

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

entities used to facilitate these transactions are VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sales or should be accounted for as secured financings under GAAP (see Note 15).

The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

(r)  Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to the issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

(s)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 2020

Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which has subsequently been amended by ASUs 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2020-02 Financial Instruments-Credit Losses (Topic 326)-Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date (SEC Update), and 2020-03 Codification Improvements to Financial Instruments. The amendments in ASU 2016-13 require entities to measure all expected credit losses (rather than incurred losses) for financial assets held at the reporting date, based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The amendments in this ASU were required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The Company adopted the new ASU on January 1, 2020. The impact of adoption was that the allowance for credit losses on Purchased Performing Loans increased by approximately $8.3 million. This transition adjustment was recorded as an increase in the Company’s allowance for credit losses and an adjustment to decrease retained earnings as of the adoption date. In addition, for Purchased Credit Deteriorated Loans, the carrying value of the portfolio was adjusted on transition to include an estimate of the allowance for credit losses as required by the new standard. For financial statement reporting purposes, this adjusted carrying value is presented net of the estimated allowance for credit losses. Consequently, the adjustments recorded on transition for Purchased Credit Deteriorated Loans do not result in any adjustment to retained earnings as of the adoption date. The Company does not consider these transition adjustments to be material to its financial position or previously reported GAAP or economic book value.

Under ASU 2016-13, credit losses for available-for-sale debt securities are measured in a manner similar to prior GAAP. However, the amendments in this ASU require that credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the allowance on available-for-sale debt securities will be limited to the extent that the fair value is less than the amortized cost. Under prior GAAP, credit impairment losses were generally required to be recorded as “other than temporary” impairment, which directly reduced the carrying amount of impaired securities, and was recorded in earnings and was not reversed if expected cash flows subsequently recovered. Under the new guidance, credit impairments on such securities (other than those related to expected sales) are recorded as an allowance for credit losses that is also recorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover. Transition to the new available-for-sale debt securities guidance did not result in a change to our retained earnings.

18

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting

In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). The amendments in this ASU provide temporary optional expedients to ease the financial reporting burden of the expected transition from the London Interbank Offered Rate (“LIBOR”) to an alternative reference rate such as the Secured Overnight Financing Rate (“SOFR”). The amendments in the ASU are elective and apply to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in ASU 2020-04 were effective for all entities as of March 12, 2020 and will generally no longer be available to apply after December 31, 2022. The Company adopted this ASU as of the effective date and will utilize the optional expedients to the extent that they apply to the Company.

19

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

3.    Residential Whole Loans

Included on the Company’s consolidated balance sheets at September 30, 2020 and December 31, 2019 are approximately $5.6 billion and $7.4 billion, respectively, of residential whole loans arising from the Company’s interests in certain trusts established to acquire the loans and certain entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated for financial reporting purposes.

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2020 and December 31, 2019:

(Dollars In Thousands)	September 30, 2020		December 31, 2019
Purchased Performing Loans:
Non-QM loans	$	2,465,148	$	3,707,245
Rehabilitation loans	699,868		1,026,097
Single-family rental loans	479,070		460,742
Seasoned performing loans	147,706		176,569
Total Purchased Performing Loans	3,791,792		5,370,653
Purchased Credit Deteriorated Loans (1)	702,013		698,717
Total Residential whole loans, at carrying value	$	4,493,805	$	6,069,370
Allowance for credit losses on residential whole loans held at carrying value	(106,246)		(3,025)
Total Residential whole loans at carrying value, net	$	4,387,559	$	6,066,345
Number of loans	13,754		17,082

(1) The amortized cost basis of Purchased Credit Deteriorated Loans was increased by $62.6 million on January 1, 2020 in connection with the adoption of ASU 2016-13.

The following table presents the components of interest income on the Company’s Residential whole loans, at carrying value for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Purchased Performing Loans:
Non-QM loans	$	25,884	$	30,258	$	112,212	$	79,250
Rehabilitation loans	10,863		15,142		39,502		38,331
Single-family rental loans	6,917		5,025		21,528		11,652
Seasoned performing loans	1,945		3,166		6,799		9,461
Total Purchased Performing Loans	45,609		53,591		180,041		138,694
Purchased Credit Deteriorated Loans	8,784		10,635		27,265		33,031
Total Residential whole loans, at carrying value	$	54,393	$	64,226	$	207,306	$	171,725

20

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2020:

September 30, 2020

	Carrying Value		Amortized Cost Basis		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Weighted Average Original FICO (3)	Aging by Amortized Cost Basis
															Past Due Days
(Dollars In Thousands)													Current		30-59		60-89		90+
Purchased Performing Loans:
Non-QM loans (4)	$	2,438,395	$	2,465,148	$	2,397,247	5.87	%	352	64	%	712	$	2,174,935	$	74,231	$	52,069	$	163,913
Rehabilitation loans (4)	677,235		699,868		699,868		7.28		4	63		718	491,343		65,166		22,995		120,364
Single-family rental loans (4)	474,045		479,070		475,072		6.28		319	70		734	439,503		16,111		7,373		16,083
Seasoned performing loans (4)	147,556		147,706		161,257		3.45		173	41		723	136,622		1,406		880		8,798
Purchased Credit Deteriorated Loans (4)(5)	650,328		702,013		812,614		4.45		289	79		N/A	N/M		N/M		N/M		122,478
Residential whole loans, at carrying value, total or weighted average	$	4,387,559	$	4,493,805	$	4,546,058	5.81	%	277

December 31, 2019

	Carrying Value		Amortized Cost Basis		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Weighted Average Original FICO (3)	Aging by UPB
															Past Due Days
(Dollars In Thousands)													Current		30-59		60-89		90+
Purchased    Performing Loans:
Non-QM loans (4)	$	3,706,857	$	3,707,245	$	3,592,701	5.96	%	368	67	%	716	$	3,492,533	$	59,963	$	19,605	$	20,600
Rehabilitation loans (4)	1,023,766		1,026,097		1,026,097		7.30		8	64		717	868,281		67,747		27,437		62,632
Single-family rental loans (4)	460,679		460,741		457,146		6.29		324	70		734	432,936		15,948		2,047		6,215
Seasoned performing loans	176,569		176,569		192,151		4.24		181	46		723	187,683		2,164		430		1,874
Purchased Credit Impaired Loans (5)	698,474		698,718		873,326		4.46		294	81		N/A	N/M		N/M		N/M		108,998
Residential whole loans, at carrying value, total or weighted average	$	6,066,345	$	6,069,370	$	6,141,421	5.96	%	288

(1)Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million and $269.2 million at September 30, 2020 and December 31, 2019, respectively, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% and 69% at September 30, 2020 and December 31, 2019, respectively. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

(3)Excludes loans for which no Fair Isaac Corporation (“FICO”) score is available.

(4)At September 30, 2020 and December 31, 2019 the difference between the Carrying Value and Amortized Cost Basis represents the related allowance for credit losses.

(5)Purchased Credit Deteriorated Loans tend to be characterized by varying performance of the underlying borrowers over time, including loans where multiple months of payments are received in a period to bring the loan to current status, followed by months where no payments are received. Accordingly, delinquency information is presented for loans that are more than 90 days past due that are considered to be seriously delinquent.

No Residential whole loans, at carrying value were sold during the three months ended September 30, 2020. During the nine months ended September 30, 2020, $1.8 billion of Non-QM loans were sold, realizing losses of $273.0 million.

21

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Allowance for Credit Losses

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential Whole Loans, at Carrying Value:

	Nine Months Ended September 30, 2020
(Dollars In Thousands)	Non-QM Loans		Rehabilitation Loans (1)(2)		Single-family Rental Loans		Seasoned Performing Loans		Purchased Credit Deteriorated Loans (3)		Totals
Allowance for credit losses at December 31, 2019	$	388	$	2,331	$	62	$	—	$	244	$	3,025
Transition adjustment on adoption of ASU 2016-13 (4)	6,904		517		754		19		62,361		70,555
Current provision	26,358		33,213		6,615		230		8,481		74,897
Write-offs	—		(428)		—		—		(219)		(647)
Valuation adjustment on loans held for sale	70,181		—		—		—		—		70,181
Allowance for credit and valuation losses at March 31, 2020	$	103,831	$	35,633	$	7,431	$	249	$	70,867	$	218,011
Current provision/(reversal)	(2,297)		(5,213)		(500)		(25)		(2,579)		(10,614)
Write-offs	—		(420)		—		—		(207)		(627)
Valuation adjustment on loans held for sale	(70,181)		—		—		—		—		(70,181)
Allowance for credit losses at June 30, 2020	$	31,353	$	30,000	$	6,931	$	224	$	68,081	$	136,589
Current provision/(reversal)	(4,568)		(7,140)		(1,906)		(74)		(16,374)		(30,062)
Write-offs	(32)		(227)		—		—		(22)		(281)
Allowance for credit losses at September 30, 2020	$	26,753	$	22,633	$	5,025	$	150	$	51,685	$	106,246

	Nine Months Ended September 30, 2019
(Dollars In Thousands)	Non-QM Loans		Rehabilitation Loans		Single-family Rental Loans		Seasoned Performing Loans		Purchased Credit Deteriorated Loans		Totals
Allowance for credit losses at December 31, 2018	$	—	$	—	$	—	$	—	$	968	$	968
Current provision	—		500		—		—		183		683
Write-offs	—		—		—		—		—		—
Allowance for credit losses at March 31, 2019	$	—	$	500	$	—	$	—	$	1,151	$	1,651
Current provision	—		—		—		—		385		385
Write-offs	—		(50)		—		—		—		(50)
Allowance for credit losses at June 30, 2019	$	—	$	450	$	—	$	—	$	1,536	$	1,986
Current provision	—		—		—		—		347		347
Write-offs	—		(62)		—		—		—		(62)
Allowance for credit losses at September 30, 2019	$	—	$	388	$	—	$	—	$	1,883	$	2,271

(1)In connection with purchased Rehabilitation loans, the Company had unfunded commitments of $73.2 million, with an allowance for credit losses of $1.6 million at September 30, 2020. Such allowance is included in “Other liabilities” in the Company’s consolidated balance sheets (see Note 9).

(2)Includes $143.4 million of loans that were assessed for credit losses based on a collateral dependent methodology.

(3)Includes $72.7 million of loans that were assessed for credit losses based on a collateral dependent methodology.

(4)Of the $70.6 million of reserves recorded on adoption of ASU 2016-13, $8.3 million was recorded as an adjustment to stockholders’ equity and $62.4 million was recorded as a “gross up” of the amortized cost basis of Purchased Credit Deteriorated Loans.

The Company adopted ASU 2016-13 (“CECL”) on January 1, 2020 (see Note 2). The anticipated impact of the COVID-19 pandemic on expected economic conditions, including forecasted unemployment, home price appreciation, and prepayment rates, for the short to medium term resulted in significantly increased estimates of credit losses recorded under CECL for the first quarter of 2020 for residential whole loans held at carrying value. As of September 30, 2020, the Company

22

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

adjusted its estimates related to future rates of unemployment, which resulted in a reversal of the allowance for loan loss in the third quarter. However, the Company continues to anticipate that deteriorated market conditions will continue for an extended period, resulting in increased delinquencies and defaults compared to historical periods. Estimates of credit losses under CECL are highly sensitive to changes in assumptions and current economic conditions have increased the difficulty of accurately forecasting future conditions.

The amortized cost basis of Purchased Performing Loans on nonaccrual status as of September 30, 2020 and December 31, 2019 was $345.6 million and $99.9 million, respectively. The amortized cost basis of Purchased Credit Deteriorated Loans on nonaccrual status as of September 30, 2020 was $148.7 million. Because Purchase Credit Deteriorated Loans were previously accounted for in pools, there were no such loans on nonaccrual status as of December 31, 2019. No interest income was recognized from loans on nonaccrual status during the nine months ended September 30, 2020. At September 30, 2020, there were approximately $134.8 million of loans on nonaccrual status that did not have an associated allowance for credit losses, because they were determined to be collateral dependent and the estimated fair value of the related collateral exceeded the carrying value of each loan.

The following table presents certain additional credit-related information regarding our residential whole loans, at carrying value:

23

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

	Amortized Cost Basis by Origination Year and LTV Bands
(Dollars In Thousands)	2020		2019		2018		2017		2016		Prior		Total
Non-QM loans
LTV < 80% (1)	$	380,729	$	1,196,185	$	684,404	$	74,862	$	6,371	$	—	$	2,342,551
LTV >= 80% (1)	48,082		35,468		29,784		9,111		152		—		122,597
Total Non-QM loans	$	428,811	$	1,231,653	$	714,188	$	83,973	$	6,523	$	—	$	2,465,148
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	32	$	—	$	—	$	—	$	32
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	32	$	—	$	—	$	—	$	32
Rehabilitation loans
LTV < 80% (1)	$	36,478	$	542,865	$	93,973	$	7,546	$	—	$	—	$	680,862
LTV >= 80% (1)	1,262		15,496		548		1,700		—		—		19,006
Total Rehabilitation loans	$	37,740	$	558,361	$	94,521	$	9,246	$	—	$	—	$	699,868
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	13	$	1,030	$	32	$	—	$	—	$	1,075
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	13	$	1,030	$	32	$	—	$	—	$	1,075
Single family rental loans
LTV < 80% (1)	$	22,400	$	287,103	$	140,017	$	13,356	$	—	$	—	$	462,876
LTV >= 80% (1)	1,394		14,588		212		—		—		—		16,194
Total Single family rental loans	$	23,794	$	301,691	$	140,229	$	13,356	$	—	$	—	$	479,070
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Seasoned performing loans
LTV < 80% (1)	$	—	$	—	$	—	$	—	$	79	$	139,538	$	139,617
LTV >= 80% (1)	—		—		—		—		—		8,089		8,089
Total Seasoned performing loans	$	—	$	—	$	—	$	—	$	79	$	147,627	$	147,706
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Purchased credit deteriorated loans
LTV < 80% (1)	$	—	$	—	$	—	$	633	$	2,982	$	420,265	$	423,880
LTV >= 80% (1)	—		—		—		—		3,184		274,950		278,134
Total Purchased credit deteriorated loans	$	—	$	—	$	—	$	633	$	6,166	$	695,215	$	702,014
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	448	$	448
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	448	$	448
Total LTV < 80% (1)	$	439,607	$	2,026,153	$	918,394	$	96,397	$	9,432	$	559,803	$	4,049,786
Total LTV >= 80% (1)	50,738		65,552		30,544		10,811		3,336		283,039		444,020
Total residential whole loans, at carrying value	$	490,345	$	2,091,705	$	948,938	$	107,208	$	12,768	$	842,842	$	4,493,806
Total Gross write-offs	$	—	$	13	$	1,062	$	32	$	—	$	448	$	1,555
Total Recoveries	—		—		—		—		—		—		—
Total Net write-offs	$	—	$	13	$	1,062	$	32	$	—	$	448	$	1,555

(1)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million at September 30, 2020, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% at September 30, 2020. Certain low value loans secured by vacant lots are categorized as LTV >= 80%.

24

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Residential Whole Loans, at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Less than 60 Days Past Due:
Outstanding principal balance	$	599,461		$	666,026
Aggregate fair value	$	577,761		$	641,616
Weighted Average LTV Ratio (1)	74.33		%	76.69		%
Number of loans	3,038			3,159
60 Days to 89 Days Past Due:
Outstanding principal balance	$	55,183		$	58,160
Aggregate fair value	$	49,188		$	53,485
Weighted Average LTV Ratio (1)	83.62		%	79.48		%
Number of loans	259			313
90 Days or More Past Due:
Outstanding principal balance	$	679,211		$	767,320
Aggregate fair value	$	602,715		$	686,482
Weighted Average LTV Ratio (1)	87.82		%	89.69		%
Number of loans	2,532			2,983
Total Residential whole loans, at fair value	$	1,229,664		$	1,381,583

(1)LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

The following table presents the components of Net gain/(loss) on residential whole loans measured at fair value through earnings for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Coupon payments, realized gains, and other income received (1)	$	17,477	$	22,202	$	54,684	$	67,966
Net unrealized gains/(losses)	58,863		13,185		(13,683)		33,312
Net gain on transfers to REO	531		4,788		3,430		15,637
Total	$	76,871	$	40,175	$	44,431	$	116,915

(1)Primarily includes gains on liquidation of non-performing loans, including the recovery of delinquent interest payments, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.

During the nine months ended September 30, 2020, loans at fair value with an aggregate unpaid principal balance of $24.1 million were sold, realizing net losses of $0.8 million.

25

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

4.                   Residential Mortgage Securities and MSR-Related Assets

Agency and Non-Agency MBS

MBS investments held as of September 30, 2020 or in prior periods include Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by: (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”), which have interest rates that reset annually or more frequently (collectively, “ARM-MBS”); and (iii) 15 and 30 year fixed-rate mortgages for Agency MBS and, for Non-Agency MBS, 30-year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS backed by securitized re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are generally structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements (see Note 7).

Agency MBS:  Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities. The Company sold its remaining holdings of Agency MBS during the quarter ended June 30, 2020.

Non-Agency MBS:  The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral. During the quarter ended June 30, 2020, the Company had sold substantially all of its holdings of Legacy Non-Agency MBS and substantially reduced its holdings of other Non-Agency MBS. The Company sold its remaining Legacy Non-Agency MBS during the quarter ended September 30, 2020.

CRT Securities

CRT securities are debt obligations issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the issuer and the principal payments received are dependent on the performance of loans in either a reference pool or an actual pool of loans. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company. The Company assesses the credit risk associated with its investments in CRT securities by assessing the current and expected future performance of the associated loan pool. The Company pledges a portion of its CRT securities as collateral against its borrowings under repurchase agreements (see Note 7).

26

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following tables present certain information about the Company’s residential mortgage securities at September 30, 2020 and December 31, 2019:

September 30, 2020

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts		Discount Designated as Credit Reserve (1)		Gross Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Net Unrealized Gain/(Loss)		Fair  Value
Non-Agency MBS (2)(3)(4)	$	60,295	$	—	$	(8,246)	$	(669)	$	51,380	$	8,015	$	(2,965)	$	5,050	$	56,430
CRT securities (5)	104,163		2,414		(69)		(20,768)		85,740		13,722		(3,127)		10,595		96,335
Total residential mortgage securities	$	164,458	$	2,414	$	(8,315)	$	(21,437)	$	137,120	$	21,737	$	(6,092)	$	15,645	$	152,765

December 31, 2019

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts		Discount Designated as Credit Reserve (1)		Gross Amortized Cost (6)		Gross Unrealized Gains		Gross Unrealized Losses		Net Unrealized Gain/(Loss)		Fair Value
Agency MBS: (7)
Fannie Mae	$	1,119,708	$	43,249	$	(22)	$	—	$	1,162,935	$	9,799	$	(14,741)	$	(4,942)	$	1,157,993
Freddie Mac	480,879		19,468		—		—		500,961		5,475		(3,968)		1,507		502,468
Ginnie Mae	3,996		73		—		—		4,069		52		—		52		4,121
Total Agency MBS	1,604,583		62,790		(22)		—		1,667,965		15,326		(18,709)		(3,383)		1,664,582
Non-Agency MBS:
Expected to Recover Par (2)(3)	722,477		—		(16,661)		—		705,816		19,861		(9)		19,852		725,668
Expected to Recover Less than Par (2)	1,472,826		—		(73,956)		(436,598)		962,272		375,598		(9)		375,589		1,337,861
Total Non-Agency MBS (4)	2,195,303		—		(90,617)		(436,598)		1,668,088		395,459		(18)		395,441		2,063,529
Total MBS	3,799,886		62,790		(90,639)		(436,598)		3,336,053		410,785		(18,727)		392,058		3,728,111
CRT securities (5)	244,932		4,318		(55)		—		249,195		6,304		(91)		6,213		255,408
Total residential mortgage securities	$	4,044,818	$	67,108	$	(90,694)	$	(436,598)	$	3,585,248	$	417,089	$	(18,818)	$	398,271	$	3,983,519

(1)Discount designated as Credit Reserve is generally not expected to be accreted into interest income.

(2)Based on management’s current estimates of future principal cash flows expected to be received.

(3)Includes RPL/NPL MBS, which at September 30, 2020 had an $57.4 million Principal/Current face, $49.2 million amortized cost and $53.8 million fair value. At December 31, 2019, RPL/NPL MBS had a $632.3 million Principal/Current face, $631.8 million amortized cost and $635.0 million fair value.

(4)At September 30, 2020 and December 31, 2019, the Company expected to recover approximately 99% and 80% of the then-current face amount of Non-Agency MBS, respectively.

(5)Amounts disclosed at September 30, 2020 includes CRT securities with a fair value of $63.3 million for which the fair value option has been elected. Such securities had $410,000 gross unrealized gains and gross unrealized losses of approximately $3.1 million at September 30, 2020. Amounts disclosed at December 31, 2019 includes CRT securities with a fair value of $255.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $6.3 million and gross unrealized losses of approximately $91,000 at December 31, 2019.

(6)Includes principal payments receivable of $614,000 at December 31, 2019, which is not included in the Principal/Current Face.

(7)Amounts disclosed at December 31, 2019 include Agency MBS with a fair value of $280.3 million, for which the fair value option has been elected. Such securities had $4.5 million unrealized gains and no gross unrealized losses at December 31, 2019, respectively.

27

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Sales of Residential Mortgage Securities

The following table presents information about the Company’s sales of its residential mortgage securities for the three and nine months ended September 30, 2020 and 2019. The Company has no continuing involvement with any of the sold securities.

	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
(In Thousands)	Sales Proceeds		Gains/(Losses)		Sales Proceeds		Gains/(Losses)
Agency MBS	$	—	$	—	$	257,289	$	2,771
Non-Agency MBS	116		48		47,867		14,444
CRT Securities	—		—		28,969		493
Total	$	116	$	48	$	334,125	$	17,708

	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
(In Thousands)	Sales Proceeds		Gains/(Losses)		Sales Proceeds		Gains/(Losses)
Agency MBS	$	1,500,875	$	(19,291)	$	360,634	$	499
Non-Agency MBS	1,318,958		107,999		244,778		41,420
CRT Securities	243,025		(27,011)		133,507		8,108
Total	$	3,062,858	$	61,697	$	738,919	$	50,027

Unrealized Losses on Residential Mortgage Securities

The following table presents information about the Company’s residential mortgage securities that were in an unrealized loss position at September 30, 2020, with respect to which no allowance for credit losses has been recorded:

Unrealized Loss Position For:

	Less than 12 Months					12 Months or more					Total
	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
(Dollars in Thousands)
Non-Agency MBS (1)	$	44,927	$	2,965	5	$	—	$	—	—	$	44,927	$	2,965
CRT securities (2)	59,553		3,127		8	—		—		—	59,553		3,127
Total residential mortgage securities	$	104,480	$	6,092	13	$	—	$	—	—	$	104,480	$	6,092

(1)Based on management’s current estimates of future principal cash flows expected to be received.

(2)Amounts disclosed at September 30, 2020 include CRT securities with a fair value of $59.6 million for which the fair value option has been elected. Such securities had unrealized losses of $3.1 million at September 30, 2020.

During the three months ended March 31, 2020, the Company recognized an impairment loss related to its Non-Agency MBS of $63.5 million based on its intent to sell, or the likelihood it will be required to sell, its remaining securities.

Gross unrealized losses on the Company’s Non-Agency MBS were $3.0 million at September 30, 2020. Based upon the most recent evaluation, the Company does not consider these unrealized losses to require an allowance for credit losses and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities that require an allowance for credit losses based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.

The Company did not recognize an allowance for credit losses (or other than temporary impairment in prior year periods) through earnings related to its Non-Agency MBS during the three and nine months ended September 30, 2020 and 2019.

28

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential mortgage securities and MSR-related assets:

	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars In Thousands)	2020		2019		2020		2019
Allowance for credit losses at beginning of period	$	—	$	—	$	—	$	—
Current provision:	—		—		—		—
Securities with no prior loss allowance	—		—		344,269		—
Securities with a prior loss allowance	—		—		—		—
Write-offs, including allowance related to securities the Company intends to sell	—		—		(344,269)		—
Allowance for credit losses at end of period	$	—	$	—	$	—	$	—

29

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Purchase Discounts on Non-Agency MBS

The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and accretable purchase discount for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
(In Thousands)	Discount Designated as Credit Reserve		Accretable Discount (1)		Discount Designated as Credit Reserve		Accretable Discount (1)
Balance at beginning of period	$	(669)	$	(8,430)	$	(479,566)	$	(117,753)
Accretion of discount	—		7		—		10,357
Realized credit losses	—		—		4,062		—
Sales/Redemptions	—		177		12,479		6,029
Transfers/release of credit reserve	—		—		930		(930)
Balance at end of period	$	(669)	$	(8,246)	$	(462,095)	$	(102,297)

	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
(In Thousands)	Discount Designated as Credit Reserve		Accretable Discount (1)		Discount Designated as Credit Reserve		Accretable Discount (1)
Balance at beginning of period	$	(436,598)	$	(90,617)	$	(516,116)	$	(155,025)
Impact of RMBS Issuer Settlement (2)	—		—		—		(1,688)
Accretion of discount	—		10,827		—		38,215
Realized credit losses	5,868		—		21,482		—
Purchases	—		—		(624)		291
Sales/Redemptions	436,885		76,233		23,842		25,231
Net impairment losses recognized in earnings	(11,513)		—		—		—
Transfers/release of credit reserve	4,689		(4,689)		9,321		(9,321)
Balance at end of period	$	(669)	$	(8,246)	$	(462,095)	$	(102,297)

(1)Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2)Includes the impact of $1.7 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2019 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

MSR-Related Assets

(a) Term Notes Backed by MSR-Related Collateral

At September 30, 2020 and December 31, 2019, the Company had $234.1 million and $1.2 billion, respectively, of term notes issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered to be largely dependent on cash flows generated by the underlying MSRs, as this impacts the cash flows available to the SPV that issued the term notes.

30

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

At September 30, 2020, these term notes had an amortized cost of $184.5 million, gross unrealized gains of $49.5 million, a weighted average yield of 12.1% and a weighted average term to maturity of 9.5 years. During the nine months ended September 30, 2020, the Company sold certain term notes for $711.7 million, realizing gains of $28.7 million, respectively. During the three months ended March 31, 2020, the Company recognized an impairment loss related to its term notes of $280.8 million based on its intent to sell, or the likelihood it will be required to sell, such notes. At December 31, 2019, the term notes had an amortized cost of $1.2 billion, gross unrealized gains of $5.2 million, a weighted average yield of 4.75% and a weighted average term to maturity of 5.3 years.

(b) Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are secured by MSRs, as well as certain other unencumbered assets owned by the borrower.

The Company has participated in a loan where the Company committed to lend $32.6 million of which approximately $18.1 million was drawn at September 30, 2020. At September 30, 2020, the coupon paid by the borrower on the drawn amount is 5.52%. The facility expires in 11 months. During the remaining commitment period, the Company receives a commitment fee between 0.25% and 1.0% based on the undrawn amount of the loan.

Impact of AFS Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	52,889	$	439,898	$	392,722	$	417,167
Unrealized gain/(loss) on Agency MBS, net	—		603		(161)		22,483
Unrealized gain on Non-Agency MBS, net	5,998		2,856		360,315		22,211
Unrealized gain on MSR term notes, net	9,084		2,024		48,431		5,391
Reclassification adjustment for MBS sales included in net income	(60)		(14,499)		(389,127)		(36,370)
Reclassification adjustment for impairment included in net income	—		—		(344,269)		—
Change in AOCI from AFS securities	15,022		(9,016)		(324,811)		13,715
Balance at end of period	$	67,911	$	430,882	$	67,911	$	430,882

31

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Interest Income on Residential Mortgage Securities and MSR-Related Assets

The following table presents the components of interest income on the Company’s residential mortgage securities and MSR- related assets for the three and nine months ended September 30, 2020 and 2019: 

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Agency MBS
Coupon interest	$	—	$	18,994	$	14,038	$	66,560
Effective yield adjustment (1)	—		(7,188)		(5,186)		(21,039)
Interest income	$	—	$	11,806	$	8,852	$	45,521
Legacy Non-Agency MBS
Coupon interest	$	42	$	21,011	$	18,222	$	68,144
Effective yield adjustment (2)(3)	6		10,336		10,564		38,003
Interest income	$	48	$	31,347	$	28,786	$	106,147
RPL/NPL MBS
Coupon interest	$	811	$	13,227	$	7,622	$	44,305
Effective yield adjustment (1)(4)	94		8		449		158
Interest income	$	905	$	13,235	$	8,071	$	44,463
CRT securities
Coupon interest	$	956	$	5,174	$	6,063	$	16,769
Effective yield adjustment (2)	420		(923)		(94)		(1,224)
Interest income	$	1,376	$	4,251	$	5,969	$	15,545
MSR-related assets
Coupon interest	$	2,991	$	15,273	$	23,332	$	38,230
Effective yield adjustment (1)(2)	3,250		1		6,857		2
Interest income	$	6,241	$	15,274	$	30,189	$	38,232

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.

(2) The effective yield adjustment is the difference between the net income calculated using the net yield less the current coupon yield. The net yield may be based on management’s estimates of the amount and timing of future cash flows or on the instrument’s contractual cash flows, depending on the relevant accounting standard.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $3.1 million during the nine months ended September 30, 2019.

(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $4,000 during the three months ended September 30, 2019 and $277,000 and $152,000 during the nine months ended September 30, 2020 and 2019, respectively.

32

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

5.    Other Assets

The following table presents the components of the Company’s Other assets at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
REO (1)	$	298,866	$	411,659
Capital contributions made to loan origination partners	108,887		147,992
Other interest-earning assets	45,442		70,468
Interest receivable	42,723		70,986
Other MBS and loan related receivables	36,342		43,842
Other	39,354		39,304
Total Other Assets	$	571,614	$	784,251

(1)    Includes $59.3 million and $27.3 million of REO that is held-for-investment at September 30, 2020 and December 31, 2019, respectively.

(a) Real Estate Owned

At September 30, 2020, the Company had 1,131 REO properties with an aggregate carrying value of $298.9 million. At December 31, 2019, the Company had 1,652 REO properties with an aggregate carrying value of $411.7 million.

At September 30, 2020, $295.7 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $132.5 million of residential whole loans held at carrying value and $487.3 million of residential whole loans held at fair value at September 30, 2020.

The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Balance at beginning of period	$	348,516	$	334,069	$	411,659	$	249,413
Adjustments to record at lower of cost or fair value	93		(3,875)		(11,796)		(9,264)
Transfer from residential whole loans (1)	15,672		61,888		74,891		193,531
Purchases and capital improvements, net	536		5,108		9,334		16,307
Disposals (2)	(65,951)		(20,990)		(185,222)		(73,787)
Balance at end of period	$	298,866	$	376,200	$	298,866	$	376,200
Number of properties	1,131		1,508		1,131		1,508

(1)Includes net gain recorded on transfer of approximately $834,000 and $5.0 million for the three months ended September 30, 2020 and 2019, respectively; and approximately $4.1 million and $16.1 million for nine months ended September 30, 2020 and 2019, respectively.

(2)During the three and nine months ended September 30, 2020, the Company sold 267 and 812 REO properties for consideration of $69.9 million and $195.2 million, realizing net gains of approximately $3.9 million and $10.0 million, respectively. During the three and nine months ended September 30, 2019, the Company sold 142 and 431 REO properties for consideration of $23.0 million and $80.0 million, realizing net gains of approximately $2.1 million and $5.8 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations.

33

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(b) Capital Contributions Made to Loan Origination Partners

The Company has made investments in several loan originators as part of its strategy to be a reliable source of capital to select partners from whom it sources residential mortgage loans through both flow arrangements and bulk purchases. To date, such contributions of capital include the following investments (based on their carrying value prior to any impairments): $31.0 million of common equity, $68.0 million of preferred equity and $75.0 million of convertible notes. In addition, for certain partners, options or warrants may have also been acquired that provide the Company the ability to increase the level of its investment if certain conditions are met. At the end of each reporting period, or earlier if circumstances warrant, the Company evaluates whether the nature of its interests and other involvement with the investee entity requires the Company to apply equity method accounting or consolidate the results of the investee entity with the Company’s financial results. To date, the nature of the Company’s interests and/or involvement with investee companies has not resulted in consolidation. Further, to the extent that the nature of the Company’s interests has resulted in the need for the Company to apply equity method accounting, the impact of such accounting on the Company’s results for periods subsequent to that in which the Company was determined to have significant influence over the investee company was not material for any period. As the interests acquired to date by the Company generally do not have a readily determinable fair value, the Company accounts for its non-equity method interests (including any acquired options and warrants) in loan originators initially at cost. The carrying value of these investments is adjusted if it is determined that an impairment has occurred or if there has been a subsequent observable transaction in either the investee company’s equity securities or a similar security that provides evidence to support an adjustment to the carrying value. Following an evaluation of the anticipated impact of the COVID-19 pandemic on economic conditions for the short to medium term, the Company recorded impairment charges of $65.2 million on investments in certain loan origination partners during the nine months ended September 30, 2020, respectively, which was included in “Impairment and other losses on securities available-for-sale and other assets” on the consolidated statements of operations. The Company did not record any impairment charges on investments in certain loan origination partners during the three months ended September 30, 2020. At September 30, 2020, approximately $840.5 million of the Company’s Residential whole loans, at carrying value were serviced by entities in which the Company has an investment.

34

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(c) Derivative Instruments

The Company’s derivative instruments have generally been comprised of Swaps, the majority of which were designated as cash flow hedges against the interest rate risk associated with certain borrowings. In addition, in connection with managing risks associated with purchases of longer duration Agency MBS, the Company has also entered into Swaps that are not designated as hedges for accounting purposes.

In response to the turmoil in the financial markets resulting from the COVID-19 pandemic experienced during the three months ended March 31, 2020, the Company unwound all of its approximately $4.1 billion of Swap hedging transactions late in the first quarter in order to recover previously posted margin. Gains or losses associated with these Swap hedging transactions are required to be transferred from AOCI to earnings over the original term of the Swap, if the underlying hedged item or transactions are assessed as probable of occurring. After the closing of several new financing transactions late in the quarter ended June 30, 2020, the Company evaluated its anticipated future financing requirements. The Company concluded that it was no longer probable that certain previously used financing strategies, including those that primarily utilized repurchase agreements with funding costs that reset on a monthly basis, would be used by the Company on an ongoing basis, as this financing strategy had been essentially replaced by the new financing transactions. Consequently, the Company concluded that it was appropriate to transfer from AOCI to earnings approximately $49.9 million of losses on Swaps that had previously been designated as hedges for accounting purposes, because the hedged transactions were no longer considered probable to occur. In addition, during the quarter ended September 30, 2020, the Company transferred from AOCI to earnings approximately $7.2 million of losses on Swaps that had been previously designated as hedges for accounting purposes as the Company had assessed that the underlying transactions were no longer probable of occurring. These amounts are included in Other income, net on the Company’s consolidated statements of operations. At September 30, 2020, there are no remaining losses included in AOCI on Swaps previously designated as hedges for accounting purposes.

The following table presents the fair value of the Company’s derivative instruments at September 30, 2020 and December 31, 2019:

		September 30, 2020				December 31, 2019
Derivative Instrument (1)	Designation	Notional Amount		Fair Value		Notional Amount		Fair Value
(In Thousands)
Swaps	Hedging	$	—	$	—	$	2,942,000	$	—
Swaps	Non-Hedging	$	—	$	—	$	230,000	$	—

(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Swaps

The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
Agency MBS, at fair value	$	—	$	2,241
Restricted cash	—		16,777
Total assets pledged against Swaps	$	—	$	19,018

35

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents information about the Company’s Swaps at September 30, 2020 and December 31, 2019:

	September 30, 2020						December 31, 2019
	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
Maturity (1)
(Dollars in Thousands)
Over 3 months to 6 months	$	—	—	%	—	%	$	200,000	2.05	%	1.70	%
Over 6 months to 12 months	—		—		—		1,430,000		2.30		1.77
Over 12 months to 24 months	—		—		—		1,300,000		2.11		1.86
Over 24 months to 36 months	—		—		—		20,000		1.38		1.90
Over 36 months to 48 months	—		—		—		222,000		2.88		1.84
Total Swaps	$	—	—	%	—	%	$	3,172,000	2.24	%	1.81	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

The following table presents the net impact of the Company’s derivative hedging instruments on its net interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,						Nine Months Ended September 30,
(Dollars in Thousands)	2020			2019			2020			2019
Interest (expense)/income attributable to Swaps	$	—		$	(322)		$	(3,359)		$	1,561
Weighted average Swap rate paid	—		%	2.29		%	2.06		%	2.32		%
Weighted average Swap rate received	—		%	2.24		%	1.63		%	2.40		%

During the nine months ended September 30, 2020, the Company recorded net losses on Swaps not designated in hedging relationships of approximately $4.3 million, which included $9.4 million of losses realized on the unwind of certain Swaps. During the three and nine months ended September 30, 2019, the Company recorded net losses on Swaps not designated in hedging relationships of approximately $929,000 and $17.3 million, respectively, which included $3.7 million and $17.7 million of losses realized on the unwind of certain Swaps. These amounts are included in Other income, net on the Company’s consolidated statements of operations.

Impact of Derivative Hedging Instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
AOCI from derivative hedging instruments:
Balance at beginning of period	$	(7,176)	$	(28,114)	$	(22,675)	$	3,121
Net loss on Swaps	—		(233)		(50,127)		(30,384)
Reclassification adjustment for losses/gains related to hedging instruments included in net income	7,176		(685)		72,802		(1,769)
Balance at end of period	$	—	$	(29,032)	$	—	$	(29,032)

36

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

6.      Financing Agreements

The following tables present the components of the Company’s Financing agreements at September 30, 2020 and December 31, 2019:

	September 30, 2020
(In Thousands)	Unpaid Principal Balance		Amortized Cost Balance		Fair Value/Carrying Value(1)
Financing agreements, at fair value
Agreements with non-mark-to-market collateral provisions	$	1,723,959	$	1,723,959	$	1,727,407
Agreements with mark-to-market collateral provisions	1,489,097		1,489,097		1,490,271
Senior secured credit agreement	481,250		462,923		473,993
Securitized debt	389,051		380,407		388,790
Total Financing agreements, at fair value	$	4,083,357	$	4,056,386	$	4,080,461
Other financing agreements
Securitized debt	$	451,197			$	448,893
Convertible senior notes	230,000				224,867
Senior notes	100,000				96,900
Total Financing agreements at carrying value	$	781,197			$	770,660
Total Financing agreements	$	4,864,554			$	4,851,121

(1)    Financing agreements at fair value are reported at estimated fair value each period as a result of the Company’s fair value option election. Other financing arrangements are reported at their carrying value (amortized cost basis) as the fair value option was not elected on these liabilities. Consequently, Total Financing agreements as presented reflects a summation of balances reported at fair value and carrying value.

Set out below is information about the Company’s Financing agreements that existed as of December 31, 2019. During the second quarter of 2020, outstanding repurchase agreement transactions at that time were renegotiated as part of a reinstatement agreement that was entered into by the Company. The Company elected to account for these reinstated transactions under the fair value option from the time these repurchase agreements were reinstated. Accordingly, as of September 30, 2020, such liabilities are reported as Financing agreements at fair value.

	December 31, 2019
(In Thousands)	Unpaid Principal Balance		Carrying Value
Repurchase agreements	$	9,140,944	$	9,139,821
Securitized debt	573,900		570,952
Convertible senior notes	230,000		223,971
Senior notes	100,000		96,862
Total Financing agreements at carrying value	$	10,044,844	$	10,031,606

(a) Financing Agreements, at Fair Value

During the second quarter of 2020, the Company entered into a $500 million senior secured credit agreement. In addition, in conjunction with its exit from forbearance arrangements, the Company entered into several new asset backed financing arrangements and renegotiated financing arrangements for certain assets with existing lenders, that resulted in the Company essentially refinancing the majority of its investment portfolio. The Company elected the fair value option on these financing

37

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

arrangements, primarily to simplify the accounting associated with costs incurred to establish the new facilities or renegotiate existing facilities.

The Company considers that the most relevant feature that distinguishes between the various asset backed financing arrangements is how the financing arrangement is collateralized, including the ability of the lender to make margin calls on the Company based on changes in value of the underlying collateral securing the financing. Accordingly, further details are provided below regarding assets that are financed with agreements that have non-mark-to-market collateral provisions and assets that are financed with agreements that have mark-to-market collateral provisions.

Agreements with non-mark-to-market collateral provisions

The Company and certain of its subsidiaries entered into a non-mark-to-market term loan facility with certain lenders to finance an aggregate amount of up to $1.65 billion. The Company’s borrowing subsidiaries have pledged, as collateral security for the facility, certain of their residential whole loans (excluding Rehabilitation loans), as well as the equity in subsidiaries that own the loans. The facility has an initial term of two years, which may be extended for up to an additional three years, subject to certain conditions, including the payment of an extension fee and provided that no events of default have occurred. For the initial two year term, the financing cost for the facility will be calculated at a spread over the lender’s financing cost, which, depending on the lender, is expected to be based either on three-month LIBOR, or an index that it expected over time to be closely correlated to changes in three-month LIBOR. At September 30, 2020, the amount financed under this facility was approximately $1.4 billion.

In addition, the Company also entered into non-mark-to-market financing facilities on Rehabilitation loans. Under these facilities, Rehabilitation loans, as well as the equity in subsidiaries that own the loans, are pledged as collateral. The facilities have a two year term and the financing cost is calculated at a spread over three-month LIBOR. At September 30, 2020, the amount financed under these facilities was approximately $359.0 million.

The following table presents information with respect to the Company’s financing agreements with non-mark-to-market collateral provisions and associated assets pledged as collateral at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Non-mark-to-market financing secured by residential whole loans at carrying value	$	1,471,269		$	—
Fair value of residential whole loans at carrying value pledged as collateral under financing agreements	$	2,323,085		$	—
Weighted average haircut on residential whole loans at carrying value	41.91		%	—		%
Non-mark-to-market financing secured by residential whole loans at fair value	$	256,138		$	—
Fair value of residential whole loans at fair value pledged as collateral under financing agreements	$	435,081		$	—
Weighted average haircut on residential whole loans at fair value	41.25		%	—		%

Agreements with mark-to-market collateral provisions

In addition to entering into the financing arrangements discussed above, the Company also entered into a reinstatement agreement with certain lending counterparties that facilitated its exit from the forbearance arrangements that the Company had previously entered into. In connection with the reinstatement agreement, terms of its prior financing arrangements on certain residential whole loans, residential mortgage securities, and MSR-related assets were renegotiated and those arrangements were reinstated on a go-forward basis. These financing arrangements continue to contain mark-to-market provisions that permit the lending counterparties to make margin calls on the Company should the value of the pledged collateral decline. The Company is also permitted to recover previously posted margin payments, should values of the pledged collateral subsequently increase. These facilities generally have a maturity ranging from one to three months and can be renewed at the discretion of the lending counterparty at financing costs reflecting prevailing market pricing. At September 30, 2020, the amount financed under these agreements was approximately $1.5 billion.

38

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents information with respect to the Company’s financing agreements with mark-to-market collateral provisions and associated assets pledged as collateral at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Mark-to-market financing agreements secured by residential whole loans (1)	$	1,231,734		$	4,743,094
Fair value of residential whole loans pledged as collateral under financing agreements (2)	$	2,002,903		$	5,986,267
Weighted average haircut on residential whole loans (3)	30.88		%	20.07		%
Mark-to-market financing agreement borrowings secured by Agency MBS	$	—		$	1,557,675
Fair value of Agency MBS pledged as collateral under financing agreements	$	—		$	1,656,373
Weighted average haircut on Agency MBS (3)	—		%	4.46		%
Mark-to-market financing agreement borrowings secured by Legacy Non-Agency MBS	$	1,282		$	1,121,802
Fair value of Legacy Non-Agency MBS pledged as collateral under financing agreements	$	2,621		$	1,420,797
Weighted average haircut on Legacy Non-Agency MBS (3)	50.00		%	20.27		%
Mark-to-market financing agreement borrowings secured by RPL/NPL MBS	$	32,950		$	495,091
Fair value of RPL/NPL MBS pledged as collateral under financing agreements	$	53,809		$	635,005
Weighted average haircut on RPL/NPL MBS (3)	38.75		%	21.52		%
Mark-to-market financing agreements secured by CRT securities	$	54,883		$	203,569
Fair value of CRT securities pledged as collateral under financing agreements	$	96,336		$	252,175
Weighted average haircut on CRT securities (3)	42.47		%	18.84		%
Mark-to-market financing agreements secured by MSR-related assets	$	135,340		$	962,515
Fair value of MSR-related assets pledged as collateral under financing agreements	$	252,183		$	1,217,002
Weighted average haircut on MSR-related assets (3)	39.87		%	21.18		%
Mark-to-market financing agreements secured by other interest-earning assets	$	34,082		$	57,198
Fair value of other interest-earning assets pledged as collateral under financing agreements	$	44,079		$	61,708
Weighted average haircut on other interest-earning assets (3)	25.00		%	22.01		%

(1)Excludes $0 and $1.1 million of unamortized debt issuance costs at September 30, 2020 and December 31, 2019, respectively.

(2)At September 30, 2020 and December 31, 2019, includes RPL/NPL MBS with an aggregate fair value of $192.7 million and $238.8 million, respectively, obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

(3) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

In addition, the Company had cash pledged as collateral in connection with its financing agreements of $5.3 million and $25.2 million at September 30, 2020 and December 31, 2019, respectively.

39

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents repricing information (excluding the impact of associated derivative hedging instruments, if any) about the Company’s financing agreements that have non-mark-to-market collateral provisions as well as those that have mark-to-market collateral provisions, at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
	Amortized Cost Basis		Weighted Average Interest Rate		Amortized Cost Basis		Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)
Within 30 days	$	2,932,213	3.36	%	$	4,472,120	2.55	%
Over 30 days to 3 months	—		—		2,746,384		3.43
Over 3 months to 12 months	280,843		3.02		1,014,441		3.36
Over 12 months	—		—		907,999		3.44
Total financing agreements	$	3,213,056	3.33	%	$	9,140,944	2.99	%
Less debt issuance costs	—				1,123
Total financing agreements less debt issuance costs	$	3,213,056			$	9,139,821

40

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The Company had financing agreements, including repurchase agreements and other forms of secured financing with 8 and 28 counterparties at September 30, 2020 and December 31, 2019, respectively. The following table presents information with respect to each counterparty under financing agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2020:

	September 30, 2020
	Counterparty Rating (1)	Amount  at Risk (2)		Weighted  Average Months  to Repricing for Repurchase Agreements	Percent of Stockholders’ Equity
Counterparty
(Dollars in Thousands)
Barclays Bank	BBB/Aa3/A	$	750,922	1	29.3	%
Credit Suisse	BBB+/Baa2/A-	574,835		1	22.4
Wells Fargo	A+/Aa2/AA-	349,825		1	13.6
Goldman Sachs (3)	BBB+/A3/A	173,266		3	6.8
Athene (4)	BBB+/N/A/BBB+	144,245		1	5.6

(1)As rated at September 30, 2020 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2)The amount at risk reflects the difference between (a) the amount loaned to the Company through financing agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3)Includes $20.6 million at risk with Goldman Sachs and $152.7 million at risk with Goldman Sachs Bank USA.

(4)Includes amounts at risk with various Athene affiliates that collectively exceed 5% of stockholders’ equity.

Senior Secured Term Loan Facility

The Company entered into a $500 million senior secured term loan facility (the “Term Loan Facility”) with certain funds, accounts and/or clients managed by affiliates of Apollo Global Management, Inc. and affiliates of Athene Holding Ltd.

The term loans were issued with original issue discount of 1%. Interest on the outstanding principal amount of the term loans will accrue at a rate of 11% per annum until the third anniversary of the original funding date. Prior to the third anniversary of the funding date, a portion of such interest, in an amount equal to up to 3% per annum, may be capitalized, compounded and added to the unpaid principal amount of the term loans. The interest rate on the term loans will increase by 1% per annum on the third anniversary of the funding date and by an additional 1% per annum on each subsequent anniversary of the funding date. Upon the occurrence and during the continuance of an event of default under the Term Loan Facility, the principal amount of all loans outstanding and, to the extent permitted by applicable law, any interest payments on such term loans or any fees or other amounts owing under the Term Loan Facility that, in either case, are then overdue, would thereafter bear interest at a rate that is 2% per annum in excess of the interest rate otherwise payable on the term loans.

The Company is permitted to voluntarily prepay the amount borrowed under the Term Loan Facility in full at any time without penalty. In addition, the Company may partially prepay the amount borrowed on only one occasion without penalty, provided such partial prepayment be in an amount of not less than $250 million. Installment payments of principal equal to 3.75% of the initial principal amount for the first three years of the Term Loan Facility and 4.50% of the initial principal amount thereafter, together with accrued and unpaid interest on such principal amount, will be required to be made on the last business day of each March, June, September and December beginning on September 30, 2020. Mandatory prepayments of the term loans are required to be made from net cash proceeds received in connection with certain events, that are set out in the credit agreement. Upon the event of a change in control as defined in the credit agreement, the Company is also required to make an offer to repay the loan at par, plus unpaid accrued interest, plus a specified redemption premium. In addition, the Company is required to comply with certain affirmative and negative covenants as specified in the Term Loan Facility that, among other things, impose certain limitations on the Company to incur liens or indebtedness, to make certain investments or enter into new businesses, to modify or waive terms on certain of the Company’s existing debt or to prepay such debt, or to pay dividends in certain circumstances. The Company must also maintain a minimum level of liquidity as defined in the Term Loan Facility. Subsequent to the end of the third quarter, the outstanding balance of the Term Loan Facility was repaid and the Term Loan Facility was terminated. Refer to note 16 for further discussion.

41

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(b) Other Financing Agreements

These arrangements were either entered into prior to the Company experiencing financial difficulties related to the COVID-19 pandemic, or, in the case of the Company’s most recent securitization, after the Company’s exit from forbearance, and were not subject to the forbearance arrangements that were entered into by the Company or any negotiations related to the Company’s exit from those arrangements.

Additional information regarding the Company’s Other financing arrangements as of September 30, 2020, is included below:

Securitized Debt

Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. The weighted average fixed rate on the securitized debt was 2.93% at September 30, 2020 (see Notes 10 and 15 for further discussion).

Convertible Senior Notes

On June 3, 2019, the Company issued $230.0 million in aggregate principal amount of its Convertible Senior Notes in an underwritten public offering, including an additional $30.0 million issued pursuant to the exercise of the underwriters’ option to purchase additional Convertible Senior Notes. The total net proceeds the Company received from the offering were approximately $223.3 million, after deducting offering expenses and the underwriting discount.  The Convertible Senior Notes bear interest at a fixed rate of 6.25% per year, paid semiannually on June 15 and December 15 of each year commencing December 15, 2019 and will mature on June 15, 2024, unless earlier converted, redeemed or repurchased in accordance with their terms. The Convertible Senior Notes are convertible at the option of the holders at any time until the close of business on the business day immediately preceding the maturity date into shares of the Company’s common stock based on an initial conversion rate of 125.7387 shares of the Company’s common stock for each $1,000 principal amount of the Convertible Senior Notes, which is equivalent to an initial conversion price of approximately $7.95 per share of common stock. The Convertible Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 6.94%. The Company does not have the right to redeem the Convertible Senior Notes prior to maturity, except to the extent necessary to preserve its status as a REIT, in which case the Company may redeem the Convertible Senior Notes, in whole or in part, at a redemption price equal to the principal amount redeemed plus accrued and unpaid interest.

The Convertible Senior Notes are the Company’s senior unsecured obligations and are effectively junior to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness and equal in right of payment to the Company’s existing and future senior unsecured obligations, including the Senior Notes.

Senior Notes

On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds the Company received from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest.

The Senior Notes are the Company’s senior unsecured obligations and are effectively junior to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness and equal in right of payment to the Company’s existing and future senior unsecured obligations, including the Convertible Senior Notes.

42

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

7. Collateral Positions

The Company pledges securities or cash as collateral to its counterparties in relation to certain of its financing arrangements. In addition, the Company receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements.  The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated financing arrangements and Swap contracts, as applicable.  In connection with these margining practices, either the Company or its counterparty may be required to pledge cash or securities as collateral.  When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral or provide collateral to the Company in the form of cash or equivalent securities.

The Company’s assets pledged as collateral are described in Notes 2(f) - Restricted Cash, 5(c) - Derivative Instruments and 6 - Repurchase Agreements. The total fair value of assets pledged as collateral with respect to the Company’s borrowings under its financing arrangements and/or derivative hedging instruments was $5.2 billion and $11.3 billion at September 30, 2020 and December 31, 2019, respectively. An aggregate of $35.8 million and $57.2 million of accrued interest on those assets had also been pledged as of September 30, 2020 and December 31, 2019, respectively.

8.    Offsetting Assets and Liabilities

Certain of the Company’s financing arrangements and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction. In the Company’s consolidated balance sheets, all balances associated with repurchase agreements are presented on a gross basis.

The fair value of financial instruments pledged against the Company’s financing arrangements was $5.2 billion and $11.2 billion at September 30, 2020 and December 31, 2019, respectively. The fair value of financial instruments pledged against the Company’s Swaps was $0 and $2.2 million at September 30, 2020 and December 31, 2019, respectively. In addition, cash that has been pledged as collateral against financing arrangements and Swaps is reported as Restricted cash on the Company’s consolidated balance sheets (see Notes 2(f), 5(c) and 6).

9. Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
Dividends and dividend equivalents payable	$	22,758	$	90,749
Accrued interest payable	14,588		18,238
Accrued expenses and other	29,136		42,819
Total Other Liabilities	$	66,482	$	151,806

10.    Commitments and Contingencies

(a) Lease Commitments

The Company pays monthly rent pursuant to three office leases.  In November 2018, the Company amended the lease for its corporate headquarters in New York, New York, under the same terms and conditions, to extend the expiration date for the lease by up to one year, through June 30, 2021, with a mutual option to terminate in February 2021.  For the three and nine months ended September 30, 2020, the Company recorded expense of approximately $739,000 and $2.1 million in connection with the lease for its current corporate headquarters.

43

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

In addition, in November 2018, the Company executed a lease agreement on new office space in New York, New York. The Company plans to relocate its corporate headquarters to this new office space upon the substantial completion of the building. The lease term specified in the agreement is fifteen years with an option to renew for an additional five years. The Company’s current estimate of annual lease rental expense under the new lease, excluding escalation charges which at this point are unknown, is approximately $4.6 million. The Company currently expects to relocate to the space in the first quarter of 2021, but this timing, as well as when it is required to begin making payments and recognize rental and other expenses under the new lease, is dependent on when the space is actually available for use.

(b) Representations and Warranties in Connection with Loan Securitization Transactions

In connection with the loan securitization transactions entered into by the Company, the Company has the obligation under certain circumstances to repurchase assets previously transferred to securitization vehicles upon breach of certain representations and warranties. As of September 30, 2020, the Company had no reserve established for repurchases of loans and was not aware of any material unsettled repurchase claims that would require the establishment of such a reserve (see Note 15).

(c) Corporate Loans

The Company has participated in loans to provide financing to entities that originate loans and own MSRs, as well as certain other unencumbered assets owned by the borrower. At September 30, 2020, Company’s commitment to lend is $32.6 million, of which $14.5 million was undrawn. (see Note 4).

(d) Rehabilitation Loan Commitments

At September 30, 2020, the Company had unfunded commitments of $73.2 million in connection with its purchased Rehabilitation loans (see Note 3).

11.    Stockholders’ Equity

(a) Preferred Stock

7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”)

On April 15, 2013, the Company completed the issuance of 8.0 million shares of its Series B Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.

As a result of the turmoil in the financial markets resulting from the spread of the novel coronavirus and the global COVID-19 pandemic, and in order to preserve liquidity, on March 25, 2020, the Company revoked the previously announced first quarter 2020 quarterly cash dividends on each of the Company's common stock and Series B Preferred Stock. The Series B Preferred Stock dividend of $0.46875 per share had been declared on February 14, 2020, and was to be paid on March 31, 2020, to stockholders of record as of the close of business March 2, 2020. Unpaid dividends on the Company's Series B Preferred Stock accrue without interest. No dividends may be paid or set apart on shares of the Company's common stock unless full cumulative dividends on the Series B Preferred Stock for all past dividend periods that have ended have been or contemporaneously are paid in cash, or a sum sufficient for such payment is set apart for payment. In addition, pursuant to the

44

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

now-terminated forbearance agreements that the Company entered into subsequent to the end of the first quarter, the Company was prohibited from paying dividends on its Series B Preferred Stock during the forbearance period, and therefore suspended the payment of dividends on the Series B Preferred Stock for the quarter ended June 30, 2020.

On July 1, 2020, the Company announced that it had reinstated the payment of dividends on its Series B Preferred Stock and declared a preferred stock dividend of $0.9375 per share, payable on July 31, 2020 to Series B Preferred stockholders of record as of July 15, 2020. Upon payment of this dividend, the Company paid in full all accumulated but previously unpaid dividends on its Series B Preferred Stock.

On August 12, 2020, the Company declared a dividend on its Series B preferred stock of $0.46875 per share. This dividend was paid on September 30, 2020, to Series B preferred stockholders of record as of September 8, 2020.

Issuance of 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”)

On February 28, 2020, the Company amended its charter through the filing of articles supplementary to reclassify 12,650,000 shares of the Company’s authorized but unissued common stock as shares of the Company’s Series C Preferred Stock. On March 2, 2020, the Company completed the issuance of 11.0 million shares of its Series C Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The total net proceeds the Company received from the offering were approximately $266.0 million, after deducting offering expenses and the underwriting discount.

The Company’s Series C Preferred Stock is entitled to receive dividends (i) from and including the original issue date to, but excluding, March 31, 2025, at a fixed rate of 6.50% per year on the $25.00 liquidation preference and (ii) from and including March 31, 2025, at a floating rate equal to three-month LIBOR plus a spread of 5.345% per year of the $25.00 per share liquidation preference before the Company’s common stock is paid any dividends, and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series C Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series C Preferred Stock is not redeemable by the Company prior to March 31, 2025, except under circumstances where it is necessary to preserve the Company’s qualification as a REIT for U.S. federal income tax purposes and upon the occurrence of certain specified change in control transactions. On or after March 31, 2025, the Company may, at its option, subject to certain procedural requirements, redeem any or all of the shares of the Series C Preferred Stock for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends thereon (whether or not authorized or declared) to, but excluding, the redemption date.

The Series C Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board, until all unpaid dividends have been paid or declared and set apart for payment. In addition, certain material and adverse changes to the terms of the Series C Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3 of the outstanding shares of Series C Preferred Stock.

Pursuant to the now-terminated forbearance agreements that the Company had previously entered into, the Company was prohibited from paying dividends on its Series C Preferred Stock during the forbearance period. On July 1, 2020, the Company announced that it had reinstated the payment of dividends on its Series C Preferred Stock and declared a preferred stock dividend of $0.53264 per share, payable on July 31, 2020 to the Series C Preferred stockholders of record as of July 15, 2020. Upon payment of this dividend, the Company paid in full all accumulated but previously unpaid dividends on its Series C Preferred Stock.

On August 12, 2020, the Company declared a dividend on its Series C preferred stock of $0.40625 per share. This dividend was paid on September 30, 2020, to Series C preferred stockholders of record as of September 8, 2020.

45

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(b)  Dividends on Common Stock

On August 6, 2020, the Company declared a regular cash dividend of $0.05 per share of common stock.  The dividend will be paid on October 30, 2020, to stockholders of record on September 30, 2020.

(c) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)

On October 15, 2019, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) under the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 9.0 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At September 30, 2020, approximately 8.8 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.

During the three and nine months ended September 30, 2020, the Company issued 4,374 and 137,740 shares of common stock through the DRSPP, raising net proceeds of approximately $11,688 and $752,095, respectively.  Since the inception of the DRSPP in September 2003 through September 30, 2020, the Company issued 34,516,508 shares pursuant to the DRSPP, raising net proceeds of $287.3 million.

(d) At-the-Market Offering Program

On August 16, 2019 the Company entered into a distribution agreement under the terms of which the Company may offer and sell shares of its common stock having an aggregate gross sales price of up to $400.0 million (the “ATM Shares”), from time to time, through various sales agents, pursuant to an at-the-market equity offering program (the “ATM Program”). Sales of the ATM Shares, if any, may be made in negotiated transactions or by transactions that are deemed to be “at-the-market” offerings, as defined in Rule 415 under the 1933 Act, including sales made directly on the New York Stock Exchange (“NYSE”) or sales made to or through a market maker other than an exchange. The sales agents are entitled to compensation of up to two percent of the gross sales price per share for any shares of common stock sold under the distribution agreement.

During the nine months ended September 30, 2020, the Company did not sell any shares of common stock through the ATM Program. At September 30, 2020, approximately $390.0 million remained outstanding for future offerings under this program.

(e)  Stock Repurchase Program

As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock.  The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the nine months ended September 30, 2020.  At September 30, 2020, 6,616,355 shares remained authorized for repurchase under the Repurchase Program. Please refer to note 16 for further discussion.

(f) Warrants

On June 15, 2020, the Company entered into an Investment Agreement with Apollo and Athene (together the “Purchasers”), under which the Company agreed to issue to the Purchasers warrants (the “Warrants”) to purchase, in the

46

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

aggregate, 37,039,106 shares (subject to adjustment in accordance with their terms) of the Company’s common stock. The Warrants are exercisable at the holder’s option at any time until the date that is the later of (i) June 15, 2025 and (ii) the first anniversary of the repayment of the Term Loan Facility (See Note 6). One half of the Warrants have an exercise price of $1.66 per share and the other half have an exercise price of $2.08 per share. The Investment Agreement and the Term Loan Facility (See Note 6) were entered into simultaneously and the $495.0 million of proceeds received were allocated between the debt ($481.0 million) and the warrants ($14.0 million). The amount allocated to the warrants was recorded in Additional paid-in capital on the Company’s consolidated balance sheets.

(g) Accumulated Other Comprehensive Income/(Loss)

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020								Nine Months Ended September 30, 2020
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Net Unrealized Gain/(Loss) on Financing Agreements (3)		Total  AOCI		Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Net Unrealized Gain/(Loss) on Financing Agreements (3)		Total  AOCI
Balance at beginning of period	$	52,889	$	(7,176)	$	—	$	45,713	$	392,722	$	(22,675)	$	—	$	370,047
OCI before reclassifications	15,082		—		(22,652)		(7,570)		408,585		(50,127)		(22,652)		335,806
Amounts reclassified from AOCI (1)	(60)		7,176		—		7,116		(733,396)		72,802		—		(660,594)
Net OCI during the period (2)	15,022		7,176		(22,652)		(454)		(324,811)		22,675		(22,652)		(324,788)
Balance at end of period	$	67,911	$	—	$	(22,652)	$	45,259	$	67,911	$	—	$	(22,652)	$	45,259

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

(3) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2019:

	Three Months Ended September 30, 2019						Nine Months Ended September 30, 2019
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net Gain/(Loss) on Swaps		Total AOCI		Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Total AOCI
Balance at beginning of period	$	439,898	$	(28,114)	$	411,784	$	417,167	$	3,121	$	420,288
OCI before reclassifications	5,483		(233)		5,250		50,085		(30,384)		19,701
Amounts reclassified from AOCI (1)	(14,499)		(685)		(15,184)		(36,370)		(1,769)		(38,139)
Net OCI during the period (2)	(9,016)		(918)		(9,934)		13,715		(32,153)		(18,438)
Balance at end of period	$	430,882	$	(29,032)	$	401,850	$	430,882	$	(29,032)	$	401,850

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

47

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Details about AOCI Components	Amounts Reclassified from AOCI				Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(60)	$	(389,127)	Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Impairment recognized in earnings	—		(344,269)		Other, net
Total AFS Securities	$	(60)	$	(733,396)
Swaps designated as cash flow hedges:
Reclassification adjustment for losses related to hedging instruments included in net income	7,176		72,802		Other, net
Total Swaps designated as cash flow hedges	7,176		72,802
Total reclassifications for period	$	7,116	$	(660,594)

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2019:

	Three Months Ended September 30, 2019		Nine Months Ended September 30, 2019
Details about AOCI Components	Amounts Reclassified from AOCI				Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(14,499)	$	(36,370)	Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Total AFS Securities	$	(14,499)	$	(36,370)
Amortization of de-designated hedging instruments	(685)		(1,769)
Total reclassifications for period	$	(15,184)	$	(38,139)

48

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

12.    EPS Calculation

The following table presents a reconciliation of the earnings/(loss) and shares used in calculating basic and diluted earnings/(loss) per share for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands, Except Per Share Amounts)	2020		2019		2020		2019
Basic Earnings/(Loss) per Share:
Net income/(loss) to common stockholders	$	87,210	$	95,599	$	(725,207)	$	277,496
Dividends declared on preferred stock	(8,219)		(3,750)		(21,578)		(11,250)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(325)		(280)		(91)		(808)
Net income/(loss) to common stockholders - basic	$	78,666	$	91,569	$	(746,876)	$	265,438
Basic weighted average common shares outstanding	453,323		451,020		453,170		450,641
Basic Earnings/(Loss) per Share	$	0.17	$	0.20	$	(1.65)	$	0.59
Diluted Earnings/(Loss) per Share:
Net income/(loss) to common stockholders - basic	$	78,666	$	91,569	(746,876)		265,438
Interest expense on Convertible Senior Notes	3,898		3,879		—		5,085
Net income/(loss) to common stockholders - diluted	$	82,564	$	95,448	$	(746,876)	$	270,523
Basic weighted average common shares outstanding	453,323		451,020		453,170		450,641
Effect of assumed conversion of Convertible Senior Notes to common shares	28,920		28,920		—		12,712
Effect of incremental shares issued on assumed conversion of Warrants	11,297		—		—		—
Diluted weighted average common shares outstanding (1)	493,540		479,940		453,170		463,353
Diluted Earnings/(Loss) per Share	$	0.17	$	0.20	$	(1.65)	$	0.58

(1)At September 30, 2020, the Company had approximately 39.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the nine months ended September 30, 2020, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.29 and approximately 37.0 million warrants with a weighted average exercise price of $1.87 per share. These equity instruments may have a dilutive impact on future EPS.  

During the nine months ended September 30, 2020, the Convertible Senior Notes were determined to be anti-dilutive and were not included in the calculation of diluted EPS under the “if-converted” method. Under this method, the periodic interest expense for dilutive notes is added back to the numerator and the weighted average number of shares that the notes are entitled to (if converted, regardless of whether the conversion option is in or out of the money) is included in the denominator for the purpose of calculating diluted EPS. The Convertible Senior Notes may have a dilutive impact on future EPS.

13.    Equity Compensation, Employment Agreements and Other Benefit Plans

(a)  Equity Compensation Plan

In accordance with the terms of the Company’s Equity Plan, which was adopted by the Company’s stockholders on June 10, 2020 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

Subject to certain exceptions, stock-based awards relating to a maximum of 18.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count toward this limit.  At

49

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

September 30, 2020, approximately 14.3 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 2.0 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until June 10, 2030.

Restricted Stock Units

Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of September 30, 2020 are designated to be settled in shares of the Company’s common stock.  The Company granted 497,507 and 1,702,220 RSUs during the three and nine months ended September 30, 2020, respectively. The Company did not grant any RSUs during the three months ended September 30, 2019 and granted 912,525 RSUs during the nine months ended September 30, 2019. There were no RSUs forfeited during the nine months ended September 30, 2020 and 20,000 RSUs forfeited during the nine months ended September 30, 2019. All RSUs outstanding at September 30, 2020 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled.  At September 30, 2020 and December 31, 2019, the Company had unrecognized compensation expense of $8.3 million and $5.5 million, respectively, related to RSUs.  The unrecognized compensation expense at September 30, 2020 is expected to be recognized over a weighted average period of 1.9 years.

Restricted Stock

The Company granted 79,545 shares of restricted common stock during the nine months ended September 30, 2020, and the Company did not grant any shares of restricted common stock during the nine months ended September 30, 2019. At September 30, 2020, the Company did not have any unvested shares of restricted common stock outstanding.

Dividend Equivalents

A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules as the Compensation Committee of the Board shall determine in its discretion.  Payments made on the Company’s outstanding dividend equivalent rights are generally charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest.  The Company made dividend equivalent payments in respect of such instruments of approximately $276,000 during the nine months ended September 30, 2020 and approximately $276,000 and $773,000 during the three and nine months ended September 30, 2019, respectively.

 Expense Recognized for Equity-Based Compensation Instruments

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
RSUs	$	2,267	$	1,288	$	5,094	$	4,724
Total	$	2,267	$	1,288	$	5,094	$	4,724

50

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

(b)  Employment Agreements

At September 30, 2020, the Company had employment agreements with three of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.

(c)  Deferred Compensation Plans

The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.

The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Non-employee directors	$	75	$	134	$	(1,483)	$	459
Total	$	75	$	134	$	(1,483)	$	459

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2020 and December 31, 2019 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,074	$	1,114	$	2,349	$	3,071
Total	$	2,074	$	1,114	$	2,349	$	3,071

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2020 and December 31, 2019, which had not been distributed through such respective date.

(d)  Savings Plan

The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the three months ended September 30, 2020 and 2019, the Company recognized expenses for matching contributions of $120,000 and $94,000, respectively, and $360,000 and $323,000 for the nine months ended September 30, 2020 and 2019, respectively.

51

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

14.  Fair Value of Financial Instruments

GAAP requires the categorization of fair value measurements into three broad levels that form a hierarchy. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Residential Whole Loans, at Fair Value

The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans. The valuation approach applied generally depends on whether the loan is considered performing or non-performing at the date the valuation is performed. For performing loans, estimates of fair value are derived using a discounted cash flow approach, where estimates of cash flows are determined from the scheduled payments, adjusted using forecasted prepayment, default and loss given default rates. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, the estimated value of the collateral, expected costs and estimated home price appreciation. Estimated cash flows for both performing and non-performing loans are discounted at yields considered appropriate to arrive at a reasonable exit price for the asset. Indications of loan value such as actual trades, bids, offers and generic market color may be used in determining the appropriate discount yield. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Residential Mortgage Securities

The Company determines the fair value of its Agency MBS based upon prices obtained from third-party pricing services, which are indicative of market activity, and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace. The Company’s Agency MBS are classified as Level 2 in the fair value hierarchy. During the quarter ended June 30, 2020, the Company sold its remaining holdings of Agency MBS.

In determining the fair value of the Company’s Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

52

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The Company’s Legacy Non-Agency MBS, RPL/NPL MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, these securities are classified as Level 2 in the fair value hierarchy. As of September 30, 2020, the Company has sold substantially all of its holdings of Legacy Non-Agency MBS and substantially reduced its holdings of other Non-Agency MBS and CRT securities.

Term Notes Backed by MSR-Related Collateral

The Company’s valuation process for term notes backed by MSR-related collateral is similar to that used for residential mortgage securities and considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral and, as applicable, the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient. Based on its evaluation of the observability of the data used in its fair value estimation process, these assets are classified as Level 2 in the fair value hierarchy.

Swaps

As previously disclosed, in response to the turmoil in the financial markets resulting from the COVID-19 pandemic experienced during the three months ended March 31, 2020, the Company unwound all of its Swap hedging transactions late in the first quarter in order to recover previously posted margin. Prior to their termination, valuations provided by the central clearing house were used for purposes of determining the fair value of the Company’s Swaps. Such valuations obtained were tested with internally developed models that applied readily observable market parameters.  Swaps were classified as Level 2 in the fair value hierarchy.

Financing Agreements, at Fair Value

Agreements with mark-to-market collateral provisions

These agreements are secured and subject to margin calls and their base interest rates reset frequently to market based rates. As a result, no credit valuation adjustment is required, and the primary factor in determining their fair value is the credit spread paid over the base rate, which is a non observable input as it is determined based on negotiations with the counterparty. The Company’s financing agreements with mark-to-market collateral provisions held at fair value are classified as Level 2 in the fair value hierarchy if the credit spreads used to price the instrument reset frequently, which is typically the case with shorter term repurchase agreement contracts collateralized by securities. Financing agreements with mark-to-market collateral provisions that are typically longer term and are collateralized by residential whole loans where the credit spread paid over the base rate on the instrument is not reset frequently are classified as Level 3 in the fair value hierarchy.

Agreements with non-mark-to-market collateral provisions

These agreements are secured, but not subject to margin calls, and their base interest rates reset frequently to market based rates. As a result, a credit valuation adjustment would only be required if there were a significant decrease in collateral value, and the primary factor in determining their fair value is the credit spread paid over the base rate, which is a non observable input as it is determined based on negotiations with the counterparty. The Company’s financing agreements with non-mark-to-market collateral provisions held at fair value are classified as Level 3 in the fair value hierarchy.

Senior Secured Credit Agreement (Term Loan Facility)

The estimated fair value of the Term Loan Facility was determined by management based on a valuation received from a third party that specializes in providing valuations on financial instruments. The most significant inputs to such valuation, market interest rates and the yield on the Company’s publicly traded financial instruments, are observable. The Company’s Term Loan Facility held at fair value is classified as Level 2 in the fair value hierarchy.

53

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2020 and December 31, 2019, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at September 30, 2020

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Residential whole loans, at fair value	$	—	$	—	$	1,229,664	$	1,229,664
Non-Agency MBS	—		56,430		—		56,430
CRT securities	—		96,335		—		96,335
Term notes backed by MSR-related collateral	—		234,091		—		234,091
Total assets carried at fair value	$	—	$	386,856	$	1,229,664	$	1,616,520
Liabilities:
Agreements with non-mark-to-market collateral provisions	$	—	$	—	$	1,727,407	$	1,727,407
Agreements with mark-to-market collateral provisions	—		258,537		1,231,734		1,490,271
Senior secured credit agreement	—		473,993		—		473,993
Securitized debt	—		388,790		—		388,790
Total liabilities carried at fair value	$	—	$	1,121,320	$	2,959,141	$	4,080,461

Fair Value at December 31, 2019

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Residential whole loans, at fair value	$	—	$	—	$	1,381,583	$	1,381,583
Non-Agency MBS	—		2,063,529		—		2,063,529
Agency MBS	—		1,664,582		—		1,664,582
CRT securities	—		255,408		—		255,408
Term notes backed by MSR-related collateral	—		1,157,463		—		1,157,463
Total assets carried at fair value	$	—	$	5,140,982	$	1,381,583	$	6,522,565

54

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents additional information for the three and nine months ended September 30, 2020 and 2019 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Residential Whole Loans, at Fair Value
	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019 (1)		2020		2019 (1)(2)
Balance at beginning of period	$	1,200,981	$	1,438,827	$	1,381,583	$	1,471,263
Purchases (2)	—		85,855		—		210,030
Changes in fair value recorded in Net gain on residential whole loans measured at fair value through earnings	58,863		13,185		(13,683)		33,312
Cash collections, net of liquidation gains/(losses)	(21,721)		(31,212)		(65,934)		(94,821)
Sales and repurchases	(929)		—		(19,460)		(1,216)
Transfer to REO	(7,530)		(53,486)		(52,842)		(165,399)
Balance at end of period	$	1,229,664	$	1,453,169	$	1,229,664	$	1,453,169

(1)Included in the activity presented for the three months ended September 30, 2019 are approximately $87.0 million of residential whole loans held at fair value the Company committed to purchase during the three months ended June 30, 2019, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2019.

(2)Included in the activity presented for the nine months ended September 30, 2019 is an adjustment of $70.6 million for loans the Company committed to purchase during the three months ended December 31, 2018, but for which the closing of the purchase transaction occurred during the three months ended March 31, 2019. The adjustment was required following the finalization of due diligence performed prior to the closing of the purchase transaction and resulted in a downward revision to the prior estimate of the loan purchase amount.

The following table presents additional information for the three and nine months ended September 30, 2019 about the Company’s investments in term notes backed by MSR-related collateral, which were classified as Level 3 prior to September 30, 2019 and measured at fair value on a recurring basis:

	Term Notes Backed by MSR-Related Collateral
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2019		2019
Balance at beginning of period	$	1,106,026	$	538,499
Purchases	—		573,137
Collection of principal	(3,920)		(12,897)
Changes in unrealized gains	2,024		5,391
Transfer to Level 2	(1,104,130)		(1,104,130)
Balance at end of period	$	—	$	—

55

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

The following table presents additional information for the three and nine months ended September 30, 2020 about the Company’s financing agreements with non-mark-to-market collateral provisions, which are classified as Level 3 and measured at fair value on a recurring basis:

	Agreements with Non-mark-to-market Collateral Provisions
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2020		2020
Balance at beginning of period	$	—	$	—
Transfer from Level 2	2,036,597		2,036,597
Payment of principal	(312,638)		(312,638)
Changes in unrealized losses	3,448		3,448
Balance at end of period	$	1,727,407	$	1,727,407

The following table presents additional information for the three and nine months ended September 30, 2020 about the Company’s financing agreements with mark-to-market collateral provisions, which are classified as Level 3 and measured at fair value on a recurring basis:

	Agreements with Mark-to-market Collateral Provisions
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2020		2020
Balance at beginning of period	$	—	$	—
Transfer from Level 2	1,386,592		1,386,592
Payment of principal	(156,032)		(156,032)
Changes in unrealized losses	1,174		1,174
Balance at end of period	$	1,231,734	$	1,231,734

At June 30, 2020, the Company’s financing agreements with non-mark-to-market collateral provisions and the Company’s financing agreements with mark-to-market collateral provisions had just been issued and were therefore classified as Level 2 since their values were based on market transactions. However, market information for similar financings was not available at September 30, 2020 and the Company valued these financing instruments based on unobservable inputs.

56

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Fair Value Methodology for Level 3 Financial Instruments

Residential Whole Loans, at Fair Value

The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2020 and December 31, 2019:

	September 30, 2020
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	774,427	Discounted cash flow	Discount rate	3.9		%	3.2-8.0%
				Prepayment rate	3.9		%	0.0-9.3%
				Default rate	6.2		%	0.0-30.3%
				Loss severity	12.7		%	0.0-100.0%
	$	454,760	Liquidation model	Discount rate	8.1		%	6.7-50.0%
				Annual change in home prices	1.9		%	(0.3)-5.5%
				Liquidation timeline (in years)	1.8			0.1-4.8
				Current value of underlying properties (3)	$	734		$12-$4,500
Total	$	1,229,187

	December 31, 2019
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	829,842	Discounted cash flow	Discount rate	4.2		%	3.8-8.0%
				Prepayment rate	4.5		%	0.7-18.0%
				Default rate	4.0		%	0.0-23.0%
				Loss severity	12.9		%	0.0-100.0%
	$	551,271	Liquidation model	Discount rate	8.0		%	6.2-50.0%
				Annual change in home prices	3.7		%	2.4-8.0%
				Liquidation timeline (in years)	1.8			0.1-4.5
				Current value of underlying properties (3)	$	684		$10-$4,500
Total	$	1,381,113

(1) Excludes approximately $477,000 and $470,000 of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2020 and December 31, 2019, respectively.

(2) Amounts are weighted based on the fair value of the underlying loan.

(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately $383,000 and $365,000 as of September 30, 2020 and December 31, 2019, respectively.

57

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Changes in market conditions, as well as changes in the assumptions or methodology used to determine fair value, could result in a significant increase or decrease in the fair value of residential whole loans. Loans valued using a discounted cash flow model are most sensitive to changes in the discount rate assumption, while loans valued using the liquidation model technique are most sensitive to changes in the current value of the underlying properties and the liquidation timeline. Increases in discount rates, default rates, loss severities, or liquidation timelines, either in isolation or collectively, would generally result in a lower fair value measurement, whereas increases in the current or expected value of the underlying properties, in isolation, would result in a higher fair value measurement. In practice, changes in valuation assumptions may not occur in isolation and the changes in any particular assumption may result in changes in other assumptions, which could offset or amplify the impact on the overall valuation.

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2020 and December 31, 2019:

	September 30, 2020	September 30, 2020				December 31, 2019
	Level in Fair Value Hierarchy	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
(In Thousands)
Financial Assets:
Residential whole loans, at carrying value	3	$	4,387,559	$	4,528,630	$	6,069,370	$	6,248,745
Residential whole loans, at fair value	3	1,229,664		1,229,664		1,381,583		1,381,583
Non-Agency MBS	2	56,430		56,430		2,063,529		2,063,529
Agency MBS	2	—		—		1,664,582		1,664,582
CRT securities	2	96,335		96,335		255,408		255,408
MSR-related assets (1)	2 and 3	252,183		252,183		1,217,002		1,217,002
Cash and cash equivalents	1	884,171		884,171		70,629		70,629
Restricted cash	1	5,303		5,303		64,035		64,035
Financial Liabilities (2):
Financing agreements with non-mark-to-market collateral provisions	3	1,727,407		1,727,407		—		—
Financing agreements with mark-to-market collateral provisions	3	1,231,734		1,231,734		4,741,971		4,753,070
Financing agreements with mark-to-market collateral provisions	2	258,537		258,537		4,397,850		4,403,139
Senior secured credit agreement	2	473,993		473,993		—		—
Securitized debt (3)	2	837,683		839,914		570,952		575,353
Convertible senior notes	2	224,867		216,919		223,971		244,088
Senior notes	1	96,900		94,311		96,862		103,231

(1)Includes $18.1 million and $59.5 million of MSR-related assets that are measured at fair value on a non-recurring basis that are classified as Level 3 in the fair value hierarchy at September 30, 2020 and December 31, 2019, respectively.

(2)Carrying value of securitized debt, Convertible Senior Notes, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.

(3)Includes Securitized debt that is carried at amortized cost basis and fair value.

Other Assets Measured at Fair Value on a Nonrecurring Basis

The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. During the nine months ended September 30, 2020 and 2019, the Company recorded REO with an aggregate estimated fair value, less estimated cost to sell, of $74.9 million and $193.5 million, respectively, at the time of foreclosure. The Company classifies fair value measurements of REO as Level 3 in the fair value hierarchy.

58

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

15.  Use of Special Purpose Entities and Variable Interest Entities

A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in a SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. 

The Company has entered into several financing transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate these transactions. See Note 2(q) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with financing transactions.

The Company has engaged in loan securitizations primarily for the purpose of obtaining improved overall financing terms as well as non-recourse financing on a portion of its residential whole loan portfolio. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying assets transferred to the VIEs.

Loan Securitization Transactions

The following table summarizes the key details of the Company’s loan securitization transactions as of September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020				December 31, 2019
Aggregate unpaid principal balance of residential whole loans sold	$	1,681,500			$	1,290,029
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors	$	1,202,616			$	802,817
Outstanding amount of Senior Bonds, at carrying value	$	448,893		(1)	$	570,952		(1)
Outstanding amount of Senior Bonds, at fair value	$	388,790			$	—
Outstanding amount of Senior Bonds, total	$	837,683			$	570,952
Weighted average fixed rate for Senior Bonds issued	2.93		%	(2)	3.68		%	(2)
Weighted average contractual maturity of Senior Bonds	36 years			(2)	30 years			(2)
Face amount of Senior Support Certificates received by the Company (3)	$	266,355			$	275,174
Cash received	$	1,193,969			$	802,815

(1)Net of $2.2 million and $2.9 million of deferred financing costs at September 30, 2020 and December 31, 2019, respectively.

(2)At September 30, 2020 and December 31, 2019, $743.9 million and $493.2 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by either 100 or 300 basis points or more at 36 months from issuance if the bond is not redeemed before such date.

(3)Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

During the three and nine months ended September 30, 2020, the Company issued Senior Bonds with a current face of $372.8 million and $399.8 million to third-party investors for proceeds of $372.8 million and $391.2 million, respectively, before offering costs and accrued interest. The Senior Bonds issued by the Company during the nine months ended September 30, 2020 are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of issuance.

As of September 30, 2020 and December 31, 2019, as a result of the transactions described above, securitized loans with a carrying value of approximately $568.6 million and $186.4 million are included in “Residential whole loans, at carrying value,” securitized loans with a fair value of approximately $521.2 million and $567.4 million are included in “Residential whole loans,

59

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

at fair value,” and REO with a carrying value approximately $80.3 million and $137.8 million are included in “Other assets” on the Company’s consolidated balance sheets, respectively. As of September 30, 2020 and December 31, 2019, the aggregate carrying value of Senior Bonds issued by consolidated VIEs was $837.7 million and $571.0 million, respectively.  These Senior Bonds are disclosed as “Securitized debt” and are included in Other liabilities on the Company’s consolidated balance sheets.  The holders of the securitized debt have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties with respect to the residential whole loans sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.

The Company concluded that the entities created to facilitate the loan securitization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the securitization transactions should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:

•whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and

•whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.

Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate the loan securitization transactions.

Residential Whole Loans and REO (including Residential Whole Loans and REO transferred to consolidated VIEs)

Included on the Company’s consolidated balance sheets as of September 30, 2020 and December 31, 2019 are a total of $5.6 billion and $7.4 billion, respectively, of residential whole loans, of which approximately $4.4 billion and $6.1 billion, respectively, are reported at carrying value and $1.2 billion and $1.4 billion, respectively, are reported at fair value. These assets, and certain of the Company’s REO assets, are directly owned by certain trusts established by the Company to acquire the loans and entities established in connection with the Company’s loan securitization transactions. The Company has assessed that these entities are required to be consolidated (see Notes 3 and 5(a)).

60

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

16. Subsequent Events

Payoff of remaining balance of Term Loan Facility

On October 9, 2020, the Company repaid $400 million of the principal outstanding on the Term Loan Facility (see note 6) and the remaining principal balance of this facility of $81,250,000 was repaid on October 30, 2020. The repayments were made without penalty or yield maintenance. Upon the full repayment, the Term Loan Facility was terminated.

Securitization of Non-QM loans

Subsequent to the end of the third quarter the Company closed on a $570 million Non-QM securitization that generated $125.1 million of additional liquidity.

Share Repurchase Authorization

On November 2, 2020, the Company’s Board of Directors authorized a share repurchase program under which the Company may repurchase up to $250 million of its common stock through the end of 2022. The Board’s authorization replaces the authorization under the Company’s existing stock repurchase program that was adopted in December 2013, which authorized the Company to repurchase up to 10 million shares of common stock and under which approximately 6.6 million shares remained available for repurchase

The stock repurchase program does not require the purchase of any minimum number of shares. The timing and extent to which the Company repurchases its shares will depend upon, among other things, market conditions, share price, liquidity, regulatory requirements and other factors, and repurchases may be commenced or suspended at any time without prior notice. Acquisitions under the share repurchase program may be made in the open market, through privately negotiated transactions or block trades or other means, in accordance with applicable securities laws.

The Company expects to fund the share repurchases from cash balances and future investment portfolio run-off. The Company currently has approximately 453.3 million shares of common stock outstanding.

61

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

In this Quarterly Report on Form 10-Q, we refer to MFA Financial, Inc. and its subsidiaries as “the Company,” “MFA,” “we,” “us,” or “our,” unless we specifically state otherwise or the context otherwise indicates.

The following discussion should be read in conjunction with our financial statements and accompanying notes included in Item 1 of this Quarterly Report on Form 10-Q as well as our Annual Report on Form 10-K for the year ended December 31, 2019.

Forward Looking Statements

When used in this Quarterly Report on Form 10-Q, in future filings with the SEC or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as “will,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “could,” “would,” “may,” the negative of these words or similar expressions, are intended to identify “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act and, as such, may involve known and unknown risks, uncertainties and assumptions.

These forward-looking statements include information about possible or assumed future results with respect to our business, financial condition, liquidity, results of operations, plans and objectives.  Statements regarding the following subjects, among others, may be forward-looking: risks related to the ongoing spread of the novel coronavirus and the COVID-19 pandemic, including its effects on the general economy and our business, financial position and results of operations (including, among other potential effects, increased delinquencies and greater than expected losses in our whole loan portfolio); changes in interest rates and the market (i.e., fair) value of our residential whole loans, MBS and other assets; changes in the prepayment rates on residential mortgage assets, an increase of which could result in a reduction of the yield on certain investments in its portfolio and could require us to reinvest the proceeds received by it as a result of such prepayments in investments with lower coupons, while a decrease in which could result in an increase in the interest rate duration of certain investments in our portfolio making their valuation more sensitive to changes in interest rates and could result in lower forecasted cash flows; credit risks underlying our assets, including changes in the default rates and management’s assumptions regarding default rates on the mortgage loans in our residential whole loan portfolio; our ability to borrow to finance our assets and the terms, including the cost, maturity and other terms, of any such borrowings; implementation of or changes in government regulations or programs affecting our business; our estimates regarding taxable income the actual amount of which is dependent on a number of factors, including, but not limited to, changes in the amount of interest income and financing costs, the method elected by us to accrete the market discount on residential whole loans and the extent of prepayments, realized losses and changes in the composition of our residential whole loan portfolios that may occur during the applicable tax period, including gain or loss on any MBS disposals and whole loan modifications, foreclosures and liquidations; the timing and amount of distributions to stockholders, which are declared and paid at the discretion of our Board and will depend on, among other things, our taxable income, our financial results and overall financial condition and liquidity, maintenance of our REIT qualification and such other factors as the Board deems relevant; our ability to maintain our qualification as a REIT for federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended (or the Investment Company Act), including statements regarding the concept release issued by the SEC relating to interpretive issues under the Investment Company Act with respect to the status under the Investment Company Act of certain companies that are engaged in the business of acquiring mortgages and mortgage-related interests; our ability to continue growing our residential whole loan portfolio, which is dependent on, among other things, the supply of loans offered for sale in the market; expected returns on our investments in nonperforming residential whole loans (or NPLs), which are affected by, among other things, the length of time required to foreclose upon, sell, liquidate or otherwise reach a resolution of the property underlying the NPL, home price values, amounts advanced to carry the asset (e.g., taxes, insurance, maintenance expenses, etc. on the underlying property) and the amount ultimately realized upon resolution of the asset; targeted or expected returns on our investments in recently-originated loans, the performance of which is, similar to our other mortgage loan investments, subject to, among other things, differences in prepayment risk, credit risk and financing cost associated with such investments; risks associated with our investments in MSR-related assets, including servicing, regulatory and economic risks, risks associated with our investments in loan originators, and risks associated with investing in real estate assets, including changes in business conditions and the general economy.  These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that we file with the SEC, could cause our actual results to differ materially from those projected in any forward-looking statements we make.  All forward-looking statements are based on beliefs, assumptions and expectations of our future performance, taking into account all information currently available.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.  New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us.  Except as required by law, we are not obligated to,

62

and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Business/General

We are an internally-managed REIT primarily engaged in the business of investing, on a leveraged basis, in residential mortgage assets, including residential whole loans, residential mortgage securities and MSR-related assets.  Our principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. We selectively invest in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.

As previously disclosed, related to the impact of the unprecedented conditions created by the COVID-19 pandemic, during the first and second quarters we engaged in asset sales and took other actions that significantly changed our asset composition. In particular, we sold our remaining Agency MBS and substantially all of our Legacy Non-Agency MBS portfolio, and substantially reduced our investments in MSR-related assets and CRT securities. During the third quarter we sold our remaining Legacy Non-Agency MBS. As a result of these actions, our primary investment asset as of September 30, 2020 is our residential whole loan portfolio. During the second quarter, to further help stabilize our financial position and liquidity, we entered into a $500 million senior secured credit agreement. In addition, during the second quarter, in conjunction with our previously disclosed exit from forbearance arrangements with lenders, we entered into several new asset-backed financing arrangements and renegotiated financing arrangements for certain assets with existing lenders, that resulted in us essentially refinancing the majority of our investment portfolio.

During the third quarter, we continued to make significant progress on initiatives to lower the cost of financing our investments with more durable forms of borrowing. For example, we completed a $390 million securitization transaction of Non-QM assets in early September, which generated $92.7 million of additional liquidity and lowered the funding costs for the associated assets by approximately 165 basis points. In addition, following the end of the third quarter we completed a $570 million Non-QM securitization transaction in late October, which generated $125.1 million of additional liquidity and lowered the funding costs for the associated assets by approximately 179 basis points.

Additionally, subsequent to the end of the third quarter we undertook steps to reduce our exposure to higher cost forms of financing that we had obtained in connection with our exit from forbearance in the second quarter. On October 9, 2020, we repaid $400 million of the principal outstanding on the senior secured loan, and the remaining balance of this facility of $81.25 million was repaid on October 30, 2020. The repayments were made without penalty or yield maintenance. These actions will reduce our costs of financing by approximately $9.4 million in the fourth quarter and approximately $53.0 million annually. Following the completion of the second Non-QM securitization described above, the repayment of the senior secured loan and the payment of the dividend to common stockholders on October 30, 2020, our cash totaled approximately $641.1 million.

At September 30, 2020, we had total assets of approximately $7.5 billion, of which $5.6 billion, or 75%, represented residential whole loans acquired through interests in certain trusts established to acquire the loans. Our Purchased Performing Loans, which as of September 30, 2020 comprised approximately 67% of our residential whole loans, include: (i) loans to finance (or refinance) one-to-four family residential properties that are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (or Non-QM loans), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (or Rehabilitation loans or Fix and Flip loans), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (or Single-family rental loans), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (or Seasoned performing loans). In addition, at September 30, 2020, we had approximately $152.8 million in investments in residential mortgage securities, which represented approximately 2% of our total assets.  At such date, this portfolio included $96.3 million of CRT securities and $56.4 million of Non-Agency MBS which were primarily comprised of RPL/NPL MBS. At September 30, 2020, our investments in MSR-related assets were $252.2 million, or 3% of our total assets. Our MSR-related assets include term notes whose cash flows are considered to be largely dependent on MSR collateral and loan participations to provide financing to mortgage originators that own MSRs. Our remaining investment-related assets, which represent approximately 7% of our total assets at September 30, 2020, were primarily comprised of REO, capital contributions made to loan origination partners, other interest-earning assets and MBS and loan-related receivables.

The results of our business operations are affected by a number of factors, many of which are beyond our control, and primarily depend on, among other things, the level of our net interest income and the market value of our assets, which is driven

63

by numerous factors, including the supply and demand for residential mortgage assets in the marketplace, the terms and availability of adequate financing, general economic and real estate conditions (both on a national and local level), the impact of government actions in the real estate and mortgage sector, and the credit performance of our credit sensitive residential mortgage assets. Changes in these factors, or uncertainty in the market regarding the potential for changes in these factors, can result in significant changes in the value and/or performance of our investment portfolio. Further, our GAAP results may be impacted by market volatility, resulting in changes in market values of certain financial instruments for which changes in fair value are recorded in net income each period, such as CRT securities and certain residential whole loans. Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds, the behavior of which involves various risks and uncertainties. Interest rates and conditional prepayment rates (or CPRs) (which measure the amount of unscheduled principal prepayment on an asset as a percentage of the asset balance), vary according to the type of investment, conditions in the financial markets, competition and other factors, none of which can be predicted with any certainty. With the adoption in January 2020 of new accounting standards for the measurement and recognition of credit losses, and given the extent of current and anticipated future investments in residential whole loans, our financial results are impacted by estimates of credit losses that are required to be recorded when loans that are not accounted for at fair value through net income are acquired or originated, as well as changes in these credit loss estimates that will be required to be made periodically.

With respect to our business operations, increases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to increase; (ii) the value of certain of our residential mortgage assets and, correspondingly, our stockholders’ equity to decline; (iii) coupons on our adjustable-rate assets to reset, on a delayed basis, to higher interest rates; (iv) prepayments on our assets to decline, thereby slowing the amortization of purchase premiums and the accretion of our purchase discounts, and slowing our ability to redeploy capital to generally higher yielding investments; and (v) the value of our derivative hedging instruments, if any, and, correspondingly, our stockholders’ equity to increase. Conversely, decreases in interest rates, in general, may over time cause: (i) the interest expense associated with our borrowings to decrease; (ii) the value of certain of our residential mortgage assets and, correspondingly, our stockholders’ equity to increase; (iii) coupons on our adjustable-rate assets, on a delayed basis, to lower interest rates; (iv) prepayments on our assets to increase, thereby accelerating the amortization of purchase premiums and the accretion of our purchase discounts, and accelerating the redeployment of our capital to generally lower yielding investments; and (v) the value of our derivative hedging instruments, if any, and, correspondingly, our stockholders’ equity to decrease.  In addition, our borrowing costs and credit lines are further affected by the type of collateral we pledge and general conditions in the credit market.

Our investments in residential mortgage assets expose us to credit risk, meaning that we are generally subject to credit losses due to the risk of delinquency, default and foreclosure on the underlying real estate collateral. Our investment process for credit sensitive assets focuses primarily on quantifying and pricing credit risk. With respect to investments in Purchased Performing Loans, we believe that sound underwriting standards, including low LTVs at origination, significantly mitigate our risk of loss. Further, we believe the discounted purchase prices paid on certain non-performing and Purchased Credit Deteriorated Loans mitigate our risk of loss in the event that, as we expect on most such investments, we receive less than 100% of the par value of these investments.

Premiums arise when we acquire an MBS at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value) or when we acquire residential whole loans at a price in excess of their aggregate principal balance Conversely, discounts arise when we acquire an MBS at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Accretable purchase discounts on these investments are accreted to interest income. Purchase premiums, which are primarily carried on certain of our CRT securities and Non-QM loans, are amortized against interest income over the life of the investment using the effective yield method, adjusted for actual prepayment activity. An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the interest income earned on these assets.

CPR levels are impacted by, among other things, conditions in the housing market, new regulations, government and private sector initiatives, interest rates, availability of credit to home borrowers, underwriting standards and the economy in general. In particular, CPR reflects the conditional repayment rate (or CRR), which measures voluntary prepayments of a loan, and the conditional default rate (or CDR), which measures involuntary prepayments resulting from defaults. CPRs on our residential mortgage securities and whole loans may differ significantly. For the three months ended September 30, 2020, the weighted average CPR on our Non-QM loan portfolio was 21.8%.

It is generally our business strategy to hold our residential mortgage assets as long-term investments. On at least a quarterly basis, excluding investments for which the fair value option has been elected or for which specialized loan accounting is otherwise applied, we assess our ability and intent to continue to hold each asset and, as part of this process, we monitor our

64

residential mortgage securities and MSR-related assets that are designated as AFS for impairment. A change in our ability and/or intent to continue to hold any of these securities that are in an unrealized loss position, or a deterioration in the underlying characteristics of these securities, could result in our recognizing future impairment charges or a loss upon the sale of any such security.

Our residential mortgage investments have longer-term contractual maturities than our financing liabilities. Even though the majority of our investments have interest rates that adjust over time based on short-term changes in corresponding interest rate indices (typically following an initial fixed-rate period for our Hybrids), the interest rates we pay on our borrowings will typically change at a faster pace than the interest rates we earn on our investments. In order to reduce this interest rate risk exposure, we may enter into derivative instruments, which in the past have generally been comprised of Swaps. The majority of our Swap derivative instruments have generally been designated as cash-flow hedges against a portion of our then current and forecasted LIBOR-based repurchase agreements. Following the significant interest rate decreases that occurred late in the first quarter of 2020, we unwound all of our Swap transactions at the end of the first quarter.

Recent Market Conditions and Our Strategy

Third quarter 2020 Portfolio Activity and impact on financial results:

At September 30, 2020, our residential mortgage asset portfolio, which includes residential whole loans and REO, residential mortgage securities and MSR-related assets, was approximately $6.3 billion compared to $6.6 billion at June 30, 2020.

The following table presents the activity for our residential mortgage asset portfolio for the three months ended September 30, 2020:

(In Millions)	June 30, 2020		Runoff (1)		Acquisitions		Other (2)		September 30, 2020		Change
Residential whole loans and REO	$	6,226	$	(455)	$	40	$	105	$	5,916	$	(310)
MSR-related assets	254		(17)		—		15		252		(2)
Residential mortgage securities	149		(2)		—		6		153		4
Totals	$	6,629	$	(474)	$	40	$	126	$	6,321	$	(308)

(1)    Primarily includes principal repayments, cash collections on Purchased Credit Deteriorated Loans and sales of REO.

(2)    Primarily includes changes in fair value and adjustments to record lower of cost or estimated fair value adjustments on REO.

At September 30, 2020, our total recorded investment in residential whole loans and REO was $5.9 billion, or 93.6% of our residential mortgage asset portfolio. Of this amount, (i) $4.4 billion is presented as Residential whole loans, at carrying value (of which $3.7 billion were Purchased Performing Loans and $650.3 million were Purchased Credit Deteriorated Loans, and (ii) $1.2 billion is presented as Residential whole loans, at fair value, in our consolidated balance sheets. For the three months ended September 30, 2020, we recognized approximately $54.4 million of income on Residential whole loans, at carrying value in Interest Income on our consolidated statements of operations, representing an effective yield of 4.63% (excluding servicing costs), with Purchased Performing Loans generating an effective yield of 4.58% and Purchased Credit Deteriorated Loans generating an effective yield of 4.89%. In addition, we recorded a net gain on residential whole loans measured at fair value through earnings of $76.9 million in Other Income, net in our consolidated statements of operations for the three months ended September 30, 2020. At September 30, 2020 and June 30, 2020, we had REO with an aggregate carrying value of $298.9 million and $348.5 million, respectively, which is included in Other assets on our consolidated balance sheets.

During the three months ended September 30, 2020, economic conditions continued to be negatively impacted by the unprecedented conditions resulting from the COVID-19 pandemic. In response to the financial impact of the COVID-19 pandemic on borrowers, and in compliance with various federal and state guidelines, during the first and second quarters of 2020 we offered short-term relief to borrowers who were contractually current at the time the pandemic started to impact the economy. Under the terms of such plans, for certain borrowers a deferral plan was entered into where missed payments were deferred to the maturity of the related loan, with a corresponding change to the loan’s next payment due date. In addition, certain borrowers were granted up to a three-month payment holiday, with payments required to resume at the conclusion of the plan. For these borrowers, all delinquent payments were contractually due at the conclusion of the payment holiday. While the majority of the borrowers granted relief have resumed making payments at the conclusion of such plans, certain borrowers, particularly in our Non-QM loan portfolio, continue to be impacted financially by the COVID-19 pandemic and have not yet

65

resumed payments. Where these borrowers became more than 90 days delinquent on payments during the quarter, interest income receivable related to the associated loans was reversed in accordance with our non-accrual policies. At September 30, 2020, Non-QM loans with an amortized cost of $163.9 million, or 6.7% of the portfolio, were more than 90 days delinquent. For these and other borrowers that have been impacted by the COVID-19 pandemic, we are continuing to evaluate loss mitigation options with respect to these loans, including forbearance, repayment plans, loan modification and foreclosure.

During the three months ended September 30, 2020, we sold our remaining investments in Legacy Non-Agency MBS for $116,000, realizing net gains of $48,000. As of September 30, 2020, our RPL/NPL MBS portfolio totaled $53.8 million. The net yield on our RPL/NPL MBS portfolio was 7.20% for the three months ended September 30, 2020, compared to 5.18% for the three months ended September 30, 2019. In addition, our investments in MSR-related assets at September 30, 2020 totaled $252.2 million. The net yield on our MSR-related assets was 11.79% for the three months ended September 30, 2020, compared to 5.26% for the three months ended September 30, 2019. Our investments in CRT securities totaled $96.3 million at September 30, 2020.

As previously disclosed, we adopted the new accounting standard addressing the measurement of credit losses on financial instruments (CECL) on January 1, 2020. With respect to our residential whole loans held at carrying value, CECL requires that reserves for credit losses be estimated at the reporting date based on life of loan expected cash flows, including anticipated prepayments and reasonable and supportable forecasts of future economic conditions. For the third quarter, a reversal of the provision for credit and valuation losses of $30.1 million was recorded on residential whole loans held at carrying value. The total allowance for credit losses recorded on residential whole loans held at carrying value at September 30, 2020 was $106.2 million. In addition, as of September 30, 2020, CECL reserves for credit losses totaling approximately $1.6 million were recorded related to undrawn commitments on loans held at carrying value.

Our GAAP book value per common share increased to $4.61 as of September 30, 2020 from $4.51 as of June 30, 2020. Economic book value per common share, a non-GAAP financial measure of our financial position that adjusts GAAP book value by the amount of unrealized mark to market gains on our residential whole loans held at carrying value, was $4.92 as of September 30, 2020, an increase from $4.46 as of June 30, 2020. Increases in GAAP and Economic book value during the third quarter reflect the broad recovery of asset prices for residential mortgage assets. For additional information regarding the calculation of Economic book value per share including a reconciliation to GAAP book value per share, refer to page 85 under the heading “Economic Book Value”.

66

Information About Our Assets

The table below presents certain information about our asset allocation at September 30, 2020:

ASSET ALLOCATION

(Dollars in Millions)	Residential Whole Loans, at Carrying Value (1)			Residential Whole Loans, at Fair Value			Residential Mortgage Securities			MSR-Related Assets			Other, net (2)		Total
Fair Value/Carrying Value	$	4,388		$	1,230		$	153		$	252		$	1,395	$	7,418
Financing Agreements with non-mark-to-market collateral provisions	(1,471)			(256)			—			—			—		(1,727)
Financing Agreements with mark-to-market collateral provisions	(1,038)			(193)			(89)			(135)			(35)		(1,490)
Less Senior secured credit agreement	—			—			—			—			(474)		(474)
Less Securitized Debt	(470)			(369)			—			—			—		(839)
Less Convertible Senior Notes	—			—			—			—			(225)		(225)
Less Senior Notes	—			—			—			—			(97)		(97)
Net Equity Allocated	$	1,409		$	412		$	64		$	117		$	564	$	2,566
Debt/Net Equity Ratio (3)	2.1		x	2.0		x	1.4		x	1.2		x			1.9		x

(1)Includes $2.4 billion of Non-QM loans, $677.2 million of Rehabilitation loans, $474.0 million of Single-family rental loans, $147.6 million of Seasoned performing loans, and $650.3 million of Purchased Credit Deteriorated Loans. At September 30, 2020, the total fair value of these loans is estimated to be approximately $4.5 billion.

(2)Includes $884.2 million of cash and cash equivalents, $5.3 million of restricted cash, $298.9 million of real estate owned, and $108.9 million of capital contributions made to loan origination partners, as well as other assets and other liabilities.    

(3)Total Debt/Net Equity ratio represents the sum of borrowings under our financing agreements noted above as a multiple of net equity allocated. 

67

Residential Whole Loans

The following table presents the contractual maturities of our residential whole loan portfolios at September 30, 2020. Amounts presented do not reflect estimates of prepayments or scheduled amortization.

(In Thousands)	Purchased Performing Loans (1)		Purchased Credit Deteriorated Loans (2)		Residential Whole Loans, at Fair Value
Amount due:
Within one year	$	648,713	$	707	$	4,614
After one year:
Over one to five years	86,090		4,383		5,452
Over five years	3,056,989		696,923		1,219,598
Total due after one year	$	3,143,079	$	701,306	$	1,225,050
Total residential whole loans	$	3,791,792	$	702,013	$	1,229,664

(1)Excludes an allowance for credit losses of $54.6 million at September 30, 2020.

(2)Excludes an allowance for credit losses of $51.7 million at September 30, 2020.

The following table presents, at September 30, 2020, the dollar amount of certain of our residential whole loans, contractually maturing after one year, and indicates whether the loans have fixed interest rates or adjustable interest rates:

(In Thousands)	Purchased Performing Loans (1)(2)		Purchased Credit  Deteriorated Loans (1)(3)		Residential Whole Loans, at Fair Value (1)
Interest rates:
Fixed	$	1,027,710	$	483,308	$	889,006
Adjustable	2,115,369		217,998		336,044
Total	$	3,143,079	$	701,306	$	1,225,050

(1)Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of September 30, 2020.

(2)Excludes an allowance for credit losses of $54.6 million at September 30, 2020.

(3)Excludes an allowance for credit losses of $51.7 million at September 30, 2020.

Residential Mortgage Securities

Non-Agency MBS

The following table presents information with respect to our Non-Agency MBS at September 30, 2020 and December 31, 2019. During the three months ended June 30, 2020, we disposed of substantially all of our investments in Legacy Non-Agency MBS:

(In Thousands)	September 30, 2020		December 31, 2019
Non-Agency MBS
Face/Par	$	60,295	$	2,195,303
Fair Value	56,430		2,063,529
Amortized Cost	51,380		1,668,088
Purchase Discount Designated as Credit Reserve	(669)		(436,598)
Purchase Discount Designated as Accretable	(8,246)		(90,617)

68

CRT Securities

At September 30, 2020, our total investment in CRT securities was $96.3 million, with a net unrealized gain of $10.6 million, a weighted average yield of 7.11% and a weighted average time to maturity of 18.7 years. At December 31, 2019, our total investment in CRT securities was $255.4 million, with a net unrealized gain of $6.2 million, a weighted average yield of 4.18% and weighted average time to maturity of 10.3 years.

Agency MBS

During the six months ended June 30, 2020, we disposed of all of our Agency MBS. At December 31, 2019, our total investment in Agency MBS was $1.7 billion, with a net unrealized loss of $3.4 million, a weighted average coupon of 3.83%.

MSR-Related Assets

At September 30, 2020 and December 31, 2019, we had $234.1 million and $1.2 billion, respectively, of term notes issued by SPVs that have acquired the rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. At September 30, 2020, these term notes had an amortized cost of $184.5 million, net unrealized gains of $49.5 million, a weighted average yield of 12.10% and a weighted average term to maturity of 9.5 years. At December 31, 2019, these term notes had an amortized cost of $1.2 billion, gross unrealized losses of approximately $5.2 million, a weighted average yield of 4.75% and a weighted average term to maturity of 5.3 years.

We have participated in a loan where we committed to lend $32.6 million of which approximately $18.1 million was drawn at September 30, 2020. At September 30, 2020, the coupon paid by the borrower on the drawn amount is 5.52%. The facility expires in 11 months.

Tax Considerations

Current period estimated taxable income

We estimate that for the nine months ended September 30, 2020, our taxable income was approximately $56.6 million. We have until the filing of our 2020 tax return (due not later than October 15, 2021) to declare the distribution of any 2020 REIT taxable income not previously distributed.

Key differences between GAAP net income and REIT Taxable Income for Residential Mortgage Securities and Residential Whole Loans

Our total Non-Agency MBS portfolio for tax differs from our portfolio reported for GAAP primarily due to the fact that for tax purposes: (i) certain of the MBS contributed to the VIEs used to facilitate MBS resecuritization transactions were deemed to be sold; and (ii) the tax basis of underlying MBS considered to be reacquired in connection with the unwind of such transactions became the fair value of such securities at the time of the unwind. For GAAP reporting purposes the underlying MBS that were included in these MBS resecuritization transactions were not considered to be sold. Similarly, for tax purposes the residential whole loans contributed to the VIE used to facilitate our second quarter 2017 loan securitization transaction were deemed to be sold for tax purposes, but not for GAAP reporting purposes. In addition, for our Non-Agency MBS and residential whole loan tax portfolios, potential timing differences arise with respect to the accretion of discount and amortization of premium into income as well as the recognition of realized losses for tax purposes as compared to GAAP. Further, use of fair value accounting for certain residential mortgage securities and residential whole loans for GAAP, but not for tax, also gives rise to potential timing differences. Consequently, our REIT taxable income calculated in a given period may differ significantly from our GAAP net income.

The determination of taxable income attributable to Non-Agency MBS and residential whole loans is dependent on a number of factors, including principal payments, defaults, loss mitigation efforts and loss severities. In estimating taxable income for Non-Agency MBS and residential whole loans during the year, management considers estimates of the amount of discount expected to be accreted. Such estimates require significant judgment and actual results may differ from these estimates. Moreover, the deductibility of realized losses from Non-Agency MBS and residential whole loans and their effect on discount accretion and premium amortization are analyzed on an asset-by-asset basis and, while they will result in a reduction of taxable income, this reduction tends to occur gradually and, primarily for Non-Agency MBS, in periods after the realized losses are reported. In addition, for securitization and resecuritization transactions that were treated as a sale of the underlying

69

MBS or residential whole loans for tax purposes, taxable gain or loss, if any, resulting from the unwind of such transactions is not recognized in GAAP net income.

Securitization transactions result in differences between GAAP net income and REIT Taxable Income

For tax purposes, depending on the transaction structure, a securitization and/or resecuritization transaction may be treated either as a sale or a financing of the underlying collateral. Income recognized from securitization and resecuritization transactions will differ for tax and GAAP purposes. For tax purposes, we own and may in the future acquire interests in securitization and/or resecuritization trusts, in which several of the classes of securities are or will be issued with original issue discount (or OID). As the holder of the retained interests in the trust, we generally will be required to include OID in our current gross interest income over the term of the applicable securities as the OID accrues. The rate at which the OID is recognized into taxable income is calculated using a constant rate of yield to maturity, with realized losses impacting the amount of OID recognized in REIT taxable income once they are actually incurred. For tax purposes, REIT taxable income may be recognized in excess of economic income (i.e., OID) or in advance of the corresponding cash flow from these assets, thereby affecting our dividend distribution requirement to stockholders. In addition, for securitization and/or resecuritization transactions that were treated as a sale of the underlying collateral for tax purposes, the unwinding of any such transaction will likely result in a taxable gain or loss that is likely not recognized in GAAP net income since securitization and resecuritization transactions are typically accounted for as financing transactions for GAAP purposes. The tax basis of underlying residential whole loans or MBS re-acquired in connection with the unwind of such transactions becomes the fair market value of such assets at the time of the unwind.

Taxable income of consolidated TRS subsidiaries is included in GAAP income, but may not be included in REIT Taxable Income

Net income generated by our TRS subsidiaries is included in consolidated GAAP net income, but may not be included in REIT taxable income in the same period. Net income of U.S. domiciled TRS subsidiaries is included in REIT taxable income when distributed by the TRS. Net income of foreign domiciled TRS subsidiaries is included in REIT taxable income as if distributed to the REIT in the taxable year it is earned by the foreign domiciled TRS.

Regulatory Developments

The U.S. Congress, Federal Reserve, U.S. Treasury, Federal Deposit Insurance Corporation, SEC and other governmental and regulatory bodies have taken and continue to consider additional actions in response to the 2007-2008 financial crisis. In particular, the Dodd-Frank Wall Street Reform and Consumer Protection Act (or the Dodd-Frank Act) created a new regulator, an independent bureau housed within the Federal Reserve System known as the Consumer Financial Protection Bureau (or the CFPB). The CFPB has broad authority over a wide range of consumer financial products and services, including mortgage lending and servicing. One portion of the Dodd-Frank Act, the Mortgage Reform and Anti-Predatory Lending Act (or Mortgage Reform Act), contains underwriting and servicing standards for the mortgage industry, restrictions on compensation for mortgage loan originators, and various other requirements related to mortgage origination and servicing. In addition, the Dodd-Frank Act grants enforcement authority and broad discretionary regulatory authority to the CFPB to prohibit or condition terms, acts or practices relating to residential mortgage loans that the CFPB finds abusive, unfair, deceptive or predatory, as well as to take other actions that the CFPB finds are necessary or proper to ensure responsible affordable mortgage credit remains available to consumers. The Dodd-Frank Act also affects the securitization of mortgages (and other assets) with requirements for risk retention by securitizers and requirements for regulating rating agencies.

Numerous regulations have been issued pursuant to the Dodd-Frank Act, including regulations regarding mortgage loan servicing, underwriting and loan originator compensation and others could be issued in the future. As a result, we are unable to fully predict at this time how the Dodd-Frank Act, as well as other laws or regulations that may be adopted in the future, will affect our business, results of operations and financial condition, or the environment for repurchase financing and other forms of borrowing, the investing environment for Agency MBS, Non-Agency MBS and/or residential mortgage loans, the securitization industry, Swaps and other derivatives. We believe that the Dodd-Frank Act and the regulations promulgated thereunder are likely to continue to increase the economic and compliance costs for participants in the mortgage and securitization industries, including us.

70

In addition to the regulatory actions being implemented under the Dodd-Frank Act, on August 31, 2011, the SEC issued a concept release under which it is reviewing interpretive issues related to Section 3(c)(5)(C) of the Investment Company Act. Section 3(c)(5)(C) excludes from the definition of “investment company” entities that are primarily engaged in, among other things, “purchasing or otherwise acquiring mortgages and other liens on and interests in real estate.” Many companies that engage in the business of acquiring mortgages and mortgage-related instruments seek to rely on existing interpretations of the SEC Staff with respect to Section 3(c)(5)(C) so as not to be deemed an investment company for the purpose of regulation under the Investment Company Act. In connection with the concept release, the SEC requested comments on, among other things, whether it should reconsider its existing interpretation of Section 3(c)(5)(C). To date the SEC has not taken or otherwise announced any further action in connection with the concept release.

The Federal Housing Finance Agency (or FHFA) and both houses of Congress have discussed and considered separate measures intended to restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac. Congress may continue to consider legislation that would significantly reform the country’s mortgage finance system, including, among other things, eliminating Freddie Mac and Fannie Mae and replacing them with a single new MBS insurance agency. Many details remain unsettled, including the scope and costs of the agencies’ guarantee and their affordable housing mission, some of which could be addressed even in the absence of large-scale reform. On March 27, 2019, President Trump issued a memorandum on federal housing finance reform that directed the Secretary of the Treasury to develop a plan for administrative and legislative reforms as soon as practicable to achieve the following housing reform goals: 1) ending the conservatorships of the Government-sponsored enterprises (or GSEs) upon the completion of specified reforms; 2) facilitating competition in the housing finance market; 3) establishing regulation of the GSEs that safeguards their safety and soundness and minimizes the risks they pose to the financial stability of the United States; and 4) providing that the federal government is properly compensated for any explicit or implicit support it provides to the GSEs or the secondary housing finance market. On September 5, 2019, in response to President Trump’s memorandum, the U.S. Department of the Treasury released a plan, developed in conjunction with the FHFA, the Department of Housing and Urban Development, and other government agencies, which includes legislative and administrative reforms to achieve each of these reform goals. At this point, it remains unclear whether any of these legislative or regulatory reforms will be enacted or implemented. The prospects for passage of any of these plans are uncertain, but the proposals underscore the potential for change to Fannie Mae and Freddie Mac. On May 20, 2020, in connection with its stated intention to responsibly end the conservatorship of the GSEs, the FHFA issued a notice of proposed rulemaking and request for comments (“Proposed Rule”) on a new regulatory capital framework for Fannie Mae and Freddie Mac. The Proposed Rule is a re-proposal of the regulatory capital framework originally proposed in 2018 that would have established new risk-based capital requirements for the GSEs and updated the minimum leverage requirements. The re-proposal contains enhancements to establish a post-conservatorship regulatory capital framework that ensures that each Enterprise operates in a safe and sound manner and is positioned to fulfill its statutory mission to provide stability and ongoing assistance to the secondary mortgage market across the economic cycle, in particular during periods of financial stress. Comments on the Proposed Rule are due 60 days after publication in in the Federal Register.

While the likelihood of enactment of major mortgage finance system reform in the short term remains uncertain, it is possible that the adoption of any such reforms could adversely affect the types of assets we can buy, the costs of these assets and our business operations.  As the FHFA and both houses of Congress continue to consider various measures intended to dramatically restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac, we expect debate and discussion on the topic to continue throughout 2020, and we cannot be certain whether alternative plans may be proposed by the Trump Administration, if any housing and/or mortgage-related legislation will emerge from committee or be approved by Congress, or the extent to which administrative reforms may be implemented, and if so, what the effect would be on our business.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law. Among the provisions in this wide-ranging law are protections for homeowners experiencing financial difficulties due to the COVID-19 pandemic, including forbearance provisions and procedures. Borrowers with federally backed mortgage loans, regardless of delinquency status, may request loan forbearance for a six-month period, which could be extended for another six-month period if necessary. Federally backed mortgage loans are loans secured by first- or subordinate-liens on 1-4 family residential real property, including individual units of condominiums and cooperatives, which are insured or guaranteed pursuant to certain government housing programs, such as by the Federal Housing Administration, Federal Housing Administration, or U.S. Department of Agriculture, or are purchased or securitized by Fannie Mae or Freddie Mac. The CARES Act also includes a temporary 60 day foreclosure moratorium that applies to federally backed mortgage loans, which lasted until July 24, 2020. However, the moratorium has been extended to December 31, 2020 by Fannie Mae, Federal Housing Administration and the U.S. Department of Agriculture. Some states and local jurisdictions have also implemented moratoriums on foreclosures.

71

Results of Operations

Quarter Ended September 30, 2020 Compared to the Quarter Ended September 30, 2019

General

For the third quarter of 2020, we had net income available to our common stock and participating securities of $79.0 million, or $0.17 per basic and diluted common share, compared to net income available to common stock and participating securities of $91.8 million, or $0.20 per basic and diluted common share, for the third quarter of 2019. Following the unprecedented disruption in residential mortgage markets due to concerns related to the COVID-19 pandemic that was experienced late in first quarter and into the second quarter of 2020, management focused on taking actions to bolster and stabilize our balance sheet including significant sales of assets to improve our liquidity position and renegotiated the financing associated with our remaining investments. The combination of the impact of assets sales as well as higher interest expense incurred related to these new financing transactions that we entered into late in the second quarter resulted in the significant reduction in net interest income from our investments in the current quarter compared to the prior year period. In addition, in the current period, we recorded lower net realized gains on sales of residential mortgage assets. These decreases were partially offset by higher gains on our residential whole loans measured at fair value through earnings and a reversal of a portion of our provision for credit losses on residential whole loans held at carrying values.

Net Interest Income

Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities. Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid. Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our investments. Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond or loan as a percentage of its unpaid balance) vary according to the type of investment, conditions in the financial markets and other factors, none of which can be predicted with any certainty.

The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”

For the third quarter of 2020, our net interest spread and margin were 0.03% and 0.76%, respectively, compared to a net interest spread and margin of 1.82% and 2.19%, respectively, for the third quarter of 2019. Our net interest income decreased by $46.8 million, or 82.22%, to $10.1 million for the third quarter of 2020 compared to net interest income of $56.9 million for the third quarter of 2019. For the third quarter of 2020, net interest income for our residential mortgage securities and MSR-related asset portfolios decreased by approximately $30.4 million compared to the third quarter of 2019, primarily due to lower average amounts invested in these securities due to portfolio sales in the first and second quarters of 2020. In addition, net interest income includes lower net interest income from residential whole loans held at carrying value of approximately $7.6 million compared to the third quarter of 2019 primarily due to lower yields earned on these assets, an increase in our average borrowings to finance our residential whole loans at carrying value portfolio, which was partially offset by lower funding costs for and higher average amounts invested in these assets. We also incurred approximately $13.8 million in interest expense related to the senior secured credit agreement we entered into during the second quarter of 2020. Net interest income for the third quarter of 2020 also includes $8.1 million of interest expense associated with residential whole loans held at fair value, reflecting a $3.6 million decrease in borrowing costs related to these investments compared to the third quarter of 2019, as a result of a decrease in our average balance to finance these assets. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.

72

Analysis of Net Interest Income

The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the three months ended September 30, 2020 and 2019. Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown. The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.

	Three Months Ended September 30,
	2020						2019
(Dollars in Thousands)	Average Balance		Interest		Average Yield/Cost		Average Balance		Interest		Average Yield/Cost
Assets:
Interest-earning assets:
Residential whole loans, at carrying value (1)	$	4,699,124	$	54,393	4.63	%	$	4,604,305	$	64,226	5.58	%
Agency MBS (2)	—		—		—		2,037,817		11,806		2.32
Legacy Non-Agency MBS (2)	2,253		48		8.52		1,214,589		31,347		10.32
RPL/NPL MBS (2)	50,293		905		7.20		1,021,398		13,235		5.18
Total MBS	52,546		953		7.25		4,273,804		56,388		5.28
CRT securities (2)	85,529		1,376		6.44		390,051		4,251		4.36
MSR-related assets (2)	211,791		6,241		11.79		1,160,627		15,274		5.26
Cash and cash equivalents (3)	754,493		100		0.05		199,070		903		1.81
Other interest-earning assets	123,073		3,017		9.81		105,867		1,679		6.34
Total interest-earning assets	5,926,556		66,080		4.46		10,733,724		142,721		5.32
Total non-interest-earning assets	1,650,120						2,448,754
Total assets	$	7,576,676					$	13,182,478
Liabilities and stockholders’ equity:
Interest-bearing liabilities:
Collateralized financing agreements (4)(5)	$	3,511,403	$	30,929	3.45	%	$	8,654,350	$	74,240	3.36	%
Securitized debt (6)	607,893		5,318		3.42		617,689		5,692		3.61
Convertible Senior Notes	224,666		3,898		6.94		223,496		3,879		6.94
Senior Notes	96,891		2,012		8.31		96,842		2,012		8.31
Senior secured credit agreement	499,796		13,807		11.00		—		—		—
Total interest-bearing liabilities	4,940,649		55,964		4.43		9,592,377		85,823		3.50
Total non-interest-bearing liabilities	118,145						189,429
Total liabilities	5,058,794						9,781,806
Stockholders’ equity	2,517,882						3,400,672
Total liabilities and stockholders’ equity	$	7,576,676					$	13,182,478
Net interest income/net interest rate spread (7)			$	10,116	0.03	%			$	56,898	1.82	%
Net interest-earning assets/net interest margin (8)	$	985,907			0.76	%	$	1,141,347			2.19	%

(1)Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.

(2)Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.

(3)Includes average interest-earning cash, cash equivalents and restricted cash.

(4)Collateralized financing agreements include the following: Secured term notes, Non-mark-to-market term-asset based financing and repurchase agreements. For additional information, see Note 6, included under Item 1 of this Quarterly Report on Form 10-Q.

(5)Average cost of financing agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.

(6)Includes both Securitized debt, at carrying value and Securitized debt, at fair value.

(7)Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.

(8)Net interest margin reflects annualized net interest income divided by average interest-earning assets.

73

Rate/Volume Analysis

The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated. Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change. The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.

	Three Months Ended September 30, 2020
	Compared to
	Three Months Ended September 30, 2019
	Increase/(Decrease) due to				Total Net Change in Interest Income/Expense
(In Thousands)	Volume		Rate
Interest-earning assets:
Residential whole loans, at carrying value (1)	$	1,299	$	(11,132)	$	(9,833)
Residential mortgage securities	(72,235)		13,925		(58,310)
MSR-related assets	(18,637)		9,604		(9,033)
Cash and cash equivalents	705		(1,508)		(803)
Other interest-earning assets	307		1,031		1,338
Total net change in income from interest-earning assets	$	(88,561)	$	11,920	$	(76,641)
Interest-bearing liabilities:
Residential whole loan at carrying value financing agreements	$	855	$	(3,369)	$	(2,514)
Residential whole loan at fair value financing agreements	(2,216)		(787)		(3,003)
Residential mortgage securities repurchase agreements	(36,909)		6,260		(30,649)
MSR-related assets repurchase agreements	(6,754)		450		(6,304)
Other repurchase agreements	(302)		(539)		(841)
Securitized debt	(89)		(285)		(374)
Convertible Senior Notes and Senior Notes	23		(4)		19
Senior secured credit agreement	13,807		—		13,807
Total net change in expense from interest-bearing liabilities	$	(31,585)	$	1,726	$	(29,859)
Net change in net interest income	$	(56,976)	$	10,194	$	(46,782)

(1)Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets.

74

The following table presents certain quarterly information regarding our net interest spread and net interest margin for the quarterly periods presented:

	Total Interest-Earning Assets and Interest- Bearing Liabilities
	Net Interest Spread (1)		Net Interest Margin (2)
Quarter Ended
September 30, 2020	0.03	%	0.76	%
June 30, 2020	(0.90)		0.02
March 31, 2020	1.82		2.20
December 31, 2019	2.33		2.68
September 30, 2019	1.82		2.19

(1)Reflects the difference between the yield on average interest-earning assets and average cost of funds.

(2)Reflects annualized net interest income divided by average interest-earning assets.

The following table presents the components of the net interest spread earned on our Residential whole loans, at carrying value for the quarterly periods presented:

	Purchased Performing Loans						Purchased Credit Deteriorated Loans						Total Residential Whole Loans, at Carrying Value
Quarter Ended	Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)
September 30, 2020	4.58	%	3.42	%	1.16	%	4.89	%	3.22	%	1.67	%	4.63	%	3.39	%	1.24	%
June 30, 2020	5.17		6.34		(1.17)		5.07		6.03		(0.96)		5.15		6.30		(1.15)
March 31, 2020	5.10		3.44		1.66		4.84		3.39		1.45		5.07		3.43		1.64
December 31, 2019	5.24		3.61		1.63		5.79		3.51		2.28		5.31		3.59		1.72
September 30, 2019	5.55		3.92		1.63		5.76		3.79		1.97		5.58		3.90		1.68

(1)Reflects annualized interest income on Residential whole loans, at carrying value divided by average amortized cost of Residential whole loans, at carrying value. Excludes servicing costs.

(2)Reflects annualized interest expense divided by average balance of repurchase agreements and securitized debt. Total Residential whole loans, at carrying value cost of funding include, 3, 5 and 3 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended March 31, 2020, December 31, 2019 and September 30, 2019, respectively. Cost of funding for the quarter ended June 30, 2020 includes the impact of amortization of $10.7 million of losses previously recorded in OCI related to Swaps unwound during the quarter ended March 31, 2020 that had been previously designated as hedges for accounting purposes. The amortization of these losses increased the funding cost by 116 basis points for Purchased Performing Loans, 107 basis points for Purchased Credit Deteriorated Loans, and 115 basis points for total Residential whole loans, at carrying value during the quarter ended June 30, 2020. At June 30, 2020, following the closing of certain financing transactions and our exit from forbearance arrangements, and an evaluation of our anticipated future financing transactions, $49.9 million of unamortized losses on Swaps previously designated as hedges for accounting purposes was transferred from OCI to earnings, as it was determined that certain financing transactions that were previously expected to be hedged by these Swaps were no longer probable of occurring. In addition, cost of funding for the quarter ended June 30, 2020 is significantly higher than prior periods as it reflects default interest and/or higher rates charged by lenders while we were under a forbearance agreement. In addition, during the quarter ended September 30, 2020, we transferred from AOCI to earnings approximately $7.2 million of losses on Swaps that had been previously designated as hedges for accounting purposes as we had assessed that the underlying transactions were no longer probable of occurring.

(3)Reflects the difference between the net yield on average Residential whole loans, at carrying value and average cost of funds on Residential whole loans, at carrying value.

75

The following table presents the components of the net interest spread earned on our residential mortgage securities and MSR-related assets for the quarterly periods presented:

	Residential Mortgage Securities						MSR-Related Assets
Quarter Ended	Net Yield (1)		Cost of Funding (2)		Net Interest Rate Spread (3)		Net Yield (1)		Cost of Funding		Net Interest Rate Spread (3)
September 30, 2020	6.75	%	3.60	%	3.15	%	11.79	%	3.43	%	8.36	%
June 30, 2020	6.09		5.23		0.86		9.96		6.21		3.75
March 31, 2020	5.40		2.72		2.68		4.74		2.56		2.18
December 31, 2019	6.54		3.26		3.28		4.88		2.82		2.06
September 30, 2019	7.44		3.21		4.23		5.26		3.23		2.03

(1)Reflects annualized interest income on divided by average amortized cost.

(2)Reflects annualized interest expense divided by average balance of repurchase agreements, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency MBS cost of funding includes 78, 36 and 1 basis points and Legacy Non-Agency MBS cost of funding includes 52, 24, and 1 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended March 31, 2020, December 31, 2019 and September 30, 2019, respectively. Cost of funding for the quarter ended June 30, 2020 includes the impact of amortization of $278,000 of losses previously recorded in OCI related to Swaps unwound during the quarter ended March 31, 2020 that had been previously designated as hedges for accounting purposes. The amortization of these losses increased the funding cost by 174 basis points for total RPL/NPL MBS during the quarter ended June 30, 2020. At June 30, 2020, following the closing of certain financing transactions and our exit from forbearance arrangements, and an evaluation of our anticipated future financing transactions, $49.9 million of unamortized losses on Swaps previously designated as hedges for accounting purposes was transferred from OCI to earnings, as it was determined that certain financing transactions that were previously expected to be hedged by these Swaps were no longer probable of occurring. In addition, during the quarter ended September 30, 2020, we transferred from AOCI to earnings approximately $7.2 million of losses on Swaps that had been previously designated as hedges for accounting purposes as we had assessed that the underlying transactions were no longer probable of occurring.

(3)Reflects the difference between the net yield on average and average cost of funds.

Interest Income

Interest income on our residential whole loans held at carrying value decreased by $9.8 million, or 15.3%, for the third quarter of 2020, to $54.4 million compared to $64.2 million for the third quarter of 2019. This decrease primarily reflects a decrease in the yield (excluding servicing costs) to 4.63% for the third quarter of 2020 from 5.58% for the third quarter of 2019 partially offset by a $94.8 million increase in the average balance of this portfolio to $4.7 billion for the third quarter of 2020 from $4.6 billion for the third quarter of 2019.

Due to previously discussed asset sales, the average amortized cost of our residential mortgage securities portfolio decreased $4.5 billion to $138.1 million for the third quarter of 2020 from $4.7 billion for the third quarter of 2019 and interest income on our residential mortgage securities portfolio decreased $58.3 million to $2.3 million for the third quarter of 2020 from $60.6 million for the third quarter of 2019. In addition, interest income on our MSR-related assets decreased $9.0 million to $6.2 million for the third quarter of 2020 from $15.3 million for the third quarter of 2019 primarily reflecting a $948.8 million decrease in the average amortized cost of this portfolio to $211.8 million for the third quarter of 2020 from $1.2 billion for the third quarter of 2019, partially offset by an increase in the yield on this portfolio to 11.79% for the third quarter of 2020 from 5.26% for the third quarter of 2019. The increase in yield noted in the third quarter was as a result of the impairment charges taken in the first quarter of 2020 that resulted in an adjustment to the amortized cost of these assets.

Interest Expense

Our interest expense for the third quarter of 2020 decreased by $29.9 million, or 34.8%, to $56.0 million from $85.8 million for the third quarter of 2019.  This decrease primarily reflects a decrease in our average repurchase agreement borrowings to finance our residential mortgage securities portfolio and MSR-related assets partially offset by approximately $13.8 million in interest expense incurred in the current period related to the senior secured credit agreement we entered into during the second quarter of 2020. The effective interest rate paid on our borrowings increased to 4.43% for the quarter ended September 30, 2020 from 3.50% for the quarter ended September 30, 2019. 

76

Provision for Credit and Valuation Losses on Residential Whole Loans Held at Carrying Value and Held-for-Sale

For the third quarter of 2020, we recorded a reversal of provision for credit losses on residential whole loans held at carrying value of $30.5 million (which includes a reversal of our provision for credit losses on undrawn commitments of $478,000). The reversal for the period reflects an adjustment to certain macro-economic inputs to our loan loss estimates and lower loan balances. For the third quarter of 2019, we recorded a provision of $347,000.

Other Income, net

For the third quarter of 2020, Other Income, net increased $14.7 million, or 23.5%, to $77.1 million compared to $62.4 million for the third quarter of 2019.  The components of Other Income, net for the third quarter of 2020 and 2019 are summarized in the table below:

	Quarter Ended September 30,
(In Thousands)	2020		2019
Net gain on residential whole loans measured at fair value through earnings	$	76,871	$	40,175
Transfer from OCI of loss on swaps previously designated as hedges for accounting purposes	(7,177)		—
Liquidation gains on Purchased Credit Deteriorated Loans and other loan related income	1,694		4,189
Impairment and other losses on securities available-for-sale and other assets	(221)		—
Net unrealized gain/(loss) on residential mortgage securities measured at fair value through earnings	91		(695)
Net realized gain on sales of residential mortgage securities	48		17,708
Other	5,804		1,052
Total Other Income, net	$	77,110	$	62,429

Operating and Other Expense

For the third quarter of 2020, we had compensation and benefits and other general and administrative expenses of $18.3 million, or 2.90% of average equity, compared to $12.9 million, or 1.52% of average equity, for the third quarter of 2019. Compensation and benefits expense increased by approximately $3.7 million to $11.7 million for the third quarter of 2020, compared to $7.9 million for the third quarter of 2019, primarily reflecting a provision for estimated severance costs in connection with a reduction in workforce that occurred in the third quarter of 2020. Our other general and administrative expenses increased by $1.6 million to $6.6 million for the quarter ended September 30, 2020, compared to $5.0 million for the third quarter of 2019, primarily due to higher Directors compensation costs as the annual grant of equity awards to non-employee Directors pursuant to the director compensation program occurred in the third quarter of 2020 rather than in the second quarter as was the case in the prior year period. In addition, higher costs for professional services, corporate insurance and administrative costs associated with financing arrangements were partially offset by lower data analytic and other IT related costs.

Operating and Other Expense for the third quarter of 2020 also includes $9.0 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses decreased compared to the prior year period by approximately $1.4 million, or 13.9%, primarily due to lower non recoverable advances and servicing fees on our residential whole loan and REO portfolios and lower loan acquisition related expenses than the prior year period, largely offset by costs related to loan securitization activities.

77

Selected Financial Ratios

The following table presents information regarding certain of our financial ratios at or for the dates presented:

At or for the Quarter Ended	Return on Average Total Assets (1)		Return on Average Total Stockholders’ Equity (2)(3)		Total Average Stockholders’ Equity to Total Average Assets (4)		Dividend Payout Ratio (5)	Leverage Multiple (6)	Book Value per Share of Common Stock (7)		Economic Book Value per Share of Common Stock (8)
September 30, 2020	4.17	%	13.85	%	33.23	%	0.29	1.9	$	4.61	$	4.92
June 30, 2020	4.33		15.70		30.08		—	2.0	4.51		4.46
March 31, 2020	(26.72)		(26.58)		24.99		—	3.4	4.34		4.09
December 31, 2019	2.92		11.90		25.48		0.95	3.0	7.04		7.44
September 30, 2019	2.79		11.24		25.80		1.00	2.8	7.09		7.41

(1)Reflects annualized net income available to common stock and participating securities divided by average total assets.

(2)Reflects annualized net income divided by average total stockholders’ equity.

(3)For the quarter ended March 31, 2020, the amount calculated reflects the quarterly net income divided by average total stockholders’ equity.

(4)Reflects total average stockholders’ equity divided by total average assets.

(5)Reflects dividends declared per share of common stock divided by earnings per share.

(6)Represents the sum of our borrowings under financing agreements and payable for unsettled purchases divided by stockholders’ equity.

(7)Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

(8)“Economic book value” is a non-GAAP financial measure of our financial position. To calculate our Economic book value, our portfolios of Residential whole loans at carrying value are adjusted to their fair value, rather than the carrying value that is required to be reported under the GAAP accounting model applied to these loans. For additional information please refer to page 85 under the heading “Economic Book Value”.

Nine Month Period Ended September 30, 2020 Compared to the Nine Month Period Ended September 30, 2019

General

For the nine months ended September 30, 2020, we had a net loss available to our common stock and participating securities of $746.8 million, or $1.65 per basic and diluted common share, compared to net income available to common stock and participating securities of $266.2 million, or $0.59 per basic common share and $0.58 per diluted common share, for the nine months ended September 30, 2019. Following the unprecedented disruption in residential mortgage markets due to concerns related to the COVID-19 pandemic that was experienced late in first quarter and into the second quarter of 2020, management was focused on taking actions to bolster and stabilize our balance sheet, improve our liquidity position and renegotiate the financing associated with our remaining investments. During the second quarter, we sold our remaining Agency MBS and substantially all of our Legacy Non-Agency MBS portfolio and substantially reduced our investments in MSR-related assets and CRT securities. During the third quarter, we sold our remaining Legacy Non-Agency MBS. In addition, as we had entered into forbearance agreements with the majority of our remaining lenders that were in place for most of the second quarter, our financing costs were dramatically increased during this period. The combination of the impact of asset sales and higher financing costs during the forbearance period resulted in the significant reduction in net interest income from our investments. During the nine months ended September 30, 2020, we also incurred unusually high professional services and other costs in connection with negotiating forbearance arrangements with our lenders, entering into new financing arrangements and reinstating prior financing arrangements on the exit from forbearance. In addition, during the nine months ended September 30, 2020, we recorded impairment losses on securities available-for-sale, net realized losses on sales of residential mortgage securities and residential whole loans, losses on terminated Swaps that had previously been designated as hedges for accounting purposes were transferred from OCI to earnings, and unrealized losses on residential mortgage securities measured at fair value through earnings. These decreases were partially offset by net gains on our residential whole loans measured at fair value through earnings. Further, we recorded a provision for credit losses on residential whole loans held at carrying value of $32.4 million, which includes a provision for credit losses on undrawn commitments of $1.6 million, during the nine months ended September 30, 2020.

Net Interest Income

78

Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities.  Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our investments.  Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond or loan as a percentage of its unpaid balance) vary according to the type of investment, conditions in the financial markets and other factors, none of which can be predicted with any certainty.

The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”

For the nine months ended September 30, 2020, our net interest spread and margin were 0.65% and 1.25%, respectively, compared to a net interest spread and margin of 1.90% and 2.29%, respectively, for the nine months ended September 30, 2019. Our net interest income decreased by $107.5 million, or 60.2%, to $71.2 million for the nine months ended September 30, 2020, from $178.7 million for the nine months ended September 30, 2019.  For the nine months ended September 30, 2020, net interest income for our residential mortgage securities and MSR-related asset portfolios decreased by approximately $79.5 million compared to the nine months ended September 30, 2019, primarily due to lower average amounts invested in these securities due to portfolio sales in the current period. In addition, we also incurred approximately $14.6 million in interest expense related to the senior secured credit agreement we entered into during the second quarter of 2020 and approximately $6.6 million higher interest expense on our Convertible Senior Notes issued in June 2019. Net interest income also includes lower net interest income from residential whole loans held at carrying value of approximately $14.2 million for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 primarily due to higher average amounts invested in these assets partially offset by higher funding costs as a result of entering into forbearance agreements and lower yields earned on our residential whole loans at carrying value portfolio. In addition, net interest income for the nine months ended September 30, 2020 also includes $30.8 million of interest expense associated with residential whole loans held at fair value, reflecting a $3.4 million decrease in borrowing costs related to these investments compared to the nine months ended September 30, 2019. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.

79

Analysis of Net Interest Income

The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the nine months ended September 30, 2020 and 2019.  Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown.  The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.

	Nine Months Ended September 30,
	2020						2019
	Average Balance		Interest		Average Yield/Cost		Average Balance		Interest		Average Yield/Cost
(Dollars in Thousands)
Assets:
Interest-earning assets:
Residential whole loans, at carrying value (1)	$	5,554,592	$	207,306	4.98	%	$	4,011,929	$	171,725	5.71	%
Agency MBS (2)	522,119		8,852		2.26		2,379,289		45,521		2.55
Legacy Non-Agency MBS (2)	356,471		28,786		10.77		1,322,559		106,147		10.70
RPL/NPL MBS (2)	195,495		8,071		5.50		1,182,484		44,463		5.01
Total MBS	1,074,085		45,709		5.67		4,884,332		196,131		5.35
CRT securities (2)	173,033		5,969		4.60		411,273		15,545		5.04
MSR-related assets (2)	598,838		30,189		6.72		959,145		38,232		5.31
Cash and cash equivalents (3)	443,034		646		0.19		186,587		2,703		1.93
Other interest-earning assets	128,565		9,089		9.43		94,708		4,272		6.01
Total interest-earning assets	7,972,147		298,908		5.00		10,547,974		428,608		5.42
Total non-interest-earning assets	1,834,040						2,465,917
Total assets	$	9,806,187					$	13,013,891
Liabilities and stockholders’ equity:
Interest-bearing liabilities:
Collateralized financing agreements (4)(5)	$	5,818,826	$	179,754	4.06	%	$	8,520,981	$	220,939	3.42	%
Securitized debt (6)	568,186		15,673		3.62		646,234		17,834		3.64
Convertible Senior Notes	224,291		11,678		6.94		98,243		5,085		6.94
Senior Notes	96,879		6,038		8.31		96,831		6,035		8.31
Senior secured credit agreement	176,939		14,571		11.00		—		—		—
Total interest-bearing liabilities	6,885,121		227,714		4.35		9,362,289		249,893		3.52
Total non-interest-bearing liabilities	122,635						242,414
Total liabilities	7,007,756						9,604,703
Stockholders’ equity	2,798,431						3,409,188
Total liabilities and stockholders’ equity	$	9,806,187					$13,013,891
Net interest income/net interest rate spread (7)			$	71,194	0.65	%			$	178,715	1.90	%
Net interest-earning assets/net interest margin (8)	$	1,087,026			1.25	%	$	1,185,685			2.29	%

(1)Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.

(2)Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.  

(3)Includes average interest-earning cash, cash equivalents and restricted cash.

(4)Collateralized financing agreements include the following: Secured term notes, Non-mark-to-market term-asset based financing, and repurchase agreements. For additional information, see Note 6, included under Item 1 of this Quarterly Report on Form 10-Q.

(5)Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.

(6)Includes both Securitized debt, at carrying value and Securitized debt, at fair value.

(7)Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.

(8)Net interest margin reflects annualized net interest income divided by average interest-earning assets.

80

Rate/Volume Analysis

The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated.  Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change.  The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.

	Nine Months Ended September 30, 2020
	Compared to
	Nine Months Ended September 30, 2019
	Increase/(Decrease) due to				Total Net Change in Interest Income/Expense
(In Thousands)	Volume		Rate
Interest-earning assets:
Residential whole loans, at carrying value (1)	$	59,688	$	(24,107)	$	35,581
Residential mortgage securities	(167,490)		7,492		(159,998)
MSR-related assets	(16,592)		8,549		(8,043)
Cash and cash equivalents	1,695		(3,752)		(2,057)
Other interest-earning assets	1,862		2,955		4,817
Total net change in income from interest-earning assets	$	(120,837)	$	(8,863)	$	(129,700)
Interest-bearing liabilities:
Residential whole loan at carrying value financing agreements	$	43,522	$	6,512	$	50,034
Residential whole loan at fair value financing agreements	(2,852)		1,381		(1,471)
Residential mortgage securities repurchase agreements	(75,707)		(6,622)		(82,329)
MSR-related assets repurchase agreements	(7,166)		919		(6,247)
Other repurchase agreements	(790)		(382)		(1,172)
Securitized debt	(2,090)		(71)		(2,161)
Convertible Senior Notes and Senior Notes	6,966		(370)		6,596
Senior secured credit agreement	14,571		—		14,571
Total net change in expense of interest-bearing liabilities	$	(23,546)	$	1,367	$	(22,179)
Net change in net interest income	$	(97,291)	$	(10,230)	$	(107,521)

(1)Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets.

81

The following table presents the components of the net interest spread earned on our Residential whole loans, at carrying value for the periods presented:

	Purchased Performing Loans						Purchased Credit Deteriorated Loans						Total Residential Whole Loans, at Carrying Value
Nine Months Ended	Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)		Net Yield (1)		Cost of Funding (2)		Net  Interest Spread (3)
September 30, 2020	4.98	%	4.43	%	0.55	%	4.93	%	4.23	%	0.70	%	4.98	%	4.41	%	0.57	%
September 30, 2019	5.69		4.11		1.58		5.76		3.05		2.71		5.71		3.88		1.83

(1)Reflects annualized interest income on Residential whole loans, at carrying value divided by average amortized cost of Residential whole loans, at carrying value. Excludes servicing costs.

(2)Reflects annualized interest expense divided by average balance of repurchase agreements and securitized debt. Total Residential whole loans, at carrying value cost of funding includes 12 and 5 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the nine months ended September 30, 2020 and 2019, respectively. Cost of funding for the nine months ended September 30, 2020 includes the impact of amortization of $12.3 million of losses previously recorded in OCI related to Swaps unwound during the quarter ended March 31, 2020 that had been previously designated as hedges for accounting purposes. The amortization of these losses increased the funding cost by 45 basis points for Purchased Performing Loans, 36 basis points for Purchased Credit Deteriorated Loans, and 44 basis points for total Residential whole loans, at carrying value. At June 30, 2020, following the closing of certain financing transactions and our exit from forbearance arrangements, and an evaluation of our anticipated future financing transactions, $49.9 million of unamortized losses on Swaps previously designated as hedges for accounting purposes was transferred from OCI to earnings, as it was determined that certain financing transactions that were previously expected to be hedged by these Swaps were no longer probable of occurring. In addition, during the quarter ended September 30, 2020, we transferred from AOCI to earnings approximately $7.2 million of losses on Swaps that had been previously designated as hedges for accounting purposes as we had assessed that the underlying transactions were no longer probable of occurring.

(3)Reflects the difference between the net yield on average Residential whole loans, at carrying value and average cost of funds on Residential whole loans, at carrying value.

The following table presents the components of the net interest spread earned on our residential mortgage securities and MSR-related assets for the periods presented:

	Residential Mortgage Securities						MSR-Related Assets
Nine Months Ended	Net Yield (1)		Cost of Funding (2)		Net Interest Spread (3)		Net Yield (1)		Cost of Funding		Net Interest Spread (3)
September 30, 2020	5.53	%	2.74	%	2.79	%	6.72	%	3.56	%	3.16	%
September 30, 2019	5.33		2.95		2.38		5.31		3.40		1.91

(1) Reflects annualized interest income divided by average amortized cost.

(2) Reflects annualized interest expense divided by average balance of repurchase agreements, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration, and securitized debt. Agency MBS cost of funding includes 33 and 8 basis points and Legacy Non-Agency MBS cost of funding includes 49 and 11 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the nine months ended September 30, 2020 and 2019, respectively. Cost of funding for the nine months ended September 30, 2020 includes the impact of amortization of $278,000 of losses previously recorded in OCI related to Swaps unwound during the quarter ended March 31, 2020 that had been previously designated as hedges for accounting purposes. The amortization of these losses increased the funding cost by 37 basis points for RPL/NPL MBS. At June 30, 2020, following the closing of certain financing transactions and the Company’s exit from forbearance arrangements, and an evaluation of the our anticipated future financing transactions, $49.9 million of unamortized losses on Swaps previously designated as hedges for accounting purposes was transferred from OCI to earnings, as it was determined that certain financing transactions that were previously expected to be hedged by these Swaps were no longer probable of occurring. In addition, during the quarter ended September 30, 2020, we transferred from AOCI to earnings approximately $7.2 million of losses on Swaps that had been previously designated as hedges for accounting purposes as we had assessed that the underlying transactions were no longer probable of occurring.

(3) Reflects the difference between the net yield and average cost of funds.

Interest Income

Interest income on our residential whole loans held at carrying value increased by $35.6 million, or 20.7%, for the nine months ended September 30, 2020 to $207.3 million compared to $171.7 million for the nine months ended September 30, 2019. This increase primarily reflects a $1.5 billion increase in the average balance of this portfolio to $5.6 billion for the nine months ended September 30, 2020 from $4.0 billion for the nine months ended September 30, 2019, partially offset by a decrease in the yield (excluding servicing costs) to 4.98% for the nine months ended September 30, 2020 from 5.71% for the nine months ended September 30, 2019.

82

Due to previously discussed asset sales, the average amortized cost of our residential mortgage securities portfolio decreased $4.0 billion to $1.2 billion for the nine months ended September 30, 2020 from $5.3 billion for the nine months ended September 30, 2019 and interest income on our residential mortgage securities portfolio decreased $160.0 million to $51.7 million for the nine months ended September 30, 2020 from $211.7 million for the nine months ended September 30, 2019. Interest income on our MSR-related assets decreased by $8.0 million to $30.2 million for the nine months ended September 30, 2020 compared to $38.2 million for the nine months ended September 30, 2019. This decrease primarily reflects a $360.3 million decrease in the average balance of these investments for the nine months ended September 30, 2020 to $598.8 million compared to $959.1 million for the nine months ended September 30, 2019, partially offset by an increase in the yield to 6.72% for the nine months ended September 30, 2020 from 5.31% for the nine months ended September 30, 2019,.

Interest Expense

Our interest expense for the nine months ended September 30, 2020 decreased by $22.2 million, or 8.9%, to $227.7 million, from $249.9 million for the nine months ended September 30, 2019.  This decrease primarily reflects a decrease in our average repurchase agreement borrowings to finance our residential mortgage securities portfolio and MSR-related assets partially offset by an increase in our average borrowings to finance residential whole loans held at carrying value and an increase in financing rates on our financing agreements. In addition in the current period we incurred interest expense of approximately $14.6 million related to the senior secured credit agreement we entered into during the second quarter of 2020 and higher interest expense of $6.6 million on our Convertible Senior Notes issued in June 2019. The effective interest rate paid on our borrowings increased to 4.35% for the nine months ended September 30, 2020, from 3.52% for the nine months ended September 30, 2019. 

Payments made and/or received on our Swaps designated as hedges for accounting purposes are a component of our borrowing costs and resulted in an increase in interest expense of $3.4 million, or 5 basis points, for the nine months ended September 30, 2020, compared to a reduction in interest expense of $1.6 million, or 3 basis points, for the nine months ended September 30, 2019.  The weighted average fixed-pay rate on our Swaps designated as hedges decreased to 2.06% for the nine months ended September 30, 2020 from 2.32% for the nine months ended September 30, 2019.  The weighted average variable interest rate received on our Swaps designated as hedges decreased to 1.63% for the nine months ended September 30, 2020 from 2.40% for the nine months ended September 30, 2019.

Provision for Credit Losses on Residential Whole Loans Held at Carrying Value

For the nine months ended September 30, 2020, we recorded a provision for credit losses on residential whole loans held at carrying value of $32.4 million (which includes a provision for credit losses on undrawn commitments of $1.6 million) compared to a provision of $1.5 million for the nine months ended September 30, 2019. As previously discussed, on January 1, 2020, we adopted the new accounting standard addressing the measurement of credit losses on financial instruments (CECL). With respect to our residential whole loans held at carrying value, CECL requires that reserves for credit losses are estimated at the reporting date based on life of loan expected cash flows, including anticipated prepayments and reasonable and supportable forecasts of future economic conditions.

83

Other Income, net

For the nine months ended September 30, 2020, Other (Loss)/Income, net decreased by $807.9 million, to a $637.5 million loss, compared to $170.5 million of income for the nine months ended September 30, 2019.  The components of Other Income, net for the nine months ended September 30, 2020 and 2019 are summarized in the table below:

	Nine Months Ended September 30,
(In Thousands)	2020		2019
Impairment and other losses on securities available-for-sale and other assets	$	(424,966)	$	—
Net realized (loss)/ gain on sales of residential mortgage securities and residential whole loans	(188,847)		50,027
Transfer from OCI of loss on swaps previously designated as hedges for accounting purposes	(57,034)		—
Net gain on residential whole loans measured at fair value through earnings	44,431		116,915
Net unrealized (loss)/gain on residential mortgage securities measured at fair value through earnings	(13,432)		7,977
Liquidation gains on Purchased Credit Deteriorated Loans and other loan related income	4,427		11,234
Other	(2,057)		(15,693)
Total Other (Loss)/Income, net	$	(637,478)	$	170,460

Operating and Other Expense

During the nine months ended September 30, 2020, we had compensation and benefits and other general and administrative expenses of $47.8 million, or 2.28% of average equity, compared to $39.9 million, or 1.56% of average equity, for the nine months ended September 30, 2019.  Compensation and benefits expense increased $4.8 million to $29.1 million for the nine months ended September 30, 2020, compared to $24.3 million for the nine months ended September 30, 2019, primarily reflecting a provision for estimated severance costs in connection with a reduction in workforce that occurred in the third quarter of 2020. Our other general and administrative expenses increased by $3.1 million to $18.7 million for the nine months ended September 30, 2020 compared to $15.6 million for the nine months ended September 30, 2019, primarily due to higher costs for professional services, corporate insurance, administrative expenses associated with financing arrangements, corporate income tax and the write-off of certain internally developed software and deferred financing costs, partially offset by lower costs associated with deferred compensation to Directors in the current year period, which were impacted by the changes in our stock price. In addition, during the current year we also incurred professional service and other costs of $44.4 million related to negotiating forbearance arrangements with our lenders entering into new financing arrangements and reinstating prior financing arrangements on the exit from forbearance.

Operating and Other Expense during the nine months ended September 30, 2020 also includes $28.6 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses decreased compared to the prior year period by approximately $1.6 million, primarily due to lower servicing fees and non-recoverable advances on our residential whole loan and REO portfolios, partially offset by costs related to loan securitization activities.

84

Selected Financial Ratios

The following table presents information regarding certain of our financial ratios at or for the dates presented:

At or for the Nine Months Ended	Return on Average Total Assets (1)		Return on Average Total Stockholders’ Equity (2)		Total Average Stockholders’ Equity to Total Average Assets (3)		Dividend Payout Ratio (4)	Leverage Multiple (5)	Book Value per Share of Common Stock (6)
September 30, 2020	(10.15)	%	(34.55)	%	28.54	%	(0.03)	1.9	$	4.61
September 30, 2019	2.73		10.85		26.20		1.02	2.8	7.09

(1)Reflects annualized net income available to common stock and participating securities divided by average total assets.

(2)Reflects annualized net income divided by average total stockholders’ equity.

(3)Reflects total average stockholders’ equity divided by total average assets.

(4)Reflects dividends declared per share of common stock divided by earnings per share.

(5)Represents the sum of borrowings under our financing agreements, and payable for unsettled purchases divided by stockholders’ equity.

(6)Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

Reconciliation of GAAP and Non-GAAP Financial Measures

Economic Book Value

“Economic book value” is a non-GAAP financial measure of our financial position. To calculate our Economic book value, our portfolios of Residential whole loans at carrying value are adjusted to their fair value, rather than the carrying value that is required to be reported under the GAAP accounting model applied to these loans. This adjustment is also reflected in the table below in our end of period stockholders’ equity. Management considers that Economic book value provides investors with a useful supplemental measure to evaluate our financial position as it reflects the impact of fair value changes for all of our residential mortgage investments, irrespective of the accounting model applied for GAAP reporting purposes. Economic book value does not represent and should not be considered as a substitute for Stockholders’ Equity, as determined in accordance with GAAP, and our calculation of this measure may not be comparable to similarly titled measures reported by other companies.

The following table provides a reconciliation of our GAAP book value per common share to our non-GAAP Economic book value per common share as of the quarterly periods below:

(In Thousands, Except Per Share Amounts)	September 30, 2020		June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019		March 31, 2019
GAAP Total Stockholders’ Equity	$	2,565.7	$	2,521.1	$	2,440.7	$	3,384.0	$	3,403.4	$	3,403.4	$	3,404.5
Preferred Stock, liquidation preference	(475.0)		(475.0)		(475.0)		(200.0)		(200.0)		(200.0)		(200.0)
GAAP Stockholders’ Equity for book value per common share	2,090.7		2,046.1		1,965.7		3,184.0		3,203.4		3,203.4		3,204.5
Adjustments:
Fair value adjustment to Residential whole loans, at carrying value	141.1		(25.3)		(113.5)		182.4		145.8		131.2		92.1
Stockholders’ Equity including fair value adjustment to Residential whole loans, at carrying value (Economic book value)	$	2,231.8	$	2,020.8	$	1,852.2	$	3,366.4	$	3,349.2	$	3,334.6	$	3,296.6
GAAP book value per common share	$	4.61	$	4.51	$	4.34	$	7.04	$	7.09	$	7.11	$	7.11
Economic book value per common share	$	4.92	$	4.46	$	4.09	$	7.44	$	7.41	$	7.40	$	7.32
Number of shares of common stock outstanding	453.3		453.2		453.1		452.4		451.7		450.6		450.5

85

Recent Accounting Standards to Be Adopted in Future Periods

In August 2020, the Financial Accounting Standards Board (or FASB) issued accounting standards update (or ASU) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (or ASU 2020-06). ASU 2020-06 was issued in order to reduce the complexity associated with recording financial instruments with characteristics of both liabilities and equity by eliminating certain accounting models associated with such instruments and enhancing disclosure requirements. ASU 2020-06 is effective for us for fiscal years beginning after December 15, 2021. Early adoption is permitted, but no earlier than in fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We do not expect ASU 2020-06 to have a material impact on our accounting or disclosures.

Liquidity and Capital Resources

General

Our principal sources of cash generally consist of borrowings under repurchase agreements and other collateralized financings, payments of principal and interest we receive on our investment portfolio, cash generated from our operating results and, to the extent such transactions are entered into, proceeds from capital market and structured financing transactions. Our most significant uses of cash are generally to pay principal and interest on our financing transactions, to purchase residential mortgage assets, to make dividend payments on our capital stock, to fund our operations, to meet margin calls and to make other investments that we consider appropriate.

We seek to employ a diverse capital raising strategy under which we may issue capital stock and other types of securities. To the extent we raise additional funds through capital market transactions, we currently anticipate using the net proceeds from such transactions to acquire additional residential mortgage-related assets, consistent with our investment policy, and for working capital, which may include, among other things, the repayment of our financing transactions. There can be no assurance, however, that we will be able to access the capital markets at any particular time or on any particular terms. We have available for issuance an unlimited amount (subject to the terms and limitations of our charter) of common stock, preferred stock, depository shares representing preferred stock, warrants, debt securities, rights and/or units pursuant to our automatic shelf registration statement and, at September 30, 2020, we had approximately 8.8 million shares of common stock available for issuance pursuant to our DRSPP shelf registration statement. During the nine months ended September 30, 2020, we issued 137,740 shares of common stock through our DRSPP, raising net proceeds of approximately $752,095. During the nine months ended September 30, 2020, we did not sell any shares of common stock through the ATM Program.

On March 2, 2020, we completed the issuance of 11.0 million shares of our Series C Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The total net proceeds we received from the offering were approximately $266.0 million, after deducting offering expenses and the underwriting discount.

Financing agreements

Our borrowings under financing agreements include a combination of shorter term and longer arrangements. Certain of these arrangements are collateralized directly by our residential mortgage investments or otherwise have recourse to the Company, while securitized debt financing is non-recourse financing. Further, certain of our financing agreements contain terms that allow the lender to make margin calls on the Company based on changes in the value of the underlying collateral securing the borrowing. Repurchase agreements and other forms of collateralized financing are renewable at the discretion of our lenders and, as such, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time. The terms of the repurchase transaction borrowings under our master repurchase agreements, as such terms relate to repayment, margin requirements and the segregation of all securities that are the subject of repurchase transactions, generally conform to the terms contained in the standard master repurchase agreement published by the Securities Industry and Financial Markets Association (or SIFMA) or the global master repurchase agreement published by SIFMA and the International Capital Market Association In addition, each lender typically requires that we include supplemental terms and conditions to the standard master repurchase agreement. Typical supplemental terms and conditions, which differ by lender, may include changes to the margin maintenance requirements, required haircuts (or the percentage amount by which the collateral value is contractually required to exceed the loan amount), purchase price maintenance requirements, requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction and cross default and setoff provisions. Other non-repurchase agreement financing arrangements also contain provisions governing collateral maintenance.

86

With respect to margin maintenance requirements for agreements secured by harder to value assets, such as residential whole loans, Non-Agency MBS and MSR-related assets, margin calls are typically determined by our counterparties based on their assessment of changes in the fair value of the underlying collateral and in accordance with the agreed upon haircuts specified in the transaction confirmation with the counterparty.  We address margin call requests in accordance with the required terms specified in the applicable agreement and such requests are typically satisfied by posting additional cash or collateral on the same business day. We review margin calls made by counterparties and assess them for reasonableness by comparing the counterparty valuation against our valuation determination. When we believe that a margin call is unnecessary because our assessment of collateral value differs from the counterparty valuation, we typically hold discussions with the counterparty and are able to resolve the matter. In the unlikely event that resolution cannot be reached, we will look to resolve the dispute based on the remedies available to us under the terms of the repurchase agreement, which in some instances may include the engagement of a third-party to review collateral valuations. For certain other agreements that do not include such provisions, we could resolve the matter by substituting collateral as permitted in accordance with the agreement or otherwise request the counterparty to return the collateral in exchange for cash to unwind the financing. For additional information regarding the Company’s various types of financing arrangements, including those of with non mark-to-market terms and the haircuts for those agreements with mark-to-market collateral provisions, see Note 6, included under Item 1 of this Quarterly Report on Form 10-Q.

We expect that we will continue to pledge residential mortgage assets as part of certain of our ongoing financing arrangements. As we experienced in the first quarter of 2020, when the value of our residential mortgage assets pledged as collateral experienced rapid decreases, margin calls under our financing arrangements could materially increase, causing an adverse change in our liquidity position. Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or otherwise become available on possibly less advantageous terms. Further, when liquidity tightens, our counterparties to our short term arrangements with mark-to-market collateral provisions may increase their required collateral cushion (or margin) requirements on new financings, including financings that we roll with the same counterparty, thereby reducing our ability to use leverage. Access to financing may also be negatively impacted by ongoing volatility in financial markets, thereby potentially adversely impacting our current or future lenders’ ability or willingness to provide us with financing. In addition, there is no assurance that favorable market conditions will exist to permit us to consummate additional securitization transactions if we determine to seek that form of financing.

Our ability to meet future margin calls will be affected by our ability to use cash or obtain financing from unpledged collateral, the amount of which can vary based on the market value of such collateral, our cash position and margin requirements. Our cash position fluctuates based on the timing of our operating, investing and financing activities and is managed based on our anticipated cash needs. (See our Consolidated Statements of Cash Flows, included under Item 1 of this Quarterly Report on Form 10-Q and “Interest Rate Risk” included under Item 3 of this Quarterly Report on Form 10-Q.)

At September 30, 2020, we had a total of $5.2 billion of residential whole loans, residential mortgage securities, MSR-related assets and other interest-earning assets and $5.3 million of restricted cash pledged to our financing counterparties. At September 30, 2020, we had access to various sources of liquidity which we estimated exceeded $940.2 million. This amount includes (i) $884.2 million of cash and cash equivalents and (ii) $56.0 million in unused capacity under our financing arrangements. Our sources of liquidity do not include restricted cash. In addition, we have $65.5 million of unencumbered residential whole loans. We are evaluating potential opportunities to finance our residential whole loans, including loan securitization.

87

The table below presents certain information about our borrowings under asset-backed financing agreements and securitized debt:

	Asset-backed Financing Agreements						Securitized Debt
Quarter Ended (1)	Quarterly Average Balance		End of Period Balance		Maximum Balance at Any Month-End		Quarterly Average Balance		End of Period Balance		Maximum Balance at Any Month-End
(In Thousands)
September 30, 2020	$	3,511,453	$	3,217,678	$	3,613,968	$	610,120	$	837,683	$	837,683
June 30, 2020	4,736,610		3,692,845		5,024,926		538,245		516,102		541,698
March 31, 2020	9,233,808		7,768,180		9,486,555		558,007		533,733		594,458
December 31, 2019	8,781,646		9,139,821		9,139,821		590,813		570,952		621,071
September 30, 2019	8,654,350		8,571,422		8,833,159		617,689		605,712		649,405

(1)The information presented in the table above excludes $230.0 million of Convertible Senior Notes issued in June 2019, $100.0 million of Senior Notes issued in April 2012, and $481.3 million of a senior secured term loan facility. The outstanding balance of both the Convertible Senior Notes and Senior Notes have been unchanged since issuance. Subsequent to the end of the third quarter of 2020, we repaid in full the outstanding principal balance of the senior secured term loan facility.

Cash Flows and Liquidity for the Nine Months Ended September 30, 2020

Our cash, cash equivalents and restricted cash increased by $754.8 million during the nine months ended September 30, 2020, reflecting: $5.9 billion provided by our investing activities, $5.1 billion used in our financing activities and $16.8 million provided by our operating activities.

At September 30, 2020, our debt-to-equity multiple was 1.9 times compared to 3.0 times at December 31, 2019. At September 30, 2020, we had borrowings under asset-backed financing agreements of $3.2 billion, of which $3.0 billion were secured by residential whole loans and $258.5 million were secured by residential mortgage securities, MSR-related assets, and other interest-earning assets. In addition, at September 30, 2020, we had securitized debt of $837.7 million in connection with our loan securitization transactions. At December 31, 2019, we had borrowings under asset-backed financing agreements of $9.1 billion, of which $4.7 billion were secured by residential whole loans, $1.6 billion were secured by Agency MBS, $1.1 billion were secured by Legacy Non-Agency MBS, $495.1 million were secured by RPL/NPL MBS, $203.6 million were secured by CRT securities, $962.5 million were secured by MSR-related assets and $57.2 million were secured by other interest-earning assets. In addition, at December 31, 2019, we had securitized debt of $571.0 million in connection with our loan securitization transactions.

During the nine months ended September 30, 2020, $5.9 billion was provided by our investing activities.  We paid $1.3 billion for purchases of residential whole loans, loan related investments and capitalized advances, and purchased $163.7 million of MSR-related assets and CRT securities funded with cash and repurchase agreement borrowings. In addition, during the nine months ended September 30, 2020, we received cash of $609.8 million from prepayments and scheduled amortization on our MBS, CRT securities and MSR-related assets, of which $137.7 million was attributable to Agency MBS, $410.9 million was from Non-Agency MBS, $56.2 million was attributable to MSR-related assets, and approximately $4.9 million was attributable to CRT securities, and we sold certain of our investment securities, MSR-related assets, and other assets for $3.8 billion, realizing net losses of $71.6 million. While we generally intend to hold our MBS and CRT securities as long-term investments, we may sell certain of our securities in order to manage our interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions. In particular, subsequent to the end of the first quarter, we sold our remaining Agency MBS, substantially all of our Legacy Non-Agency MBS portfolio and substantially reduced our investments in MSR-related assets and CRT securities. During the three months ended September 30, 2020, we sold our remaining Legacy Non-Agency MBS. During the nine months ended September 30, 2020, we received $1.3 billion of principal payments on residential whole loans and $203.6 million of proceeds on sales of REO. 

In connection with our repurchase agreement financings and Swaps, we routinely receive margin calls/reverse margin calls from our counterparties and make margin calls to our counterparties. Margin calls and reverse margin calls, which requirements vary over time, may occur daily between us and any of our counterparties when the value of collateral pledged changes from the amount contractually required. The value of securities pledged as collateral fluctuates reflecting changes in: (i) the face (or par) value of our assets; (ii) market interest rates and/or other market conditions; and (iii) the market value of our

88

Swaps. Margin calls/reverse margin calls are satisfied when we pledge/receive additional collateral in the form of additional assets and/or cash.

The table below summarizes our margin activity with respect to our repurchase agreement financings and derivative hedging instruments for the quarterly periods presented:

	Collateral Pledged to Meet Margin Calls						Cash and Securities Received for Reverse Margin Calls		Net Assets Received/(Pledged) for Margin Activity
For the Quarter Ended (1)	Fair Value of Securities Pledged		Cash Pledged		Aggregate Assets Pledged For Margin Calls
(In Thousands)
September 30, 2020	$	—	$	2,526	$	2,526	$	2,199	$	(327)
June 30, 2020	—		108,999		108,999		322,682		213,683
March 31, 2020	30,187		213,392		243,579		67,343		(176,236)
December 31, 2019	—		26,972		26,972		18,311		(8,661)
September 30, 2019	77,214		35,271		112,485		129,132		16,647

(1) Excludes variation margin payments on the Company’s cleared Swaps which are treated as a legal settlement of the exposure under the Swap contract.

We are subject to various financial covenants under our financing agreements, which include minimum liquidity and net worth requirements, net worth decline limitations and maximum debt-to-equity ratios. We were in compliance with all financial covenants as of September 30, 2020.

Off-Balance Sheet Arrangements

We have not participated in transactions that create relationships with unconsolidated entities or financial partnerships which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Inflation

Substantially all of our assets and liabilities are financial in nature. As a result, changes in interest rates and other factors impact our performance far more than does inflation. Our results of operations and reported assets, liabilities and equity are measured with reference to historical cost or fair value without considering inflation.

89

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

We seek to manage our risks related to interest rates, liquidity, prepayment speeds, market value and the credit quality of our assets while, at the same time, seeking to provide an opportunity to stockholders to realize attractive total returns through ownership of our capital stock. While we do not seek to avoid risk, we seek, consistent with our investment policies, to: assume risk that can be quantified based on management’s judgment and experience and actively manage such risk; earn sufficient returns to justify the taking of such risks; and maintain capital levels consistent with the risks that we undertake.

Interest Rate Risk

We generally acquire interest-rate sensitive assets and fund them with interest-rate sensitive liabilities, a portion of which are typically hedged with Swaps. We are exposed to interest rate risk on our residential mortgage assets, as well as on our liabilities. Changes in interest rates can affect our net interest income and the fair value of our assets and liabilities.

In general, when interest rates change, borrowing costs on our financing agreements will change more quickly than the yield on our assets. In a rising interest rate environment, the borrowing costs of our repurchase agreements may increase faster than the interest income on our assets, thereby reducing our net income. In order to mitigate compression in net income based on such interest rate movements, we may use Swaps to lock in a portion of the net interest spread between assets and liabilities.

When interest rates change, the fair value of our residential mortgage assets could change at a different rate than the fair value of our liabilities. We measure the sensitivity of our portfolio to changes in interest rates by estimating the duration of our assets and liabilities. Duration is the approximate percentage change in fair value for a 100 basis point parallel shift in the yield curve. In general, our assets have higher duration than our liabilities and in order to reduce this exposure we use Swaps to reduce the gap in duration between our assets and liabilities.

The fair value of our re-performing residential whole loans is dependent on the value of the underlying real estate collateral, past and expected delinquency status of the borrower as well as the level of interest rates. For certain residential whole loans that were purchased as re-performing loans, because the borrower is not delinquent on their mortgage payments but is less likely to prepay the loan due to weak credit history and/or high LTV, we believe these loans exhibit positive duration. We estimate the duration of our re-performing residential whole loans using management’s assumptions.

The fair value of our Non-QM loans and Single-family rental loans are typically dependent on the value of the underlying real estate collateral, as well as the level of interest rates. Because these loans are primarily newly or recently originated performing loans, we believe these investments exhibit positive duration. Given the short duration of our Rehabilitation loans, we believe the fair value of these loans exhibits little sensitivity to changes in interest rates. We estimate the duration of these Purchased Performing Loans held at carrying value using management’s assumptions.

The fair value of our non-performing residential whole loans is typically primarily dependent on the value of the underlying real estate collateral and the time required for collateral liquidation. Since neither the value of the collateral nor the liquidation timeline is generally sensitive to interest rates, we believe their fair value exhibits little sensitivity to interest rates. We estimate the duration of our non-performing residential whole loans using management’s assumptions.

We typically use Swaps as part of our overall interest rate risk management strategy. Such derivative financial instruments are intended to act as a hedge against future interest rate increases on our financing transactions. While use of such derivatives does not extend the maturities of our borrowings under repurchase agreements, they do, in effect, lock in a fixed rate of interest over their term for a corresponding amount of our repurchase agreement financings that are hedged. 

The interest rates for the vast majority of our investments, financings and hedging transactions are either explicitly or indirectly based on LIBOR. On July 27, 2017, the United Kingdom Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. At this time, it is not possible to predict the effect of such change, including the establishment of potential alternative reference rates, on the economy or markets we are active in either currently or in the future, or on any of our assets or liabilities whose interest rates are based on LIBOR. We are in the process of evaluating the potential impact of a discontinuation of LIBOR after 2021 on our portfolio, as well as the related accounting impact. However, we expect that in the near term, we will work closely with the Trustee companies and/or other entities that are involved in calculating the interest rates for our residential mortgage securities and securitized debt, our loan servicers for our hybrid and floating rate loans, and with the various counterparties to our financing and hedging transactions in order to determine what changes, if any, are required to be made to existing agreements for these transactions.

90

Shock Table

The information presented in the following “Shock Table” projects the potential impact of sudden parallel changes in interest rates on our net interest income and portfolio value over the next 12 months based on the assets in our investment portfolio at September 30, 2020. All changes in income and value are measured as the percentage change from the projected net interest income and portfolio value under the base interest rate scenario at September 30, 2020.

Change in Interest Rates	Estimated Value of Assets (1)		Estimated Value of Securitized and Other Fixed Rate Debt		Estimated Value of Financial Instruments		Change in Estimated Value		Percentage Change in Net Interest Income		Percentage Change in Portfolio Value
(Dollars in Thousands)
+100 Basis Point Increase	$	7,338,936	$	9,758	$	7,348,694	$	(143,322)	8.38	%	(1.91)	%
+ 50 Basis Point Increase	$	7,428,701	$	(2,068)	$	7,426,633	$	(65,383)	4.60	%	(0.87)	%
Actual at September 30, 2020	$	7,505,910	$	(13,894)	$	7,492,016	$	—	—	%	—	%
- 50 Basis Point Decrease	$	7,570,563	$	(25,719)	$	7,544,844	$	52,828	(5.08)	%	0.71	%
-100 Basis Point Decrease	$	7,622,661	$	(37,545)	$	7,585,116	$	93,100	(9.39)	%	1.24	%

(1)Such assets include residential whole loans and REO, MBS and CRT securities, MSR-related assets, cash and cash equivalents and restricted cash.

Certain assumptions have been made in connection with the calculation of the information set forth in the Shock Table and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes. The base interest rate scenario assumes interest rates at September 30, 2020. The analysis presented utilizes assumptions and estimates based on management’s judgment and experience.  Furthermore, while we generally expect to retain the majority of our assets and the associated interest rate risk to maturity, future purchases and sales of assets could materially change our interest rate risk profile. It should be specifically noted that the information set forth in the above table and all related disclosure constitute forward-looking statements within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act. Actual results could differ significantly from those estimated in the Shock Table above.

The Shock Table quantifies the potential changes in net interest income and portfolio value, which includes the value of our securitized and other fixed rate date (which are carried at fair value), should interest rates immediately change (i.e., are shocked). The Shock Table presents the estimated impact of interest rates instantaneously rising 50 and 100 basis points, and falling 50 and 100 basis points. The cash flows associated with our portfolio for each rate shock are calculated based on assumptions, including, but not limited to, prepayment speeds, yield on replacement assets, the slope of the yield curve and composition of our portfolio. Assumptions made with respect to the interest rate sensitive liabilities include anticipated interest rates, collateral requirements as a percent of repurchase agreement financings, and the amounts and terms of borrowing. At September 30, 2020, we applied a floor of 0% for all anticipated interest rates included in our assumptions. Due to this floor, it is anticipated that any hypothetical interest rate shock decrease would have a limited positive impact on our funding costs; however, because prepayments speeds are unaffected by this floor, it is expected that any increase in our prepayment speeds (occurring as a result of any interest rate shock decrease or otherwise) could result in an acceleration of premium amortization on our Agency MBS and discount accretion on our Non-Agency MBS and in the reinvestment of principal repayments in lower yielding assets. As a result, because the presence of this floor limits the positive impact of interest rate decrease on our funding costs, hypothetical interest rate shock decreases could cause a decline in the fair value of our financial instruments and our net interest income.

At September 30, 2020, the impact on portfolio value was approximated using estimated net effective duration (i.e., the price sensitivity to changes in interest rates), including the effect of securitized and other fixed rate debt, of 1.57 which is the weighted average of 2.39 for our Residential whole loans, 0.61 for our Non-Agency investments, (1.46) for our securitized debt, and other fixed rate debt, and 0.11 for our Other assets and cash and cash equivalents. Estimated convexity (i.e., the approximate change in duration relative to the change in interest rates) of the portfolio was (0.65), which is the weighted average of (0.84) for our Residential whole loans, zero for our securitized and other fixed rate debt, zero for our Non-Agency MBS and zero for our Other assets and cash and cash equivalents. The impact on our net interest income is driven mainly by the difference between portfolio yield and cost of funding of our repurchase agreements.  Our asset/liability structure is generally such that an increase in interest rates would be expected to result in a decrease in net interest income, as our borrowings are generally shorter in term than our interest-earning assets. When interest rates are shocked, prepayment assumptions are adjusted based on management’s expectations along with the results from the prepayment model.

91

Credit Risk

We are exposed to credit risk through our credit sensitive residential mortgage investments, in particular residential whole loans and CRT securities and to a lesser extent our investments in RPL/NPL MBS and MSR-related assets. As discussed above, since the end of the first quarter we have engaged in asset sales and taken other actions that significantly changed our asset composition subsequent to March 31, 2020. During the third quarter of 2020, we sold the remainder of our Legacy Non-Agency MBS. As a result, our primary credit risk currently relates to our residential whole loans.

Our exposure to credit risk from our credit sensitive investments is discussed in more detail below:

Residential Whole Loans

We are exposed to credit risk from our investments in residential whole loans. Our investment process for non-performing and Purchased Credit Deteriorated Loans is focused on quantifying and pricing credit risk. Non-Performing and Purchased Credit Deteriorated Loans are acquired at purchase prices that are generally discounted to the contractual loan balances based on a number of factors, including the impaired credit history of the borrower and the value of the collateral securing the loan. In addition, as we generally own the mortgage-servicing rights associated with these loans, our process is also focused on selecting a sub-servicer with the appropriate expertise to mitigate losses and maximize our overall return. This involves, among other things, performing due diligence on the sub-servicer prior to their engagement as well as ongoing oversight and surveillance. To the extent that delinquencies and defaults on these loans are higher than our expectation at the time the loans were purchased, the discounted purchase price at which the asset is acquired is intended to provide a level of protection against financial loss.

Credit risk on Purchased Performing Loans is mitigated through our process to underwrite the loan before it is purchased and includes an assessment of the borrower’s financial condition and ability to repay the loan, nature of the collateral and relatively low LTV, including after-repair LTV for the majority of our Rehabilitation loans.

The following table presents certain information about our Residential whole loans, at carrying value at September 30, 2020:

	Purchased Performing Loans						Purchased Credit Deteriorated Loans
	Loans with an LTV:						Loans with an LTV:
(Dollars in Thousands)	80% or Below			Above 80%			80% or Below			Above 80%			Total
Amortized cost	$	3,659,498		$	132,294		$	423,880		$	278,134		$	4,493,806
Unpaid principal balance (UPB)	$	3,601,206		$	132,238		$	467,432		$	345,182		$	4,546,058
Weighted average coupon (1)	6.1		%	6.5		%	4.5		%	4.4		%	5.8		%
Weighted average term to maturity (months)	273			335			267			319			277
Weighted average LTV (2)	62.8		%	86.3		%	56.8		%	108.7		%	66.3		%
Loans 90+ days delinquent (UPB)	$	293,277		$	12,326		$	63,682		$	83,842		$	453,127

(1)Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68%. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

92

The following table presents the five largest geographic concentrations by state of our residential whole loan portfolio at September 30, 2020:

Property Location	Percent of Interest-Bearing Unpaid Principal Balance
California	35.0	%
Florida	13.2	%
New York	7.7	%
New Jersey	5.4	%
Georgia	3.3	%

RPL/NPL MBS

These securities are backed by re-performing and non-performing loans, were purchased primarily at prices around par and represent the senior and mezzanine tranches of the related securitizations. The majority of these securities are structured with significant credit enhancement (typically approximately 50%) and the subordinate tranches absorb all credit losses (until those tranches are extinguished) and typically receive no cash flow (interest or principal) until the senior tranche is paid off. Prior to purchase, we analyze the deal structure in order to assess the associated credit risk. Subsequent to purchase, the ongoing credit risk associated with the deal is evaluated by analyzing the extent to which actual credit losses occur that result in a reduction in the amount of subordination enjoyed by our bond.

CRT Securities

We are exposed to potential credit losses from our investments in CRT securities issued by or sponsored by Fannie Mae and Freddie Mac. While CRT securities are issued by or sponsored by these GSEs, payment of principal on these securities is not guaranteed. As an investor in a CRT security, we may incur a loss if losses on the mortgage loans in the reference pool exceed the credit enhancement on the underlying CRT security owned by us or if an actual pool of loans experience losses. We assess the credit risk associated with our investments in CRT securities by assessing the current and expected future performance of the associated loan pool.

MSR-Related Assets

Term Notes

We have invested in certain term notes that are issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered by us to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. In addition, credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

Corporate Loan

We have participated in a loan agreement to provide financing to an entity that originates residential whole loans and owns the related MSRs. We assess the credit risk associated with this loan participation by considering various factors, including the current status of the loan, changes in fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

Credit Spread Risk

Credit spreads measure the additional yield demanded by investors in financial instruments based on the credit risk associated with an instrument relative to benchmark interest rates. They are impacted by the available supply and demand for instruments with various levels of credit risk. Widening credit spreads would result in higher yields being required by investors in financial instruments. Credit spread widening generally results in lower values of the financial instruments we hold at that time, but will generally result in a higher yield on future investments with similar credit risk. It is possible that the credit spreads on our assets and liabilities, including hedges, will not always move in tandem. Consequently, changes in credit spreads can result in volatility in our financial results and reported book value.

93

Liquidity Risk

The primary liquidity risk we face arises from financing long-maturity assets with shorter-term borrowings primarily in the form of repurchase agreement financings. This risk was particularly pronounced during the first quarter of 2020, as conditions created by the COVID-19 pandemic resulted in us receiving an usually high number of margin calls, negatively impacting our overall liquidity and ultimately leading us to enter into the Forbearance Agreements.

We pledge residential mortgage assets and cash to secure our financing agreements. Our financing agreements with mark-to-market collateral provisions require us to pledge additional collateral in the event the market value of the assets pledged decreases, in order maintain the lenders contractually specified collateral cushion, which is measured as the difference between the loan amount and the market value of the asset pledged as collateral. Should the value of our residential mortgage assets pledged as collateral suddenly decrease, margin calls under our repurchase agreements would likely increase, causing an adverse change in our liquidity position. Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or be available on possibly less advantageous terms. Further, when liquidity tightens, our repurchase agreement counterparties may increase our collateral cushion (or margin) requirements on new financings, including repurchase agreement borrowings that we roll with the same counterparty, reducing our ability to use leverage.

At September 30, 2020, we had access to various sources of liquidity which we estimate to be in excess of $940.2 million, an amount which includes: (i) $884.2 million of cash and cash equivalents and (ii) $56.0 million in unused capacity under our financing arrangements. Our sources of liquidity do not include restricted cash. In addition, at September 30, 2020 we had $65.5 million of unencumbered residential whole loans.

Prepayment Risk

Premiums arise when we acquire an MBS or loan at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value) or when we acquire residential whole loans at a price in excess of their aggregate principal balance.  Conversely, discounts arise when we acquire an MBS or loan at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Premiums paid are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income.  Purchase premiums, which are primarily carried on our Non-QM loans and certain CRT securities, are amortized against interest income over the life of the investment using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the interest income earned on these assets. Generally, if prepayments on Non-Agency MBS and residential whole loans purchased at significant discounts and not accounted for at fair value are less than anticipated, we expect that the income recognized on these assets will be reduced and impairments and/or credit loss reserves may result.

In addition, increased prepayments are generally associated with decreasing market interest rates as borrowers are able to refinance their mortgages at lower rates. Therefore, increased prepayments on our investments may accelerate the redeployment of our capital to generally lower yielding investments. Similarly, decreased prepayments are generally associated with increasing market interest rates and may slow our ability to redeploy capital to generally higher yielding investments.

94

Item 4.  Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

Management, under the direction of its Chief Executive Officer and Chief Financial Officer, is responsible for maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act) that are designed to ensure that information required to be disclosed in reports filed or submitted under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

In connection with the preparation of this Quarterly Report on Form 10-Q, management reviewed and evaluated the Company’s disclosure controls and procedures.  The evaluation was performed under the direction of the Company’s Chief Executive Officer and Chief Financial Officer to determine the effectiveness, as of September 30, 2020, of the design and operation of the Company’s disclosure controls and procedures.  Based on that review and evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company’s current disclosure controls and procedures, as designed and implemented, were effective as of September 30, 2020. Notwithstanding the foregoing, a control system, no matter how well designed, implemented and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s current periodic reports.

(b) Changes in Internal Control over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2020 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

95

PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

There are no material pending legal proceedings to which we are a party or any of our assets are subject.

Item 1A. Risk Factors

For a discussion of the Company’s risk factors, see Part 1, Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”), as supplemented by the risk factors described under “Item 1.A. Risk Factors” in the Company’s Quarterly Reports on Form 10-Q for the three months ended March 31, 2020 (the “2020 Q1 Form 10-Q”) and six months ended June 30,2020 (the “2020 Q2 Form 10-Q”). There are no material changes from the risk factors set forth in the 2019 10-K, the 2020 Q1 Form 10-Q and the 2020 Q2 Form 10-Q. However, the risks and uncertainties that the Company faces are not limited to those set forth in the 2019 Form 10-K and the 2020 Q1 Form 10-Q and the 2020 Q2 Form 10-Q. Additional risks and uncertainties not currently known to the Company (or that it currently believes to be immaterial) may also adversely affect the Company’s business and the trading price of our securities.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities

As previously disclosed, in August 2005, the Company’s Board authorized a repurchase program, to repurchase up to 4.0 million shares of the Company’s outstanding common stock under the Repurchase Program.  The Board reaffirmed such authorization in May 2010.  In December, 2013, the Company’s Board increased the number of shares authorized for repurchase to an aggregate of 10.0 million shares (under which approximately 6.6 million shares remained available for repurchase at September 30, 2020).  

The Company engaged in no share repurchase activity during the third quarter of 2020 pursuant to the repurchase program nor did it withhold any restricted shares (under the terms of grants under its Equity Plan) to offset tax withholding obligations that occur upon the vesting and release of restricted stock awards and/or RSUs.

In November 2020, the Company’s Board authorized a new share repurchase program under which the Company may repurchase up to $250 million of its outstanding common stock. The authorization under this repurchase program expires at the end of 2022. The Board’s authorization replaces and supersedes the authorization under the repurchase program that was adopted in December 2013.

The stock repurchase program does not require the purchase of any minimum number of shares. Subject to applicable securities laws, repurchases of common stock under the repurchase program may be made at times and in amounts as the Company deems appropriate, using available cash resources. The timing and extent to which the Company repurchases its shares will depend upon, among other things, market conditions, share price, liquidity, regulatory requirements and other factors, and repurchases may be commenced or suspended at any time without prior notice. Acquisitions under the share repurchase program may be made in the open market, through privately negotiated transactions or block trades or other means, in accordance with applicable securities laws (including, in the Company’s discretion, through the use of one or more plans adopted under Rule 10b-5-1 promulgated under the 1934 Act).

Shares of common stock repurchased by the Company under the repurchase program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock. The repurchase program may be suspended or discontinued by the Company at any time and without prior notice.

Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Mine Safety Disclosures

None.

96

Item 5.  Other Information

None.

Item 6. Exhibits

The list of exhibits required to be filed as exhibits to this report are listed on page E-1 hereof, under “Exhibit Index,” which is incorporated herein by reference.

97

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 5, 2020	MFA FINANCIAL, INC.
	(Registrant)
	By:	/s/ Stephen D. Yarad
		Stephen D. Yarad
		Chief Financial Officer
		and Chief Accounting Officer
		(Principal Financial Officer)

98

EXHIBIT INDEX

The following exhibits are filed as part of this Quarterly Report:

Exhibit	Description
31.1	Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in iXBRL (Inline Extensible Business Reporting Language): (i) our Consolidated Balance Sheets as of September 30, 2020 (Unaudited) and December 31, 2019; (ii) our Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2020 and 2019; (iii) our Consolidated Statements of Comprehensive Income / (Loss) (Unaudited) for the three and nine months ended September 30, 2020 and 2019; (iv) Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) for the three and nine months ended September 30, 2020 and 2019; (v) our Consolidated Statements of Cash Flows (Unaudited) for the three months ended September 30, 2020 and 2019; and (vi) the notes to our Unaudited Consolidated Financial Statements.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

E-1

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Craig L. Knutson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of MFA Financial, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: November 5, 2020
By:	/s/ Craig L. Knutson
	Name: Craig L. Knutson
	Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Stephen D. Yarad, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of MFA Financial, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: November 5, 2020
By:	/s/ Stephen D. Yarad
	Name: Stephen D. Yarad
	Title: Chief Financial Officer
	and Chief Accounting Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

The undersigned, the Chief Executive Officer of MFA Financial, Inc. (the “Company”), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020 (the “Form 10-Q”), filed herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Craig L. Knutson	Date: November 5, 2020
	Name: Craig L. Knutson
	Title: President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes—Oxley Act of 2002, and is not being “filed” as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section.  This certification shall not be deemed to be incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.1 is expressly and specifically incorporated by reference in any such filing.

A signed original of this statement required by Section 906 had been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

The undersigned, the Chief Financial Officer of MFA Financial, Inc. (the “Company”), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020 (the “Form 10-Q”), filed herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Stephen D. Yarad	Date: November 5, 2020
	Name: Stephen D. Yarad
	Title: Chief Financial Officer
	and Chief Accounting Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes—Oxley Act of 2002, and is not being “filed” as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section.  This certification shall not be deemed to be incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.2 is expressly and specifically incorporated by reference in any such filing.

A signed original of this statement required by Section 906 had been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover page - shares	9 Months Ended
	Sep. 30, 2020	Oct. 29, 2020
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2020
Entity File Number	1-13991
Entity Registrant Name	MFA FINANCIAL, INC.
Entity Central Index Key	0001055160
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	13-3974868
Entity Address, Address Line One	350 Park Avenue, 20th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	207-6400
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		453,333,220
Common Stock, par value $0.01 per share
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	MFA
Security Exchange Name	NYSE
7.50% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share
Entity Information [Line Items]
Title of 12(b) Security	7.50% Series B Cumulative RedeemablePreferred Stock, par value $0.01 per share
Trading Symbol	MFA/PB
Security Exchange Name	NYSE
6.50% Series C Cumulative Redeemable Preferred Stock [Member]
Entity Information [Line Items]
Title of 12(b) Security	6.50% Series C Cumulative RedeemablePreferred Stock, par value $0.01 per share
Trading Symbol	MFA/PC
Security Exchange Name	NYSE
8.00% Senior Notes due 2042
Entity Information [Line Items]
Title of 12(b) Security	8.00% Senior Notes due 2042
Trading Symbol	MFO
Security Exchange Name	NYSE

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Assets:
Residential whole loans, at carrying value ($3,843,153 and $4,847,782 pledged as collateral, respectively) (1)	[1]	$ 4,493,805	$ 6,069,370
Residential whole loans, at fair value ($705,666 and $794,684 pledged as collateral, respectively) (1)	[1]	1,229,664	1,381,583
Allowance for credit losses on residential whole loans held at carrying value		(106,246)	(3,025)
Total residential whole loans, net		5,617,223	7,447,928
Residential mortgage securities, at fair value ($152,765 and $3,966,591 pledged as collateral, respectively)		152,765	3,983,519
Mortgage servicing rights (“MSR”) related assets ($252,183 and $1,217,002 pledged as collateral, respectively)		252,183	1,217,002
Cash and cash equivalents		884,171	70,629
Restricted cash		5,303	64,035
Other assets		571,614	784,251
Total Assets		7,483,259	13,567,364
Liabilities:
Financing agreements ($4,080,461 and $0 held at fair value, respectively)		4,851,121	10,031,606
Other liabilities		66,482	151,806
Total Liabilities		4,917,603	10,183,412
Commitments and contingencies (See Note 10)
Stockholders’ Equity:
Common stock, $0.01 par value; 874,300 and 886,950 shares authorized; 453,333 and 452,369 shares issued and outstanding, respectively		4,533	4,524
Additional paid-in capital, in excess of par		3,924,584	3,640,341
Accumulated deficit		(1,408,910)	(631,040)
Accumulated other comprehensive income		45,259	370,047
Total Stockholders’ Equity		2,565,656	3,383,952
Total Liabilities and Stockholders’ Equity		7,483,259	13,567,364
Non-Agency MBS Transferred to Consolidated VIEs
Assets:
Residential whole loans, at carrying value ($3,843,153 and $4,847,782 pledged as collateral, respectively) (1)		568,600	186,400
Residential whole loans, at fair value ($705,666 and $794,684 pledged as collateral, respectively) (1)		521,200	567,400
Series B Preferred Stock
Stockholders’ Equity:
Preferred stock		80	80
Series C Preferred Stock
Stockholders’ Equity:
Preferred stock		$ 110	$ 0

[1] Includes approximately $568.6 million and $186.4 million of Residential whole loans, at carrying value and $521.2 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Residential whole loans, carrying value	$ 3,843,153,000	$ 4,847,782,000
Residential whole loans, fair value	705,666,000	794,684,000
Servicing rights pledged as collateral	252,183,000	1,217,002,000
Financial agreements held at fair value	4,080,461,000	$ 0
Preferred stock, liquidation preference, value	$ 275,000,000
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	874,300	886,950
Common stock, shares issued (in shares)	453,333	452,369
Common stock, shares outstanding (in shares)	453,333	452,369
Collateral Pledged | Non-Agency MBS
Securities, at fair value, pledged as collateral	$ 152,765,000	$ 3,966,591,000
Series B Preferred Stock
Preferred stock par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	8,050	8,050
Preferred Stock, dividend rate	7.50%	7.50%
Preferred stock, shares issued (in shares)	8,000	8,000
Preferred stock, shares outstanding (in shares)	8,000	8,000
Preferred stock, liquidation preference, value	$ 200,000,000	$ 200,000,000
Series C Preferred Stock
Preferred stock par value (usd per share)	$ 0.01
Preferred stock, shares authorized (in shares)	12,650
Preferred Stock, dividend rate	6.50%
Preferred stock, shares issued (in shares)	11,000

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Interest Income:
Residential whole loans held at carrying value	$ 54,393	$ 64,226	$ 207,306	$ 171,725
Residential mortgage securities	2,329	60,639	51,678	211,676
MSR-related assets	6,241	15,274	30,189	38,232
Other interest-earning assets	3,017	1,679	9,089	4,272
Cash and cash equivalent investments	100	903	646	2,703
Interest Income	66,080	142,721	298,908	428,608
Interest Expense:
Asset-backed and other collateralized financing arrangements	50,054	79,932	209,998	238,773
Other interest expense	5,910	5,891	17,716	11,120
Interest Expense	55,964	85,823	227,714	249,893
Net Interest Income	10,116	56,898	71,194	178,715
Reversal/(Provision) for credit and valuation losses on residential whole loans and other financial instruments	27,244	(347)	(38,090)	(1,538)
Net Interest Income after Provision for Credit and Valuation Losses	37,360	56,551	33,104	177,177
Other Income, net:
Impairment and other losses on securities available-for-sale and other assets	(221)	0	(424,966)	0
Net realized gain/(loss) on sales of residential mortgage securities and residential whole loans	48	17,708	(188,847)	50,027
Net unrealized gain/(loss) on residential mortgage securities measured at fair value through earnings	91	(695)	(13,432)	7,977
Net gain on residential whole loans measured at fair value through earnings	76,871	40,175	44,431	116,915
Loss on terminated swaps previously designated as hedges for accounting purposes	(7,177)	0	(57,034)	0
Other, net	7,498	5,241	2,370	(4,459)
Other Income/(Loss), net	77,110	62,429	(637,478)	170,460
Operating and Other Expense:
Compensation and benefits	11,657	7,920	29,134	24,315
Other general and administrative expense	6,611	5,022	18,656	15,601
Loan servicing, financing and other related costs	8,992	10,439	28,609	30,225
Costs associated with restructuring/forbearance agreement	0	0	44,434	0
Operating and Other Expense	27,260	23,381	120,833	70,141
Net Income/(Loss)	87,210	95,599	(725,207)	277,496
Less Preferred Stock Dividend Requirement	8,219	3,750	21,578	11,250
Net Income/(Loss) Available to Common Stock and Participating Securities	$ 78,991	$ 91,849	$ (746,785)	$ 266,246
Basic Earnings per Common Share (usd per share)	$ 0.17	$ 0.20	$ (1.65)	$ 0.59
Diluted Earnings per Common Share (usd per share)	$ 0.17	$ 0.20	$ (1.65)	$ 0.58

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income/(loss)	$ 87,210	$ 95,599	$ (725,207)	$ 277,496
Other Comprehensive Income/(Loss):
Unrealized gains on securities available-for-sale	15,082	5,483	408,585	50,085
Reclassification adjustment for MBS sales included in net income	(60)	(14,499)	(389,127)	(36,370)
Reclassification adjustment for impairments included in net income	0	0	(344,269)	0
Derivative hedging instrument fair value changes, net	0	(233)	(50,127)	(30,384)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk	(22,652)	0	(22,652)	0
Reclassification adjustment for losses/(gains) related to hedging instruments included in net income	7,176	(685)	72,802	(1,769)
Other Comprehensive Income/(Loss)	(454)	(9,934)	(324,788)	(18,438)
Comprehensive income before preferred stock dividends	86,756	85,665	(1,049,995)	259,058
Dividends required on preferred stock	(8,219)	(3,750)	(21,578)	(11,250)
Comprehensive Income/(Loss) Available to Common Stock and Participating Securities	$ 78,537	$ 81,915	$ (1,071,573)	$ 247,808

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Series C Preferred Stock		Series B Preferred Stock	[3]	Preferred Stock Series C Preferred Stock	Preferred Stock Series B Preferred Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Series C Preferred Stock	Accumulated Deficit	Accumulated Deficit Series C Preferred Stock	[3]	Accumulated Deficit Series B Preferred Stock	[3]	Accumulated Other Comprehensive Income	Revision of Prior Period, Accounting Standards Update, Adjustment	Revision of Prior Period, Accounting Standards Update, Adjustment Accumulated Deficit
Balance (in shares) at Dec. 31, 2018								8,000,000	449,787,000
Balance at Dec. 31, 2018		$ 3,416,101						$ 80	$ 4,498	$ 3,623,275		$ (632,040)					$ 420,288
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		88,857										88,857
Issuance of stock, net of expenses (in shares)									1,066,000
Issuance of stock, net of expenses		551							$ 7	544
Repurchase of shares of common stock (in shares)	[1]								(370,000)
Repurchase of shares of common stock	[1]	(2,610)								(2,610)
Equity based compensation expense		992								992
Accrued dividends attributable to stock-based awards		435								435
Dividends declared on common stock		(90,097)										(90,097)
Dividends declared on preferred stock		(3,750)										(3,750)
Dividends attributable to dividend equivalents		(256)										(256)
Change in unrealized gains on MBS, net		5,094															5,094
Derivative hedging instrument fair value changes and amortization, net		(10,786)															(10,786)
Balance (in shares) at Mar. 31, 2019								8,000,000	450,483,000
Balance at Mar. 31, 2019		3,404,531						$ 80	$ 4,505	3,622,636		(637,286)					414,596
Balance (in shares) at Dec. 31, 2018								8,000,000	449,787,000
Balance at Dec. 31, 2018		3,416,101						$ 80	$ 4,498	3,623,275		(632,040)					420,288
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		277,496
Dividends declared on preferred stock		(11,250)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk		0
Balance (in shares) at Sep. 30, 2019								8,000,000	451,692,000
Balance at Sep. 30, 2019		3,403,426						$ 80	$ 4,517	3,634,140		(637,161)					401,850
Increase (Decrease) in Stockholders' Equity
Adjustments related to tax withholding for share-based compensation									$ 2,600
Shares paid for tax withholding for share based compensation (in shares)									370,244
Balance (in shares) at Mar. 31, 2019								8,000,000	450,483,000
Balance at Mar. 31, 2019		3,404,531						$ 80	$ 4,505	3,622,636		(637,286)					414,596
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		93,040										93,040
Issuance of stock, net of expenses (in shares)									139,000
Issuance of stock, net of expenses		586							$ 1	585
Equity based compensation expense		2,438								2,438
Accrued dividends attributable to stock-based awards		(260)								(260)
Dividends declared on common stock		(90,124)										(90,124)
Dividends declared on preferred stock		(3,750)										(3,750)
Dividends attributable to dividend equivalents		(276)										(276)
Change in unrealized gains on MBS, net		17,637															17,637
Derivative hedging instrument fair value changes and amortization, net		(20,449)															(20,449)
Balance (in shares) at Jun. 30, 2019								8,000,000	450,622,000
Balance at Jun. 30, 2019		3,403,373						$ 80	$ 4,506	3,625,399		(638,396)					411,784
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		95,599										95,599
Issuance of stock, net of expenses (in shares)									1,070,000
Issuance of stock, net of expenses		7,724							$ 11	7,713
Equity based compensation expense		1,288								1,288
Accrued dividends attributable to stock-based awards		(260)								(260)
Dividends declared on common stock		(90,338)										(90,338)
Dividends declared on preferred stock		(3,750)										(3,750)
Dividends attributable to dividend equivalents		(276)										(276)
Change in unrealized gains on MBS, net		(9,016)															(9,016)
Derivative hedging instrument fair value changes and amortization, net		(918)															(918)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk		0
Balance (in shares) at Sep. 30, 2019								8,000,000	451,692,000
Balance at Sep. 30, 2019		3,403,426						$ 80	$ 4,517	3,634,140		(637,161)					401,850
Balance (in shares) at Dec. 31, 2019							0	8,000,000	452,369,000
Balance at Dec. 31, 2019		3,383,952					$ 0	$ 80	$ 4,524	3,640,341		(631,040)					370,047	$ (8,326)	$ (8,326)
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		(908,995)										(908,995)
Issuance of stock, net of expenses (in shares)							11,000,000		1,106,000
Issuance of stock, net of expenses		687	$ 266,029				$ 110		$ 7	680	$ 265,919
Repurchase of shares of common stock (in shares)	[2]								(337,000)
Repurchase of shares of common stock	[2]	(2,652)								(2,652)
Equity based compensation expense		1,266								1,266
Accrued dividends attributable to stock-based awards		1,059								1,059
Change in unrealized gains on MBS, net		(243,812)															(243,812)
Derivative hedging instrument fair value changes and amortization, net		(48,533)															(48,533)
Balance (in shares) at Mar. 31, 2020							11,000,000	8,000,000	453,138,000
Balance at Mar. 31, 2020		2,440,675					$ 110	$ 80	$ 4,531	3,906,613		(1,548,361)					77,702
Balance (in shares) at Dec. 31, 2019							0	8,000,000	452,369,000
Balance at Dec. 31, 2019		3,383,952					$ 0	$ 80	$ 4,524	3,640,341		(631,040)					370,047	$ (8,326)	$ (8,326)
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		(725,207)
Dividends declared on preferred stock		(21,578)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk		(22,652)
Balance (in shares) at Sep. 30, 2020							11,000,000	8,000,000	453,333,000
Balance at Sep. 30, 2020		2,565,656					$ 110	$ 80	$ 4,533	3,924,584		(1,408,910)					45,259
Increase (Decrease) in Stockholders' Equity
Adjustments related to tax withholding for share-based compensation									$ 2,700
Shares paid for tax withholding for share based compensation (in shares)									337,026
Balance (in shares) at Mar. 31, 2020							11,000,000	8,000,000	453,138,000
Balance at Mar. 31, 2020		2,440,675					$ 110	$ 80	$ 4,531	3,906,613		(1,548,361)					77,702
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		96,578										96,578
Issuance of stock, net of expenses (in shares)									106,000
Issuance of stock, net of expenses		37							$ 1	36
Equity based compensation expense		1,709								1,709
Change in unrealized gains on MBS, net		(96,021)															(96,021)
Derivative hedging instrument fair value changes and amortization, net		64,032															64,032
Warrants Issued		14,041
Balance (in shares) at Jun. 30, 2020							11,000,000	8,000,000	453,244,000
Balance at Jun. 30, 2020		2,521,051					$ 110	$ 80	$ 4,532	3,922,399		(1,451,783)					45,713
Increase (Decrease) in Stockholders' Equity
Net income/(loss)		87,210										87,210
Issuance of stock, net of expenses (in shares)									89,000
Issuance of stock, net of expenses		1							$ 1
Equity based compensation expense		2,266								2,266
Accrued dividends attributable to stock-based awards		(81)								(81)
Dividends declared on common stock		(22,667)										(22,667)
Dividends declared on preferred stock		(8,219)	$ (10,328)	[3]	$ (11,250)								$ (10,328)		$ (11,250)
Dividends attributable to dividend equivalents		(92)										(92)
Change in unrealized gains on MBS, net		15,022															15,022
Derivative hedging instrument fair value changes and amortization, net		7,176															7,176
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk		(22,652)															(22,652)
Balance (in shares) at Sep. 30, 2020							11,000,000	8,000,000	453,333,000
Balance at Sep. 30, 2020		$ 2,565,656					$ 110	$ 80	$ 4,533	$ 3,924,584		$ (1,408,910)					$ 45,259

[1] For the nine months ended September 30, 2019, includes approximately $2.6 million (370,244 shares) surrendered for tax purposes related to equity-based compensation awards.

[2] For the nine months ended September 30, 2020 includes approximately $2.7 million (337,026 shares) surrendered for tax purposes related to equity-based compensation awards.

[3] Includes reinstated dividends that were unpaid through June 30, 2020, and were paid during the three months ended September 30, 2020 (see Note11(a)).

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares						3 Months Ended				9 Months Ended		12 Months Ended
	Aug. 12, 2020	Aug. 06, 2020	Jul. 01, 2020	Feb. 14, 2020	Apr. 15, 2013	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Common stock, cash dividends declared (in dollars per share)		$ 0.05				$ 0.05	$ 0.20	$ 0.20	$ 0.20
Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
Preferred Stock, dividend rate										7.50%		7.50%
Dividend declared per share, preferred stock (in dollars per share)	$ 0.46875		$ 0.9375	$ 0.46875		1.40625	$ 0.46875	$ 0.46875	$ 0.46875
Preferred Stock | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
Preferred Stock, dividend rate					7.50%					7.50%	7.50%
Preferred Stock, liquidation preference per share (in dollars per share)					$ 25.00	$ 25.00				$ 25.00		$ 25.00

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows From Operating Activities:
Net income/(loss)	$ (725,207)	$ 277,496
Adjustments to reconcile net income to net cash provided by operating activities:
Losses/(gains) on residential whole loans and real estate owned, net	280,142	(61,125)
Gains on residential mortgage securities and MSR related assets, net	(71,569)	(58,005)
Impairment and other losses on securities available-for-sale and other assets	424,966	0
Losses on terminated swaps previously designated as hedges and other	57,034	0
Accretion of purchase discounts on residential mortgage securities, residential whole loans and MSR-related assets	(27,585)	(45,990)
Amortization of purchase premiums on residential mortgage securities and residential whole loans, and amortization of terminated hedging instruments	40,952	32,085
Provision for credit and valuation losses on residential whole loans and other financial instruments	38,090	0
Net valuation and other non-cash losses included in net income	16,388	22,026
Decrease/(increase) in other assets	459	(24,647)
(Decrease)/increase in other liabilities	(16,919)	11,756
Net cash provided by operating activities	16,751	153,596
Cash Flows From Investing Activities:
Purchases of residential whole loans, loan related investments and capitalized advances	(1,345,422)	(2,988,229)
Proceeds from sales of residential whole loans	1,521,060	0
Principal payments on residential whole loans	1,261,319	906,072
Principal payments on residential mortgage securities and MSR-related assets	609,758	1,555,449
Proceeds from sales of residential mortgage securities, MSR-related assets, and other assets	3,790,148	735,768
Purchases of residential mortgage securities and MSR-related assets	(163,748)	(837,591)
Proceeds from sales of real estate owned	203,603	81,206
Purchases of real estate owned and capital improvements	(9,334)	(15,671)
Additions to leasehold improvements, furniture and fixtures	(1,425)	(1,351)
Net cash provided by/(used in) investing activities	5,865,959	(564,347)
Cash Flows From Financing Activities:
Principal payments on financing agreements with mark-to-market collateral provisions	(21,401,578)	(54,103,776)
Proceeds from borrowings under financing agreements with mark-to-market collateral provisions	13,749,720	54,796,010
Principal payments on financing agreements with non-mark-to-market collateral provisions	(312,638)	0
Proceeds from borrowings under financing agreements with non-mark-to-market collateral provisions	2,036,597	0
Principal payments made on senior secured credit agreement	(18,750)	0
Proceeds from issuance of senior secured credit agreement	480,959	0
Principal payments on securitized debt	(133,450)	(79,350)
Proceeds from issuance of securitized debt	391,154	0
Proceeds from issuance of convertible senior notes	0	223,311
Payments made for settlements and unwinds of Swaps	(88,405)	(47,622)
Proceeds from issuance of series C preferred stock	275,000	0
Payments made for costs related to series C preferred stock issuance	(8,948)	0
Proceeds from issuances of common stock	725	8,861
Proceeds from the issuance of warrants	14,041	0
Dividends paid on preferred stock	(21,578)	(11,250)
Dividends paid on common stock and dividend equivalents	(90,749)	(270,951)
Net cash (used in)/provided by financing activities	(5,127,900)	515,233
Net increase in cash, cash equivalents and restricted cash	754,810	104,482
Cash, cash equivalents and restricted cash at beginning of period	134,664	88,709
Cash, cash equivalents and restricted cash at end of period	889,474	193,191
Supplemental Disclosure of Cash Flow Information
Interest Paid	213,318	237,644
Non-cash Investing and Financing Activities:
Transfer from residential whole loans to real estate owned	74,891	193,531
Dividends and dividend equivalents declared and unpaid	22,758	90,614
Payable for unsettled residential whole loan purchases	$ 0	$ 59,524

XML

Organization

9 Months Ended

Sep. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as taxable REIT subsidiaries (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Note 2(n))

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

(a)  Basis of Presentation and Consolidation

The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted in accordance with these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2020 and results of operations for all periods presented have been made.  The results of operations for the three and nine months ended September 30, 2020 should not be construed as indicative of the results to be expected for the full year.

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including impairment, valuation allowances and loss allowances on residential whole loans (see Note 3), mortgage-backed securities (“MBS”) (see Note 4) and Other Assets (see Note 5), valuation of MBS, CRT securities and MSR-related assets (see Notes 4 and 14), income recognition and valuation of residential whole loans (see Notes 3 and 14), valuation of derivative instruments (see Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount (see Note 4).  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (see Note 2(n)).  Actual results could differ from those estimates.

The Company has one reportable segment since it manages its business and analyzes and reports its results of operations on the basis of one operating segment: investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries. All intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.

(b)  Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed- and adjustable-rate residential mortgage loans acquired through consolidated trusts in secondary market transactions. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for Purchased Credit Deteriorated Loans that are held at carrying value is typically utilized by the Company for Purchased Credit Deteriorated Loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company also acquires Purchased Performing Loans that are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required credit loss reserves (as discussed below) differ from those used for Purchased Credit Deteriorated Loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against financing agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans that are subject to an extended period of due diligence that crosses a reporting date are recorded in our balance sheet at amounts reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Residential whole loans purchased under flow arrangements with loan origination partners are generally recorded at the transaction settlement date. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any financing agreement until the closing of the purchase transaction. Interest income, credit related losses and changes in the fair value of loans held at fair value are recorded post settlement for acquired loans and until transaction settlement for sold loans (see Notes 3, 6, 7, 14 and 15).

Residential Whole Loans at Carrying Value

Purchased Performing Loans

Acquisitions of Purchased Performing Loans to date have been primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties that are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to four-family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”). Purchased Performing Loans are initially recorded at their purchase price. Interest income on Purchased Performing Loans acquired at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any amortization of premium or accretion of discount, adjusted for actual prepayment activity. For loans acquired with related servicing rights retained by the seller, interest income is reported net of related serving costs.

An allowance for credit losses is recorded at acquisition, and maintained on an ongoing basis, for all losses expected to be incurred over the life of the respective loan. Any required credit loss allowance would reduce the net carrying value of the loan with a corresponding charge to earnings, and may increase or decrease over time. Significant judgments are required in determining any allowance for credit loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended, and interest accruals are reversed against income, for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful (i.e., such loans are placed on nonaccrual status). For nonaccrual loans other than Fix and Flip loans, all payments are applied to principal under the cost recovery method. For nonaccrual Fix and Flip loans, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged. Modified loans are considered

“troubled debt restructurings” if the Company grants a concession to a borrower who is experiencing financial difficulty (including the interpretation of this definition set forth in OCC Bulletin 2020-35).

Charge-offs to the allowance for loan losses occur when losses are confirmed through the receipt of cash or other consideration from the completion of a sale; when a modification or restructuring takes place in which we grant a concession to a borrower or agree to a discount in full or partial satisfaction of the loan; when we take ownership and control of the underlying collateral in full satisfaction of the loan; when loans are reclassified as other investments; or when significant collection efforts have ceased and it is highly likely that a loss has been realized.

The aggregate allowance for credit losses is equal to the sum of the losses expected to be incurred over the life of each respective loan. These losses were estimated by projecting each loan’s expected cash flows based on their contractual terms, expected prepayments, and estimated default and loss severity rates. The default and severity rates were estimated based on the following steps: (i) obtained the Company’s historical experience through an entire economic cycle for each loan type or, to the extent the Company did not have sufficient historical loss experience for a given loan type, publicly available data derived from the historical loss experience of certain banks, which data the Company believes is generally representative of its portfolio, (ii) obtained historical economic data (U.S. unemployment rates and home price appreciation) over the same period, and (iii) estimated default and severity rates during three distinct future periods based on historical default and severity rates during periods when economic conditions similar to those forecasted were experienced. The three periods were as follows: (i) a one-year forecast of economic conditions based on U.S. unemployment rates and home price appreciation, followed by (ii) a two-year “reversion” period during which economic conditions (U.S. unemployment rates and home price appreciation) are projected to revert to historical averages on a straight line basis, followed by (iii) the remaining life of each loan, during which period economic conditions (U.S. unemployment rates and home price appreciation) are projected to equal historical averages. In addition, a liability is established (and recorded in Other Liabilities) each period using a similar methodology for committed but undrawn loan amounts. This methodology has not changed from the calculation of the allowance for credit losses on January 1, 2020 pursuant to the transition to ASU 2016-13 as described below under “New Accounting Standards and Interpretations,” other than a change in the reversion period from one year to two years to reflect the expected ongoing impact of current conditions (see Note 3).

Purchased Credit Deteriorated Loans

The Company has elected to account for these loans as credit impaired as they have experienced a more-than-insignificant deterioration in credit quality since origination and were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price on a net basis, after establishing an initial allowance for credit losses (their initial cost basis is equal to their purchase price plus the initial allowance for credit losses). Subsequent to acquisition, the gross recorded amount for these loans reflects the initial cost basis, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded cost basis reduced by any allowance for credit losses. Interest income on such loans purchased is recorded each period based on the contractual coupon net of amortization of the difference between their cost basis and unpaid principal balance (“UPB”), subject to the Company’s nonaccrual policy.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

Cash received (or accrued) representing coupon interest payments on residential whole loans held at fair value is not included in Interest Income, but rather is included in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in unrealized gains or losses reported each period.

(c)  Residential Mortgage Securities

Prior to the quarter ended June 30, 2020, the Company had invested in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). The Company disposed of its investments in Agency MBS during the quarter and has substantially reduced its investments in Non-Agency MBS. In addition, the Company has investments in CRT securities that are issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the issuer and the principal payments received are dependent on the performance of loans in either a reference pool or an actual pool of loans. As the loans in the underlying pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company.

Designation

MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an allowance for losses is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company had elected the fair value option for certain of its previously held Agency MBS that it did not intend to hold to maturity. These securities were carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk-sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on their outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Determination of Fair Value for Residential Mortgage Securities

In determining the fair value of the Company’s residential mortgage securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity (see Note 14).

Allowance for credit losses

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities, as well as securities for which a credit loss allowance had been previously recorded, on at least a quarterly basis and determines whether any changes to the allowance for credit losses are required.  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize a write-down through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an impaired security, only the portion of the impairment related to credit losses is recognized through a loss allowance charged to earnings with the remainder recognized through AOCI on the Company’s consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Credit loss allowances are subject to reversal through earnings resulting from improvements in expected cash flows. The determination as to whether to record (or reverse) a credit loss allowance is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of future performance and cash flow projections.  As a result, the timing and amount of losses constitute material estimates that are susceptible to significant change (see Note 4).

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the allowance related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s residential mortgage securities pledged as collateral against financing agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(d) MSR-Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR-related assets, are discussed in more detail below. The Company’s MSR-related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR-related assets are recorded on the trade date (see Notes 4, 6, 7 and 14).

Term Notes Backed by MSR-Related Collateral

The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR-related collateral are treated as AFS securities and reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI, subject to impairment and loss allowances. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes is similar to that used for residential mortgage securities and considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral, as applicable, and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations, subject to loss allowances. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

(e)  Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its financing counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at September 30, 2020 and December 31, 2019. At September 30, 2020 and December 31, 2019, the Company had cash and cash equivalents of $884.2 million and $70.6 million, respectively. At September 30, 2020, the Company had $837.6 million of investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation (“FDIC”) or any other government agency. As of December 31, 2019, the Company had $39.6 million worth of investments in overnight money market funds. In addition, deposits in FDIC insured accounts generally exceed insured limits (see Notes 7 and 14).

(f)  Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s Swaps and/or financing agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to financing agreement and/or Swap counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap and/or financing agreements.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its financing agreements and/or Swaps of $5.3 million and $64.0 million at September 30, 2020 and December 31, 2019, respectively (see Notes 5(c), 6, 7 and 14).

(g) Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on

the Company’s consolidated statements of operations. The Company has acquired certain properties that it holds for investment purposes, including rentals to third parties. These properties are held at their historical basis less depreciation, and are subject to impairment. Related rental income and expenses are recorded in Other Income, net (see Note 5).

(h)  Depreciation

Leasehold Improvements, Real estate and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. The building component of real estate held-for-investment is depreciated over 27.5 years.

(i)  Loan Securitization and Other Debt Issuance Costs

Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing its 6.25% Convertible Senior Notes due 2024 (“Convertible Senior Notes”) and its 8% Senior Notes due 2042 (“Senior Notes”). These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges (unless the debt is recorded at fair value, as discussed below), are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For the Convertible Senior Notes and Senior Notes, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and, in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

(j)  Financing Agreements

The Company finances the majority of its residential mortgage assets with financing agreements that include repurchase agreements and other forms of collateralized financing.  Under repurchase agreements, the Company sells assets to a lender and agrees to repurchase the same assets in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements and other forms of collateralized financing, the Company pledges its assets as collateral to secure the borrowing, in an amount which is equal to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional assets or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the assets pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings collateralized by residential mortgage securities and MSR-related assets typically have terms ranging from one month to six months at inception, while the majority of our financing arrangements collateralized by residential whole loans have terms of twelve months or longer.  Should a counterparty decide not to renew a financing arrangement at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable on such collateral (see Notes 6, 7 and 14).

The Company has elected the fair value option on certain of its financing agreements. These agreements are reported at their fair value, with changes in fair value being recorded in earnings each period (or other comprehensive income, to the extent

the change results from a change in instrument specific credit risk), as further detailed in Note 6. Financing costs, including “up front” fees paid at inception related to financing agreements at fair value are expensed as incurred. Interest expense is recorded based on the current interest rate in effect for the related agreement.

(k)  Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. 

The Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period, subject only to continued employment, and others of which cliff vest after a three-year period, subject to both continued employment and the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total shareholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total shareholder return over a specified period constitute a “market condition,” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.

The Company makes dividend equivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company (see Notes 2(l) and 13).

(l)  Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s dividend equivalents attached to/associated with RSUs, to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of RSUs outstanding that are unvested and have dividends that are subject to forfeiture, and for the effect of outstanding warrants, using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments (if any), are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  In addition, the Company’s Convertible Senior Notes are included in the calculation of diluted EPS if the assumed conversion into common shares is dilutive, using the “if-converted” method. This involves adding back the periodic interest expense associated with the Convertible Senior Notes to the numerator and by adding the shares that would be issued in an assumed conversion (regardless of whether the conversion option is in or out of the money) to the denominator for the purposes of calculating diluted EPS (see Note 12).

(m)  Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and terminated hedging relationships, as well as the portion of unrealized gains/(losses) on its financing agreements held at fair value related to instrument-specific credit risk, and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

(n)  U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”), and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business is conducted through one or more TRS, the net taxable income earned by its domestic TRS, if any, is subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of the Company’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No net deferred tax benefit was recorded by the Company for the nine months ended September 30, 2020 and 2019, related to the net taxable losses in the TRS, since a valuation allowance for the full amount of the associated deferred tax asset of approximately $75.5 million was recognized as its recovery is not considered more likely than not. The related net operating loss carryforwards generated prior to 2018 will begin to expire in 2034; those generated in 2020, 2019 and 2018 can be carried back to each of the five taxable years preceding the taxable year of such loss and thereafter can be carried forward and do not expire.

Based on its analysis of any potentially uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2020, December 31, 2019, or September 30, 2019. As of the date of this filing the Company’s tax returns for tax years 2017 through 2019 are open to examination.

(o)  Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments have generally been comprised of Swaps, the majority of which were designated as cash flow hedges against the interest rate risk associated with its borrowings.

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at the inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

During the first quarter of 2020, the Company terminated all of its Swaps. Prior to their termination, Swaps were carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value was positive, or in Other liabilities, if their fair value was negative.  Changes in the fair value of the Company’s Swaps previously designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense and are treated as an operating cash flow.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate (see Notes 5(c), 7 and 14).

Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statements of operations.

(p)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its financial assets and liabilities at the time of acquisition or issuance. Subsequent changes in the fair value of these financial instruments are generally reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable (see Notes 2(b), 2(c), 3, 4 and 14).

(q)  Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without the additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) the holders of the equity investment at risk have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into several financing transactions which resulted in the Company forming entities to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the

entities used to facilitate these transactions are VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sales or should be accounted for as secured financings under GAAP (see Note 15).

The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

(r)  Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to the issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

(s)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 2020

Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which has subsequently been amended by ASUs 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2020-02 Financial Instruments-Credit Losses (Topic 326)-Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date (SEC Update), and 2020-03 Codification Improvements to Financial Instruments. The amendments in ASU 2016-13 require entities to measure all expected credit losses (rather than incurred losses) for financial assets held at the reporting date, based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The amendments in this ASU were required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The Company adopted the new ASU on January 1, 2020. The impact of adoption was that the allowance for credit losses on Purchased Performing Loans increased by approximately $8.3 million. This transition adjustment was recorded as an increase in the Company’s allowance for credit losses and an adjustment to decrease retained earnings as of the adoption date. In addition, for Purchased Credit Deteriorated Loans, the carrying value of the portfolio was adjusted on transition to include an estimate of the allowance for credit losses as required by the new standard. For financial statement reporting purposes, this adjusted carrying value is presented net of the estimated allowance for credit losses. Consequently, the adjustments recorded on transition for Purchased Credit Deteriorated Loans do not result in any adjustment to retained earnings as of the adoption date. The Company does not consider these transition adjustments to be material to its financial position or previously reported GAAP or economic book value.

Under ASU 2016-13, credit losses for available-for-sale debt securities are measured in a manner similar to prior GAAP. However, the amendments in this ASU require that credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the allowance on available-for-sale debt securities will be limited to the extent that the fair value is less than the amortized cost. Under prior GAAP, credit impairment losses were generally required to be recorded as “other than temporary” impairment, which directly reduced the carrying amount of impaired securities, and was recorded in earnings and was not reversed if expected cash flows subsequently recovered. Under the new guidance, credit impairments on such securities (other than those related to expected sales) are recorded as an allowance for credit losses that is also recorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover. Transition to the new available-for-sale debt securities guidance did not result in a change to our retained earnings.

Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting

In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). The amendments in this ASU provide temporary optional expedients to ease the financial reporting burden of the expected transition from the London Interbank Offered Rate (“LIBOR”) to an alternative reference rate such as the Secured Overnight Financing Rate (“SOFR”). The amendments in the ASU are elective and apply to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in ASU 2020-04 were effective for all entities as of March 12, 2020 and will generally no longer be available to apply after December 31, 2022. The Company adopted this ASU as of the effective date and will utilize the optional expedients to the extent that they apply to the Company.

XML

Residential Whole Loans

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Residential Whole Loans

Residential Whole Loans

Included on the Company’s consolidated balance sheets at September 30, 2020 and December 31, 2019 are approximately $5.6 billion and $7.4 billion, respectively, of residential whole loans arising from the Company’s interests in certain trusts established to acquire the loans and certain entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated for financial reporting purposes.

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2020 and December 31, 2019:

(Dollars In Thousands)	September 30, 2020		December 31, 2019
Purchased Performing Loans:
Non-QM loans	$	2,465,148	$	3,707,245
Rehabilitation loans	699,868		1,026,097
Single-family rental loans	479,070		460,742
Seasoned performing loans	147,706		176,569
Total Purchased Performing Loans	3,791,792		5,370,653
Purchased Credit Deteriorated Loans (1)	702,013		698,717
Total Residential whole loans, at carrying value	$	4,493,805	$	6,069,370
Allowance for credit losses on residential whole loans held at carrying value	(106,246)		(3,025)
Total Residential whole loans at carrying value, net	$	4,387,559	$	6,066,345
Number of loans	13,754		17,082

(1) The amortized cost basis of Purchased Credit Deteriorated Loans was increased by $62.6 million on January 1, 2020 in connection with the adoption of ASU 2016-13.

The following table presents the components of interest income on the Company’s Residential whole loans, at carrying value for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Purchased Performing Loans:
Non-QM loans	$	25,884	$	30,258	$	112,212	$	79,250
Rehabilitation loans	10,863		15,142		39,502		38,331
Single-family rental loans	6,917		5,025		21,528		11,652
Seasoned performing loans	1,945		3,166		6,799		9,461
Total Purchased Performing Loans	45,609		53,591		180,041		138,694
Purchased Credit Deteriorated Loans	8,784		10,635		27,265		33,031
Total Residential whole loans, at carrying value	$	54,393	$	64,226	$	207,306	$	171,725

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2020:

September 30, 2020

	Carrying Value		Amortized Cost Basis		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Weighted Average Original FICO (3)	Aging by Amortized Cost Basis
															Past Due Days
(Dollars In Thousands)													Current		30-59		60-89		90+
Purchased Performing Loans:
Non-QM loans (4)	$	2,438,395	$	2,465,148	$	2,397,247	5.87	%	352	64	%	712	$	2,174,935	$	74,231	$	52,069	$	163,913
Rehabilitation loans (4)	677,235		699,868		699,868		7.28		4	63		718	491,343		65,166		22,995		120,364
Single-family rental loans (4)	474,045		479,070		475,072		6.28		319	70		734	439,503		16,111		7,373		16,083
Seasoned performing loans (4)	147,556		147,706		161,257		3.45		173	41		723	136,622		1,406		880		8,798
Purchased Credit Deteriorated Loans (4)(5)	650,328		702,013		812,614		4.45		289	79		N/A	N/M		N/M		N/M		122,478
Residential whole loans, at carrying value, total or weighted average	$	4,387,559	$	4,493,805	$	4,546,058	5.81	%	277

December 31, 2019

	Carrying Value		Amortized Cost Basis		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Weighted Average Original FICO (3)	Aging by UPB
															Past Due Days
(Dollars In Thousands)													Current		30-59		60-89		90+
Purchased    Performing Loans:
Non-QM loans (4)	$	3,706,857	$	3,707,245	$	3,592,701	5.96	%	368	67	%	716	$	3,492,533	$	59,963	$	19,605	$	20,600
Rehabilitation loans (4)	1,023,766		1,026,097		1,026,097		7.30		8	64		717	868,281		67,747		27,437		62,632
Single-family rental loans (4)	460,679		460,741		457,146		6.29		324	70		734	432,936		15,948		2,047		6,215
Seasoned performing loans	176,569		176,569		192,151		4.24		181	46		723	187,683		2,164		430		1,874
Purchased Credit Impaired Loans (5)	698,474		698,718		873,326		4.46		294	81		N/A	N/M		N/M		N/M		108,998
Residential whole loans, at carrying value, total or weighted average	$	6,066,345	$	6,069,370	$	6,141,421	5.96	%	288

(1)Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million and $269.2 million at September 30, 2020 and December 31, 2019, respectively, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% and 69% at September 30, 2020 and December 31, 2019, respectively. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

(3)Excludes loans for which no Fair Isaac Corporation (“FICO”) score is available.

(4)At September 30, 2020 and December 31, 2019 the difference between the Carrying Value and Amortized Cost Basis represents the related allowance for credit losses.

(5)Purchased Credit Deteriorated Loans tend to be characterized by varying performance of the underlying borrowers over time, including loans where multiple months of payments are received in a period to bring the loan to current status, followed by months where no payments are received. Accordingly, delinquency information is presented for loans that are more than 90 days past due that are considered to be seriously delinquent.

No Residential whole loans, at carrying value were sold during the three months ended September 30, 2020. During the nine months ended September 30, 2020, $1.8 billion of Non-QM loans were sold, realizing losses of $273.0 million.

Allowance for Credit Losses

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential Whole Loans, at Carrying Value:

	Nine Months Ended September 30, 2020
(Dollars In Thousands)	Non-QM Loans		Rehabilitation Loans (1)(2)		Single-family Rental Loans		Seasoned Performing Loans		Purchased Credit Deteriorated Loans (3)		Totals
Allowance for credit losses at December 31, 2019	$	388	$	2,331	$	62	$	—	$	244	$	3,025
Transition adjustment on adoption of ASU 2016-13 (4)	6,904		517		754		19		62,361		70,555
Current provision	26,358		33,213		6,615		230		8,481		74,897
Write-offs	—		(428)		—		—		(219)		(647)
Valuation adjustment on loans held for sale	70,181		—		—		—		—		70,181
Allowance for credit and valuation losses at March 31, 2020	$	103,831	$	35,633	$	7,431	$	249	$	70,867	$	218,011
Current provision/(reversal)	(2,297)		(5,213)		(500)		(25)		(2,579)		(10,614)
Write-offs	—		(420)		—		—		(207)		(627)
Valuation adjustment on loans held for sale	(70,181)		—		—		—		—		(70,181)
Allowance for credit losses at June 30, 2020	$	31,353	$	30,000	$	6,931	$	224	$	68,081	$	136,589
Current provision/(reversal)	(4,568)		(7,140)		(1,906)		(74)		(16,374)		(30,062)
Write-offs	(32)		(227)		—		—		(22)		(281)
Allowance for credit losses at September 30, 2020	$	26,753	$	22,633	$	5,025	$	150	$	51,685	$	106,246

	Nine Months Ended September 30, 2019
(Dollars In Thousands)	Non-QM Loans		Rehabilitation Loans		Single-family Rental Loans		Seasoned Performing Loans		Purchased Credit Deteriorated Loans		Totals
Allowance for credit losses at December 31, 2018	$	—	$	—	$	—	$	—	$	968	$	968
Current provision	—		500		—		—		183		683
Write-offs	—		—		—		—		—		—
Allowance for credit losses at March 31, 2019	$	—	$	500	$	—	$	—	$	1,151	$	1,651
Current provision	—		—		—		—		385		385
Write-offs	—		(50)		—		—		—		(50)
Allowance for credit losses at June 30, 2019	$	—	$	450	$	—	$	—	$	1,536	$	1,986
Current provision	—		—		—		—		347		347
Write-offs	—		(62)		—		—		—		(62)
Allowance for credit losses at September 30, 2019	$	—	$	388	$	—	$	—	$	1,883	$	2,271

(1)In connection with purchased Rehabilitation loans, the Company had unfunded commitments of $73.2 million, with an allowance for credit losses of $1.6 million at September 30, 2020. Such allowance is included in “Other liabilities” in the Company’s consolidated balance sheets (see Note 9).

(2)Includes $143.4 million of loans that were assessed for credit losses based on a collateral dependent methodology.

(3)Includes $72.7 million of loans that were assessed for credit losses based on a collateral dependent methodology.

(4)Of the $70.6 million of reserves recorded on adoption of ASU 2016-13, $8.3 million was recorded as an adjustment to stockholders’ equity and $62.4 million was recorded as a “gross up” of the amortized cost basis of Purchased Credit Deteriorated Loans.

The Company adopted ASU 2016-13 (“CECL”) on January 1, 2020 (see Note 2). The anticipated impact of the COVID-19 pandemic on expected economic conditions, including forecasted unemployment, home price appreciation, and prepayment rates, for the short to medium term resulted in significantly increased estimates of credit losses recorded under CECL for the first quarter of 2020 for residential whole loans held at carrying value. As of September 30, 2020, the Company

adjusted its estimates related to future rates of unemployment, which resulted in a reversal of the allowance for loan loss in the third quarter. However, the Company continues to anticipate that deteriorated market conditions will continue for an extended period, resulting in increased delinquencies and defaults compared to historical periods. Estimates of credit losses under CECL are highly sensitive to changes in assumptions and current economic conditions have increased the difficulty of accurately forecasting future conditions.

The amortized cost basis of Purchased Performing Loans on nonaccrual status as of September 30, 2020 and December 31, 2019 was $345.6 million and $99.9 million, respectively. The amortized cost basis of Purchased Credit Deteriorated Loans on nonaccrual status as of September 30, 2020 was $148.7 million. Because Purchase Credit Deteriorated Loans were previously accounted for in pools, there were no such loans on nonaccrual status as of December 31, 2019. No interest income was recognized from loans on nonaccrual status during the nine months ended September 30, 2020. At September 30, 2020, there were approximately $134.8 million of loans on nonaccrual status that did not have an associated allowance for credit losses, because they were determined to be collateral dependent and the estimated fair value of the related collateral exceeded the carrying value of each loan.

The following table presents certain additional credit-related information regarding our residential whole loans, at carrying value:

	Amortized Cost Basis by Origination Year and LTV Bands
(Dollars In Thousands)	2020		2019		2018		2017		2016		Prior		Total
Non-QM loans
LTV < 80% (1)	$	380,729	$	1,196,185	$	684,404	$	74,862	$	6,371	$	—	$	2,342,551
LTV >= 80% (1)	48,082		35,468		29,784		9,111		152		—		122,597
Total Non-QM loans	$	428,811	$	1,231,653	$	714,188	$	83,973	$	6,523	$	—	$	2,465,148
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	32	$	—	$	—	$	—	$	32
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	32	$	—	$	—	$	—	$	32
Rehabilitation loans
LTV < 80% (1)	$	36,478	$	542,865	$	93,973	$	7,546	$	—	$	—	$	680,862
LTV >= 80% (1)	1,262		15,496		548		1,700		—		—		19,006
Total Rehabilitation loans	$	37,740	$	558,361	$	94,521	$	9,246	$	—	$	—	$	699,868
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	13	$	1,030	$	32	$	—	$	—	$	1,075
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	13	$	1,030	$	32	$	—	$	—	$	1,075
Single family rental loans
LTV < 80% (1)	$	22,400	$	287,103	$	140,017	$	13,356	$	—	$	—	$	462,876
LTV >= 80% (1)	1,394		14,588		212		—		—		—		16,194
Total Single family rental loans	$	23,794	$	301,691	$	140,229	$	13,356	$	—	$	—	$	479,070
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Seasoned performing loans
LTV < 80% (1)	$	—	$	—	$	—	$	—	$	79	$	139,538	$	139,617
LTV >= 80% (1)	—		—		—		—		—		8,089		8,089
Total Seasoned performing loans	$	—	$	—	$	—	$	—	$	79	$	147,627	$	147,706
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Purchased credit deteriorated loans
LTV < 80% (1)	$	—	$	—	$	—	$	633	$	2,982	$	420,265	$	423,880
LTV >= 80% (1)	—		—		—		—		3,184		274,950		278,134
Total Purchased credit deteriorated loans	$	—	$	—	$	—	$	633	$	6,166	$	695,215	$	702,014
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	448	$	448
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	448	$	448
Total LTV < 80% (1)	$	439,607	$	2,026,153	$	918,394	$	96,397	$	9,432	$	559,803	$	4,049,786
Total LTV >= 80% (1)	50,738		65,552		30,544		10,811		3,336		283,039		444,020
Total residential whole loans, at carrying value	$	490,345	$	2,091,705	$	948,938	$	107,208	$	12,768	$	842,842	$	4,493,806
Total Gross write-offs	$	—	$	13	$	1,062	$	32	$	—	$	448	$	1,555
Total Recoveries	—		—		—		—		—		—		—
Total Net write-offs	$	—	$	13	$	1,062	$	32	$	—	$	448	$	1,555

(1)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million at September 30, 2020, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% at September 30, 2020. Certain low value loans secured by vacant lots are categorized as LTV >= 80%.

Residential Whole Loans, at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Less than 60 Days Past Due:
Outstanding principal balance	$	599,461		$	666,026
Aggregate fair value	$	577,761		$	641,616
Weighted Average LTV Ratio (1)	74.33		%	76.69		%
Number of loans	3,038			3,159
60 Days to 89 Days Past Due:
Outstanding principal balance	$	55,183		$	58,160
Aggregate fair value	$	49,188		$	53,485
Weighted Average LTV Ratio (1)	83.62		%	79.48		%
Number of loans	259			313
90 Days or More Past Due:
Outstanding principal balance	$	679,211		$	767,320
Aggregate fair value	$	602,715		$	686,482
Weighted Average LTV Ratio (1)	87.82		%	89.69		%
Number of loans	2,532			2,983
Total Residential whole loans, at fair value	$	1,229,664		$	1,381,583

(1)LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

The following table presents the components of Net gain/(loss) on residential whole loans measured at fair value through earnings for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Coupon payments, realized gains, and other income received (1)	$	17,477	$	22,202	$	54,684	$	67,966
Net unrealized gains/(losses)	58,863		13,185		(13,683)		33,312
Net gain on transfers to REO	531		4,788		3,430		15,637
Total	$	76,871	$	40,175	$	44,431	$	116,915

(1)Primarily includes gains on liquidation of non-performing loans, including the recovery of delinquent interest payments, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.

During the nine months ended September 30, 2020, loans at fair value with an aggregate unpaid principal balance of $24.1 million were sold, realizing net losses of $0.8 million.

XML

Residential Mortgage Securities and MSR-Related Assets

9 Months Ended

Sep. 30, 2020

Investments, Debt and Equity Securities [Abstract]

Residential Mortgage Securities and MSR-Related Assets

Residential Mortgage Securities and MSR-Related Assets

Agency and Non-Agency MBS

MBS investments held as of September 30, 2020 or in prior periods include Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by: (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”), which have interest rates that reset annually or more frequently (collectively, “ARM-MBS”); and (iii) 15 and 30 year fixed-rate mortgages for Agency MBS and, for Non-Agency MBS, 30-year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS backed by securitized re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are generally structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements (see Note 7).

Agency MBS:  Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities. The Company sold its remaining holdings of Agency MBS during the quarter ended June 30, 2020.

Non-Agency MBS:  The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral. During the quarter ended June 30, 2020, the Company had sold substantially all of its holdings of Legacy Non-Agency MBS and substantially reduced its holdings of other Non-Agency MBS. The Company sold its remaining Legacy Non-Agency MBS during the quarter ended September 30, 2020.

CRT Securities

CRT securities are debt obligations issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the issuer and the principal payments received are dependent on the performance of loans in either a reference pool or an actual pool of loans. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company. The Company assesses the credit risk associated with its investments in CRT securities by assessing the current and expected future performance of the associated loan pool. The Company pledges a portion of its CRT securities as collateral against its borrowings under repurchase agreements (see Note 7).

The following tables present certain information about the Company’s residential mortgage securities at September 30, 2020 and December 31, 2019:

September 30, 2020

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts		Discount Designated as Credit Reserve (1)		Gross Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Net Unrealized Gain/(Loss)		Fair  Value
Non-Agency MBS (2)(3)(4)	$	60,295	$	—	$	(8,246)	$	(669)	$	51,380	$	8,015	$	(2,965)	$	5,050	$	56,430
CRT securities (5)	104,163		2,414		(69)		(20,768)		85,740		13,722		(3,127)		10,595		96,335
Total residential mortgage securities	$	164,458	$	2,414	$	(8,315)	$	(21,437)	$	137,120	$	21,737	$	(6,092)	$	15,645	$	152,765

December 31, 2019

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts		Discount Designated as Credit Reserve (1)		Gross Amortized Cost (6)		Gross Unrealized Gains		Gross Unrealized Losses		Net Unrealized Gain/(Loss)		Fair Value
Agency MBS: (7)
Fannie Mae	$	1,119,708	$	43,249	$	(22)	$	—	$	1,162,935	$	9,799	$	(14,741)	$	(4,942)	$	1,157,993
Freddie Mac	480,879		19,468		—		—		500,961		5,475		(3,968)		1,507		502,468
Ginnie Mae	3,996		73		—		—		4,069		52		—		52		4,121
Total Agency MBS	1,604,583		62,790		(22)		—		1,667,965		15,326		(18,709)		(3,383)		1,664,582
Non-Agency MBS:
Expected to Recover Par (2)(3)	722,477		—		(16,661)		—		705,816		19,861		(9)		19,852		725,668
Expected to Recover Less than Par (2)	1,472,826		—		(73,956)		(436,598)		962,272		375,598		(9)		375,589		1,337,861
Total Non-Agency MBS (4)	2,195,303		—		(90,617)		(436,598)		1,668,088		395,459		(18)		395,441		2,063,529
Total MBS	3,799,886		62,790		(90,639)		(436,598)		3,336,053		410,785		(18,727)		392,058		3,728,111
CRT securities (5)	244,932		4,318		(55)		—		249,195		6,304		(91)		6,213		255,408
Total residential mortgage securities	$	4,044,818	$	67,108	$	(90,694)	$	(436,598)	$	3,585,248	$	417,089	$	(18,818)	$	398,271	$	3,983,519

(1)Discount designated as Credit Reserve is generally not expected to be accreted into interest income.

(2)Based on management’s current estimates of future principal cash flows expected to be received.

(3)Includes RPL/NPL MBS, which at September 30, 2020 had an $57.4 million Principal/Current face, $49.2 million amortized cost and $53.8 million fair value. At December 31, 2019, RPL/NPL MBS had a $632.3 million Principal/Current face, $631.8 million amortized cost and $635.0 million fair value.

(4)At September 30, 2020 and December 31, 2019, the Company expected to recover approximately 99% and 80% of the then-current face amount of Non-Agency MBS, respectively.

(5)Amounts disclosed at September 30, 2020 includes CRT securities with a fair value of $63.3 million for which the fair value option has been elected. Such securities had $410,000 gross unrealized gains and gross unrealized losses of approximately $3.1 million at September 30, 2020. Amounts disclosed at December 31, 2019 includes CRT securities with a fair value of $255.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $6.3 million and gross unrealized losses of approximately $91,000 at December 31, 2019.

(6)Includes principal payments receivable of $614,000 at December 31, 2019, which is not included in the Principal/Current Face.

(7)Amounts disclosed at December 31, 2019 include Agency MBS with a fair value of $280.3 million, for which the fair value option has been elected. Such securities had $4.5 million unrealized gains and no gross unrealized losses at December 31, 2019, respectively.

Sales of Residential Mortgage Securities

The following table presents information about the Company’s sales of its residential mortgage securities for the three and nine months ended September 30, 2020 and 2019. The Company has no continuing involvement with any of the sold securities.

	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
(In Thousands)	Sales Proceeds		Gains/(Losses)		Sales Proceeds		Gains/(Losses)
Agency MBS	$	—	$	—	$	257,289	$	2,771
Non-Agency MBS	116		48		47,867		14,444
CRT Securities	—		—		28,969		493
Total	$	116	$	48	$	334,125	$	17,708

	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
(In Thousands)	Sales Proceeds		Gains/(Losses)		Sales Proceeds		Gains/(Losses)
Agency MBS	$	1,500,875	$	(19,291)	$	360,634	$	499
Non-Agency MBS	1,318,958		107,999		244,778		41,420
CRT Securities	243,025		(27,011)		133,507		8,108
Total	$	3,062,858	$	61,697	$	738,919	$	50,027

Unrealized Losses on Residential Mortgage Securities

The following table presents information about the Company’s residential mortgage securities that were in an unrealized loss position at September 30, 2020, with respect to which no allowance for credit losses has been recorded:

Unrealized Loss Position For:

	Less than 12 Months					12 Months or more					Total
	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
(Dollars in Thousands)
Non-Agency MBS (1)	$	44,927	$	2,965	5	$	—	$	—	—	$	44,927	$	2,965
CRT securities (2)	59,553		3,127		8	—		—		—	59,553		3,127
Total residential mortgage securities	$	104,480	$	6,092	13	$	—	$	—	—	$	104,480	$	6,092

(1)Based on management’s current estimates of future principal cash flows expected to be received.

(2)Amounts disclosed at September 30, 2020 include CRT securities with a fair value of $59.6 million for which the fair value option has been elected. Such securities had unrealized losses of $3.1 million at September 30, 2020.

During the three months ended March 31, 2020, the Company recognized an impairment loss related to its Non-Agency MBS of $63.5 million based on its intent to sell, or the likelihood it will be required to sell, its remaining securities.

Gross unrealized losses on the Company’s Non-Agency MBS were $3.0 million at September 30, 2020. Based upon the most recent evaluation, the Company does not consider these unrealized losses to require an allowance for credit losses and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities that require an allowance for credit losses based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.

The Company did not recognize an allowance for credit losses (or other than temporary impairment in prior year periods) through earnings related to its Non-Agency MBS during the three and nine months ended September 30, 2020 and 2019.

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential mortgage securities and MSR-related assets:

	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars In Thousands)	2020		2019		2020		2019
Allowance for credit losses at beginning of period	$	—	$	—	$	—	$	—
Current provision:	—		—		—		—
Securities with no prior loss allowance	—		—		344,269		—
Securities with a prior loss allowance	—		—		—		—
Write-offs, including allowance related to securities the Company intends to sell	—		—		(344,269)		—
Allowance for credit losses at end of period	$	—	$	—	$	—	$	—

Purchase Discounts on Non-Agency MBS

The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and accretable purchase discount for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
(In Thousands)	Discount Designated as Credit Reserve		Accretable Discount (1)		Discount Designated as Credit Reserve		Accretable Discount (1)
Balance at beginning of period	$	(669)	$	(8,430)	$	(479,566)	$	(117,753)
Accretion of discount	—		7		—		10,357
Realized credit losses	—		—		4,062		—
Sales/Redemptions	—		177		12,479		6,029
Transfers/release of credit reserve	—		—		930		(930)
Balance at end of period	$	(669)	$	(8,246)	$	(462,095)	$	(102,297)

	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
(In Thousands)	Discount Designated as Credit Reserve		Accretable Discount (1)		Discount Designated as Credit Reserve		Accretable Discount (1)
Balance at beginning of period	$	(436,598)	$	(90,617)	$	(516,116)	$	(155,025)
Impact of RMBS Issuer Settlement (2)	—		—		—		(1,688)
Accretion of discount	—		10,827		—		38,215
Realized credit losses	5,868		—		21,482		—
Purchases	—		—		(624)		291
Sales/Redemptions	436,885		76,233		23,842		25,231
Net impairment losses recognized in earnings	(11,513)		—		—		—
Transfers/release of credit reserve	4,689		(4,689)		9,321		(9,321)
Balance at end of period	$	(669)	$	(8,246)	$	(462,095)	$	(102,297)

(1)Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2)Includes the impact of $1.7 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2019 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

MSR-Related Assets

(a) Term Notes Backed by MSR-Related Collateral

At September 30, 2020 and December 31, 2019, the Company had $234.1 million and $1.2 billion, respectively, of term notes issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered to be largely dependent on cash flows generated by the underlying MSRs, as this impacts the cash flows available to the SPV that issued the term notes.

At September 30, 2020, these term notes had an amortized cost of $184.5 million, gross unrealized gains of $49.5 million, a weighted average yield of 12.1% and a weighted average term to maturity of 9.5 years. During the nine months ended September 30, 2020, the Company sold certain term notes for $711.7 million, realizing gains of $28.7 million, respectively. During the three months ended March 31, 2020, the Company recognized an impairment loss related to its term notes of $280.8 million based on its intent to sell, or the likelihood it will be required to sell, such notes. At December 31, 2019, the term notes had an amortized cost of $1.2 billion, gross unrealized gains of $5.2 million, a weighted average yield of 4.75% and a weighted average term to maturity of 5.3 years.

(b) Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are secured by MSRs, as well as certain other unencumbered assets owned by the borrower.

The Company has participated in a loan where the Company committed to lend $32.6 million of which approximately $18.1 million was drawn at September 30, 2020. At September 30, 2020, the coupon paid by the borrower on the drawn amount is 5.52%. The facility expires in 11 months. During the remaining commitment period, the Company receives a commitment fee between 0.25% and 1.0% based on the undrawn amount of the loan.

Impact of AFS Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	52,889	$	439,898	$	392,722	$	417,167
Unrealized gain/(loss) on Agency MBS, net	—		603		(161)		22,483
Unrealized gain on Non-Agency MBS, net	5,998		2,856		360,315		22,211
Unrealized gain on MSR term notes, net	9,084		2,024		48,431		5,391
Reclassification adjustment for MBS sales included in net income	(60)		(14,499)		(389,127)		(36,370)
Reclassification adjustment for impairment included in net income	—		—		(344,269)		—
Change in AOCI from AFS securities	15,022		(9,016)		(324,811)		13,715
Balance at end of period	$	67,911	$	430,882	$	67,911	$	430,882

Interest Income on Residential Mortgage Securities and MSR-Related Assets

The following table presents the components of interest income on the Company’s residential mortgage securities and MSR- related assets for the three and nine months ended September 30, 2020 and 2019: 

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Agency MBS
Coupon interest	$	—	$	18,994	$	14,038	$	66,560
Effective yield adjustment (1)	—		(7,188)		(5,186)		(21,039)
Interest income	$	—	$	11,806	$	8,852	$	45,521
Legacy Non-Agency MBS
Coupon interest	$	42	$	21,011	$	18,222	$	68,144
Effective yield adjustment (2)(3)	6		10,336		10,564		38,003
Interest income	$	48	$	31,347	$	28,786	$	106,147
RPL/NPL MBS
Coupon interest	$	811	$	13,227	$	7,622	$	44,305
Effective yield adjustment (1)(4)	94		8		449		158
Interest income	$	905	$	13,235	$	8,071	$	44,463
CRT securities
Coupon interest	$	956	$	5,174	$	6,063	$	16,769
Effective yield adjustment (2)	420		(923)		(94)		(1,224)
Interest income	$	1,376	$	4,251	$	5,969	$	15,545
MSR-related assets
Coupon interest	$	2,991	$	15,273	$	23,332	$	38,230
Effective yield adjustment (1)(2)	3,250		1		6,857		2
Interest income	$	6,241	$	15,274	$	30,189	$	38,232

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.

(2) The effective yield adjustment is the difference between the net income calculated using the net yield less the current coupon yield. The net yield may be based on management’s estimates of the amount and timing of future cash flows or on the instrument’s contractual cash flows, depending on the relevant accounting standard.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $3.1 million during the nine months ended September 30, 2019.

(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $4,000 during the three months ended September 30, 2019 and $277,000 and $152,000 during the nine months ended September 30, 2020 and 2019, respectively.

XML

Other Assets

9 Months Ended

Sep. 30, 2020

Other Assets [Abstract]

Other Assets

Other Assets

The following table presents the components of the Company’s Other assets at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
REO (1)	$	298,866	$	411,659
Capital contributions made to loan origination partners	108,887		147,992
Other interest-earning assets	45,442		70,468
Interest receivable	42,723		70,986
Other MBS and loan related receivables	36,342		43,842
Other	39,354		39,304
Total Other Assets	$	571,614	$	784,251

(1)    Includes $59.3 million and $27.3 million of REO that is held-for-investment at September 30, 2020 and December 31, 2019, respectively.

(a) Real Estate Owned

At September 30, 2020, the Company had 1,131 REO properties with an aggregate carrying value of $298.9 million. At December 31, 2019, the Company had 1,652 REO properties with an aggregate carrying value of $411.7 million.

At September 30, 2020, $295.7 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $132.5 million of residential whole loans held at carrying value and $487.3 million of residential whole loans held at fair value at September 30, 2020.

The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Balance at beginning of period	$	348,516	$	334,069	$	411,659	$	249,413
Adjustments to record at lower of cost or fair value	93		(3,875)		(11,796)		(9,264)
Transfer from residential whole loans (1)	15,672		61,888		74,891		193,531
Purchases and capital improvements, net	536		5,108		9,334		16,307
Disposals (2)	(65,951)		(20,990)		(185,222)		(73,787)
Balance at end of period	$	298,866	$	376,200	$	298,866	$	376,200
Number of properties	1,131		1,508		1,131		1,508

(1)Includes net gain recorded on transfer of approximately $834,000 and $5.0 million for the three months ended September 30, 2020 and 2019, respectively; and approximately $4.1 million and $16.1 million for nine months ended September 30, 2020 and 2019, respectively.

(2)During the three and nine months ended September 30, 2020, the Company sold 267 and 812 REO properties for consideration of $69.9 million and $195.2 million, realizing net gains of approximately $3.9 million and $10.0 million, respectively. During the three and nine months ended September 30, 2019, the Company sold 142 and 431 REO properties for consideration of $23.0 million and $80.0 million, realizing net gains of approximately $2.1 million and $5.8 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations.

(b) Capital Contributions Made to Loan Origination Partners

The Company has made investments in several loan originators as part of its strategy to be a reliable source of capital to select partners from whom it sources residential mortgage loans through both flow arrangements and bulk purchases. To date, such contributions of capital include the following investments (based on their carrying value prior to any impairments): $31.0 million of common equity, $68.0 million of preferred equity and $75.0 million of convertible notes. In addition, for certain partners, options or warrants may have also been acquired that provide the Company the ability to increase the level of its investment if certain conditions are met. At the end of each reporting period, or earlier if circumstances warrant, the Company evaluates whether the nature of its interests and other involvement with the investee entity requires the Company to apply equity method accounting or consolidate the results of the investee entity with the Company’s financial results. To date, the nature of the Company’s interests and/or involvement with investee companies has not resulted in consolidation. Further, to the extent that the nature of the Company’s interests has resulted in the need for the Company to apply equity method accounting, the impact of such accounting on the Company’s results for periods subsequent to that in which the Company was determined to have significant influence over the investee company was not material for any period. As the interests acquired to date by the Company generally do not have a readily determinable fair value, the Company accounts for its non-equity method interests (including any acquired options and warrants) in loan originators initially at cost. The carrying value of these investments is adjusted if it is determined that an impairment has occurred or if there has been a subsequent observable transaction in either the investee company’s equity securities or a similar security that provides evidence to support an adjustment to the carrying value. Following an evaluation of the anticipated impact of the COVID-19 pandemic on economic conditions for the short to medium term, the Company recorded impairment charges of $65.2 million on investments in certain loan origination partners during the nine months ended September 30, 2020, respectively, which was included in “Impairment and other losses on securities available-for-sale and other assets” on the consolidated statements of operations. The Company did not record any impairment charges on investments in certain loan origination partners during the three months ended September 30, 2020. At September 30, 2020, approximately $840.5 million of the Company’s Residential whole loans, at carrying value were serviced by entities in which the Company has an investment.

(c) Derivative Instruments

The Company’s derivative instruments have generally been comprised of Swaps, the majority of which were designated as cash flow hedges against the interest rate risk associated with certain borrowings. In addition, in connection with managing risks associated with purchases of longer duration Agency MBS, the Company has also entered into Swaps that are not designated as hedges for accounting purposes.

In response to the turmoil in the financial markets resulting from the COVID-19 pandemic experienced during the three months ended March 31, 2020, the Company unwound all of its approximately $4.1 billion of Swap hedging transactions late in the first quarter in order to recover previously posted margin. Gains or losses associated with these Swap hedging transactions are required to be transferred from AOCI to earnings over the original term of the Swap, if the underlying hedged item or transactions are assessed as probable of occurring. After the closing of several new financing transactions late in the quarter ended June 30, 2020, the Company evaluated its anticipated future financing requirements. The Company concluded that it was no longer probable that certain previously used financing strategies, including those that primarily utilized repurchase agreements with funding costs that reset on a monthly basis, would be used by the Company on an ongoing basis, as this financing strategy had been essentially replaced by the new financing transactions. Consequently, the Company concluded that it was appropriate to transfer from AOCI to earnings approximately $49.9 million of losses on Swaps that had previously been designated as hedges for accounting purposes, because the hedged transactions were no longer considered probable to occur. In addition, during the quarter ended September 30, 2020, the Company transferred from AOCI to earnings approximately $7.2 million of losses on Swaps that had been previously designated as hedges for accounting purposes as the Company had assessed that the underlying transactions were no longer probable of occurring. These amounts are included in Other income, net on the Company’s consolidated statements of operations. At September 30, 2020, there are no remaining losses included in AOCI on Swaps previously designated as hedges for accounting purposes.

The following table presents the fair value of the Company’s derivative instruments at September 30, 2020 and December 31, 2019:

		September 30, 2020				December 31, 2019
Derivative Instrument (1)	Designation	Notional Amount		Fair Value		Notional Amount		Fair Value
(In Thousands)
Swaps	Hedging	$	—	$	—	$	2,942,000	$	—
Swaps	Non-Hedging	$	—	$	—	$	230,000	$	—

(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Swaps

The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
Agency MBS, at fair value	$	—	$	2,241
Restricted cash	—		16,777
Total assets pledged against Swaps	$	—	$	19,018

The following table presents information about the Company’s Swaps at September 30, 2020 and December 31, 2019:

	September 30, 2020						December 31, 2019
	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
Maturity (1)
(Dollars in Thousands)
Over 3 months to 6 months	$	—	—	%	—	%	$	200,000	2.05	%	1.70	%
Over 6 months to 12 months	—		—		—		1,430,000		2.30		1.77
Over 12 months to 24 months	—		—		—		1,300,000		2.11		1.86
Over 24 months to 36 months	—		—		—		20,000		1.38		1.90
Over 36 months to 48 months	—		—		—		222,000		2.88		1.84
Total Swaps	$	—	—	%	—	%	$	3,172,000	2.24	%	1.81	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

The following table presents the net impact of the Company’s derivative hedging instruments on its net interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,						Nine Months Ended September 30,
(Dollars in Thousands)	2020			2019			2020			2019
Interest (expense)/income attributable to Swaps	$	—		$	(322)		$	(3,359)		$	1,561
Weighted average Swap rate paid	—		%	2.29		%	2.06		%	2.32		%
Weighted average Swap rate received	—		%	2.24		%	1.63		%	2.40		%

During the nine months ended September 30, 2020, the Company recorded net losses on Swaps not designated in hedging relationships of approximately $4.3 million, which included $9.4 million of losses realized on the unwind of certain Swaps. During the three and nine months ended September 30, 2019, the Company recorded net losses on Swaps not designated in hedging relationships of approximately $929,000 and $17.3 million, respectively, which included $3.7 million and $17.7 million of losses realized on the unwind of certain Swaps. These amounts are included in Other income, net on the Company’s consolidated statements of operations.

Impact of Derivative Hedging Instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
AOCI from derivative hedging instruments:
Balance at beginning of period	$	(7,176)	$	(28,114)	$	(22,675)	$	3,121
Net loss on Swaps	—		(233)		(50,127)		(30,384)
Reclassification adjustment for losses/gains related to hedging instruments included in net income	7,176		(685)		72,802		(1,769)
Balance at end of period	$	—	$	(29,032)	$	—	$	(29,032)

XML

Financing Agreements

9 Months Ended

Sep. 30, 2020

Disclosure of Repurchase Agreements [Abstract]

Financing Agreements

Financing Agreements

The following tables present the components of the Company’s Financing agreements at September 30, 2020 and December 31, 2019:

	September 30, 2020
(In Thousands)	Unpaid Principal Balance		Amortized Cost Balance		Fair Value/Carrying Value(1)
Financing agreements, at fair value
Agreements with non-mark-to-market collateral provisions	$	1,723,959	$	1,723,959	$	1,727,407
Agreements with mark-to-market collateral provisions	1,489,097		1,489,097		1,490,271
Senior secured credit agreement	481,250		462,923		473,993
Securitized debt	389,051		380,407		388,790
Total Financing agreements, at fair value	$	4,083,357	$	4,056,386	$	4,080,461
Other financing agreements
Securitized debt	$	451,197			$	448,893
Convertible senior notes	230,000				224,867
Senior notes	100,000				96,900
Total Financing agreements at carrying value	$	781,197			$	770,660
Total Financing agreements	$	4,864,554			$	4,851,121

(1)    Financing agreements at fair value are reported at estimated fair value each period as a result of the Company’s fair value option election. Other financing arrangements are reported at their carrying value (amortized cost basis) as the fair value option was not elected on these liabilities. Consequently, Total Financing agreements as presented reflects a summation of balances reported at fair value and carrying value.

Set out below is information about the Company’s Financing agreements that existed as of December 31, 2019. During the second quarter of 2020, outstanding repurchase agreement transactions at that time were renegotiated as part of a reinstatement agreement that was entered into by the Company. The Company elected to account for these reinstated transactions under the fair value option from the time these repurchase agreements were reinstated. Accordingly, as of September 30, 2020, such liabilities are reported as Financing agreements at fair value.

	December 31, 2019
(In Thousands)	Unpaid Principal Balance		Carrying Value
Repurchase agreements	$	9,140,944	$	9,139,821
Securitized debt	573,900		570,952
Convertible senior notes	230,000		223,971
Senior notes	100,000		96,862
Total Financing agreements at carrying value	$	10,044,844	$	10,031,606

(a) Financing Agreements, at Fair Value

During the second quarter of 2020, the Company entered into a $500 million senior secured credit agreement. In addition, in conjunction with its exit from forbearance arrangements, the Company entered into several new asset backed financing arrangements and renegotiated financing arrangements for certain assets with existing lenders, that resulted in the Company essentially refinancing the majority of its investment portfolio. The Company elected the fair value option on these financing

arrangements, primarily to simplify the accounting associated with costs incurred to establish the new facilities or renegotiate existing facilities.

The Company considers that the most relevant feature that distinguishes between the various asset backed financing arrangements is how the financing arrangement is collateralized, including the ability of the lender to make margin calls on the Company based on changes in value of the underlying collateral securing the financing. Accordingly, further details are provided below regarding assets that are financed with agreements that have non-mark-to-market collateral provisions and assets that are financed with agreements that have mark-to-market collateral provisions.

Agreements with non-mark-to-market collateral provisions

The Company and certain of its subsidiaries entered into a non-mark-to-market term loan facility with certain lenders to finance an aggregate amount of up to $1.65 billion. The Company’s borrowing subsidiaries have pledged, as collateral security for the facility, certain of their residential whole loans (excluding Rehabilitation loans), as well as the equity in subsidiaries that own the loans. The facility has an initial term of two years, which may be extended for up to an additional three years, subject to certain conditions, including the payment of an extension fee and provided that no events of default have occurred. For the initial two year term, the financing cost for the facility will be calculated at a spread over the lender’s financing cost, which, depending on the lender, is expected to be based either on three-month LIBOR, or an index that it expected over time to be closely correlated to changes in three-month LIBOR. At September 30, 2020, the amount financed under this facility was approximately $1.4 billion.

In addition, the Company also entered into non-mark-to-market financing facilities on Rehabilitation loans. Under these facilities, Rehabilitation loans, as well as the equity in subsidiaries that own the loans, are pledged as collateral. The facilities have a two year term and the financing cost is calculated at a spread over three-month LIBOR. At September 30, 2020, the amount financed under these facilities was approximately $359.0 million.

The following table presents information with respect to the Company’s financing agreements with non-mark-to-market collateral provisions and associated assets pledged as collateral at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Non-mark-to-market financing secured by residential whole loans at carrying value	$	1,471,269		$	—
Fair value of residential whole loans at carrying value pledged as collateral under financing agreements	$	2,323,085		$	—
Weighted average haircut on residential whole loans at carrying value	41.91		%	—		%
Non-mark-to-market financing secured by residential whole loans at fair value	$	256,138		$	—
Fair value of residential whole loans at fair value pledged as collateral under financing agreements	$	435,081		$	—
Weighted average haircut on residential whole loans at fair value	41.25		%	—		%

Agreements with mark-to-market collateral provisions

In addition to entering into the financing arrangements discussed above, the Company also entered into a reinstatement agreement with certain lending counterparties that facilitated its exit from the forbearance arrangements that the Company had previously entered into. In connection with the reinstatement agreement, terms of its prior financing arrangements on certain residential whole loans, residential mortgage securities, and MSR-related assets were renegotiated and those arrangements were reinstated on a go-forward basis. These financing arrangements continue to contain mark-to-market provisions that permit the lending counterparties to make margin calls on the Company should the value of the pledged collateral decline. The Company is also permitted to recover previously posted margin payments, should values of the pledged collateral subsequently increase. These facilities generally have a maturity ranging from one to three months and can be renewed at the discretion of the lending counterparty at financing costs reflecting prevailing market pricing. At September 30, 2020, the amount financed under these agreements was approximately $1.5 billion.

The following table presents information with respect to the Company’s financing agreements with mark-to-market collateral provisions and associated assets pledged as collateral at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Mark-to-market financing agreements secured by residential whole loans (1)	$	1,231,734		$	4,743,094
Fair value of residential whole loans pledged as collateral under financing agreements (2)	$	2,002,903		$	5,986,267
Weighted average haircut on residential whole loans (3)	30.88		%	20.07		%
Mark-to-market financing agreement borrowings secured by Agency MBS	$	—		$	1,557,675
Fair value of Agency MBS pledged as collateral under financing agreements	$	—		$	1,656,373
Weighted average haircut on Agency MBS (3)	—		%	4.46		%
Mark-to-market financing agreement borrowings secured by Legacy Non-Agency MBS	$	1,282		$	1,121,802
Fair value of Legacy Non-Agency MBS pledged as collateral under financing agreements	$	2,621		$	1,420,797
Weighted average haircut on Legacy Non-Agency MBS (3)	50.00		%	20.27		%
Mark-to-market financing agreement borrowings secured by RPL/NPL MBS	$	32,950		$	495,091
Fair value of RPL/NPL MBS pledged as collateral under financing agreements	$	53,809		$	635,005
Weighted average haircut on RPL/NPL MBS (3)	38.75		%	21.52		%
Mark-to-market financing agreements secured by CRT securities	$	54,883		$	203,569
Fair value of CRT securities pledged as collateral under financing agreements	$	96,336		$	252,175
Weighted average haircut on CRT securities (3)	42.47		%	18.84		%
Mark-to-market financing agreements secured by MSR-related assets	$	135,340		$	962,515
Fair value of MSR-related assets pledged as collateral under financing agreements	$	252,183		$	1,217,002
Weighted average haircut on MSR-related assets (3)	39.87		%	21.18		%
Mark-to-market financing agreements secured by other interest-earning assets	$	34,082		$	57,198
Fair value of other interest-earning assets pledged as collateral under financing agreements	$	44,079		$	61,708
Weighted average haircut on other interest-earning assets (3)	25.00		%	22.01		%

(1)Excludes $0 and $1.1 million of unamortized debt issuance costs at September 30, 2020 and December 31, 2019, respectively.

(2)At September 30, 2020 and December 31, 2019, includes RPL/NPL MBS with an aggregate fair value of $192.7 million and $238.8 million, respectively, obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

(3) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

In addition, the Company had cash pledged as collateral in connection with its financing agreements of $5.3 million and $25.2 million at September 30, 2020 and December 31, 2019, respectively.

The following table presents repricing information (excluding the impact of associated derivative hedging instruments, if any) about the Company’s financing agreements that have non-mark-to-market collateral provisions as well as those that have mark-to-market collateral provisions, at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
	Amortized Cost Basis		Weighted Average Interest Rate		Amortized Cost Basis		Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)
Within 30 days	$	2,932,213	3.36	%	$	4,472,120	2.55	%
Over 30 days to 3 months	—		—		2,746,384		3.43
Over 3 months to 12 months	280,843		3.02		1,014,441		3.36
Over 12 months	—		—		907,999		3.44
Total financing agreements	$	3,213,056	3.33	%	$	9,140,944	2.99	%
Less debt issuance costs	—				1,123
Total financing agreements less debt issuance costs	$	3,213,056			$	9,139,821

The Company had financing agreements, including repurchase agreements and other forms of secured financing with 8 and 28 counterparties at September 30, 2020 and December 31, 2019, respectively. The following table presents information with respect to each counterparty under financing agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2020:

	September 30, 2020
	Counterparty Rating (1)	Amount  at Risk (2)		Weighted  Average Months  to Repricing for Repurchase Agreements	Percent of Stockholders’ Equity
Counterparty
(Dollars in Thousands)
Barclays Bank	BBB/Aa3/A	$	750,922	1	29.3	%
Credit Suisse	BBB+/Baa2/A-	574,835		1	22.4
Wells Fargo	A+/Aa2/AA-	349,825		1	13.6
Goldman Sachs (3)	BBB+/A3/A	173,266		3	6.8
Athene (4)	BBB+/N/A/BBB+	144,245		1	5.6

(1)As rated at September 30, 2020 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2)The amount at risk reflects the difference between (a) the amount loaned to the Company through financing agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3)Includes $20.6 million at risk with Goldman Sachs and $152.7 million at risk with Goldman Sachs Bank USA.

(4)Includes amounts at risk with various Athene affiliates that collectively exceed 5% of stockholders’ equity.

Senior Secured Term Loan Facility

The Company entered into a $500 million senior secured term loan facility (the “Term Loan Facility”) with certain funds, accounts and/or clients managed by affiliates of Apollo Global Management, Inc. and affiliates of Athene Holding Ltd.

The term loans were issued with original issue discount of 1%. Interest on the outstanding principal amount of the term loans will accrue at a rate of 11% per annum until the third anniversary of the original funding date. Prior to the third anniversary of the funding date, a portion of such interest, in an amount equal to up to 3% per annum, may be capitalized, compounded and added to the unpaid principal amount of the term loans. The interest rate on the term loans will increase by 1% per annum on the third anniversary of the funding date and by an additional 1% per annum on each subsequent anniversary of the funding date. Upon the occurrence and during the continuance of an event of default under the Term Loan Facility, the principal amount of all loans outstanding and, to the extent permitted by applicable law, any interest payments on such term loans or any fees or other amounts owing under the Term Loan Facility that, in either case, are then overdue, would thereafter bear interest at a rate that is 2% per annum in excess of the interest rate otherwise payable on the term loans.

The Company is permitted to voluntarily prepay the amount borrowed under the Term Loan Facility in full at any time without penalty. In addition, the Company may partially prepay the amount borrowed on only one occasion without penalty, provided such partial prepayment be in an amount of not less than $250 million. Installment payments of principal equal to 3.75% of the initial principal amount for the first three years of the Term Loan Facility and 4.50% of the initial principal amount thereafter, together with accrued and unpaid interest on such principal amount, will be required to be made on the last business day of each March, June, September and December beginning on September 30, 2020. Mandatory prepayments of the term loans are required to be made from net cash proceeds received in connection with certain events, that are set out in the credit agreement. Upon the event of a change in control as defined in the credit agreement, the Company is also required to make an offer to repay the loan at par, plus unpaid accrued interest, plus a specified redemption premium. In addition, the Company is required to comply with certain affirmative and negative covenants as specified in the Term Loan Facility that, among other things, impose certain limitations on the Company to incur liens or indebtedness, to make certain investments or enter into new businesses, to modify or waive terms on certain of the Company’s existing debt or to prepay such debt, or to pay dividends in certain circumstances. The Company must also maintain a minimum level of liquidity as defined in the Term Loan Facility. Subsequent to the end of the third quarter, the outstanding balance of the Term Loan Facility was repaid and the Term Loan Facility was terminated. Refer to note 16 for further discussion.

(b) Other Financing Agreements

These arrangements were either entered into prior to the Company experiencing financial difficulties related to the COVID-19 pandemic, or, in the case of the Company’s most recent securitization, after the Company’s exit from forbearance, and were not subject to the forbearance arrangements that were entered into by the Company or any negotiations related to the Company’s exit from those arrangements.

Additional information regarding the Company’s Other financing arrangements as of September 30, 2020, is included below:

Securitized Debt

Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. The weighted average fixed rate on the securitized debt was 2.93% at September 30, 2020 (see Notes 10 and 15 for further discussion).

Convertible Senior Notes

On June 3, 2019, the Company issued $230.0 million in aggregate principal amount of its Convertible Senior Notes in an underwritten public offering, including an additional $30.0 million issued pursuant to the exercise of the underwriters’ option to purchase additional Convertible Senior Notes. The total net proceeds the Company received from the offering were approximately $223.3 million, after deducting offering expenses and the underwriting discount.  The Convertible Senior Notes bear interest at a fixed rate of 6.25% per year, paid semiannually on June 15 and December 15 of each year commencing December 15, 2019 and will mature on June 15, 2024, unless earlier converted, redeemed or repurchased in accordance with their terms. The Convertible Senior Notes are convertible at the option of the holders at any time until the close of business on the business day immediately preceding the maturity date into shares of the Company’s common stock based on an initial conversion rate of 125.7387 shares of the Company’s common stock for each $1,000 principal amount of the Convertible Senior Notes, which is equivalent to an initial conversion price of approximately $7.95 per share of common stock. The Convertible Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 6.94%. The Company does not have the right to redeem the Convertible Senior Notes prior to maturity, except to the extent necessary to preserve its status as a REIT, in which case the Company may redeem the Convertible Senior Notes, in whole or in part, at a redemption price equal to the principal amount redeemed plus accrued and unpaid interest.

The Convertible Senior Notes are the Company’s senior unsecured obligations and are effectively junior to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness and equal in right of payment to the Company’s existing and future senior unsecured obligations, including the Senior Notes.

Senior Notes

On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds the Company received from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest.

The Senior Notes are the Company’s senior unsecured obligations and are effectively junior to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness and equal in right of payment to the Company’s existing and future senior unsecured obligations, including the Convertible Senior Notes.

XML

Collateral Positions

9 Months Ended

Sep. 30, 2020

Collateral Positions

Collateral Positions

Collateral Positions

The Company pledges securities or cash as collateral to its counterparties in relation to certain of its financing arrangements. In addition, the Company receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements.  The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated financing arrangements and Swap contracts, as applicable.  In connection with these margining practices, either the Company or its counterparty may be required to pledge cash or securities as collateral.  When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral or provide collateral to the Company in the form of cash or equivalent securities.

The Company’s assets pledged as collateral are described in Notes 2(f) - Restricted Cash, 5(c) - Derivative Instruments and 6 - Repurchase Agreements. The total fair value of assets pledged as collateral with respect to the Company’s borrowings under its financing arrangements and/or derivative hedging instruments was $5.2 billion and $11.3 billion at September 30, 2020 and December 31, 2019, respectively. An aggregate of $35.8 million and $57.2 million of accrued interest on those assets had also been pledged as of September 30, 2020 and December 31, 2019, respectively.

XML

Offsetting Assets and Liabilities

9 Months Ended

Sep. 30, 2020

Offsetting [Abstract]

Offsetting Assets and Liabilities

Offsetting Assets and Liabilities

Certain of the Company’s financing arrangements and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction. In the Company’s consolidated balance sheets, all balances associated with repurchase agreements are presented on a gross basis.

The fair value of financial instruments pledged against the Company’s financing arrangements was $5.2 billion and $11.2 billion at September 30, 2020 and December 31, 2019, respectively. The fair value of financial instruments pledged against the Company’s Swaps was $0 and $2.2 million at September 30, 2020 and December 31, 2019, respectively. In addition, cash that has been pledged as collateral against financing arrangements and Swaps is reported as Restricted cash on the Company’s consolidated balance sheets (see Notes 2(f), 5(c) and 6).

XML

Other Liabilities

9 Months Ended

Sep. 30, 2020

Other Liabilities [Abstract]

Other Liabilities

Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
Dividends and dividend equivalents payable	$	22,758	$	90,749
Accrued interest payable	14,588		18,238
Accrued expenses and other	29,136		42,819
Total Other Liabilities	$	66,482	$	151,806

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

(a) Lease Commitments

The Company pays monthly rent pursuant to three office leases.  In November 2018, the Company amended the lease for its corporate headquarters in New York, New York, under the same terms and conditions, to extend the expiration date for the lease by up to one year, through June 30, 2021, with a mutual option to terminate in February 2021.  For the three and nine months ended September 30, 2020, the Company recorded expense of approximately $739,000 and $2.1 million in connection with the lease for its current corporate headquarters.

In addition, in November 2018, the Company executed a lease agreement on new office space in New York, New York. The Company plans to relocate its corporate headquarters to this new office space upon the substantial completion of the building. The lease term specified in the agreement is fifteen years with an option to renew for an additional five years. The Company’s current estimate of annual lease rental expense under the new lease, excluding escalation charges which at this point are unknown, is approximately $4.6 million. The Company currently expects to relocate to the space in the first quarter of 2021, but this timing, as well as when it is required to begin making payments and recognize rental and other expenses under the new lease, is dependent on when the space is actually available for use.

(b) Representations and Warranties in Connection with Loan Securitization Transactions

In connection with the loan securitization transactions entered into by the Company, the Company has the obligation under certain circumstances to repurchase assets previously transferred to securitization vehicles upon breach of certain representations and warranties. As of September 30, 2020, the Company had no reserve established for repurchases of loans and was not aware of any material unsettled repurchase claims that would require the establishment of such a reserve (see Note 15).

(c) Corporate Loans

The Company has participated in loans to provide financing to entities that originate loans and own MSRs, as well as certain other unencumbered assets owned by the borrower. At September 30, 2020, Company’s commitment to lend is $32.6 million, of which $14.5 million was undrawn. (see Note 4).

(d) Rehabilitation Loan Commitments

At September 30, 2020, the Company had unfunded commitments of $73.2 million in connection with its purchased Rehabilitation loans (see Note 3).

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2020

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

(a) Preferred Stock

7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”)

On April 15, 2013, the Company completed the issuance of 8.0 million shares of its Series B Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.

As a result of the turmoil in the financial markets resulting from the spread of the novel coronavirus and the global COVID-19 pandemic, and in order to preserve liquidity, on March 25, 2020, the Company revoked the previously announced first quarter 2020 quarterly cash dividends on each of the Company's common stock and Series B Preferred Stock. The Series B Preferred Stock dividend of $0.46875 per share had been declared on February 14, 2020, and was to be paid on March 31, 2020, to stockholders of record as of the close of business March 2, 2020. Unpaid dividends on the Company's Series B Preferred Stock accrue without interest. No dividends may be paid or set apart on shares of the Company's common stock unless full cumulative dividends on the Series B Preferred Stock for all past dividend periods that have ended have been or contemporaneously are paid in cash, or a sum sufficient for such payment is set apart for payment. In addition, pursuant to the

now-terminated forbearance agreements that the Company entered into subsequent to the end of the first quarter, the Company was prohibited from paying dividends on its Series B Preferred Stock during the forbearance period, and therefore suspended the payment of dividends on the Series B Preferred Stock for the quarter ended June 30, 2020.

On July 1, 2020, the Company announced that it had reinstated the payment of dividends on its Series B Preferred Stock and declared a preferred stock dividend of $0.9375 per share, payable on July 31, 2020 to Series B Preferred stockholders of record as of July 15, 2020. Upon payment of this dividend, the Company paid in full all accumulated but previously unpaid dividends on its Series B Preferred Stock.

On August 12, 2020, the Company declared a dividend on its Series B preferred stock of $0.46875 per share. This dividend was paid on September 30, 2020, to Series B preferred stockholders of record as of September 8, 2020.

Issuance of 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”)

On February 28, 2020, the Company amended its charter through the filing of articles supplementary to reclassify 12,650,000 shares of the Company’s authorized but unissued common stock as shares of the Company’s Series C Preferred Stock. On March 2, 2020, the Company completed the issuance of 11.0 million shares of its Series C Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The total net proceeds the Company received from the offering were approximately $266.0 million, after deducting offering expenses and the underwriting discount.

The Company’s Series C Preferred Stock is entitled to receive dividends (i) from and including the original issue date to, but excluding, March 31, 2025, at a fixed rate of 6.50% per year on the $25.00 liquidation preference and (ii) from and including March 31, 2025, at a floating rate equal to three-month LIBOR plus a spread of 5.345% per year of the $25.00 per share liquidation preference before the Company’s common stock is paid any dividends, and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series C Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series C Preferred Stock is not redeemable by the Company prior to March 31, 2025, except under circumstances where it is necessary to preserve the Company’s qualification as a REIT for U.S. federal income tax purposes and upon the occurrence of certain specified change in control transactions. On or after March 31, 2025, the Company may, at its option, subject to certain procedural requirements, redeem any or all of the shares of the Series C Preferred Stock for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends thereon (whether or not authorized or declared) to, but excluding, the redemption date.

The Series C Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board, until all unpaid dividends have been paid or declared and set apart for payment. In addition, certain material and adverse changes to the terms of the Series C Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3 of the outstanding shares of Series C Preferred Stock.

Pursuant to the now-terminated forbearance agreements that the Company had previously entered into, the Company was prohibited from paying dividends on its Series C Preferred Stock during the forbearance period. On July 1, 2020, the Company announced that it had reinstated the payment of dividends on its Series C Preferred Stock and declared a preferred stock dividend of $0.53264 per share, payable on July 31, 2020 to the Series C Preferred stockholders of record as of July 15, 2020. Upon payment of this dividend, the Company paid in full all accumulated but previously unpaid dividends on its Series C Preferred Stock.

On August 12, 2020, the Company declared a dividend on its Series C preferred stock of $0.40625 per share. This dividend was paid on September 30, 2020, to Series C preferred stockholders of record as of September 8, 2020.

(b)  Dividends on Common Stock

On August 6, 2020, the Company declared a regular cash dividend of $0.05 per share of common stock.  The dividend will be paid on October 30, 2020, to stockholders of record on September 30, 2020.

(c) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)

On October 15, 2019, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) under the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 9.0 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At September 30, 2020, approximately 8.8 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.

During the three and nine months ended September 30, 2020, the Company issued 4,374 and 137,740 shares of common stock through the DRSPP, raising net proceeds of approximately $11,688 and $752,095, respectively.  Since the inception of the DRSPP in September 2003 through September 30, 2020, the Company issued 34,516,508 shares pursuant to the DRSPP, raising net proceeds of $287.3 million.

(d) At-the-Market Offering Program

On August 16, 2019 the Company entered into a distribution agreement under the terms of which the Company may offer and sell shares of its common stock having an aggregate gross sales price of up to $400.0 million (the “ATM Shares”), from time to time, through various sales agents, pursuant to an at-the-market equity offering program (the “ATM Program”). Sales of the ATM Shares, if any, may be made in negotiated transactions or by transactions that are deemed to be “at-the-market” offerings, as defined in Rule 415 under the 1933 Act, including sales made directly on the New York Stock Exchange (“NYSE”) or sales made to or through a market maker other than an exchange. The sales agents are entitled to compensation of up to two percent of the gross sales price per share for any shares of common stock sold under the distribution agreement.

During the nine months ended September 30, 2020, the Company did not sell any shares of common stock through the ATM Program. At September 30, 2020, approximately $390.0 million remained outstanding for future offerings under this program.

(e)  Stock Repurchase Program

As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock.  The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the nine months ended September 30, 2020.  At September 30, 2020, 6,616,355 shares remained authorized for repurchase under the Repurchase Program. Please refer to note 16 for further discussion.

(f) Warrants

On June 15, 2020, the Company entered into an Investment Agreement with Apollo and Athene (together the “Purchasers”), under which the Company agreed to issue to the Purchasers warrants (the “Warrants”) to purchase, in the

aggregate, 37,039,106 shares (subject to adjustment in accordance with their terms) of the Company’s common stock. The Warrants are exercisable at the holder’s option at any time until the date that is the later of (i) June 15, 2025 and (ii) the first anniversary of the repayment of the Term Loan Facility (See Note 6). One half of the Warrants have an exercise price of $1.66 per share and the other half have an exercise price of $2.08 per share. The Investment Agreement and the Term Loan Facility (See Note 6) were entered into simultaneously and the $495.0 million of proceeds received were allocated between the debt ($481.0 million) and the warrants ($14.0 million). The amount allocated to the warrants was recorded in Additional paid-in capital on the Company’s consolidated balance sheets.

(g) Accumulated Other Comprehensive Income/(Loss)

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020								Nine Months Ended September 30, 2020
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Net Unrealized Gain/(Loss) on Financing Agreements (3)		Total  AOCI		Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Net Unrealized Gain/(Loss) on Financing Agreements (3)		Total  AOCI
Balance at beginning of period	$	52,889	$	(7,176)	$	—	$	45,713	$	392,722	$	(22,675)	$	—	$	370,047
OCI before reclassifications	15,082		—		(22,652)		(7,570)		408,585		(50,127)		(22,652)		335,806
Amounts reclassified from AOCI (1)	(60)		7,176		—		7,116		(733,396)		72,802		—		(660,594)
Net OCI during the period (2)	15,022		7,176		(22,652)		(454)		(324,811)		22,675		(22,652)		(324,788)
Balance at end of period	$	67,911	$	—	$	(22,652)	$	45,259	$	67,911	$	—	$	(22,652)	$	45,259

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

(3) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2019:

	Three Months Ended September 30, 2019						Nine Months Ended September 30, 2019
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net Gain/(Loss) on Swaps		Total AOCI		Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Total AOCI
Balance at beginning of period	$	439,898	$	(28,114)	$	411,784	$	417,167	$	3,121	$	420,288
OCI before reclassifications	5,483		(233)		5,250		50,085		(30,384)		19,701
Amounts reclassified from AOCI (1)	(14,499)		(685)		(15,184)		(36,370)		(1,769)		(38,139)
Net OCI during the period (2)	(9,016)		(918)		(9,934)		13,715		(32,153)		(18,438)
Balance at end of period	$	430,882	$	(29,032)	$	401,850	$	430,882	$	(29,032)	$	401,850

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Details about AOCI Components	Amounts Reclassified from AOCI				Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(60)	$	(389,127)	Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Impairment recognized in earnings	—		(344,269)		Other, net
Total AFS Securities	$	(60)	$	(733,396)
Swaps designated as cash flow hedges:
Reclassification adjustment for losses related to hedging instruments included in net income	7,176		72,802		Other, net
Total Swaps designated as cash flow hedges	7,176		72,802
Total reclassifications for period	$	7,116	$	(660,594)

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2019:

	Three Months Ended September 30, 2019		Nine Months Ended September 30, 2019
Details about AOCI Components	Amounts Reclassified from AOCI				Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(14,499)	$	(36,370)	Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Total AFS Securities	$	(14,499)	$	(36,370)
Amortization of de-designated hedging instruments	(685)		(1,769)
Total reclassifications for period	$	(15,184)	$	(38,139)

XML

EPS Calculation

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

EPS Calculation

EPS Calculation

The following table presents a reconciliation of the earnings/(loss) and shares used in calculating basic and diluted earnings/(loss) per share for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands, Except Per Share Amounts)	2020		2019		2020		2019
Basic Earnings/(Loss) per Share:
Net income/(loss) to common stockholders	$	87,210	$	95,599	$	(725,207)	$	277,496
Dividends declared on preferred stock	(8,219)		(3,750)		(21,578)		(11,250)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(325)		(280)		(91)		(808)
Net income/(loss) to common stockholders - basic	$	78,666	$	91,569	$	(746,876)	$	265,438
Basic weighted average common shares outstanding	453,323		451,020		453,170		450,641
Basic Earnings/(Loss) per Share	$	0.17	$	0.20	$	(1.65)	$	0.59
Diluted Earnings/(Loss) per Share:
Net income/(loss) to common stockholders - basic	$	78,666	$	91,569	(746,876)		265,438
Interest expense on Convertible Senior Notes	3,898		3,879		—		5,085
Net income/(loss) to common stockholders - diluted	$	82,564	$	95,448	$	(746,876)	$	270,523
Basic weighted average common shares outstanding	453,323		451,020		453,170		450,641
Effect of assumed conversion of Convertible Senior Notes to common shares	28,920		28,920		—		12,712
Effect of incremental shares issued on assumed conversion of Warrants	11,297		—		—		—
Diluted weighted average common shares outstanding (1)	493,540		479,940		453,170		463,353
Diluted Earnings/(Loss) per Share	$	0.17	$	0.20	$	(1.65)	$	0.58

(1)At September 30, 2020, the Company had approximately 39.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the nine months ended September 30, 2020, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.29 and approximately 37.0 million warrants with a weighted average exercise price of $1.87 per share. These equity instruments may have a dilutive impact on future EPS.  

During the nine months ended September 30, 2020, the Convertible Senior Notes were determined to be anti-dilutive and were not included in the calculation of diluted EPS under the “if-converted” method. Under this method, the periodic interest expense for dilutive notes is added back to the numerator and the weighted average number of shares that the notes are entitled to (if converted, regardless of whether the conversion option is in or out of the money) is included in the denominator for the purpose of calculating diluted EPS. The Convertible Senior Notes may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans

9 Months Ended

Sep. 30, 2020

Compensation Related Costs [Abstract]

Equity Compensation, Employment Agreements and Other Benefit Plans

Equity Compensation, Employment Agreements and Other Benefit Plans

(a)  Equity Compensation Plan

In accordance with the terms of the Company’s Equity Plan, which was adopted by the Company’s stockholders on June 10, 2020 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

Subject to certain exceptions, stock-based awards relating to a maximum of 18.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count toward this limit.  At

September 30, 2020, approximately 14.3 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 2.0 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until June 10, 2030.

Restricted Stock Units

Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of September 30, 2020 are designated to be settled in shares of the Company’s common stock.  The Company granted 497,507 and 1,702,220 RSUs during the three and nine months ended September 30, 2020, respectively. The Company did not grant any RSUs during the three months ended September 30, 2019 and granted 912,525 RSUs during the nine months ended September 30, 2019. There were no RSUs forfeited during the nine months ended September 30, 2020 and 20,000 RSUs forfeited during the nine months ended September 30, 2019. All RSUs outstanding at September 30, 2020 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled.  At September 30, 2020 and December 31, 2019, the Company had unrecognized compensation expense of $8.3 million and $5.5 million, respectively, related to RSUs.  The unrecognized compensation expense at September 30, 2020 is expected to be recognized over a weighted average period of 1.9 years.

Restricted Stock

The Company granted 79,545 shares of restricted common stock during the nine months ended September 30, 2020, and the Company did not grant any shares of restricted common stock during the nine months ended September 30, 2019. At September 30, 2020, the Company did not have any unvested shares of restricted common stock outstanding.

Dividend Equivalents

A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules as the Compensation Committee of the Board shall determine in its discretion.  Payments made on the Company’s outstanding dividend equivalent rights are generally charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest.  The Company made dividend equivalent payments in respect of such instruments of approximately $276,000 during the nine months ended September 30, 2020 and approximately $276,000 and $773,000 during the three and nine months ended September 30, 2019, respectively.

 Expense Recognized for Equity-Based Compensation Instruments

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
RSUs	$	2,267	$	1,288	$	5,094	$	4,724
Total	$	2,267	$	1,288	$	5,094	$	4,724

(b)  Employment Agreements

At September 30, 2020, the Company had employment agreements with three of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.

(c)  Deferred Compensation Plans

The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.

The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Non-employee directors	$	75	$	134	$	(1,483)	$	459
Total	$	75	$	134	$	(1,483)	$	459

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2020 and December 31, 2019 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,074	$	1,114	$	2,349	$	3,071
Total	$	2,074	$	1,114	$	2,349	$	3,071

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2020 and December 31, 2019, which had not been distributed through such respective date.

(d)  Savings Plan

The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the three months ended September 30, 2020 and 2019, the Company recognized expenses for matching contributions of $120,000 and $94,000, respectively, and $360,000 and $323,000 for the nine months ended September 30, 2020 and 2019, respectively.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

GAAP requires the categorization of fair value measurements into three broad levels that form a hierarchy. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Residential Whole Loans, at Fair Value

The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans. The valuation approach applied generally depends on whether the loan is considered performing or non-performing at the date the valuation is performed. For performing loans, estimates of fair value are derived using a discounted cash flow approach, where estimates of cash flows are determined from the scheduled payments, adjusted using forecasted prepayment, default and loss given default rates. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, the estimated value of the collateral, expected costs and estimated home price appreciation. Estimated cash flows for both performing and non-performing loans are discounted at yields considered appropriate to arrive at a reasonable exit price for the asset. Indications of loan value such as actual trades, bids, offers and generic market color may be used in determining the appropriate discount yield. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Residential Mortgage Securities

The Company determines the fair value of its Agency MBS based upon prices obtained from third-party pricing services, which are indicative of market activity, and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace. The Company’s Agency MBS are classified as Level 2 in the fair value hierarchy. During the quarter ended June 30, 2020, the Company sold its remaining holdings of Agency MBS.

In determining the fair value of the Company’s Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

The Company’s Legacy Non-Agency MBS, RPL/NPL MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, these securities are classified as Level 2 in the fair value hierarchy. As of September 30, 2020, the Company has sold substantially all of its holdings of Legacy Non-Agency MBS and substantially reduced its holdings of other Non-Agency MBS and CRT securities.

Term Notes Backed by MSR-Related Collateral

The Company’s valuation process for term notes backed by MSR-related collateral is similar to that used for residential mortgage securities and considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral and, as applicable, the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient. Based on its evaluation of the observability of the data used in its fair value estimation process, these assets are classified as Level 2 in the fair value hierarchy.

Swaps

As previously disclosed, in response to the turmoil in the financial markets resulting from the COVID-19 pandemic experienced during the three months ended March 31, 2020, the Company unwound all of its Swap hedging transactions late in the first quarter in order to recover previously posted margin. Prior to their termination, valuations provided by the central clearing house were used for purposes of determining the fair value of the Company’s Swaps. Such valuations obtained were tested with internally developed models that applied readily observable market parameters.  Swaps were classified as Level 2 in the fair value hierarchy.

Financing Agreements, at Fair Value

Agreements with mark-to-market collateral provisions

These agreements are secured and subject to margin calls and their base interest rates reset frequently to market based rates. As a result, no credit valuation adjustment is required, and the primary factor in determining their fair value is the credit spread paid over the base rate, which is a non observable input as it is determined based on negotiations with the counterparty. The Company’s financing agreements with mark-to-market collateral provisions held at fair value are classified as Level 2 in the fair value hierarchy if the credit spreads used to price the instrument reset frequently, which is typically the case with shorter term repurchase agreement contracts collateralized by securities. Financing agreements with mark-to-market collateral provisions that are typically longer term and are collateralized by residential whole loans where the credit spread paid over the base rate on the instrument is not reset frequently are classified as Level 3 in the fair value hierarchy.

Agreements with non-mark-to-market collateral provisions

These agreements are secured, but not subject to margin calls, and their base interest rates reset frequently to market based rates. As a result, a credit valuation adjustment would only be required if there were a significant decrease in collateral value, and the primary factor in determining their fair value is the credit spread paid over the base rate, which is a non observable input as it is determined based on negotiations with the counterparty. The Company’s financing agreements with non-mark-to-market collateral provisions held at fair value are classified as Level 3 in the fair value hierarchy.

Senior Secured Credit Agreement (Term Loan Facility)

The estimated fair value of the Term Loan Facility was determined by management based on a valuation received from a third party that specializes in providing valuations on financial instruments. The most significant inputs to such valuation, market interest rates and the yield on the Company’s publicly traded financial instruments, are observable. The Company’s Term Loan Facility held at fair value is classified as Level 2 in the fair value hierarchy.

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2020 and December 31, 2019, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at September 30, 2020

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Residential whole loans, at fair value	$	—	$	—	$	1,229,664	$	1,229,664
Non-Agency MBS	—		56,430		—		56,430
CRT securities	—		96,335		—		96,335
Term notes backed by MSR-related collateral	—		234,091		—		234,091
Total assets carried at fair value	$	—	$	386,856	$	1,229,664	$	1,616,520
Liabilities:
Agreements with non-mark-to-market collateral provisions	$	—	$	—	$	1,727,407	$	1,727,407
Agreements with mark-to-market collateral provisions	—		258,537		1,231,734		1,490,271
Senior secured credit agreement	—		473,993		—		473,993
Securitized debt	—		388,790		—		388,790
Total liabilities carried at fair value	$	—	$	1,121,320	$	2,959,141	$	4,080,461

Fair Value at December 31, 2019

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Residential whole loans, at fair value	$	—	$	—	$	1,381,583	$	1,381,583
Non-Agency MBS	—		2,063,529		—		2,063,529
Agency MBS	—		1,664,582		—		1,664,582
CRT securities	—		255,408		—		255,408
Term notes backed by MSR-related collateral	—		1,157,463		—		1,157,463
Total assets carried at fair value	$	—	$	5,140,982	$	1,381,583	$	6,522,565

Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents additional information for the three and nine months ended September 30, 2020 and 2019 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Residential Whole Loans, at Fair Value
	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019 (1)		2020		2019 (1)(2)
Balance at beginning of period	$	1,200,981	$	1,438,827	$	1,381,583	$	1,471,263
Purchases (2)	—		85,855		—		210,030
Changes in fair value recorded in Net gain on residential whole loans measured at fair value through earnings	58,863		13,185		(13,683)		33,312
Cash collections, net of liquidation gains/(losses)	(21,721)		(31,212)		(65,934)		(94,821)
Sales and repurchases	(929)		—		(19,460)		(1,216)
Transfer to REO	(7,530)		(53,486)		(52,842)		(165,399)
Balance at end of period	$	1,229,664	$	1,453,169	$	1,229,664	$	1,453,169

(1)Included in the activity presented for the three months ended September 30, 2019 are approximately $87.0 million of residential whole loans held at fair value the Company committed to purchase during the three months ended June 30, 2019, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2019.

(2)Included in the activity presented for the nine months ended September 30, 2019 is an adjustment of $70.6 million for loans the Company committed to purchase during the three months ended December 31, 2018, but for which the closing of the purchase transaction occurred during the three months ended March 31, 2019. The adjustment was required following the finalization of due diligence performed prior to the closing of the purchase transaction and resulted in a downward revision to the prior estimate of the loan purchase amount.

The following table presents additional information for the three and nine months ended September 30, 2019 about the Company’s investments in term notes backed by MSR-related collateral, which were classified as Level 3 prior to September 30, 2019 and measured at fair value on a recurring basis:

	Term Notes Backed by MSR-Related Collateral
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2019		2019
Balance at beginning of period	$	1,106,026	$	538,499
Purchases	—		573,137
Collection of principal	(3,920)		(12,897)
Changes in unrealized gains	2,024		5,391
Transfer to Level 2	(1,104,130)		(1,104,130)
Balance at end of period	$	—	$	—

The following table presents additional information for the three and nine months ended September 30, 2020 about the Company’s financing agreements with non-mark-to-market collateral provisions, which are classified as Level 3 and measured at fair value on a recurring basis:

	Agreements with Non-mark-to-market Collateral Provisions
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2020		2020
Balance at beginning of period	$	—	$	—
Transfer from Level 2	2,036,597		2,036,597
Payment of principal	(312,638)		(312,638)
Changes in unrealized losses	3,448		3,448
Balance at end of period	$	1,727,407	$	1,727,407

The following table presents additional information for the three and nine months ended September 30, 2020 about the Company’s financing agreements with mark-to-market collateral provisions, which are classified as Level 3 and measured at fair value on a recurring basis:

	Agreements with Mark-to-market Collateral Provisions
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2020		2020
Balance at beginning of period	$	—	$	—
Transfer from Level 2	1,386,592		1,386,592
Payment of principal	(156,032)		(156,032)
Changes in unrealized losses	1,174		1,174
Balance at end of period	$	1,231,734	$	1,231,734

At June 30, 2020, the Company’s financing agreements with non-mark-to-market collateral provisions and the Company’s financing agreements with mark-to-market collateral provisions had just been issued and were therefore classified as Level 2 since their values were based on market transactions. However, market information for similar financings was not available at September 30, 2020 and the Company valued these financing instruments based on unobservable inputs.

Fair Value Methodology for Level 3 Financial Instruments

Residential Whole Loans, at Fair Value

The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2020 and December 31, 2019:

	September 30, 2020
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	774,427	Discounted cash flow	Discount rate	3.9		%	3.2-8.0%
				Prepayment rate	3.9		%	0.0-9.3%
				Default rate	6.2		%	0.0-30.3%
				Loss severity	12.7		%	0.0-100.0%
	$	454,760	Liquidation model	Discount rate	8.1		%	6.7-50.0%
				Annual change in home prices	1.9		%	(0.3)-5.5%
				Liquidation timeline (in years)	1.8			0.1-4.8
				Current value of underlying properties (3)	$	734		$12-$4,500
Total	$	1,229,187

	December 31, 2019
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	829,842	Discounted cash flow	Discount rate	4.2		%	3.8-8.0%
				Prepayment rate	4.5		%	0.7-18.0%
				Default rate	4.0		%	0.0-23.0%
				Loss severity	12.9		%	0.0-100.0%
	$	551,271	Liquidation model	Discount rate	8.0		%	6.2-50.0%
				Annual change in home prices	3.7		%	2.4-8.0%
				Liquidation timeline (in years)	1.8			0.1-4.5
				Current value of underlying properties (3)	$	684		$10-$4,500
Total	$	1,381,113

(1) Excludes approximately $477,000 and $470,000 of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2020 and December 31, 2019, respectively.

(2) Amounts are weighted based on the fair value of the underlying loan.

(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately $383,000 and $365,000 as of September 30, 2020 and December 31, 2019, respectively.

Changes in market conditions, as well as changes in the assumptions or methodology used to determine fair value, could result in a significant increase or decrease in the fair value of residential whole loans. Loans valued using a discounted cash flow model are most sensitive to changes in the discount rate assumption, while loans valued using the liquidation model technique are most sensitive to changes in the current value of the underlying properties and the liquidation timeline. Increases in discount rates, default rates, loss severities, or liquidation timelines, either in isolation or collectively, would generally result in a lower fair value measurement, whereas increases in the current or expected value of the underlying properties, in isolation, would result in a higher fair value measurement. In practice, changes in valuation assumptions may not occur in isolation and the changes in any particular assumption may result in changes in other assumptions, which could offset or amplify the impact on the overall valuation.

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2020 and December 31, 2019:

	September 30, 2020	September 30, 2020				December 31, 2019
	Level in Fair Value Hierarchy	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
(In Thousands)
Financial Assets:
Residential whole loans, at carrying value	3	$	4,387,559	$	4,528,630	$	6,069,370	$	6,248,745
Residential whole loans, at fair value	3	1,229,664		1,229,664		1,381,583		1,381,583
Non-Agency MBS	2	56,430		56,430		2,063,529		2,063,529
Agency MBS	2	—		—		1,664,582		1,664,582
CRT securities	2	96,335		96,335		255,408		255,408
MSR-related assets (1)	2 and 3	252,183		252,183		1,217,002		1,217,002
Cash and cash equivalents	1	884,171		884,171		70,629		70,629
Restricted cash	1	5,303		5,303		64,035		64,035
Financial Liabilities (2):
Financing agreements with non-mark-to-market collateral provisions	3	1,727,407		1,727,407		—		—
Financing agreements with mark-to-market collateral provisions	3	1,231,734		1,231,734		4,741,971		4,753,070
Financing agreements with mark-to-market collateral provisions	2	258,537		258,537		4,397,850		4,403,139
Senior secured credit agreement	2	473,993		473,993		—		—
Securitized debt (3)	2	837,683		839,914		570,952		575,353
Convertible senior notes	2	224,867		216,919		223,971		244,088
Senior notes	1	96,900		94,311		96,862		103,231

(1)Includes $18.1 million and $59.5 million of MSR-related assets that are measured at fair value on a non-recurring basis that are classified as Level 3 in the fair value hierarchy at September 30, 2020 and December 31, 2019, respectively.

(2)Carrying value of securitized debt, Convertible Senior Notes, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.

(3)Includes Securitized debt that is carried at amortized cost basis and fair value.

Other Assets Measured at Fair Value on a Nonrecurring Basis

The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. During the nine months ended September 30, 2020 and 2019, the Company recorded REO with an aggregate estimated fair value, less estimated cost to sell, of $74.9 million and $193.5 million, respectively, at the time of foreclosure. The Company classifies fair value measurements of REO as Level 3 in the fair value hierarchy.

XML

Use of Special Purpose Entities and Variable Interest Entities

9 Months Ended

Sep. 30, 2020

Use of Special Purpose Entities and Variable Interest Entities

Use of Special Purpose Entities and Variable Interest Entities

Use of Special Purpose Entities and Variable Interest Entities

A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in a SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. 

The Company has entered into several financing transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate these transactions. See Note 2(q) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with financing transactions.

The Company has engaged in loan securitizations primarily for the purpose of obtaining improved overall financing terms as well as non-recourse financing on a portion of its residential whole loan portfolio. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying assets transferred to the VIEs.

Loan Securitization Transactions

The following table summarizes the key details of the Company’s loan securitization transactions as of September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020				December 31, 2019
Aggregate unpaid principal balance of residential whole loans sold	$	1,681,500			$	1,290,029
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors	$	1,202,616			$	802,817
Outstanding amount of Senior Bonds, at carrying value	$	448,893		(1)	$	570,952		(1)
Outstanding amount of Senior Bonds, at fair value	$	388,790			$	—
Outstanding amount of Senior Bonds, total	$	837,683			$	570,952
Weighted average fixed rate for Senior Bonds issued	2.93		%	(2)	3.68		%	(2)
Weighted average contractual maturity of Senior Bonds	36 years			(2)	30 years			(2)
Face amount of Senior Support Certificates received by the Company (3)	$	266,355			$	275,174
Cash received	$	1,193,969			$	802,815

(1)Net of $2.2 million and $2.9 million of deferred financing costs at September 30, 2020 and December 31, 2019, respectively.

(2)At September 30, 2020 and December 31, 2019, $743.9 million and $493.2 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by either 100 or 300 basis points or more at 36 months from issuance if the bond is not redeemed before such date.

(3)Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

During the three and nine months ended September 30, 2020, the Company issued Senior Bonds with a current face of $372.8 million and $399.8 million to third-party investors for proceeds of $372.8 million and $391.2 million, respectively, before offering costs and accrued interest. The Senior Bonds issued by the Company during the nine months ended September 30, 2020 are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of issuance.

As of September 30, 2020 and December 31, 2019, as a result of the transactions described above, securitized loans with a carrying value of approximately $568.6 million and $186.4 million are included in “Residential whole loans, at carrying value,” securitized loans with a fair value of approximately $521.2 million and $567.4 million are included in “Residential whole loans,

at fair value,” and REO with a carrying value approximately $80.3 million and $137.8 million are included in “Other assets” on the Company’s consolidated balance sheets, respectively. As of September 30, 2020 and December 31, 2019, the aggregate carrying value of Senior Bonds issued by consolidated VIEs was $837.7 million and $571.0 million, respectively.  These Senior Bonds are disclosed as “Securitized debt” and are included in Other liabilities on the Company’s consolidated balance sheets.  The holders of the securitized debt have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties with respect to the residential whole loans sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.

The Company concluded that the entities created to facilitate the loan securitization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the securitization transactions should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:

•whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and

•whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.

Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate the loan securitization transactions.

Residential Whole Loans and REO (including Residential Whole Loans and REO transferred to consolidated VIEs)

Included on the Company’s consolidated balance sheets as of September 30, 2020 and December 31, 2019 are a total of $5.6 billion and $7.4 billion, respectively, of residential whole loans, of which approximately $4.4 billion and $6.1 billion, respectively, are reported at carrying value and $1.2 billion and $1.4 billion, respectively, are reported at fair value. These assets, and certain of the Company’s REO assets, are directly owned by certain trusts established by the Company to acquire the loans and entities established in connection with the Company’s loan securitization transactions. The Company has assessed that these entities are required to be consolidated (see Notes 3 and 5(a)).

XML

Subsequent Events

9 Months Ended

Sep. 30, 2020

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Payoff of remaining balance of Term Loan Facility

On October 9, 2020, the Company repaid $400 million of the principal outstanding on the Term Loan Facility (see note 6) and the remaining principal balance of this facility of $81,250,000 was repaid on October 30, 2020. The repayments were made without penalty or yield maintenance. Upon the full repayment, the Term Loan Facility was terminated.

Securitization of Non-QM loans

Subsequent to the end of the third quarter the Company closed on a $570 million Non-QM securitization that generated $125.1 million of additional liquidity.

Share Repurchase Authorization

On November 2, 2020, the Company’s Board of Directors authorized a share repurchase program under which the Company may repurchase up to $250 million of its common stock through the end of 2022. The Board’s authorization replaces the authorization under the Company’s existing stock repurchase program that was adopted in December 2013, which authorized the Company to repurchase up to 10 million shares of common stock and under which approximately 6.6 million shares remained available for repurchase

The stock repurchase program does not require the purchase of any minimum number of shares. The timing and extent to which the Company repurchases its shares will depend upon, among other things, market conditions, share price, liquidity, regulatory requirements and other factors, and repurchases may be commenced or suspended at any time without prior notice. Acquisitions under the share repurchase program may be made in the open market, through privately negotiated transactions or block trades or other means, in accordance with applicable securities laws.

The Company expects to fund the share repurchases from cash balances and future investment portfolio run-off. The Company currently has approximately 453.3 million shares of common stock outstanding.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Basis of Presentation and Consolidation

Basis of Presentation and Consolidation

The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted in accordance with these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2020 and results of operations for all periods presented have been made.  The results of operations for the three and nine months ended September 30, 2020 should not be construed as indicative of the results to be expected for the full year.

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including impairment, valuation allowances and loss allowances on residential whole loans (see Note 3), mortgage-backed securities (“MBS”) (see Note 4) and Other Assets (see Note 5), valuation of MBS, CRT securities and MSR-related assets (see Notes 4 and 14), income recognition and valuation of residential whole loans (see Notes 3 and 14), valuation of derivative instruments (see Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount (see Note 4).  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest (see Note 2(n)).  Actual results could differ from those estimates.

The Company has one reportable segment since it manages its business and analyzes and reports its results of operations on the basis of one operating segment: investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries. All intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.

Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed- and adjustable-rate residential mortgage loans acquired through consolidated trusts in secondary market transactions. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for Purchased Credit Deteriorated Loans that are held at carrying value is typically utilized by the Company for Purchased Credit Deteriorated Loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company also acquires Purchased Performing Loans that are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required credit loss reserves (as discussed below) differ from those used for Purchased Credit Deteriorated Loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against financing agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans that are subject to an extended period of due diligence that crosses a reporting date are recorded in our balance sheet at amounts reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Residential whole loans purchased under flow arrangements with loan origination partners are generally recorded at the transaction settlement date. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any financing agreement until the closing of the purchase transaction. Interest income, credit related losses and changes in the fair value of loans held at fair value are recorded post settlement for acquired loans and until transaction settlement for sold loans (see Notes 3, 6, 7, 14 and 15).

Residential Whole Loans at Carrying Value

Purchased Performing Loans

Acquisitions of Purchased Performing Loans to date have been primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties that are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to four-family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”). Purchased Performing Loans are initially recorded at their purchase price. Interest income on Purchased Performing Loans acquired at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any amortization of premium or accretion of discount, adjusted for actual prepayment activity. For loans acquired with related servicing rights retained by the seller, interest income is reported net of related serving costs.

An allowance for credit losses is recorded at acquisition, and maintained on an ongoing basis, for all losses expected to be incurred over the life of the respective loan. Any required credit loss allowance would reduce the net carrying value of the loan with a corresponding charge to earnings, and may increase or decrease over time. Significant judgments are required in determining any allowance for credit loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended, and interest accruals are reversed against income, for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful (i.e., such loans are placed on nonaccrual status). For nonaccrual loans other than Fix and Flip loans, all payments are applied to principal under the cost recovery method. For nonaccrual Fix and Flip loans, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged. Modified loans are considered

“troubled debt restructurings” if the Company grants a concession to a borrower who is experiencing financial difficulty (including the interpretation of this definition set forth in OCC Bulletin 2020-35).

Charge-offs to the allowance for loan losses occur when losses are confirmed through the receipt of cash or other consideration from the completion of a sale; when a modification or restructuring takes place in which we grant a concession to a borrower or agree to a discount in full or partial satisfaction of the loan; when we take ownership and control of the underlying collateral in full satisfaction of the loan; when loans are reclassified as other investments; or when significant collection efforts have ceased and it is highly likely that a loss has been realized.

The aggregate allowance for credit losses is equal to the sum of the losses expected to be incurred over the life of each respective loan. These losses were estimated by projecting each loan’s expected cash flows based on their contractual terms, expected prepayments, and estimated default and loss severity rates. The default and severity rates were estimated based on the following steps: (i) obtained the Company’s historical experience through an entire economic cycle for each loan type or, to the extent the Company did not have sufficient historical loss experience for a given loan type, publicly available data derived from the historical loss experience of certain banks, which data the Company believes is generally representative of its portfolio, (ii) obtained historical economic data (U.S. unemployment rates and home price appreciation) over the same period, and (iii) estimated default and severity rates during three distinct future periods based on historical default and severity rates during periods when economic conditions similar to those forecasted were experienced. The three periods were as follows: (i) a one-year forecast of economic conditions based on U.S. unemployment rates and home price appreciation, followed by (ii) a two-year “reversion” period during which economic conditions (U.S. unemployment rates and home price appreciation) are projected to revert to historical averages on a straight line basis, followed by (iii) the remaining life of each loan, during which period economic conditions (U.S. unemployment rates and home price appreciation) are projected to equal historical averages. In addition, a liability is established (and recorded in Other Liabilities) each period using a similar methodology for committed but undrawn loan amounts. This methodology has not changed from the calculation of the allowance for credit losses on January 1, 2020 pursuant to the transition to ASU 2016-13 as described below under “New Accounting Standards and Interpretations,” other than a change in the reversion period from one year to two years to reflect the expected ongoing impact of current conditions (see Note 3).

Purchased Credit Deteriorated Loans

The Company has elected to account for these loans as credit impaired as they have experienced a more-than-insignificant deterioration in credit quality since origination and were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price on a net basis, after establishing an initial allowance for credit losses (their initial cost basis is equal to their purchase price plus the initial allowance for credit losses). Subsequent to acquisition, the gross recorded amount for these loans reflects the initial cost basis, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded cost basis reduced by any allowance for credit losses. Interest income on such loans purchased is recorded each period based on the contractual coupon net of amortization of the difference between their cost basis and unpaid principal balance (“UPB”), subject to the Company’s nonaccrual policy.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

Cash received (or accrued) representing coupon interest payments on residential whole loans held at fair value is not included in Interest Income, but rather is included in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in unrealized gains or losses reported each period.

Residential Mortgage Securities

Residential Mortgage Securities

Prior to the quarter ended June 30, 2020, the Company had invested in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). The Company disposed of its investments in Agency MBS during the quarter and has substantially reduced its investments in Non-Agency MBS. In addition, the Company has investments in CRT securities that are issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the issuer and the principal payments received are dependent on the performance of loans in either a reference pool or an actual pool of loans. As the loans in the underlying pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company.

Designation

MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an allowance for losses is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company had elected the fair value option for certain of its previously held Agency MBS that it did not intend to hold to maturity. These securities were carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk-sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on their outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Determination of Fair Value for Residential Mortgage Securities

In determining the fair value of the Company’s residential mortgage securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity (see Note 14).

Allowance for credit losses

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities, as well as securities for which a credit loss allowance had been previously recorded, on at least a quarterly basis and determines whether any changes to the allowance for credit losses are required.  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize a write-down through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an impaired security, only the portion of the impairment related to credit losses is recognized through a loss allowance charged to earnings with the remainder recognized through AOCI on the Company’s consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Credit loss allowances are subject to reversal through earnings resulting from improvements in expected cash flows. The determination as to whether to record (or reverse) a credit loss allowance is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of future performance and cash flow projections.  As a result, the timing and amount of losses constitute material estimates that are susceptible to significant change (see Note 4).

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the allowance related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s residential mortgage securities pledged as collateral against financing agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date.

MSR-Related Assets

MSR-Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR-related assets, are discussed in more detail below. The Company’s MSR-related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR-related assets are recorded on the trade date (see Notes 4, 6, 7 and 14).

Term Notes Backed by MSR-Related Collateral

The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR-related collateral are treated as AFS securities and reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI, subject to impairment and loss allowances. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes is similar to that used for residential mortgage securities and considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral, as applicable, and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations, subject to loss allowances. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

Cash and Cash Equivalents

Cash and Cash Equivalents  Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its financing counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at September 30, 2020 and December 31, 2019.

Restricted Cash

Restricted Cash  Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s Swaps and/or financing agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to financing agreement and/or Swap counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap and/or financing agreements.

Real Estate Owned (REO)

Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on

the Company’s consolidated statements of operations. The Company has acquired certain properties that it holds for investment purposes, including rentals to third parties. These properties are held at their historical basis less depreciation, and are subject to impairment. Related rental income and expenses are recorded in Other Income, net

Depreciation

Depreciation

Leasehold Improvements, Real estate and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. The building component of real estate held-for-investment is depreciated over 27.5 years.

Loan Securitization and Other Debt Issuance Costs

Loan Securitization and Other Debt Issuance Costs

Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing its 6.25% Convertible Senior Notes due 2024 (“Convertible Senior Notes”) and its 8% Senior Notes due 2042 (“Senior Notes”). These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges (unless the debt is recorded at fair value, as discussed below), are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For the Convertible Senior Notes and Senior Notes, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and, in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

Financing Arrangements

Financing Agreements

The Company finances the majority of its residential mortgage assets with financing agreements that include repurchase agreements and other forms of collateralized financing.  Under repurchase agreements, the Company sells assets to a lender and agrees to repurchase the same assets in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements and other forms of collateralized financing, the Company pledges its assets as collateral to secure the borrowing, in an amount which is equal to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional assets or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the assets pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings collateralized by residential mortgage securities and MSR-related assets typically have terms ranging from one month to six months at inception, while the majority of our financing arrangements collateralized by residential whole loans have terms of twelve months or longer.  Should a counterparty decide not to renew a financing arrangement at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable on such collateral

Equity-Based Compensation

Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. 

The Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period, subject only to continued employment, and others of which cliff vest after a three-year period, subject to both continued employment and the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total shareholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total shareholder return over a specified period constitute a “market condition,” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.

The Company makes dividend equivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company

Earnings per Common Share (EPS)

Earnings per Common Share (“EPS”)  Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s dividend equivalents attached to/associated with RSUs, to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of RSUs outstanding that are unvested and have dividends that are subject to forfeiture, and for the effect of outstanding warrants, using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments (if any), are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  In addition, the Company’s Convertible Senior Notes are included in the calculation of diluted EPS if the assumed conversion into common shares is dilutive, using the “if-converted” method. This involves adding back the periodic interest expense associated with the Convertible Senior Notes to the numerator and by adding the shares that would be issued in an assumed conversion (regardless of whether the conversion option is in or out of the money) to the denominator for the purposes of calculating diluted EPS

Comprehensive Income/(Loss)

Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and terminated hedging relationships, as well as the portion of unrealized gains/(losses) on its financing agreements held at fair value related to instrument-specific credit risk, and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

U.S. Federal Income Taxes

U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”), and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business is conducted through one or more TRS, the net taxable income earned by its domestic TRS, if any, is subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of the Company’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No net deferred tax benefit was recorded by the Company for the nine months ended September 30, 2020 and 2019, related to the net taxable losses in the TRS, since a valuation allowance for the full amount of the associated deferred tax asset of approximately $75.5 million was recognized as its recovery is not considered more likely than not. The related net operating loss carryforwards generated prior to 2018 will begin to expire in 2034; those generated in 2020, 2019 and 2018 can be carried back to each of the five taxable years preceding the taxable year of such loss and thereafter can be carried forward and do not expire.

Based on its analysis of any potentially uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2020, December 31, 2019, or September 30, 2019. As of the date of this filing the Company’s tax returns for tax years 2017 through 2019 are open to examination.

Derivative Financial Instruments

Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments have generally been comprised of Swaps, the majority of which were designated as cash flow hedges against the interest rate risk associated with its borrowings.

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at the inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

During the first quarter of 2020, the Company terminated all of its Swaps. Prior to their termination, Swaps were carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value was positive, or in Other liabilities, if their fair value was negative.  Changes in the fair value of the Company’s Swaps previously designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense and are treated as an operating cash flow.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate (see Notes 5(c), 7 and 14).

Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statements of operations.

Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its financial assets and liabilities at the time of acquisition or issuance. Subsequent changes in the fair value of these financial instruments are generally reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable

Variable Interest Entities

Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without the additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) the holders of the equity investment at risk have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into several financing transactions which resulted in the Company forming entities to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the

entities used to facilitate these transactions are VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sales or should be accounted for as secured financings under GAAP (see Note 15).

The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering Costs Related to Issuance and Redemption of Preferred Stock Offering costs related to the issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

New Accounting Standards and Interpretations

New Accounting Standards and Interpretations

Accounting Standards Adopted in 2020

Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which has subsequently been amended by ASUs 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2020-02 Financial Instruments-Credit Losses (Topic 326)-Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date (SEC Update), and 2020-03 Codification Improvements to Financial Instruments. The amendments in ASU 2016-13 require entities to measure all expected credit losses (rather than incurred losses) for financial assets held at the reporting date, based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The amendments in this ASU were required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The Company adopted the new ASU on January 1, 2020. The impact of adoption was that the allowance for credit losses on Purchased Performing Loans increased by approximately $8.3 million. This transition adjustment was recorded as an increase in the Company’s allowance for credit losses and an adjustment to decrease retained earnings as of the adoption date. In addition, for Purchased Credit Deteriorated Loans, the carrying value of the portfolio was adjusted on transition to include an estimate of the allowance for credit losses as required by the new standard. For financial statement reporting purposes, this adjusted carrying value is presented net of the estimated allowance for credit losses. Consequently, the adjustments recorded on transition for Purchased Credit Deteriorated Loans do not result in any adjustment to retained earnings as of the adoption date. The Company does not consider these transition adjustments to be material to its financial position or previously reported GAAP or economic book value.

Under ASU 2016-13, credit losses for available-for-sale debt securities are measured in a manner similar to prior GAAP. However, the amendments in this ASU require that credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the allowance on available-for-sale debt securities will be limited to the extent that the fair value is less than the amortized cost. Under prior GAAP, credit impairment losses were generally required to be recorded as “other than temporary” impairment, which directly reduced the carrying amount of impaired securities, and was recorded in earnings and was not reversed if expected cash flows subsequently recovered. Under the new guidance, credit impairments on such securities (other than those related to expected sales) are recorded as an allowance for credit losses that is also recorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover. Transition to the new available-for-sale debt securities guidance did not result in a change to our retained earnings.

Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting

In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). The amendments in this ASU provide temporary optional expedients to ease the financial reporting burden of the expected transition from the London Interbank Offered Rate (“LIBOR”) to an alternative reference rate such as the Secured Overnight Financing Rate (“SOFR”). The amendments in the ASU are elective and apply to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in ASU 2020-04 were effective for all entities as of March 12, 2020 and will generally no longer be available to apply after December 31, 2022. The Company adopted this ASU as of the effective date and will utilize the optional expedients to the extent that they apply to the Company.

XML

Residential Whole Loans (Tables)

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2020 and December 31, 2019:

(Dollars In Thousands)	September 30, 2020		December 31, 2019
Purchased Performing Loans:
Non-QM loans	$	2,465,148	$	3,707,245
Rehabilitation loans	699,868		1,026,097
Single-family rental loans	479,070		460,742
Seasoned performing loans	147,706		176,569
Total Purchased Performing Loans	3,791,792		5,370,653
Purchased Credit Deteriorated Loans (1)	702,013		698,717
Total Residential whole loans, at carrying value	$	4,493,805	$	6,069,370
Allowance for credit losses on residential whole loans held at carrying value	(106,246)		(3,025)
Total Residential whole loans at carrying value, net	$	4,387,559	$	6,066,345
Number of loans	13,754		17,082

(1) The amortized cost basis of Purchased Credit Deteriorated Loans was increased by $62.6 million on January 1, 2020 in connection with the adoption of ASU 2016-13.

Schedule of Interest Income Components

The following table presents the components of interest income on the Company’s Residential whole loans, at carrying value for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Purchased Performing Loans:
Non-QM loans	$	25,884	$	30,258	$	112,212	$	79,250
Rehabilitation loans	10,863		15,142		39,502		38,331
Single-family rental loans	6,917		5,025		21,528		11,652
Seasoned performing loans	1,945		3,166		6,799		9,461
Total Purchased Performing Loans	45,609		53,591		180,041		138,694
Purchased Credit Deteriorated Loans	8,784		10,635		27,265		33,031
Total Residential whole loans, at carrying value	$	54,393	$	64,226	$	207,306	$	171,725

Financing Receivable Credit Quality Indicators

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2020:

September 30, 2020

	Carrying Value		Amortized Cost Basis		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Weighted Average Original FICO (3)	Aging by Amortized Cost Basis
															Past Due Days
(Dollars In Thousands)													Current		30-59		60-89		90+
Purchased Performing Loans:
Non-QM loans (4)	$	2,438,395	$	2,465,148	$	2,397,247	5.87	%	352	64	%	712	$	2,174,935	$	74,231	$	52,069	$	163,913
Rehabilitation loans (4)	677,235		699,868		699,868		7.28		4	63		718	491,343		65,166		22,995		120,364
Single-family rental loans (4)	474,045		479,070		475,072		6.28		319	70		734	439,503		16,111		7,373		16,083
Seasoned performing loans (4)	147,556		147,706		161,257		3.45		173	41		723	136,622		1,406		880		8,798
Purchased Credit Deteriorated Loans (4)(5)	650,328		702,013		812,614		4.45		289	79		N/A	N/M		N/M		N/M		122,478
Residential whole loans, at carrying value, total or weighted average	$	4,387,559	$	4,493,805	$	4,546,058	5.81	%	277

December 31, 2019

	Carrying Value		Amortized Cost Basis		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Weighted Average Original FICO (3)	Aging by UPB
															Past Due Days
(Dollars In Thousands)													Current		30-59		60-89		90+
Purchased    Performing Loans:
Non-QM loans (4)	$	3,706,857	$	3,707,245	$	3,592,701	5.96	%	368	67	%	716	$	3,492,533	$	59,963	$	19,605	$	20,600
Rehabilitation loans (4)	1,023,766		1,026,097		1,026,097		7.30		8	64		717	868,281		67,747		27,437		62,632
Single-family rental loans (4)	460,679		460,741		457,146		6.29		324	70		734	432,936		15,948		2,047		6,215
Seasoned performing loans	176,569		176,569		192,151		4.24		181	46		723	187,683		2,164		430		1,874
Purchased Credit Impaired Loans (5)	698,474		698,718		873,326		4.46		294	81		N/A	N/M		N/M		N/M		108,998
Residential whole loans, at carrying value, total or weighted average	$	6,066,345	$	6,069,370	$	6,141,421	5.96	%	288

(1)Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million and $269.2 million at September 30, 2020 and December 31, 2019, respectively, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% and 69% at September 30, 2020 and December 31, 2019, respectively. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

(3)Excludes loans for which no Fair Isaac Corporation (“FICO”) score is available.

(4)At September 30, 2020 and December 31, 2019 the difference between the Carrying Value and Amortized Cost Basis represents the related allowance for credit losses.

(5)Purchased Credit Deteriorated Loans tend to be characterized by varying performance of the underlying borrowers over time, including loans where multiple months of payments are received in a period to bring the loan to current status, followed by months where no payments are received. Accordingly, delinquency information is presented for loans that are more than 90 days past due that are considered to be seriously delinquent.

The following table presents certain additional credit-related information regarding our residential whole loans, at carrying value:

	Amortized Cost Basis by Origination Year and LTV Bands
(Dollars In Thousands)	2020		2019		2018		2017		2016		Prior		Total
Non-QM loans
LTV < 80% (1)	$	380,729	$	1,196,185	$	684,404	$	74,862	$	6,371	$	—	$	2,342,551
LTV >= 80% (1)	48,082		35,468		29,784		9,111		152		—		122,597
Total Non-QM loans	$	428,811	$	1,231,653	$	714,188	$	83,973	$	6,523	$	—	$	2,465,148
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	32	$	—	$	—	$	—	$	32
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	32	$	—	$	—	$	—	$	32
Rehabilitation loans
LTV < 80% (1)	$	36,478	$	542,865	$	93,973	$	7,546	$	—	$	—	$	680,862
LTV >= 80% (1)	1,262		15,496		548		1,700		—		—		19,006
Total Rehabilitation loans	$	37,740	$	558,361	$	94,521	$	9,246	$	—	$	—	$	699,868
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	13	$	1,030	$	32	$	—	$	—	$	1,075
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	13	$	1,030	$	32	$	—	$	—	$	1,075
Single family rental loans
LTV < 80% (1)	$	22,400	$	287,103	$	140,017	$	13,356	$	—	$	—	$	462,876
LTV >= 80% (1)	1,394		14,588		212		—		—		—		16,194
Total Single family rental loans	$	23,794	$	301,691	$	140,229	$	13,356	$	—	$	—	$	479,070
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Seasoned performing loans
LTV < 80% (1)	$	—	$	—	$	—	$	—	$	79	$	139,538	$	139,617
LTV >= 80% (1)	—		—		—		—		—		8,089		8,089
Total Seasoned performing loans	$	—	$	—	$	—	$	—	$	79	$	147,627	$	147,706
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	—	$	—
Purchased credit deteriorated loans
LTV < 80% (1)	$	—	$	—	$	—	$	633	$	2,982	$	420,265	$	423,880
LTV >= 80% (1)	—		—		—		—		3,184		274,950		278,134
Total Purchased credit deteriorated loans	$	—	$	—	$	—	$	633	$	6,166	$	695,215	$	702,014
Nine Months Ended September 30, 2020 Gross write-offs	$	—	$	—	$	—	$	—	$	—	$	448	$	448
Nine Months Ended September 30, 2020 Recoveries	—		—		—		—		—		—		—
Nine Months Ended September 30, 2020 Net write-offs	$	—	$	—	$	—	$	—	$	—	$	448	$	448
Total LTV < 80% (1)	$	439,607	$	2,026,153	$	918,394	$	96,397	$	9,432	$	559,803	$	4,049,786
Total LTV >= 80% (1)	50,738		65,552		30,544		10,811		3,336		283,039		444,020
Total residential whole loans, at carrying value	$	490,345	$	2,091,705	$	948,938	$	107,208	$	12,768	$	842,842	$	4,493,806
Total Gross write-offs	$	—	$	13	$	1,062	$	32	$	—	$	448	$	1,555
Total Recoveries	—		—		—		—		—		—		—
Total Net write-offs	$	—	$	13	$	1,062	$	32	$	—	$	448	$	1,555

(1)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $222.2 million at September 30, 2020, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% at September 30, 2020. Certain low value loans secured by vacant lots are categorized as LTV >= 80%.

Schedule of Credit Losses

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential Whole Loans, at Carrying Value:

	Nine Months Ended September 30, 2020
(Dollars In Thousands)	Non-QM Loans		Rehabilitation Loans (1)(2)		Single-family Rental Loans		Seasoned Performing Loans		Purchased Credit Deteriorated Loans (3)		Totals
Allowance for credit losses at December 31, 2019	$	388	$	2,331	$	62	$	—	$	244	$	3,025
Transition adjustment on adoption of ASU 2016-13 (4)	6,904		517		754		19		62,361		70,555
Current provision	26,358		33,213		6,615		230		8,481		74,897
Write-offs	—		(428)		—		—		(219)		(647)
Valuation adjustment on loans held for sale	70,181		—		—		—		—		70,181
Allowance for credit and valuation losses at March 31, 2020	$	103,831	$	35,633	$	7,431	$	249	$	70,867	$	218,011
Current provision/(reversal)	(2,297)		(5,213)		(500)		(25)		(2,579)		(10,614)
Write-offs	—		(420)		—		—		(207)		(627)
Valuation adjustment on loans held for sale	(70,181)		—		—		—		—		(70,181)
Allowance for credit losses at June 30, 2020	$	31,353	$	30,000	$	6,931	$	224	$	68,081	$	136,589
Current provision/(reversal)	(4,568)		(7,140)		(1,906)		(74)		(16,374)		(30,062)
Write-offs	(32)		(227)		—		—		(22)		(281)
Allowance for credit losses at September 30, 2020	$	26,753	$	22,633	$	5,025	$	150	$	51,685	$	106,246

	Nine Months Ended September 30, 2019
(Dollars In Thousands)	Non-QM Loans		Rehabilitation Loans		Single-family Rental Loans		Seasoned Performing Loans		Purchased Credit Deteriorated Loans		Totals
Allowance for credit losses at December 31, 2018	$	—	$	—	$	—	$	—	$	968	$	968
Current provision	—		500		—		—		183		683
Write-offs	—		—		—		—		—		—
Allowance for credit losses at March 31, 2019	$	—	$	500	$	—	$	—	$	1,151	$	1,651
Current provision	—		—		—		—		385		385
Write-offs	—		(50)		—		—		—		(50)
Allowance for credit losses at June 30, 2019	$	—	$	450	$	—	$	—	$	1,536	$	1,986
Current provision	—		—		—		—		347		347
Write-offs	—		(62)		—		—		—		(62)
Allowance for credit losses at September 30, 2019	$	—	$	388	$	—	$	—	$	1,883	$	2,271

(1)In connection with purchased Rehabilitation loans, the Company had unfunded commitments of $73.2 million, with an allowance for credit losses of $1.6 million at September 30, 2020. Such allowance is included in “Other liabilities” in the Company’s consolidated balance sheets (see Note 9).

(2)Includes $143.4 million of loans that were assessed for credit losses based on a collateral dependent methodology.

(3)Includes $72.7 million of loans that were assessed for credit losses based on a collateral dependent methodology.

(4)Of the $70.6 million of reserves recorded on adoption of ASU 2016-13, $8.3 million was recorded as an adjustment to stockholders’ equity and $62.4 million was recorded as a “gross up” of the amortized cost basis of Purchased Credit Deteriorated Loans.

Residential Whole Loans, Fair Value

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Less than 60 Days Past Due:
Outstanding principal balance	$	599,461		$	666,026
Aggregate fair value	$	577,761		$	641,616
Weighted Average LTV Ratio (1)	74.33		%	76.69		%
Number of loans	3,038			3,159
60 Days to 89 Days Past Due:
Outstanding principal balance	$	55,183		$	58,160
Aggregate fair value	$	49,188		$	53,485
Weighted Average LTV Ratio (1)	83.62		%	79.48		%
Number of loans	259			313
90 Days or More Past Due:
Outstanding principal balance	$	679,211		$	767,320
Aggregate fair value	$	602,715		$	686,482
Weighted Average LTV Ratio (1)	87.82		%	89.69		%
Number of loans	2,532			2,983
Total Residential whole loans, at fair value	$	1,229,664		$	1,381,583

(1)LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

Residential Whole Loans, Fair Value, Component of Net gain on residential whole loans

The following table presents the components of Net gain/(loss) on residential whole loans measured at fair value through earnings for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Coupon payments, realized gains, and other income received (1)	$	17,477	$	22,202	$	54,684	$	67,966
Net unrealized gains/(losses)	58,863		13,185		(13,683)		33,312
Net gain on transfers to REO	531		4,788		3,430		15,637
Total	$	76,871	$	40,175	$	44,431	$	116,915

(1)Primarily includes gains on liquidation of non-performing loans, including the recovery of delinquent interest payments, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.

XML

Residential Mortgage Securities and MSR-Related Assets (Tables)

9 Months Ended

Sep. 30, 2020

Investments, Debt and Equity Securities [Abstract]

Schedule of information about MBS and CRT Securities

The following tables present certain information about the Company’s residential mortgage securities at September 30, 2020 and December 31, 2019:

September 30, 2020

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts		Discount Designated as Credit Reserve (1)		Gross Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Net Unrealized Gain/(Loss)		Fair  Value
Non-Agency MBS (2)(3)(4)	$	60,295	$	—	$	(8,246)	$	(669)	$	51,380	$	8,015	$	(2,965)	$	5,050	$	56,430
CRT securities (5)	104,163		2,414		(69)		(20,768)		85,740		13,722		(3,127)		10,595		96,335
Total residential mortgage securities	$	164,458	$	2,414	$	(8,315)	$	(21,437)	$	137,120	$	21,737	$	(6,092)	$	15,645	$	152,765

December 31, 2019

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts		Discount Designated as Credit Reserve (1)		Gross Amortized Cost (6)		Gross Unrealized Gains		Gross Unrealized Losses		Net Unrealized Gain/(Loss)		Fair Value
Agency MBS: (7)
Fannie Mae	$	1,119,708	$	43,249	$	(22)	$	—	$	1,162,935	$	9,799	$	(14,741)	$	(4,942)	$	1,157,993
Freddie Mac	480,879		19,468		—		—		500,961		5,475		(3,968)		1,507		502,468
Ginnie Mae	3,996		73		—		—		4,069		52		—		52		4,121
Total Agency MBS	1,604,583		62,790		(22)		—		1,667,965		15,326		(18,709)		(3,383)		1,664,582
Non-Agency MBS:
Expected to Recover Par (2)(3)	722,477		—		(16,661)		—		705,816		19,861		(9)		19,852		725,668
Expected to Recover Less than Par (2)	1,472,826		—		(73,956)		(436,598)		962,272		375,598		(9)		375,589		1,337,861
Total Non-Agency MBS (4)	2,195,303		—		(90,617)		(436,598)		1,668,088		395,459		(18)		395,441		2,063,529
Total MBS	3,799,886		62,790		(90,639)		(436,598)		3,336,053		410,785		(18,727)		392,058		3,728,111
CRT securities (5)	244,932		4,318		(55)		—		249,195		6,304		(91)		6,213		255,408
Total residential mortgage securities	$	4,044,818	$	67,108	$	(90,694)	$	(436,598)	$	3,585,248	$	417,089	$	(18,818)	$	398,271	$	3,983,519

(1)Discount designated as Credit Reserve is generally not expected to be accreted into interest income.

(2)Based on management’s current estimates of future principal cash flows expected to be received.

(3)Includes RPL/NPL MBS, which at September 30, 2020 had an $57.4 million Principal/Current face, $49.2 million amortized cost and $53.8 million fair value. At December 31, 2019, RPL/NPL MBS had a $632.3 million Principal/Current face, $631.8 million amortized cost and $635.0 million fair value.

(4)At September 30, 2020 and December 31, 2019, the Company expected to recover approximately 99% and 80% of the then-current face amount of Non-Agency MBS, respectively.

(5)Amounts disclosed at September 30, 2020 includes CRT securities with a fair value of $63.3 million for which the fair value option has been elected. Such securities had $410,000 gross unrealized gains and gross unrealized losses of approximately $3.1 million at September 30, 2020. Amounts disclosed at December 31, 2019 includes CRT securities with a fair value of $255.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $6.3 million and gross unrealized losses of approximately $91,000 at December 31, 2019.

(6)Includes principal payments receivable of $614,000 at December 31, 2019, which is not included in the Principal/Current Face.

(7)Amounts disclosed at December 31, 2019 include Agency MBS with a fair value of $280.3 million, for which the fair value option has been elected. Such securities had $4.5 million unrealized gains and no gross unrealized losses at December 31, 2019, respectively.

Schedule of Sale of Residential Mortgage Securities

The following table presents information about the Company’s sales of its residential mortgage securities for the three and nine months ended September 30, 2020 and 2019. The Company has no continuing involvement with any of the sold securities.

	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
(In Thousands)	Sales Proceeds		Gains/(Losses)		Sales Proceeds		Gains/(Losses)
Agency MBS	$	—	$	—	$	257,289	$	2,771
Non-Agency MBS	116		48		47,867		14,444
CRT Securities	—		—		28,969		493
Total	$	116	$	48	$	334,125	$	17,708

	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
(In Thousands)	Sales Proceeds		Gains/(Losses)		Sales Proceeds		Gains/(Losses)
Agency MBS	$	1,500,875	$	(19,291)	$	360,634	$	499
Non-Agency MBS	1,318,958		107,999		244,778		41,420
CRT Securities	243,025		(27,011)		133,507		8,108
Total	$	3,062,858	$	61,697	$	738,919	$	50,027

Schedule of information about MBS and CRT Securities that were in an unrealized loss position

The following table presents information about the Company’s residential mortgage securities that were in an unrealized loss position at September 30, 2020, with respect to which no allowance for credit losses has been recorded:

Unrealized Loss Position For:

	Less than 12 Months					12 Months or more					Total
	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
(Dollars in Thousands)
Non-Agency MBS (1)	$	44,927	$	2,965	5	$	—	$	—	—	$	44,927	$	2,965
CRT securities (2)	59,553		3,127		8	—		—		—	59,553		3,127
Total residential mortgage securities	$	104,480	$	6,092	13	$	—	$	—	—	$	104,480	$	6,092

(1)Based on management’s current estimates of future principal cash flows expected to be received.

(2)Amounts disclosed at September 30, 2020 include CRT securities with a fair value of $59.6 million for which the fair value option has been elected. Such securities had unrealized losses of $3.1 million at September 30, 2020.

Schedule of Credit Losses

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential mortgage securities and MSR-related assets:

	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars In Thousands)	2020		2019		2020		2019
Allowance for credit losses at beginning of period	$	—	$	—	$	—	$	—
Current provision:	—		—		—		—
Securities with no prior loss allowance	—		—		344,269		—
Securities with a prior loss allowance	—		—		—		—
Write-offs, including allowance related to securities the Company intends to sell	—		—		(344,269)		—
Allowance for credit losses at end of period	$	—	$	—	$	—	$	—

Schedule of changes in the components of the purchase discount on Non-Agency MBS

The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and accretable purchase discount for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30, 2020				Three Months Ended September 30, 2019
(In Thousands)	Discount Designated as Credit Reserve		Accretable Discount (1)		Discount Designated as Credit Reserve		Accretable Discount (1)
Balance at beginning of period	$	(669)	$	(8,430)	$	(479,566)	$	(117,753)
Accretion of discount	—		7		—		10,357
Realized credit losses	—		—		4,062		—
Sales/Redemptions	—		177		12,479		6,029
Transfers/release of credit reserve	—		—		930		(930)
Balance at end of period	$	(669)	$	(8,246)	$	(462,095)	$	(102,297)

	Nine Months Ended September 30, 2020				Nine Months Ended September 30, 2019
(In Thousands)	Discount Designated as Credit Reserve		Accretable Discount (1)		Discount Designated as Credit Reserve		Accretable Discount (1)
Balance at beginning of period	$	(436,598)	$	(90,617)	$	(516,116)	$	(155,025)
Impact of RMBS Issuer Settlement (2)	—		—		—		(1,688)
Accretion of discount	—		10,827		—		38,215
Realized credit losses	5,868		—		21,482		—
Purchases	—		—		(624)		291
Sales/Redemptions	436,885		76,233		23,842		25,231
Net impairment losses recognized in earnings	(11,513)		—		—		—
Transfers/release of credit reserve	4,689		(4,689)		9,321		(9,321)
Balance at end of period	$	(669)	$	(8,246)	$	(462,095)	$	(102,297)

(1)Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2)Includes the impact of $1.7 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2019 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

Schedule of impact of AFS on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	52,889	$	439,898	$	392,722	$	417,167
Unrealized gain/(loss) on Agency MBS, net	—		603		(161)		22,483
Unrealized gain on Non-Agency MBS, net	5,998		2,856		360,315		22,211
Unrealized gain on MSR term notes, net	9,084		2,024		48,431		5,391
Reclassification adjustment for MBS sales included in net income	(60)		(14,499)		(389,127)		(36,370)
Reclassification adjustment for impairment included in net income	—		—		(344,269)		—
Change in AOCI from AFS securities	15,022		(9,016)		(324,811)		13,715
Balance at end of period	$	67,911	$	430,882	$	67,911	$	430,882

Schedule of interest income on MBS, CRT Securities and MSR Related Assets

The following table presents the components of interest income on the Company’s residential mortgage securities and MSR- related assets for the three and nine months ended September 30, 2020 and 2019: 

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Agency MBS
Coupon interest	$	—	$	18,994	$	14,038	$	66,560
Effective yield adjustment (1)	—		(7,188)		(5,186)		(21,039)
Interest income	$	—	$	11,806	$	8,852	$	45,521
Legacy Non-Agency MBS
Coupon interest	$	42	$	21,011	$	18,222	$	68,144
Effective yield adjustment (2)(3)	6		10,336		10,564		38,003
Interest income	$	48	$	31,347	$	28,786	$	106,147
RPL/NPL MBS
Coupon interest	$	811	$	13,227	$	7,622	$	44,305
Effective yield adjustment (1)(4)	94		8		449		158
Interest income	$	905	$	13,235	$	8,071	$	44,463
CRT securities
Coupon interest	$	956	$	5,174	$	6,063	$	16,769
Effective yield adjustment (2)	420		(923)		(94)		(1,224)
Interest income	$	1,376	$	4,251	$	5,969	$	15,545
MSR-related assets
Coupon interest	$	2,991	$	15,273	$	23,332	$	38,230
Effective yield adjustment (1)(2)	3,250		1		6,857		2
Interest income	$	6,241	$	15,274	$	30,189	$	38,232

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.

(2) The effective yield adjustment is the difference between the net income calculated using the net yield less the current coupon yield. The net yield may be based on management’s estimates of the amount and timing of future cash flows or on the instrument’s contractual cash flows, depending on the relevant accounting standard.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $3.1 million during the nine months ended September 30, 2019.

(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $4,000 during the three months ended September 30, 2019 and $277,000 and $152,000 during the nine months ended September 30, 2020 and 2019, respectively.

XML

Other Assets (Tables)

9 Months Ended

Sep. 30, 2020

Other Assets [Abstract]

Schedule of other assets

The following table presents the components of the Company’s Other assets at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
REO (1)	$	298,866	$	411,659
Capital contributions made to loan origination partners	108,887		147,992
Other interest-earning assets	45,442		70,468
Interest receivable	42,723		70,986
Other MBS and loan related receivables	36,342		43,842
Other	39,354		39,304
Total Other Assets	$	571,614	$	784,251

(1)    Includes $59.3 million and $27.3 million of REO that is held-for-investment at September 30, 2020 and December 31, 2019, respectively.

Schedule of activity for real estate owned

The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Balance at beginning of period	$	348,516	$	334,069	$	411,659	$	249,413
Adjustments to record at lower of cost or fair value	93		(3,875)		(11,796)		(9,264)
Transfer from residential whole loans (1)	15,672		61,888		74,891		193,531
Purchases and capital improvements, net	536		5,108		9,334		16,307
Disposals (2)	(65,951)		(20,990)		(185,222)		(73,787)
Balance at end of period	$	298,866	$	376,200	$	298,866	$	376,200
Number of properties	1,131		1,508		1,131		1,508

(1)Includes net gain recorded on transfer of approximately $834,000 and $5.0 million for the three months ended September 30, 2020 and 2019, respectively; and approximately $4.1 million and $16.1 million for nine months ended September 30, 2020 and 2019, respectively.

(2)During the three and nine months ended September 30, 2020, the Company sold 267 and 812 REO properties for consideration of $69.9 million and $195.2 million, realizing net gains of approximately $3.9 million and $10.0 million, respectively. During the three and nine months ended September 30, 2019, the Company sold 142 and 431 REO properties for consideration of $23.0 million and $80.0 million, realizing net gains of approximately $2.1 million and $5.8 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations.

Schedule of derivative instruments and balance sheet location

The following table presents the fair value of the Company’s derivative instruments at September 30, 2020 and December 31, 2019:

		September 30, 2020				December 31, 2019
Derivative Instrument (1)	Designation	Notional Amount		Fair Value		Notional Amount		Fair Value
(In Thousands)
Swaps	Hedging	$	—	$	—	$	2,942,000	$	—
Swaps	Non-Hedging	$	—	$	—	$	230,000	$	—

(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Schedule of assets pledged as collateral against derivative contracts

The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
Agency MBS, at fair value	$	—	$	2,241
Restricted cash	—		16,777
Total assets pledged against Swaps	$	—	$	19,018

Schedule of information about swaps

The following table presents information about the Company’s Swaps at September 30, 2020 and December 31, 2019:

	September 30, 2020						December 31, 2019
	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
Maturity (1)
(Dollars in Thousands)
Over 3 months to 6 months	$	—	—	%	—	%	$	200,000	2.05	%	1.70	%
Over 6 months to 12 months	—		—		—		1,430,000		2.30		1.77
Over 12 months to 24 months	—		—		—		1,300,000		2.11		1.86
Over 24 months to 36 months	—		—		—		20,000		1.38		1.90
Over 36 months to 48 months	—		—		—		222,000		2.88		1.84
Total Swaps	$	—	—	%	—	%	$	3,172,000	2.24	%	1.81	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

Schedule of interest expense and the weighted average interest rate paid and received on swaps

The following table presents the net impact of the Company’s derivative hedging instruments on its net interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,						Nine Months Ended September 30,
(Dollars in Thousands)	2020			2019			2020			2019
Interest (expense)/income attributable to Swaps	$	—		$	(322)		$	(3,359)		$	1,561
Weighted average Swap rate paid	—		%	2.29		%	2.06		%	2.32		%
Weighted average Swap rate received	—		%	2.24		%	1.63		%	2.40		%

Schedule of impact of hedging instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
AOCI from derivative hedging instruments:
Balance at beginning of period	$	(7,176)	$	(28,114)	$	(22,675)	$	3,121
Net loss on Swaps	—		(233)		(50,127)		(30,384)
Reclassification adjustment for losses/gains related to hedging instruments included in net income	7,176		(685)		72,802		(1,769)
Balance at end of period	$	—	$	(29,032)	$	—	$	(29,032)

XML

Financing Agreements (Tables)

9 Months Ended

Sep. 30, 2020

Disclosure of Repurchase Agreements [Abstract]

Financing Agreements

The following tables present the components of the Company’s Financing agreements at September 30, 2020 and December 31, 2019:

	September 30, 2020
(In Thousands)	Unpaid Principal Balance		Amortized Cost Balance		Fair Value/Carrying Value(1)
Financing agreements, at fair value
Agreements with non-mark-to-market collateral provisions	$	1,723,959	$	1,723,959	$	1,727,407
Agreements with mark-to-market collateral provisions	1,489,097		1,489,097		1,490,271
Senior secured credit agreement	481,250		462,923		473,993
Securitized debt	389,051		380,407		388,790
Total Financing agreements, at fair value	$	4,083,357	$	4,056,386	$	4,080,461
Other financing agreements
Securitized debt	$	451,197			$	448,893
Convertible senior notes	230,000				224,867
Senior notes	100,000				96,900
Total Financing agreements at carrying value	$	781,197			$	770,660
Total Financing agreements	$	4,864,554			$	4,851,121

(1)    Financing agreements at fair value are reported at estimated fair value each period as a result of the Company’s fair value option election. Other financing arrangements are reported at their carrying value (amortized cost basis) as the fair value option was not elected on these liabilities. Consequently, Total Financing agreements as presented reflects a summation of balances reported at fair value and carrying value.

Set out below is information about the Company’s Financing agreements that existed as of December 31, 2019. During the second quarter of 2020, outstanding repurchase agreement transactions at that time were renegotiated as part of a reinstatement agreement that was entered into by the Company. The Company elected to account for these reinstated transactions under the fair value option from the time these repurchase agreements were reinstated. Accordingly, as of September 30, 2020, such liabilities are reported as Financing agreements at fair value.

	December 31, 2019
(In Thousands)	Unpaid Principal Balance		Carrying Value
Repurchase agreements	$	9,140,944	$	9,139,821
Securitized debt	573,900		570,952
Convertible senior notes	230,000		223,971
Senior notes	100,000		96,862
Total Financing agreements at carrying value	$	10,044,844	$	10,031,606

Financing agreements with non-mark-to-market collateral provisions and associated assets pledged as collateral

The following table presents information with respect to the Company’s financing agreements with non-mark-to-market collateral provisions and associated assets pledged as collateral at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Non-mark-to-market financing secured by residential whole loans at carrying value	$	1,471,269		$	—
Fair value of residential whole loans at carrying value pledged as collateral under financing agreements	$	2,323,085		$	—
Weighted average haircut on residential whole loans at carrying value	41.91		%	—		%
Non-mark-to-market financing secured by residential whole loans at fair value	$	256,138		$	—
Fair value of residential whole loans at fair value pledged as collateral under financing agreements	$	435,081		$	—
Weighted average haircut on residential whole loans at fair value	41.25		%	—		%

Schedule of Company's borrowings under repurchase agreements and associated assets pledged as collateral

The following table presents information with respect to the Company’s financing agreements with mark-to-market collateral provisions and associated assets pledged as collateral at September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020			December 31, 2019
Mark-to-market financing agreements secured by residential whole loans (1)	$	1,231,734		$	4,743,094
Fair value of residential whole loans pledged as collateral under financing agreements (2)	$	2,002,903		$	5,986,267
Weighted average haircut on residential whole loans (3)	30.88		%	20.07		%
Mark-to-market financing agreement borrowings secured by Agency MBS	$	—		$	1,557,675
Fair value of Agency MBS pledged as collateral under financing agreements	$	—		$	1,656,373
Weighted average haircut on Agency MBS (3)	—		%	4.46		%
Mark-to-market financing agreement borrowings secured by Legacy Non-Agency MBS	$	1,282		$	1,121,802
Fair value of Legacy Non-Agency MBS pledged as collateral under financing agreements	$	2,621		$	1,420,797
Weighted average haircut on Legacy Non-Agency MBS (3)	50.00		%	20.27		%
Mark-to-market financing agreement borrowings secured by RPL/NPL MBS	$	32,950		$	495,091
Fair value of RPL/NPL MBS pledged as collateral under financing agreements	$	53,809		$	635,005
Weighted average haircut on RPL/NPL MBS (3)	38.75		%	21.52		%
Mark-to-market financing agreements secured by CRT securities	$	54,883		$	203,569
Fair value of CRT securities pledged as collateral under financing agreements	$	96,336		$	252,175
Weighted average haircut on CRT securities (3)	42.47		%	18.84		%
Mark-to-market financing agreements secured by MSR-related assets	$	135,340		$	962,515
Fair value of MSR-related assets pledged as collateral under financing agreements	$	252,183		$	1,217,002
Weighted average haircut on MSR-related assets (3)	39.87		%	21.18		%
Mark-to-market financing agreements secured by other interest-earning assets	$	34,082		$	57,198
Fair value of other interest-earning assets pledged as collateral under financing agreements	$	44,079		$	61,708
Weighted average haircut on other interest-earning assets (3)	25.00		%	22.01		%

(1)Excludes $0 and $1.1 million of unamortized debt issuance costs at September 30, 2020 and December 31, 2019, respectively.

(2)At September 30, 2020 and December 31, 2019, includes RPL/NPL MBS with an aggregate fair value of $192.7 million and $238.8 million, respectively, obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

(3) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

Schedule of repricing information about borrowings under repurchase agreements

The following table presents repricing information (excluding the impact of associated derivative hedging instruments, if any) about the Company’s financing agreements that have non-mark-to-market collateral provisions as well as those that have mark-to-market collateral provisions, at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
	Amortized Cost Basis		Weighted Average Interest Rate		Amortized Cost Basis		Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)
Within 30 days	$	2,932,213	3.36	%	$	4,472,120	2.55	%
Over 30 days to 3 months	—		—		2,746,384		3.43
Over 3 months to 12 months	280,843		3.02		1,014,441		3.36
Over 12 months	—		—		907,999		3.44
Total financing agreements	$	3,213,056	3.33	%	$	9,140,944	2.99	%
Less debt issuance costs	—				1,123
Total financing agreements less debt issuance costs	$	3,213,056			$	9,139,821

Schedule of information about counterparty for repurchase agreements for which the entity had greater than 5% of stockholders' equity at risk

The following table presents information with respect to each counterparty under financing agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2020:

	September 30, 2020
	Counterparty Rating (1)	Amount  at Risk (2)		Weighted  Average Months  to Repricing for Repurchase Agreements	Percent of Stockholders’ Equity
Counterparty
(Dollars in Thousands)
Barclays Bank	BBB/Aa3/A	$	750,922	1	29.3	%
Credit Suisse	BBB+/Baa2/A-	574,835		1	22.4
Wells Fargo	A+/Aa2/AA-	349,825		1	13.6
Goldman Sachs (3)	BBB+/A3/A	173,266		3	6.8
Athene (4)	BBB+/N/A/BBB+	144,245		1	5.6

(1)As rated at September 30, 2020 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2)The amount at risk reflects the difference between (a) the amount loaned to the Company through financing agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3)Includes $20.6 million at risk with Goldman Sachs and $152.7 million at risk with Goldman Sachs Bank USA.

(4)Includes amounts at risk with various Athene affiliates that collectively exceed 5% of stockholders’ equity.

XML

Other Liabilities (Tables)

9 Months Ended

Sep. 30, 2020

Other Liabilities [Abstract]

Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2020 and December 31, 2019:

(In Thousands)	September 30, 2020		December 31, 2019
Dividends and dividend equivalents payable	$	22,758	$	90,749
Accrued interest payable	14,588		18,238
Accrued expenses and other	29,136		42,819
Total Other Liabilities	$	66,482	$	151,806

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2020

Stockholders' Equity Note [Abstract]

Schedule of changes in balances of each component of the entity's AOCI

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020								Nine Months Ended September 30, 2020
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Net Unrealized Gain/(Loss) on Financing Agreements (3)		Total  AOCI		Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Net Unrealized Gain/(Loss) on Financing Agreements (3)		Total  AOCI
Balance at beginning of period	$	52,889	$	(7,176)	$	—	$	45,713	$	392,722	$	(22,675)	$	—	$	370,047
OCI before reclassifications	15,082		—		(22,652)		(7,570)		408,585		(50,127)		(22,652)		335,806
Amounts reclassified from AOCI (1)	(60)		7,176		—		7,116		(733,396)		72,802		—		(660,594)
Net OCI during the period (2)	15,022		7,176		(22,652)		(454)		(324,811)		22,675		(22,652)		(324,788)
Balance at end of period	$	67,911	$	—	$	(22,652)	$	45,259	$	67,911	$	—	$	(22,652)	$	45,259

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

(3) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2019:

	Three Months Ended September 30, 2019						Nine Months Ended September 30, 2019
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net Gain/(Loss) on Swaps		Total AOCI		Net Unrealized Gain/(Loss) on AFS Securities		Net  Gain/(Loss) on Swaps		Total AOCI
Balance at beginning of period	$	439,898	$	(28,114)	$	411,784	$	417,167	$	3,121	$	420,288
OCI before reclassifications	5,483		(233)		5,250		50,085		(30,384)		19,701
Amounts reclassified from AOCI (1)	(14,499)		(685)		(15,184)		(36,370)		(1,769)		(38,139)
Net OCI during the period (2)	(9,016)		(918)		(9,934)		13,715		(32,153)		(18,438)
Balance at end of period	$	430,882	$	(29,032)	$	401,850	$	430,882	$	(29,032)	$	401,850

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

Information about the significant amounts reclassified out of the entity's AOCI

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2020:

	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Details about AOCI Components	Amounts Reclassified from AOCI				Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(60)	$	(389,127)	Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Impairment recognized in earnings	—		(344,269)		Other, net
Total AFS Securities	$	(60)	$	(733,396)
Swaps designated as cash flow hedges:
Reclassification adjustment for losses related to hedging instruments included in net income	7,176		72,802		Other, net
Total Swaps designated as cash flow hedges	7,176		72,802
Total reclassifications for period	$	7,116	$	(660,594)

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2019:

	Three Months Ended September 30, 2019		Nine Months Ended September 30, 2019
Details about AOCI Components	Amounts Reclassified from AOCI				Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(14,499)	$	(36,370)	Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Total AFS Securities	$	(14,499)	$	(36,370)
Amortization of de-designated hedging instruments	(685)		(1,769)
Total reclassifications for period	$	(15,184)	$	(38,139)

XML

EPS Calculation (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS

The following table presents a reconciliation of the earnings/(loss) and shares used in calculating basic and diluted earnings/(loss) per share for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands, Except Per Share Amounts)	2020		2019		2020		2019
Basic Earnings/(Loss) per Share:
Net income/(loss) to common stockholders	$	87,210	$	95,599	$	(725,207)	$	277,496
Dividends declared on preferred stock	(8,219)		(3,750)		(21,578)		(11,250)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(325)		(280)		(91)		(808)
Net income/(loss) to common stockholders - basic	$	78,666	$	91,569	$	(746,876)	$	265,438
Basic weighted average common shares outstanding	453,323		451,020		453,170		450,641
Basic Earnings/(Loss) per Share	$	0.17	$	0.20	$	(1.65)	$	0.59
Diluted Earnings/(Loss) per Share:
Net income/(loss) to common stockholders - basic	$	78,666	$	91,569	(746,876)		265,438
Interest expense on Convertible Senior Notes	3,898		3,879		—		5,085
Net income/(loss) to common stockholders - diluted	$	82,564	$	95,448	$	(746,876)	$	270,523
Basic weighted average common shares outstanding	453,323		451,020		453,170		450,641
Effect of assumed conversion of Convertible Senior Notes to common shares	28,920		28,920		—		12,712
Effect of incremental shares issued on assumed conversion of Warrants	11,297		—		—		—
Diluted weighted average common shares outstanding (1)	493,540		479,940		453,170		463,353
Diluted Earnings/(Loss) per Share	$	0.17	$	0.20	$	(1.65)	$	0.58

(1)At September 30, 2020, the Company had approximately 39.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the nine months ended September 30, 2020, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.29 and approximately 37.0 million warrants with a weighted average exercise price of $1.87 per share. These equity instruments may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2020

Compensation Related Costs [Abstract]

Schedule of expenses related to equity-based compensation

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
RSUs	$	2,267	$	1,288	$	5,094	$	4,724
Total	$	2,267	$	1,288	$	5,094	$	4,724

Schedule of expenses related to deferred compensation plans

The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Non-employee directors	$	75	$	134	$	(1,483)	$	459
Total	$	75	$	134	$	(1,483)	$	459

Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2020 and December 31, 2019 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,074	$	1,114	$	2,349	$	3,071
Total	$	2,074	$	1,114	$	2,349	$	3,071

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2020 and December 31, 2019, which had not been distributed through such respective date.

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Schedule of fair value measurement inputs and valuation techniques

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2020 and December 31, 2019, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at September 30, 2020

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Residential whole loans, at fair value	$	—	$	—	$	1,229,664	$	1,229,664
Non-Agency MBS	—		56,430		—		56,430
CRT securities	—		96,335		—		96,335
Term notes backed by MSR-related collateral	—		234,091		—		234,091
Total assets carried at fair value	$	—	$	386,856	$	1,229,664	$	1,616,520
Liabilities:
Agreements with non-mark-to-market collateral provisions	$	—	$	—	$	1,727,407	$	1,727,407
Agreements with mark-to-market collateral provisions	—		258,537		1,231,734		1,490,271
Senior secured credit agreement	—		473,993		—		473,993
Securitized debt	—		388,790		—		388,790
Total liabilities carried at fair value	$	—	$	1,121,320	$	2,959,141	$	4,080,461

Fair Value at December 31, 2019

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Residential whole loans, at fair value	$	—	$	—	$	1,381,583	$	1,381,583
Non-Agency MBS	—		2,063,529		—		2,063,529
Agency MBS	—		1,664,582		—		1,664,582
CRT securities	—		255,408		—		255,408
Term notes backed by MSR-related collateral	—		1,157,463		—		1,157,463
Total assets carried at fair value	$	—	$	5,140,982	$	1,381,583	$	6,522,565

The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2020 and December 31, 2019:

	September 30, 2020
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	774,427	Discounted cash flow	Discount rate	3.9		%	3.2-8.0%
				Prepayment rate	3.9		%	0.0-9.3%
				Default rate	6.2		%	0.0-30.3%
				Loss severity	12.7		%	0.0-100.0%
	$	454,760	Liquidation model	Discount rate	8.1		%	6.7-50.0%
				Annual change in home prices	1.9		%	(0.3)-5.5%
				Liquidation timeline (in years)	1.8			0.1-4.8
				Current value of underlying properties (3)	$	734		$12-$4,500
Total	$	1,229,187

	December 31, 2019
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	829,842	Discounted cash flow	Discount rate	4.2		%	3.8-8.0%
				Prepayment rate	4.5		%	0.7-18.0%
				Default rate	4.0		%	0.0-23.0%
				Loss severity	12.9		%	0.0-100.0%
	$	551,271	Liquidation model	Discount rate	8.0		%	6.2-50.0%
				Annual change in home prices	3.7		%	2.4-8.0%
				Liquidation timeline (in years)	1.8			0.1-4.5
				Current value of underlying properties (3)	$	684		$10-$4,500
Total	$	1,381,113

(1) Excludes approximately $477,000 and $470,000 of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2020 and December 31, 2019, respectively.

(2) Amounts are weighted based on the fair value of the underlying loan.

(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately $383,000 and $365,000 as of September 30, 2020 and December 31, 2019, respectively.

Schedule of significant unobservable inputs used in fair value measurement of residential whole loans

The following table presents additional information for the three and nine months ended September 30, 2020 and 2019 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Residential Whole Loans, at Fair Value
	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019 (1)		2020		2019 (1)(2)
Balance at beginning of period	$	1,200,981	$	1,438,827	$	1,381,583	$	1,471,263
Purchases (2)	—		85,855		—		210,030
Changes in fair value recorded in Net gain on residential whole loans measured at fair value through earnings	58,863		13,185		(13,683)		33,312
Cash collections, net of liquidation gains/(losses)	(21,721)		(31,212)		(65,934)		(94,821)
Sales and repurchases	(929)		—		(19,460)		(1,216)
Transfer to REO	(7,530)		(53,486)		(52,842)		(165,399)
Balance at end of period	$	1,229,664	$	1,453,169	$	1,229,664	$	1,453,169

(1)Included in the activity presented for the three months ended September 30, 2019 are approximately $87.0 million of residential whole loans held at fair value the Company committed to purchase during the three months ended June 30, 2019, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2019.

(2)Included in the activity presented for the nine months ended September 30, 2019 is an adjustment of $70.6 million for loans the Company committed to purchase during the three months ended December 31, 2018, but for which the closing of the purchase transaction occurred during the three months ended March 31, 2019. The adjustment was required following the finalization of due diligence performed prior to the closing of the purchase transaction and resulted in a downward revision to the prior estimate of the loan purchase amount.

The following table presents additional information for the three and nine months ended September 30, 2019 about the Company’s investments in term notes backed by MSR-related collateral, which were classified as Level 3 prior to September 30, 2019 and measured at fair value on a recurring basis:

	Term Notes Backed by MSR-Related Collateral
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2019		2019
Balance at beginning of period	$	1,106,026	$	538,499
Purchases	—		573,137
Collection of principal	(3,920)		(12,897)
Changes in unrealized gains	2,024		5,391
Transfer to Level 2	(1,104,130)		(1,104,130)
Balance at end of period	$	—	$	—

The following table presents additional information for the three and nine months ended September 30, 2020 about the Company’s financing agreements with non-mark-to-market collateral provisions, which are classified as Level 3 and measured at fair value on a recurring basis:

	Agreements with Non-mark-to-market Collateral Provisions
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2020		2020
Balance at beginning of period	$	—	$	—
Transfer from Level 2	2,036,597		2,036,597
Payment of principal	(312,638)		(312,638)
Changes in unrealized losses	3,448		3,448
Balance at end of period	$	1,727,407	$	1,727,407

The following table presents additional information for the three and nine months ended September 30, 2020 about the Company’s financing agreements with mark-to-market collateral provisions, which are classified as Level 3 and measured at fair value on a recurring basis:

	Agreements with Mark-to-market Collateral Provisions
	Three Months Ended September 30,		Nine Months Ended September 30,
(In Thousands)	2020		2020
Balance at beginning of period	$	—	$	—
Transfer from Level 2	1,386,592		1,386,592
Payment of principal	(156,032)		(156,032)
Changes in unrealized losses	1,174		1,174
Balance at end of period	$	1,231,734	$	1,231,734

Schedule of carrying value and fair value of financial instruments

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2020 and December 31, 2019:

	September 30, 2020	September 30, 2020				December 31, 2019
	Level in Fair Value Hierarchy	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
(In Thousands)
Financial Assets:
Residential whole loans, at carrying value	3	$	4,387,559	$	4,528,630	$	6,069,370	$	6,248,745
Residential whole loans, at fair value	3	1,229,664		1,229,664		1,381,583		1,381,583
Non-Agency MBS	2	56,430		56,430		2,063,529		2,063,529
Agency MBS	2	—		—		1,664,582		1,664,582
CRT securities	2	96,335		96,335		255,408		255,408
MSR-related assets (1)	2 and 3	252,183		252,183		1,217,002		1,217,002
Cash and cash equivalents	1	884,171		884,171		70,629		70,629
Restricted cash	1	5,303		5,303		64,035		64,035
Financial Liabilities (2):
Financing agreements with non-mark-to-market collateral provisions	3	1,727,407		1,727,407		—		—
Financing agreements with mark-to-market collateral provisions	3	1,231,734		1,231,734		4,741,971		4,753,070
Financing agreements with mark-to-market collateral provisions	2	258,537		258,537		4,397,850		4,403,139
Senior secured credit agreement	2	473,993		473,993		—		—
Securitized debt (3)	2	837,683		839,914		570,952		575,353
Convertible senior notes	2	224,867		216,919		223,971		244,088
Senior notes	1	96,900		94,311		96,862		103,231

(1)Includes $18.1 million and $59.5 million of MSR-related assets that are measured at fair value on a non-recurring basis that are classified as Level 3 in the fair value hierarchy at September 30, 2020 and December 31, 2019, respectively.

(2)Carrying value of securitized debt, Convertible Senior Notes, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.

(3)Includes Securitized debt that is carried at amortized cost basis and fair value.

XML

Use of Special Purpose Entities and Variable Interest Entities (Tables)

9 Months Ended

Sep. 30, 2020

Use of Special Purpose Entities and Variable Interest Entities

Summary of key details related to securitization transactions

The following table summarizes the key details of the Company’s loan securitization transactions as of September 30, 2020 and December 31, 2019:

(Dollars in Thousands)	September 30, 2020				December 31, 2019
Aggregate unpaid principal balance of residential whole loans sold	$	1,681,500			$	1,290,029
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors	$	1,202,616			$	802,817
Outstanding amount of Senior Bonds, at carrying value	$	448,893		(1)	$	570,952		(1)
Outstanding amount of Senior Bonds, at fair value	$	388,790			$	—
Outstanding amount of Senior Bonds, total	$	837,683			$	570,952
Weighted average fixed rate for Senior Bonds issued	2.93		%	(2)	3.68		%	(2)
Weighted average contractual maturity of Senior Bonds	36 years			(2)	30 years			(2)
Face amount of Senior Support Certificates received by the Company (3)	$	266,355			$	275,174
Cash received	$	1,193,969			$	802,815

(1)Net of $2.2 million and $2.9 million of deferred financing costs at September 30, 2020 and December 31, 2019, respectively.

(2)At September 30, 2020 and December 31, 2019, $743.9 million and $493.2 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by either 100 or 300 basis points or more at 36 months from issuance if the bond is not redeemed before such date.

(3)Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

XML

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2020 segment
Accounting Policies [Abstract]
Number of reportable segments	1
Number of operating segments	1

XML

Summary of Significant Accounting Policies (Residential Whole Loans) (Details)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Number of days considered to classify loans delinquent	60 days
Weighted Average LTV Ratio	80.00%

XML

Summary of Significant Accounting Policies (Cash and Cash Equivalents) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash and cash equivalents	$ 884,171	$ 70,629
Overnight money market funds	837,600	39,600
Restricted cash	$ 5,303	$ 64,035

XML

Summary of Significant Accounting Policies (Depreciation) (Details)	9 Months Ended
	Sep. 30, 2020
Furniture, fixtures, computers and related hardwares | Minimum
Estimated useful life of long-lived assets
Estimated useful life	5 years
Furniture, fixtures, computers and related hardwares | Maximum
Estimated useful life of long-lived assets
Estimated useful life	8 years
Building
Estimated useful life of long-lived assets
Estimated useful life	27 years 6 months

XML

Summary of Significant Accounting Policies (Loan Securitization and Other Debt Issuance Costs ) (Details)	Sep. 30, 2020
Convertible Senior Note Due 2024
Debt Instrument [Line Items]
Stated interest rate	6.25%
Senior Note Due 2042
Debt Instrument [Line Items]
Stated interest rate	8.00%

XML

Summary of Significant Accounting Policies (Repurchase Agreements) (Details)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Repurchase financing period, low end of range	1 month
Repurchase financing period, high end of range	6 months
Repurchase financings collateralized by residential whole loans, high end	12 months

XML

Summary of Significant Accounting Policies (Equity Based Compensation) (Details) - RSUs	63 Months Ended
	Mar. 31, 2019
Share based compensation
Vesting period of restricted share units (RSUs)	3 years
Period for measuring market condition of award	3 years

XML

Summary of Significant Accounting Policies (Income Tax) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Percentage of annual REIT taxable income distributed to stockholders	100.00%
REIT income tax expense	$ 0
Deferred income tax expense (benefit)	0	$ 0
Valuation allowance decrease	$ 75,500,000

XML

Summary of Significant Accounting Policies (Accounting Standards Adopted in 2020) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Allowance for loan loss	$ 106,246	$ 136,589	$ 218,011		$ 3,025	$ 2,271	$ 1,986	$ 1,651	$ 968
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Allowance for loan loss				$ 8,300

XML

Residential Whole Loans (Narrative) (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Receivables [Abstract]
Total residential whole loans	$ 5,600,000,000			$ 5,600,000,000	$ 7,400,000,000
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loss on sale of financing receivable	(800,000)
Valuation allowance adjustment		$ 70,181,000	$ (70,181,000)
Interest income				0
Unpaid principal balance of loans	24,100,000			24,100,000
Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, sale				1,800,000,000
Loss on sale of financing receivable				273,000,000.0
Valuation allowance adjustment		70,181,000	(70,181,000)
Purchased Performing Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, nonaccrual	345,600,000			345,600,000	$ 99,900,000
Purchased Credit Deteriorated Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Valuation allowance adjustment		$ 0	$ 0
Financing receivable, nonaccrual	148,700,000			148,700,000
Without Associated Credit Losses
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, nonaccrual	$ 134,800,000			$ 134,800,000

XML

Residential Whole Loans (Residential Whole Loans, at Carrying Value) (Details) $ in Thousands		Sep. 30, 2020 USD ($) loan	Jan. 01, 2020 USD ($)	Dec. 31, 2019 USD ($) loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 3,791,792		$ 5,370,653
Purchased Credit Deteriorated Loans		702,013		698,717
Total Residential whole loans, at carrying value	[1]	4,493,805		6,069,370
Allowance for credit losses on residential whole loans held at carrying value		(106,246)		(3,025)
Total Residential whole loans at carrying value, net		$ 4,387,559		$ 6,066,345
Number of loans | loan		13,754		17,082
Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 2,465,148		$ 3,707,245
Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		699,868		1,026,097
Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		479,070		460,742
Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 147,706		$ 176,569
Cumulative Effect, Period of Adoption, Adjustment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Credit Deteriorated Loans			$ 62,600

[1] Includes approximately $568.6 million and $186.4 million of Residential whole loans, at carrying value and $521.2 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.

XML

Residential Whole Loans (Interest Income Components) (Details) - Residential whole loans - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 54,393	$ 64,226	$ 207,306	$ 171,725
Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	25,884	30,258	112,212	79,250
Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	10,863	15,142	39,502	38,331
Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	6,917	5,025	21,528	11,652
Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	1,945	3,166	6,799	9,461
Purchased Performing Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	45,609	53,591	180,041	138,694
Purchased credit impaired loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 8,784	$ 10,635	$ 27,265	$ 33,031

XML

Residential Whole Loans (Residential Whole Loans, at Carrying Value - Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 3,791,792		$ 5,370,653
Purchased Credit Deteriorated Loans		702,013		698,717
Residential whole loans, at carrying value, total or weighted average		$ 4,493,806
Weighted Average LTV Ratio		80.00%
Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 2,465,148		3,707,245
Residential whole loans, at carrying value, total or weighted average		2,465,148
Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		699,868		1,026,097
Residential whole loans, at carrying value, total or weighted average		699,868
Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		479,070		460,742
Residential whole loans, at carrying value, total or weighted average		479,070
Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		147,706		176,569
Residential whole loans, at carrying value, total or weighted average		$ 147,706
90 or more
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average LTV Ratio		87.82%	89.69%
Settled Whole Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Residential whole loans, at carrying value, total or weighted average		$ 4,387,559		6,066,345
Amortized Cost Basis		4,493,805		6,069,370
Unpaid Principal Balance (“UPB”)		$ 4,546,058		$ 6,141,421
Weighted Average Coupon		5.81%		5.96%
Weighted Average Term to Maturity (Months)	288 months	277 months
Settled Whole Loans | Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 2,438,395		$ 3,706,857
Amortized Cost Basis		2,465,148		3,707,245
Unpaid Principal Balance (“UPB”)		$ 2,397,247		$ 3,592,701
Weighted Average Coupon		5.87%		5.96%
Weighted Average Term to Maturity (Months)	368 months	352 months
Weighted Average LTV Ratio	67.00%	64.00%
Weighted Average FICO Scores	716	712
Settled Whole Loans | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 677,235		$ 1,023,766
Amortized Cost Basis		699,868		1,026,097
Unpaid Principal Balance (“UPB”)		$ 699,868		$ 1,026,097
Weighted Average Coupon		7.28%		7.30%
Weighted Average Term to Maturity (Months)	8 months	4 months
Weighted Average LTV Ratio	64.00%	63.00%
Weighted Average FICO Scores	717	718
Settled Whole Loans | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 474,045		$ 460,679
Amortized Cost Basis		479,070		460,741
Unpaid Principal Balance (“UPB”)		$ 475,072		$ 457,146
Weighted Average Coupon		6.28%		6.29%
Weighted Average Term to Maturity (Months)	324 months	319 months
Weighted Average LTV Ratio	70.00%	70.00%
Weighted Average FICO Scores	734	734
Settled Whole Loans | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 147,556		$ 176,569
Amortized Cost Basis		147,706		176,569
Unpaid Principal Balance (“UPB”)		$ 161,257		$ 192,151
Weighted Average Coupon		3.45%		4.24%
Weighted Average Term to Maturity (Months)	181 months	173 months
Weighted Average LTV Ratio	46.00%	41.00%
Weighted Average FICO Scores	723	723
Settled Whole Loans | Purchased credit impaired loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Credit Deteriorated Loans		$ 650,328		$ 698,474
Amortized Cost Basis		702,013		698,718
Unpaid Principal Balance (“UPB”)		$ 812,614		$ 873,326
Weighted Average Coupon		4.45%		4.46%
Weighted Average Term to Maturity (Months)	294 months	289 months
Weighted Average LTV Ratio	81.00%	79.00%
Settled Whole Loans | Certain Rehabilitation Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased Performing Loans		$ 222,200		$ 269,200
Weighted Average LTV Ratio	69.00%	68.00%
Settled Whole Loans | Current | Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		$ 2,174,935		3,492,533
Settled Whole Loans | Current | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		491,343		868,281
Settled Whole Loans | Current | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		439,503		432,936
Settled Whole Loans | Current | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		136,622		187,683
Settled Whole Loans | 30-59 | Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		74,231		59,963
Settled Whole Loans | 30-59 | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		65,166		67,747
Settled Whole Loans | 30-59 | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		16,111		15,948
Settled Whole Loans | 30-59 | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		1,406		2,164
Settled Whole Loans | 60-89 | Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		52,069		19,605
Settled Whole Loans | 60-89 | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		22,995		27,437
Settled Whole Loans | 60-89 | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		7,373		2,047
Settled Whole Loans | 60-89 | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		880		430
Settled Whole Loans | 90 or more | Non-QM Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		163,913		20,600
Settled Whole Loans | 90 or more | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		120,364		62,632
Settled Whole Loans | 90 or more | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		16,083		6,215
Settled Whole Loans | 90 or more | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		8,798		1,874
Settled Whole Loans | 90 or more | Purchased credit impaired loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amortized Cost Basis		$ 122,478		$ 108,998

XML

Residential Whole Loans (Allowance for Credit Losses) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 136,589	$ 218,011	$ 3,025	$ 1,986	$ 1,651	$ 968	$ 3,025
Transition adjustment on adoption of ASU 2016-13			70,555				70,600
Current provision	(30,062)	(10,614)	74,897	347	385	683
Write-offs	(281)	(627)	(647)	(62)	(50)	0	(1,555)
Valuation adjustment on loans held for sale		(70,181)	70,181
Ending balance	106,246	136,589	218,011	2,271	1,986	1,651	106,246
Residential whole loans, at carrying value	4,493,806						4,493,806
Gross up of the amortized cost basis of Purchased Credit Deteriorated Loans							62,400
Non-QM Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	31,353	103,831	388	0	0	0	388
Transition adjustment on adoption of ASU 2016-13			6,904
Current provision	(4,568)	(2,297)	26,358	0	0	0
Write-offs	(32)	0	0	0	0	0
Valuation adjustment on loans held for sale		(70,181)	70,181
Ending balance	26,753	31,353	103,831	0	0	0	26,753
Rehabilitation loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	30,000	35,633	2,331	450	500	0	2,331
Transition adjustment on adoption of ASU 2016-13			517
Current provision	(7,140)	(5,213)	33,213	0	0	500
Write-offs	(227)	(420)	(428)	(62)	(50)	0
Valuation adjustment on loans held for sale		0	0
Ending balance	22,633	30,000	35,633	388	450	500	22,633
Residential whole loans, at carrying value	143,400						143,400
Single-family rental loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	6,931	7,431	62	0	0	0	62
Transition adjustment on adoption of ASU 2016-13			754
Current provision	(1,906)	(500)	6,615	0	0	0
Write-offs	0	0	0	0	0	0
Valuation adjustment on loans held for sale		0	0
Ending balance	5,025	6,931	7,431	0	0	0	5,025
Seasoned performing loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	224	249	0	0	0	0	0
Transition adjustment on adoption of ASU 2016-13			19
Current provision	(74)	(25)	230	0	0	0
Write-offs	0	0	0	0	0	0
Valuation adjustment on loans held for sale		0	0
Ending balance	150	224	249	0	0	0	150
Purchased Credit Deteriorated Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	68,081	70,867	244	1,536	1,151	968	244
Transition adjustment on adoption of ASU 2016-13			62,361
Current provision	(16,374)	(2,579)	8,481	347	385	183
Write-offs	(22)	(207)	(219)	0	0	0
Valuation adjustment on loans held for sale		0	0
Ending balance	51,685	$ 68,081	$ 70,867	$ 1,883	$ 1,536	$ 1,151	51,685
Residential whole loans, at carrying value	72,700						72,700
Unfunded Loan Commitment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Ending balance	1,600						1,600
Commitment to lend, unfunded	73,200						73,200
Non-QM Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Write-offs							(32)
Residential whole loans, at carrying value	$ 2,465,148						$ 2,465,148

XML

Residential Whole Loans (Additional Credit Related Information) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
2020	$ 490,345						$ 490,345
2019	2,091,705						2,091,705
2018	948,938						948,938
2017	107,208						107,208
2016	12,768						12,768
Prior	842,842						842,842
Residential whole loans, at carrying value, total or weighted average	4,493,806						4,493,806
Gross write-offs, 2019							13
Gross write-offs, 2018							1,062
Gross write-offs, 2017							32
Gross write-offs, prior							448
Nine Months Ended September 30, 2020 Gross write-offs	281	$ 627	$ 647	$ 62	$ 50	$ 0	1,555
Net write-offs, 2019							13
Net write-offs, 2018							1,062
Net write-offs, 2017							32
Net write-offs							448
Total Recoveries							0
Nine Months Ended September 30, 2020 Net write-offs							1,555
Purchased Performing Loans	3,791,792						$ 3,791,792	$ 5,370,653
Ratio Loan-To-Value							80.00%
Debt-to-Value Ratio, Less than 80 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	439,607						$ 439,607
2019	2,026,153						2,026,153
2018	918,394						918,394
2017	96,397						96,397
2016	9,432						9,432
Prior	559,803						559,803
Residential whole loans, at carrying value, total or weighted average	4,049,786						4,049,786
Debt-to-Value Ratio, 80 to 100 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	50,738						50,738
2019	65,552						65,552
2018	30,544						30,544
2017	10,811						10,811
2016	3,336						3,336
Prior	283,039						283,039
Residential whole loans, at carrying value, total or weighted average	444,020						444,020
Non-QM Loans
Financing Receivable, Credit Quality Indicator [Line Items]
2020	428,811						428,811
2019	1,231,653						1,231,653
2018	714,188						714,188
2017	83,973						83,973
2016	6,523						6,523
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	2,465,148						2,465,148
Gross write-offs, 2018							32
Nine Months Ended September 30, 2020 Gross write-offs							32
Net write-offs, 2018							32
Nine Months Ended September 30, 2020 Net write-offs							32
Purchased Performing Loans	2,465,148						2,465,148	3,707,245
Non-QM Loans | Debt-to-Value Ratio, Less than 80 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	380,729						380,729
2019	1,196,185						1,196,185
2018	684,404						684,404
2017	74,862						74,862
2016	6,371						6,371
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	2,342,551						2,342,551
Non-QM Loans | Debt-to-Value Ratio, 80 to 100 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	48,082						48,082
2019	35,468						35,468
2018	29,784						29,784
2017	9,111						9,111
2016	152						152
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	122,597						122,597
Rehabilitation loans
Financing Receivable, Credit Quality Indicator [Line Items]
2020	37,740						37,740
2019	558,361						558,361
2018	94,521						94,521
2017	9,246						9,246
2016	0						0
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	699,868						699,868
Gross write-offs, 2019							13
Gross write-offs, 2018							1,030
Gross write-offs, 2017							32
Gross write-offs, prior							0
Nine Months Ended September 30, 2020 Gross write-offs							1,075
Net write-offs, 2019							13
Net write-offs, 2018							1,030
Net write-offs, 2017							32
Net write-offs							0
Nine Months Ended September 30, 2020 Net write-offs							1,075
Purchased Performing Loans	699,868						699,868	1,026,097
Rehabilitation loans | Debt-to-Value Ratio, Less than 80 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	36,478						36,478
2019	542,865						542,865
2018	93,973						93,973
2017	7,546						7,546
2016	0						0
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	680,862						680,862
Rehabilitation loans | Debt-to-Value Ratio, 80 to 100 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	1,262						1,262
2019	15,496						15,496
2018	548						548
2017	1,700						1,700
2016	0						0
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	19,006						19,006
Single-family rental loans
Financing Receivable, Credit Quality Indicator [Line Items]
2020	23,794						23,794
2019	301,691						301,691
2018	140,229						140,229
2017	13,356						13,356
2016	0						0
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	479,070						479,070
Purchased Performing Loans	479,070						479,070	460,742
Single-family rental loans | Debt-to-Value Ratio, Less than 80 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	22,400						22,400
2019	287,103						287,103
2018	140,017						140,017
2017	13,356						13,356
2016	0						0
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	462,876						462,876
Single-family rental loans | Debt-to-Value Ratio, 80 to 100 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	1,394						1,394
2019	14,588						14,588
2018	212						212
2017	0						0
2016	0						0
Prior	0						0
Residential whole loans, at carrying value, total or weighted average	16,194						16,194
Seasoned performing loans
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0						0
2019	0						0
2018	0						0
2017	0						0
2016	79						79
Prior	147,627						147,627
Residential whole loans, at carrying value, total or weighted average	147,706						147,706
Purchased Performing Loans	147,706						147,706	176,569
Seasoned performing loans | Debt-to-Value Ratio, Less than 80 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0						0
2019	0						0
2018	0						0
2017	0						0
2016	79						79
Prior	139,538						139,538
Residential whole loans, at carrying value, total or weighted average	139,617						139,617
Seasoned performing loans | Debt-to-Value Ratio, 80 to 100 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0						0
2019	0						0
2018	0						0
2017	0						0
2016	0						0
Prior	8,089						8,089
Residential whole loans, at carrying value, total or weighted average	8,089						8,089
Purchased Credit Deteriorated Loans
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0						0
2019	0						0
2018	0						0
2017	633						633
2016	6,166						6,166
Prior	695,215						695,215
Residential whole loans, at carrying value, total or weighted average	702,014						702,014
Gross write-offs, prior							448
Nine Months Ended September 30, 2020 Gross write-offs							448
Net write-offs							448
Total Recoveries							0
Nine Months Ended September 30, 2020 Net write-offs							448
Purchased Credit Deteriorated Loans | Debt-to-Value Ratio, Less than 80 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0						0
2019	0						0
2018	0						0
2017	633						633
2016	2,982						2,982
Prior	420,265						420,265
Residential whole loans, at carrying value, total or weighted average	423,880						423,880
Purchased Credit Deteriorated Loans | Debt-to-Value Ratio, 80 to 100 Percent
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0						0
2019	0						0
2018	0						0
2017	0						0
2016	3,184						3,184
Prior	274,950						274,950
Residential whole loans, at carrying value, total or weighted average	278,134						278,134
Settled Whole Loans
Financing Receivable, Credit Quality Indicator [Line Items]
Residential whole loans, at carrying value, total or weighted average	4,387,559						4,387,559	6,066,345
Settled Whole Loans | Non-QM Loans
Financing Receivable, Credit Quality Indicator [Line Items]
Purchased Performing Loans	2,438,395						$ 2,438,395	3,706,857
Ratio Loan-To-Value			67.00%				64.00%
Settled Whole Loans | Rehabilitation loans
Financing Receivable, Credit Quality Indicator [Line Items]
Purchased Performing Loans	677,235						$ 677,235	1,023,766
Ratio Loan-To-Value			64.00%				63.00%
Settled Whole Loans | Single-family rental loans
Financing Receivable, Credit Quality Indicator [Line Items]
Purchased Performing Loans	474,045						$ 474,045	460,679
Ratio Loan-To-Value			70.00%				70.00%
Settled Whole Loans | Seasoned performing loans
Financing Receivable, Credit Quality Indicator [Line Items]
Purchased Performing Loans	147,556						$ 147,556	176,569
Ratio Loan-To-Value			46.00%				41.00%
Settled Whole Loans | Certain Rehabilitation Loans
Financing Receivable, Credit Quality Indicator [Line Items]
Purchased Performing Loans	$ 222,200						$ 222,200	$ 269,200
Ratio Loan-To-Value			69.00%				68.00%

XML

Residential Whole Loans (Fair Value) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($) loan	Sep. 30, 2019 loan	Dec. 31, 2019 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average LTV Ratio	80.00%
Total Residential whole loans, at fair value	$ 1,229,664		$ 1,381,583
Less than 60 Days Past Due:
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance	599,461		666,026
Aggregate fair value	$ 577,761		641,616
Weighted Average LTV Ratio	74.33%	76.69%
Number of loans | loan	3,038	3,159
60 Days to 89 Days Past Due:
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance	$ 55,183		58,160
Aggregate fair value	$ 49,188		53,485
Weighted Average LTV Ratio	83.62%	79.48%
Number of loans | loan	259	313
90 Days or More Past Due:
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance	$ 679,211		767,320
Aggregate fair value	$ 602,715		$ 686,482
Weighted Average LTV Ratio	87.82%	89.69%
Number of loans | loan	2,532	2,983

XML

Residential Whole Loans (Fair Value Components of Net Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Receivables [Abstract]
Coupon payments, realized gains and other income received	$ 17,477	$ 22,202	$ 54,684	$ 67,966
Net unrealized gains/(losses)	58,863	13,185	(13,683)	33,312
Net gain on transfers to REO	531	4,788	3,430	15,637
Total	$ 76,871	$ 40,175	$ 44,431	$ 116,915

XML

Residential Mortgage Securities and MSR-Related Assets (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Securities, Available-for-sale [Line Items]
Minimum term of fixed rate mortgages underlying MBS			15 years
Maximum term of fixed rate mortgages underlying MBS			30 years
Impairment and other losses on securities available-for-sale and other assets	$ (221)	$ 0	$ (424,966)	$ 0
Available-for-sale, unrealized loss position, accumulated loss	6,092		6,092
Loans in Unrealized Loss Position
Debt Securities, Available-for-sale [Line Items]
Impairment and other losses on securities available-for-sale and other assets			(63,500)
Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, unrealized loss position, accumulated loss	$ 3,000		$ 3,000
Minimum | RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Debt instrument, basis spread on variable rate			3.00%
Debt instrument, coupon step-up period			36 months
Maximum | RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Debt instrument, basis spread on variable rate			4.00%
Debt instrument, coupon step-up period			48 months

XML

Residential Mortgage Securities and MSR-Related Assets (Residential and Mortgage Securities) (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	$ 164,458,000	$ 4,044,818,000
Purchase Premiums	2,414,000	67,108,000
Accretable Purchase Discounts	(8,315,000)	(90,694,000)
Discount Designated as Credit Reserve and OTTI	(21,437,000)	(436,598,000)
Amortized Cost	137,120,000	3,585,248,000
Gross Unrealized Gains	21,737,000	417,089,000
Gross Unrealized Losses	(6,092,000)	(18,818,000)
Net Unrealized Gain/(Loss)	15,645,000	398,271,000
Fair  Value	152,765,000	3,983,519,000
Principal payments receivable		614,000
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		1,604,583,000
Purchase Premiums		62,790,000
Accretable Purchase Discounts		(22,000)
Discount Designated as Credit Reserve and OTTI		0
Amortized Cost		1,667,965,000
Gross Unrealized Gains		15,326,000
Gross Unrealized Losses		(18,709,000)
Net Unrealized Gain/(Loss)		(3,383,000)
Fair  Value		1,664,582,000
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member] | Fannie Mae
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		1,119,708,000
Purchase Premiums		43,249,000
Accretable Purchase Discounts		(22,000)
Discount Designated as Credit Reserve and OTTI		0
Amortized Cost		1,162,935,000
Gross Unrealized Gains		9,799,000
Gross Unrealized Losses		(14,741,000)
Net Unrealized Gain/(Loss)		(4,942,000)
Fair  Value		1,157,993,000
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member] | Freddie Mac
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		480,879,000
Purchase Premiums		19,468,000
Accretable Purchase Discounts		0
Discount Designated as Credit Reserve and OTTI		0
Amortized Cost		500,961,000
Gross Unrealized Gains		5,475,000
Gross Unrealized Losses		(3,968,000)
Net Unrealized Gain/(Loss)		1,507,000
Fair  Value		502,468,000
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member] | Ginnie Mae
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		3,996,000
Purchase Premiums		73,000
Accretable Purchase Discounts		0
Discount Designated as Credit Reserve and OTTI		0
Amortized Cost		4,069,000
Gross Unrealized Gains		52,000
Gross Unrealized Losses		0
Net Unrealized Gain/(Loss)		52,000
Fair  Value		4,121,000
Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	60,295,000	2,195,303,000
Purchase Premiums	0	0
Accretable Purchase Discounts	(8,246,000)	(90,617,000)
Discount Designated as Credit Reserve and OTTI	(669,000)	(436,598,000)
Amortized Cost	51,380,000	1,668,088,000
Gross Unrealized Gains	8,015,000	395,459,000
Gross Unrealized Losses	(2,965,000)	(18,000)
Net Unrealized Gain/(Loss)	5,050,000	395,441,000
Fair  Value	$ 56,430,000	2,063,529,000
Expected to Recover Par
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		722,477,000
Purchase Premiums		0
Accretable Purchase Discounts		(16,661,000)
Discount Designated as Credit Reserve and OTTI		0
Amortized Cost		705,816,000
Gross Unrealized Gains		19,861,000
Gross Unrealized Losses		(9,000)
Net Unrealized Gain/(Loss)		19,852,000
Fair  Value		725,668,000
Expected to Recover Less Than Par
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		1,472,826,000
Purchase Premiums		0
Accretable Purchase Discounts		(73,956,000)
Discount Designated as Credit Reserve and OTTI		(436,598,000)
Amortized Cost		962,272,000
Gross Unrealized Gains		375,598,000
Gross Unrealized Losses		(9,000)
Net Unrealized Gain/(Loss)		375,589,000
Fair  Value		$ 1,337,861,000
Percentage of current face amount of Non-Agency MBS to be recovered	99.00%	80.00%
Total MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face		$ 3,799,886,000
Purchase Premiums		62,790,000
Accretable Purchase Discounts		(90,639,000)
Discount Designated as Credit Reserve and OTTI		(436,598,000)
Amortized Cost		3,336,053,000
Gross Unrealized Gains		410,785,000
Gross Unrealized Losses		(18,727,000)
Net Unrealized Gain/(Loss)		392,058,000
Fair  Value		3,728,111,000
CRT securities
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	$ 104,163,000	244,932,000
Purchase Premiums	2,414,000	4,318,000
Accretable Purchase Discounts	(69,000)	(55,000)
Discount Designated as Credit Reserve and OTTI	(20,768,000)	0
Amortized Cost	85,740,000	249,195,000
Gross Unrealized Gains	13,722,000	6,304,000
Gross Unrealized Losses	(3,127,000)	(91,000)
Net Unrealized Gain/(Loss)	10,595,000	6,213,000
Fair  Value	96,335,000	255,408,000
RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	57,400,000	632,300,000
Amortized Cost	49,200,000	631,800,000
Fair  Value	53,800,000	635,000,000.0
CRT, Fair Value Option
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Gains	410,000	6,300,000
Gross Unrealized Losses	(3,100,000)	(91,000)
Fair  Value	$ 63,300,000	255,400,000
Agency MBS, Fair Value Option
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Gains		4,500,000
Gross Unrealized Losses		0
Debt securities, fair value option		$ 280,300,000

XML

Residential Mortgage Securities and MSR-Related Assets (Sale of MBS) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Securities, Available-for-sale [Line Items]
Sales Proceeds	$ 116	$ 334,125	$ 3,062,858	$ 738,919
Gains/(Losses)	48	17,708	61,697	50,027
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Debt Securities, Available-for-sale [Line Items]
Sales Proceeds	0	257,289	1,500,875	360,634
Gains/(Losses)	0	2,771	(19,291)	499
Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Sales Proceeds	116	47,867	1,318,958	244,778
Gains/(Losses)	48	14,444	107,999	41,420
CRT securities
Debt Securities, Available-for-sale [Line Items]
Sales Proceeds	0	28,969	243,025	133,507
Gains/(Losses)	$ 0	$ 493	$ (27,011)	$ 8,108

XML

Residential Mortgage Securities and MSR-Related Assets (Unrealized Losses) (Details) $ in Thousands	Sep. 30, 2020 USD ($) security	Dec. 31, 2019 USD ($)
Fair Value
Less than 12 Months	$ 104,480
12 Months or more	0
Total	104,480
Unrealized Losses
Less than 12 Months	6,092
12 Months or more	0
Total	$ 6,092
Number of Securities
Less than 12 months (in security) | security	13
12 months or more (in security) | security	0
Fair  Value	$ 152,765	$ 3,983,519
Gross unrealized losses	6,092	18,818
Non-Agency MBS
Unrealized Losses
Total	3,000
Number of Securities
Fair  Value	56,430	2,063,529
Gross unrealized losses	2,965	18
Total MBS
Fair Value
Less than 12 Months	44,927
12 Months or more	0
Total	44,927
Unrealized Losses
Less than 12 Months	2,965
12 Months or more	0
Total	$ 2,965
Number of Securities
Less than 12 months (in security) | security	5
12 months or more (in security) | security	0
Fair  Value		3,728,111
Gross unrealized losses		18,727
CRT securities
Fair Value
Less than 12 Months	$ 59,553
12 Months or more	0
Total	59,553
Unrealized Losses
Less than 12 Months	3,127
12 Months or more	0
Total	$ 3,127
Number of Securities
Less than 12 months (in security) | security	8
12 months or more (in security) | security	0
Fair  Value	$ 96,335	255,408
Gross unrealized losses	3,127	$ 91
CRT in Loss Positions Only, Fair Value Option
Number of Securities
Fair  Value	59,600
Gross unrealized losses	$ 3,100

XML

Residential Mortgage Securities and MSR-Related Assets (Purchase Discounts) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Changes in the components of the purchase discount on Non-Agency MBS
Realized credit losses	$ 0	$ 0	$ (344,269)	$ 0
Discount Designated as Credit Reserve | Non-Agency MBS
Changes in the components of the purchase discount on Non-Agency MBS
Balance at beginning of period	(669)	(479,566)	(436,598)	(516,116)
Impact of RMBS Issuer Settlement			0	0
Accretion of discount	0	0	0	0
Realized credit losses	0	4,062	5,868	21,482
Purchases			0	(624)
Sales/Redemptions	0	12,479	436,885	23,842
Net impairment losses recognized in earnings			(11,513)	0
Transfers/release of credit reserve	0	930	4,689	9,321
Balance at end of period	(669)	(462,095)	(669)	(462,095)
Accretable Discount | Non-Agency MBS
Changes in the components of the purchase discount on Non-Agency MBS
Balance at beginning of period	(8,430)	(117,753)	(90,617)	(155,025)
Impact of RMBS Issuer Settlement			0	(1,688)
Accretion of discount	7	10,357	10,827	38,215
Realized credit losses	0	0	0	0
Purchases			0	291
Sales/Redemptions	177	6,029	76,233	25,231
Net impairment losses recognized in earnings			0	0
Transfers/release of credit reserve	0	(930)	(4,689)	(9,321)
Balance at end of period	$ (8,246)	$ (102,297)	$ (8,246)	(102,297)
Jp Morgan Chase
Changes in the components of the purchase discount on Non-Agency MBS
Proceeds from legal settlements				$ 1,700

XML

Residential Mortgage Securities and MSR-Related Assets (Credit Losses Rollforward) (Details) - Mortgage-backed Securities, Issued by US Government Sponsored Enterprises - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Allowance for credit losses at beginning of period	$ 0	$ 0	$ 0	$ 0
Securities with no prior loss allowance	0	0	344,269,000	0
Securities with a prior loss allowance	0	0	0	0
Write-offs, including allowance related to securities the Company intends to sell	0	0	(344,269,000)	0
Allowance for credit losses at end of period	$ 0	$ 0	$ 0	$ 0

XML

Residential Mortgage Securities and MSR-Related Assets (MSR Related Assets - Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Term notes backed by MSR-related collateral
Debt Securities, Available-for-sale [Line Items]
Term notes backed by MSR related collateral		$ 234,091	$ 1,157,463
Amortized costs		184,500	1,200,000
Gross unrealized gains		$ 49,500	$ 5,200
Weighted average yield	4.75%	12.10%
Weighted average to maturity	5 years 3 months 18 days	9 years 6 months
Proceeds from sale of MSR		$ 711,700
Realized losses		28,700
Impairment		280,800
Corporate Loan
Debt Securities, Available-for-sale [Line Items]
Commitment to lend		32,600
Amount drawn		$ 18,100
Interest coupon rate		5.52%
Debt term		11 months
Minimum | Corporate Loan
Debt Securities, Available-for-sale [Line Items]
Commitment fee on undrawn amount		0.25%
Maximum | Corporate Loan
Debt Securities, Available-for-sale [Line Items]
Commitment fee on undrawn amount		1.00%

XML

Residential Mortgage Securities and MSR-Related Assets (Impact of AFS Securities on AOCI) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
AOCI from AFS Securities:
Unrealized gain on AFS securities at beginning of period	$ 52,889	$ 439,898	$ 392,722	$ 417,167
Unrealized (loss)/gain on AFS securities, net	15,082	5,483	408,585	50,085
Reclassification adjustment for MBS sales included in net income	(60)	(14,499)	(389,127)	(36,370)
Reclassification adjustment for impairment included in net income	0	0	(344,269)	0
Change in AOCI from AFS securities	15,022	(9,016)	(324,811)	13,715
Balance at end of period	67,911	430,882	67,911	430,882
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
AOCI from AFS Securities:
Unrealized (loss)/gain on AFS securities, net	0	603	(161)	22,483
Non-Agency MBS
AOCI from AFS Securities:
Unrealized (loss)/gain on AFS securities, net	5,998	2,856	360,315	22,211
MSR-related assets
AOCI from AFS Securities:
Unrealized (loss)/gain on AFS securities, net	$ 9,084	$ 2,024	$ 48,431	$ 5,391

XML

Residential Mortgage Securities and MSR-Related Assets (Interest Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Debt Securities, Available-for-sale [Line Items]
Interest income	$ 2,329	$ 60,639	$ 51,678	$ 211,676
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Debt Securities, Available-for-sale [Line Items]
Coupon interest	0	18,994	14,038	66,560
Effective yield adjustment	0	(7,188)	(5,186)	(21,039)
Interest income	0	11,806	8,852	45,521
Legacy Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Coupon interest	42	21,011	18,222	68,144
Effective yield adjustment	6	10,336	10,564	38,003
Interest income	48	31,347	28,786	106,147
Accretion Income				3,100
RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Coupon interest	811	13,227	7,622	44,305
Effective yield adjustment	94	8	449	158
Interest income	905	13,235	8,071	44,463
Accretion Income		4	277	152
CRT securities
Debt Securities, Available-for-sale [Line Items]
Coupon interest	956	5,174	6,063	16,769
Effective yield adjustment	420	(923)	(94)	(1,224)
Interest income	1,376	4,251	5,969	15,545
MSR-related assets
Debt Securities, Available-for-sale [Line Items]
Coupon interest	2,991	15,273	23,332	38,230
Effective yield adjustment	3,250	1	6,857	2
Interest income	$ 6,241	$ 15,274	$ 30,189	$ 38,232

XML

Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Other Assets [Abstract]
REO	$ 298,866	$ 348,516	$ 411,659	$ 376,200	$ 334,069	$ 249,413
Capital contributions made to loan origination partners	108,887		147,992
Other interest-earning assets	45,442		70,468
Interest receivable	42,723		70,986
Other MBS and loan related receivables	36,342		43,842
Other	39,354		39,304
Total Other Assets	571,614		784,251
Real estate held-for-investment	$ 59,300		$ 27,300

XML

Other Assets (Real Estate Owned) (Details) $ in Thousands	Sep. 30, 2020 USD ($) property	Jun. 30, 2020 USD ($)	Dec. 31, 2019 USD ($) property	Sep. 30, 2019 USD ($) property	Jun. 30, 2019 USD ($)	Dec. 31, 2018 USD ($)
Real Estate Properties [Line Items]
Number of real estate owned properties | property	1,131		1,652	1,508
Real estate owned	$ 298,866	$ 348,516	$ 411,659	$ 376,200	$ 334,069	$ 249,413
Residential Whole Loans acquired through foreclosure ordered in lieu	295,700
Carrying Value
Real Estate Properties [Line Items]
Mortgage loans in process of foreclosure	132,500
Estimated Fair Value
Real Estate Properties [Line Items]
Mortgage loans in process of foreclosure	$ 487,300

XML

Other Assets (Real Estate Owned - Activity) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020 USD ($) property	Sep. 30, 2019 USD ($) property	Sep. 30, 2020 USD ($) property	Sep. 30, 2019 USD ($) property	Dec. 31, 2019 property
Real Estate Owned [Roll Forward]
Balance at beginning of period	$ 348,516	$ 334,069	$ 411,659	$ 249,413
Adjustments to record at lower of cost or fair value	93	(3,875)	(11,796)	(9,264)
Transfer from residential whole loans	15,672	61,888	74,891	193,531
Purchases and capital improvements, net	536	5,108	9,334	16,307
Disposals	(65,951)	(20,990)	(185,222)	(73,787)
Balance at end of period	$ 298,866	$ 376,200	$ 298,866	$ 376,200
Number of properties | property	1,131	1,508	1,131	1,508	1,652
Gain recorded on transfer from residential whole loans to real estate owned	$ 834	$ 5,000	$ 4,100	$ 16,100
Properties sold during period | property	267	142	812	431
Proceeds from sale of real estate	$ 69,900	$ 23,000	$ 195,200	$ 80,000
Gain on sales of real estate owned	$ 3,900	$ 2,100	$ 10,000	$ 5,800

XML

Other Assets (Capital Contributions Made to Loan Origination Partners) (Details) - Loan Originators	3 Months Ended	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)
Other Assets [Line Items]
Equity method investments	$ 31,000,000.0	$ 31,000,000.0
Equity investment, convertible notes	75,000,000.0	75,000,000.0
Impairment on investment	0	65,200,000
Company’s residential whole loans at carrying value are serviced by entities the Company has an investment in	840,500,000	840,500,000
Preferred Stock
Other Assets [Line Items]
Equity method investments	$ 68,000,000.0	$ 68,000,000.0

XML

Other Assets (Derivative Instruments Narrative) (Details )	3 Months Ended	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)
Derivative [Line Items]
Derivative, terminated amount	$ 4,100,000,000	$ 4,100,000,000
Loss on discontinuation of cash flow hedge due to forecasted transaction probable of not occurring	$ 7,200,000
Swap | Hedging
Derivative [Line Items]
Reclassification of hedge gain (loss) from AOCI		(49,900,000)
Loss on derivative		$ 0

XML

Other Assets (Derivative Instruments - Balance Sheet Location) (Details) - Swap - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Hedging
Derivative Instruments
Notional Amount	$ 0	$ 2,942,000
Fair Value	0	0
Non-Hedging
Derivative Instruments
Notional Amount	0	230,000
Fair Value	$ 0	$ 0

XML

Other Assets (Derivative Instruments) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
AOCI from derivative hedging instruments:
Balance at beginning of period	$ (7,176,000)	$ (28,114,000)	$ (22,675,000)	$ 3,121,000
Net loss on Swaps	0	(233,000)	(50,127,000)	(30,384,000)
Reclassification adjustment for losses/(gains) related to hedging instruments included in net income	7,176,000	(685,000)	72,802,000	(1,769,000)
Balance at end of period	0	(29,032,000)	0	(29,032,000)
Interest Rate Contract
Derivative [Line Items]
Assets pledged	0		0		$ 19,018,000
Swaps, at fair value
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 3,172,000,000
Weighted average fixed-pay rate	0.00%		0.00%		2.24%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.81%
Interest (expense)/income attributable to Swaps	$ 0	$ (322,000)	$ (3,359,000)	$ 1,561,000
Weighted average Swap rate paid	0.00%	2.29%	2.06%	2.32%
Weighted average Swap rate received	0.00%	2.24%	1.63%	2.40%
Swaps, at fair value | Over 3 months to 6 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 200,000,000
Weighted average fixed-pay rate	0.00%		0.00%		2.05%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.70%
Swaps, at fair value | Over 6 months to 12 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 1,430,000,000
Weighted average fixed-pay rate	0.00%		0.00%		2.30%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.77%
Swaps, at fair value | Over 12 months to 24 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 1,300,000,000
Weighted average fixed-pay rate	0.00%		0.00%		2.11%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.86%
Swaps, at fair value | Over 24 months to 36 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 20,000,000
Weighted average fixed-pay rate	0.00%		0.00%		1.38%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.90%
Swaps, at fair value | Over 36 months to 48 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 222,000,000
Weighted average fixed-pay rate	0.00%		0.00%		2.88%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.84%
Swap | Hedging
Derivative [Line Items]
Loss on derivative			$ 0
Swap | Non-Hedging
Derivative [Line Items]
Loss on derivative		$ 929,000	4,300,000	$ 17,300,000
Realized loss		$ 3,700,000	9,400,000	$ 17,700,000
Agency MBS, at fair value | Interest Rate Contract
Derivative [Line Items]
Assets pledged	$ 0		0		$ 2,241,000
Restricted cash | Interest Rate Contract
Derivative [Line Items]
Assets pledged	$ 0		$ 0		$ 16,777,000

XML

Financing Agreements (Financing Agreements) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Jun. 26, 2020	Dec. 31, 2019
Financing Agreements [Line Items]
Unpaid Principal Balance	$ 4,864,554			$ 10,044,844
Fair value / Carrying Value	4,851,121			10,031,606
Financing agreements with non-mark-to-market collateral provisions
Financing Agreements [Line Items]
Unpaid Principal Balance	1,723,959
Amortized Cost Balance	1,723,959
Fair value / Carrying Value	1,727,407
Financing agreements with mark-to-market collateral provisions
Financing Agreements [Line Items]
Unpaid Principal Balance	1,489,097
Amortized Cost Balance	1,489,097
Fair value / Carrying Value	1,490,271		$ 1,650,000
Senior secured credit agreement
Financing Agreements [Line Items]
Unpaid Principal Balance	481,250	$ 500,000
Amortized Cost Balance	462,923
Fair value / Carrying Value	473,993
Securitized debt
Financing Agreements [Line Items]
Unpaid Principal Balance	389,051			573,900
Amortized Cost Balance	380,407
Fair value / Carrying Value	388,790			570,952
Total Financing agreements, at fair value
Financing Agreements [Line Items]
Unpaid Principal Balance	4,083,357
Amortized Cost Balance	4,056,386
Fair value / Carrying Value	4,080,461
Repurchase agreements
Financing Agreements [Line Items]
Unpaid Principal Balance				9,140,944
Fair value / Carrying Value				9,139,821
Securitized debt
Financing Agreements [Line Items]
Unpaid Principal Balance	451,197
Fair value / Carrying Value	448,893
Convertible senior notes
Financing Agreements [Line Items]
Unpaid Principal Balance	230,000			230,000
Fair value / Carrying Value	224,867			223,971
Senior notes
Financing Agreements [Line Items]
Unpaid Principal Balance	100,000			100,000
Fair value / Carrying Value	96,900			$ 96,862
Total Financing agreements at carrying value
Financing Agreements [Line Items]
Unpaid Principal Balance	781,197
Fair value / Carrying Value	$ 770,660

XML

Financing Agreements (Financing Agreements, at Fair Values Narrative) (Details) - USD ($) $ in Thousands		9 Months Ended
	Jun. 26, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Financing Agreements [Line Items]
Agreement amount		$ 4,864,554		$ 10,044,844
Financial instruments		4,851,121		$ 10,031,606
Senior secured credit agreement
Financing Agreements [Line Items]
Agreement amount		481,250	$ 500,000
Financial instruments		473,993
Financing agreements with mark-to-market collateral provisions
Financing Agreements [Line Items]
Agreement amount		1,489,097
Financial instruments	$ 1,650,000	1,490,271
Financing agreements with non-mark-to-market collateral provisions
Financing Agreements [Line Items]
Agreement amount		1,723,959
Financial instruments		1,727,407
Non Mark to Market Financing Facilities
Financing Agreements [Line Items]
Financial instruments		1,400,000
Debt instrument term	2 years
Debt instrument, term, extension	3 years
Non Mark to Market Financing Facilities on Rehabilitation Loans
Financing Agreements [Line Items]
Long-term debt, term	2 years
Debt outstanding		$ 359,000
Minimum | Financing agreements with mark-to-market collateral provisions
Financing Agreements [Line Items]
Debt instrument term		1 month
Maximum | Financing agreements with mark-to-market collateral provisions
Financing Agreements [Line Items]
Debt instrument term		3 months

XML

Financing Agreements (Borrowings Under Repurchase Agreement And Associated Assets Pledged as Collateral) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Assets Sold under Agreements to Repurchase [Line Items]
Fair value of securities pledged as collateral under repurchase agreements	$ 5,200,000	$ 11,300,000
Non Mark to Market Financing Facilities
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	1,471,269	0
Fair value of securities pledged as collateral under repurchase agreements	$ 2,323,085	$ 0
Weighted average haircut (percent)	41.91%	0.00%
Financing agreements with non-mark-to-market collateral provisions
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 256,138	$ 0
Fair value of securities pledged as collateral under repurchase agreements	$ 435,081	$ 0
Weighted average haircut (percent)	41.25%	0.00%
Residential whole loans
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 1,231,734	$ 4,743,094
Fair value of securities pledged as collateral under repurchase agreements	$ 2,002,903	$ 5,986,267
Weighted average haircut (percent)	30.88%	20.07%
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 0	$ 1,557,675
Fair value of securities pledged as collateral under repurchase agreements	$ 0	$ 1,656,373
Weighted average haircut (percent)	0.00%	4.46%
Non-Agency MBS
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 1,282	$ 1,121,802
Fair value of securities pledged as collateral under repurchase agreements	$ 2,621	$ 1,420,797
Weighted average haircut (percent)	50.00%	20.27%
RPL/NPL MBS
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 32,950	$ 495,091
Fair value of securities pledged as collateral under repurchase agreements	$ 53,809	$ 635,005
Weighted average haircut (percent)	38.75%	21.52%
CRT securities
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 54,883	$ 203,569
Fair value of securities pledged as collateral under repurchase agreements	$ 96,336	$ 252,175
Weighted average haircut (percent)	42.47%	18.84%
MSR-related assets
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 135,340	$ 962,515
Fair value of securities pledged as collateral under repurchase agreements	$ 252,183	$ 1,217,002
Weighted average haircut (percent)	39.87%	21.18%
Other Interest Earning Assets
Assets Sold under Agreements to Repurchase [Line Items]
Carrying Value	$ 34,082	$ 57,198
Fair value of securities pledged as collateral under repurchase agreements	$ 44,079	$ 61,708
Weighted average haircut (percent)	25.00%	22.01%
Repurchase Agreement Borrowings
Assets Sold under Agreements to Repurchase [Line Items]
Unamortized debt issuance expense	$ 0	$ 1,123
Loan Securitization
Assets Sold under Agreements to Repurchase [Line Items]
Fair value of securities pledged as collateral under repurchase agreements	192,700	238,800
Financing Agreement
Assets Sold under Agreements to Repurchase [Line Items]
Cash pledged as collateral	$ 5,300	$ 25,200

XML

Financing Agreements (Borrowings Under Repurchase Agreement) (Details) - Repurchase Agreement Borrowings - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Other financing agreements	$ 3,213,056	$ 9,140,944
Weighted Average Interest Rate	3.33%	2.99%
Less debt issuance costs	$ 0	$ 1,123
Total financing agreements less debt issuance costs	3,213,056	9,139,821
Within 30 days
Debt Securities, Available-for-sale [Line Items]
Other financing agreements	$ 2,932,213	$ 4,472,120
Weighted Average Interest Rate	3.36%	2.55%
Over 30 days to 3 months
Debt Securities, Available-for-sale [Line Items]
Other financing agreements	$ 0	$ 2,746,384
Weighted Average Interest Rate	0.00%	3.43%
Over 3 months to 12 months
Debt Securities, Available-for-sale [Line Items]
Other financing agreements	$ 280,843	$ 1,014,441
Weighted Average Interest Rate	3.02%	3.36%
Over 12 months
Debt Securities, Available-for-sale [Line Items]
Other financing agreements	$ 0	$ 907,999
Weighted Average Interest Rate	0.00%	3.44%

XML

Financing Agreements (Counterparty for Repurchase Agreement) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($) counterparty	Dec. 31, 2019 counterparty
Repurchase agreements counterparty risk
Number of counterparties | counterparty	8	28
Threshold of stockholders' equity at risk with single counterparty to repurchase agreements or linked transactions (greater than) (percent)	5.00%
Amounts at risk exceeding equity	5.00%
Barclays Bank
Repurchase agreements counterparty risk
Amount at Risk	$ 750,922
Weighted  Average Months  to Repricing for Repurchase Agreements	1 month
Percent of Stockholders’ Equity	29.30%
Credit Suisse
Repurchase agreements counterparty risk
Amount at Risk	$ 574,835
Weighted  Average Months  to Repricing for Repurchase Agreements	1 month
Percent of Stockholders’ Equity	22.40%
Wells Fargo
Repurchase agreements counterparty risk
Amount at Risk	$ 349,825
Weighted  Average Months  to Repricing for Repurchase Agreements	1 month
Percent of Stockholders’ Equity	13.60%
Goldman Sachs
Repurchase agreements counterparty risk
Amount at Risk	$ 173,266
Weighted  Average Months  to Repricing for Repurchase Agreements	3 months
Percent of Stockholders’ Equity	6.80%
Goldman Sachs Lending Partners
Repurchase agreements counterparty risk
Amount at Risk	$ 20,600
Goldman Sachs Bank USA
Repurchase agreements counterparty risk
Amount at Risk	152,700
Athene
Repurchase agreements counterparty risk
Amount at Risk	$ 144,245
Weighted  Average Months  to Repricing for Repurchase Agreements	1 month
Percent of Stockholders’ Equity	5.60%

XML

Financing Agreements (Securitized Debt) (Details)	Sep. 30, 2020	Dec. 31, 2019
Asset-backed Securities, Securitized Loans and Receivables
Debt Instrument [Line Items]
Weighted average interest rate	2.93%	3.68%

XML

Financing Agreements (Senior Secured Credit Agreement - Narrative) (Details) - Senior Secured Term Loan Facility	Jun. 26, 2020 USD ($)
Repurchase agreements counterparty risk
Debt instrument, face amount	$ 500,000,000
Original issue discount, term loan	1.00%
Stated interest rate	11.00%
Optional prepayment rate prior to 3rd anniversary	3.00%
Interest rate increase on third anniversary	1.00%
Additional interest rate increase on each subsequent anniversary of the Funding Date	1.00%
Increase upon of default status	2.00%
Optional prepayment amount	$ 250,000,000
First Three Years
Repurchase agreements counterparty risk
Stated interest rate	3.75%
After Third Year
Repurchase agreements counterparty risk
Stated interest rate	4.50%

XML

Financing Agreements (Convertible Senior Notes) (Details)		9 Months Ended
	Jun. 03, 2019 USD ($) $ / shares	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)
Debt Instrument [Line Items]
Proceeds from issuance of Series C Preferred Stock		$ 0	$ 223,311,000
Convertible Debt
Debt Instrument [Line Items]
Proceeds from issuance of Series C Preferred Stock	$ 230,000,000.0
Proceed from debt net of offering expenses and underwriting discount	$ 223,300,000
Stated interest rate	6.25%
Conversion ratio	125.7387
Debt instrument, face amount	$ 1,000
Conversion price | $ / shares	$ 7.95
Effective interest rate	6.94%
Additional Convertible Senior Notes
Debt Instrument [Line Items]
Proceeds from issuance of Series C Preferred Stock	$ 30,000,000.0

XML

Financing Agreements (Senior Notes) (Details) - Senior Notes $ in Millions	Apr. 11, 2012 USD ($)
Debt Instrument [Line Items]
Proceeds from issuance of debt	$ 100.0
Proceed from debt net of offering expenses and underwriting discount	$ 96.6
Stated interest rate	8.00%
Effective interest rate	8.31%
Redemption price as percentage of principal amount	100.00%

XML

Collateral Positions (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Collateral Positions
Fair value of securities pledged as collateral under repurchase agreements	$ 5,200.0	$ 11,300.0
Accrued interest on assets	$ 35.8	$ 57.2

XML

Offsetting Assets and Liabilities (Narrative) (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Offsetting [Abstract]
Fair value of financial instruments pledged against the repurchase agreements and other advances	$ 5,200,000,000	$ 11,200,000,000
Fair value of securities pledged against the swaps	$ 0	$ 2,200,000

XML

Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Other Liabilities [Abstract]
Dividends and dividend equivalents payable	$ 22,758	$ 90,749
Accrued interest payable	14,588	18,238
Accrued expenses and other	29,136	42,819
Total Other Liabilities	$ 66,482	$ 151,806

XML

Commitments and Contingencies (Lease Commitments) (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($) lease
Lease Commitments
Number of operating leases | lease		3
Corporate headquarters
Lease Commitments
Lease cost	$ 739	$ 2,100
New Corporate Headquarters Location
Lease Commitments
Lease term	15 years	15 years
Renewal term	5 years	5 years
Lease liability	$ 4,600	$ 4,600

XML

Commitments and Contingencies (Representations and Warranties in Connection with Loan Securitization Transactions) (Details)	Sep. 30, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Repurchase loans allowance	$ 0

XML

Commitments and Contingencies (Corporate Loans) (Details) - Corporate Loan $ in Millions	Sep. 30, 2020 USD ($)
Other Commitments [Line Items]
Commitment to lend	$ 32.6
Remaining borrowing capacity	$ 14.5

XML

Commitments and Contingencies (Rehabilitation Loan Commitments) (Details) $ in Millions	Sep. 30, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Unfunded commitment for rehabilitation loans	$ 73.2

XML

Stockholders' Equity (Narrative) (Details)									1 Months Ended	3 Months Ended				9 Months Ended		12 Months Ended	202 Months Ended
	Aug. 12, 2020 $ / shares	Aug. 06, 2020 $ / shares	Jul. 01, 2020 $ / shares	Jun. 15, 2020 USD ($) $ / shares shares	Mar. 02, 2020 USD ($)	Feb. 28, 2020 $ / shares shares	Feb. 14, 2020 $ / shares	Apr. 15, 2013 $ / shares shares	Mar. 31, 2020 quarter director	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2019 $ / shares	Jun. 30, 2019 $ / shares	Mar. 31, 2019 $ / shares	Sep. 30, 2020 USD ($) quarter director $ / shares shares	Sep. 30, 2019 USD ($)	Dec. 31, 2019 $ / shares shares	Jun. 30, 2020 USD ($) shares	Oct. 15, 2019 shares	Aug. 16, 2019 USD ($)	Dec. 31, 2013 shares	Aug. 31, 2005 shares
Stockholders' Equity
Common stock, cash dividends declared (in dollars per share)		$ 0.05								$ 0.05	$ 0.20	$ 0.20	$ 0.20
Proceeds from issuance of redeemable preferred stock | $														$ 275,000,000	$ 0
Aggregate number of shares of common stock authorized (in shares) | shares										874,300,000				874,300,000		886,950,000
Number of shares authorized to be repurchased under the Repurchase Program (in shares) | shares																				10,000,000.0	4,000,000.0
Number of remaining shares authorized to be repurchased under the Repurchase Program (in shares) | shares										6,616,355				6,616,355
Number of shares called by warrant (in shares) | shares				37,039,106
Proceeds from issuance of warrants | $				$ 495,000,000.0										$ 14,041,000	$ 0
DRSPP
Stockholders' Equity
Aggregate number of shares of common stock authorized (in shares) | shares																		9,000,000.0
Shares of common stock authorized and available for issuance (in shares) | shares										8,800,000				8,800,000
Common shares issued through DRSPP (in shares) | shares										4,374				137,740			34,516,508
Net proceeds from shares issued through DRSPP | $										$ 11,688				$ 752,095			$ 287,300,000
Series B Preferred Stock
Stockholders' Equity
Preferred Stock, dividend rate														7.50%		7.50%
Preferred stock, shares issued (in shares) | shares										8,000,000				8,000,000		8,000,000
Preferred stock par value (usd per share)										$ 0.01				$ 0.01		$ 0.01
Dividend declared per share, preferred stock (in dollars per share)	$ 0.46875		$ 0.9375				$ 0.46875			$ 1.40625	$ 0.46875	$ 0.46875	$ 0.46875
Series C Preferred Stock
Stockholders' Equity
Preferred Stock, dividend rate														6.50%
Preferred stock, shares issued (in shares) | shares										11,000,000				11,000,000
Preferred stock par value (usd per share)										$ 0.01				$ 0.01
Dividend declared per share, preferred stock (in dollars per share)										0.93889
Amount of preferred dividends in arrears (USD per share)	$ 0.40625													$ 0.53264
Preferred Stock | Series B Preferred Stock
Stockholders' Equity
Preferred Stock, dividend rate								7.50%						7.50%	7.50%
Preferred stock, shares issued (in shares) | shares								8,000,000.0
Preferred stock par value (usd per share)								$ 0.01
Preferred stock, liquidation preference (in dollars per share)								25.00		$ 25.00				$ 25.00		$ 25.00
Preferred stock, redemption price (in dollars per share)								$ 25.00
Maximum quarters without dividends to get voting rights, in quarters | quarter														6
Number of additional directors that can be elected by preferred stock holders | director														2
Percentage required for making material changes								66.67%
Preferred Stock | Series C Preferred Stock
Stockholders' Equity
Preferred Stock, dividend rate						6.50%
Preferred stock, shares issued (in shares) | shares						11,000,000.0
Preferred stock par value (usd per share)						$ 0.01
Preferred stock, liquidation preference (in dollars per share)						25.00
Preferred stock, redemption price (in dollars per share)						$ 25.00
Maximum quarters without dividends to get voting rights, in quarters | quarter									6
Number of additional directors that can be elected by preferred stock holders | director									2
Shares reclassified to redeemable capital stock (in shares) | shares						12,650,000
Proceeds from issuance of redeemable preferred stock | $					$ 266,000,000.0
Warrant
Stockholders' Equity
Proceeds from issuance of warrants | $				$ 14,000,000.0
At The Market
Stockholders' Equity
At-the-market, maximum potential proceeds | $																			$ 400,000,000.0
Sales commission of gross sales price																			2.00%
Number of shares issued (in shares) | shares										0
Value remaining outstanding for future offerings | $										$ 390,000,000.0				$ 390,000,000.0
LIBOR | Preferred Stock | Series C Preferred Stock
Stockholders' Equity
Debt instrument, basis spread on variable rate						5.345%
Exercise Price Range One
Stockholders' Equity
Warrant exercise price (usd per share)				$ 1.66
Exercise Price Range Two
Stockholders' Equity
Warrant exercise price (usd per share)				$ 2.08
Debt
Stockholders' Equity
Proceeds from issuance of warrants | $				$ 481,000,000.0

XML

Stockholders' Equity (Dividends on Common Stock) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Aug. 06, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019
Equity [Abstract]
Dividend Per Share	$ 0.05	$ 0.05	$ 0.20	$ 0.20	$ 0.20
Dividends payable		$ 22,758	$ 90,614

XML

Stockholders' Equity (Accumulated Other Comprehensive Income/(Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Components of accumulated other comprehensive income/(loss)
Balance	$ 2,521,051	$ 3,403,373	$ 3,383,952	$ 3,416,101
OCI before reclassifications	(7,570)		335,806	19,701
Amounts reclassified from AOCI	7,116	(15,184)	(660,594)	(38,139)
Other Comprehensive Income/(Loss)	(454)	(9,934)	(324,788)	(18,438)
Balance	2,565,656	3,403,426	2,565,656	3,403,426
Total  AOCI
Components of accumulated other comprehensive income/(loss)
Balance	45,713	411,784	370,047	420,288
OCI before reclassifications		5,250
Amounts reclassified from AOCI		(15,184)
Other Comprehensive Income/(Loss)		(9,934)
Balance	45,259	401,850	45,259	401,850
Net Unrealized Gain/(Loss) on AFS Securities
Components of accumulated other comprehensive income/(loss)
Balance	52,889	439,898	392,722	417,167
OCI before reclassifications	15,082	5,483	408,585	50,085
Amounts reclassified from AOCI	(60)	(14,499)	(733,396)	(36,370)
Other Comprehensive Income/(Loss)	15,022	(9,016)	(324,811)	13,715
Balance	67,911	430,882	67,911	430,882
Net (Loss)/Gain on Swaps
Components of accumulated other comprehensive income/(loss)
Balance	(7,176)	(28,114)	(22,675)	3,121
OCI before reclassifications	0	(233)	(50,127)	(30,384)
Amounts reclassified from AOCI	7,176	(685)	72,802	(1,769)
Other Comprehensive Income/(Loss)	7,176	(918)	22,675	(32,153)
Balance	0	$ (29,032)	0	$ (29,032)
Net Unrealized Gain/(Loss) on Financing Agreements
Components of accumulated other comprehensive income/(loss)
Balance	0		0
OCI before reclassifications	(22,652)		(22,652)
Amounts reclassified from AOCI	0		0
Other Comprehensive Income/(Loss)	(22,652)		(22,652)
Balance	$ (22,652)		$ (22,652)

XML

Stockholders' Equity (Amounts Reclassified out of AOCI) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Amounts Reclassified from AOCI
Net income/(loss) to common stockholders - basic	$ 78,666	$ 91,569	$ (746,876)	$ 265,438
Total reclassifications for period	7,116	(15,184)	(660,594)	(38,139)
Amounts Reclassified from AOCI | Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest
Amounts Reclassified from AOCI
Realized gain on sale of securities	(60)	(14,499)	(389,127)	(36,370)
Impairment recognized in earnings	0		(344,269)
Net income/(loss) to common stockholders - basic	(60)	(14,499)	(733,396)	(36,370)
Amounts Reclassified from AOCI | Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent
Amounts Reclassified from AOCI
Total Swaps designated as cash flow hedges	$ 7,176		$ 72,802
Amortization of de-designated hedging instruments		$ (685)		$ (1,769)

XML

EPS Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Basic Earnings/(Loss) per Share:
Net income/(loss) to common stockholders	$ 87,210	$ 96,578	$ (908,995)	$ 95,599	$ 93,040	$ 88,857	$ (725,207)	$ 277,496
Dividends declared on preferred stock	(8,219)			(3,750)	$ (3,750)	$ (3,750)	(21,578)	(11,250)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(325)			(280)			(91)	(808)
Net income/(loss) to common stockholders - basic	$ 78,666			$ 91,569			$ (746,876)	$ 265,438
Basic weighted average common shares outstanding (in shares)	453,323			451,020			453,170	450,641
Basic (Loss)/Earnings per Share (usd per share)	$ 0.17			$ 0.20			$ (1.65)	$ 0.59
Diluted Earnings/(Loss) per Share:
Net income/(loss) to common stockholders - basic	$ 78,666			$ 91,569			$ (746,876)	$ 265,438
Interest expense on Convertible Senior Notes	3,898			3,879			0	5,085
Net income/(loss) to common stockholders - diluted	$ 82,564			$ 95,448			$ (746,876)	$ 270,523
Basic weighted average common shares outstanding (in shares)	453,323			451,020			453,170	450,641
Effect of assumed Convertible Senior Notes conversion to common shares (in shares)	28,920			28,920			0	12,712
Effect of Warrants (in shares)	11,297			0			0	0
Diluted weighted average common shares outstanding (in shares)	493,540			479,940			453,170	463,353
Diluted EPS (usd per share)	$ 0.17			$ 0.20			$ (1.65)	$ 0.58
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares)							39,000
RSUs
Diluted Earnings/(Loss) per Share:
Weighted average grant date fair value (in dollars per share)	6.29						$ 6.29
Warrant
Diluted Earnings/(Loss) per Share:
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares)							37,000
Weighted average grant date fair value (in dollars per share)	$ 1.87						$ 1.87

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Share based compensation
Maximum shares authorized for grant	18,000,000.0		18,000,000.0
Shares available for grant (in shares)	14,300,000		14,300,000
RSUs
Share based compensation
Awards granted (in shares)	497,507	0	1,702,220	912,525
Forfeitures (in shares)			0	20,000
Unrecognized compensation cost	$ 8,300,000		$ 8,300,000		$ 5,500,000
Period for recognizing unrecognized compensation cost			1 year 10 months 24 days
Restricted shares of common stock
Share based compensation
Awards granted (in shares)			79,545	0
Share-based awards outstanding (in shares)	0		0
Dividend Equivalent Rights
Share based compensation
Equivalent rights payment		$ 276,000	$ 276,000	$ 773,000
Equity Compensation Plan
Share based compensation
Maximum number of common shares that can be granted to participant in any one year			2,000,000.0
Period during which a participant can be awarded the maximum number of shares allowable under the Plan			1 year
Maximum percentage of common shares that can be owned or deemed to be owned by a participant (more than)			9.80%

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Allocated Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share based compensation
Allocated expense	$ 2,267	$ 1,288	$ 5,094	$ 4,724
RSUs
Share based compensation
Allocated expense	$ 2,267	$ 1,288	$ 5,094	$ 4,724

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Details 2) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020 USD ($) officer	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($) officer	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Deferred Compensation Activity
Number of officers having employment agreements with the company | officer	3		3
Deferred Compensation Plans
Deferred Compensation Activity
Deferrable compensation by the employee, maximum			100.00%
Non-employee directors	$ 75	$ 134	$ (1,483)	$ 459
Undistributed Income Deferred	2,074		2,074		$ 2,349
Liability Under Deferred Plans	1,114		1,114		3,071
Deferred Compensation Plans | Non-employee directors
Deferred Compensation Activity
Non-employee directors	75	134	(1,483)	459
Undistributed Income Deferred	2,074		2,074		2,349
Liability Under Deferred Plans	1,114		$ 1,114		$ 3,071
Savings Plan
Deferred Compensation Activity
Employer contribution percentage on first 3 percent of eligible compensation deferred by employees (percent)			100.00%
Percentage of eligible compensation deferred by employees qualifying for 100 percent matching contribution (percent)			3.00%
Employer contribution percentage on next 2 percent of eligible compensation deferred by employees (percent)			50.00%
Percentage of eligible compensation deferred by employees qualifying for 50 percent matching contribution (percent)			2.00%
Percentage of employer matching contributions that vest immediately (percent)			100.00%
Expenses for matching contributions	$ 120	$ 94	$ 360	$ 323

XML

Fair Value of Financial Instruments (Fair Value Hierarchy) (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Assets:
Residential whole loans, at fair value	[1]	$ 1,229,664	$ 1,381,583
Fair  Value		152,765	3,983,519
Total assets carried at fair value		1,616,520	6,522,565
Liabilities:
Securitized debt		388,790
Residential whole loans, at fair value
Assets:
Residential whole loans, at fair value		1,229,664	1,381,583
Liabilities:
Total liabilities carried at fair value		4,080,461
Non-Agency MBS
Assets:
Fair  Value		56,430	2,063,529
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Assets:
Fair  Value			1,664,582
CRT securities
Assets:
Fair  Value		96,335	255,408
Term notes backed by MSR-related collateral
Assets:
Term notes backed by MSR related collateral		234,091	1,157,463
Financing agreements with non-mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		1,727,407
Financing agreements with mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		1,490,271
Senior secured credit agreement
Liabilities:
Liabilities carried at fair value		473,993
Level 1
Assets:
Total assets carried at fair value		0	0
Liabilities:
Securitized debt		0
Level 1 | Residential whole loans, at fair value
Assets:
Residential whole loans, at fair value		0	0
Liabilities:
Total liabilities carried at fair value		0
Level 1 | Non-Agency MBS
Assets:
Fair  Value		0	0
Level 1 | Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Assets:
Fair  Value			0
Level 1 | CRT securities
Assets:
Fair  Value		0	0
Level 1 | Term notes backed by MSR-related collateral
Assets:
Term notes backed by MSR related collateral		0	0
Level 1 | Financing agreements with non-mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		0
Level 1 | Financing agreements with mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		0
Level 1 | Senior secured credit agreement
Liabilities:
Liabilities carried at fair value		0
Level 2
Assets:
Total assets carried at fair value		386,856	5,140,982
Liabilities:
Securitized debt		388,790
Level 2 | Residential whole loans, at fair value
Assets:
Residential whole loans, at fair value		0	0
Liabilities:
Total liabilities carried at fair value		1,121,320
Level 2 | Non-Agency MBS
Assets:
Fair  Value		56,430	2,063,529
Level 2 | Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Assets:
Fair  Value			1,664,582
Level 2 | CRT securities
Assets:
Fair  Value		96,335	255,408
Level 2 | Term notes backed by MSR-related collateral
Assets:
Term notes backed by MSR related collateral		234,091	1,157,463
Level 2 | Financing agreements with non-mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		0
Level 2 | Financing agreements with mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		258,537
Level 2 | Senior secured credit agreement
Liabilities:
Liabilities carried at fair value		473,993
Level 3
Assets:
Total assets carried at fair value		1,229,664	1,381,583
Liabilities:
Securitized debt		0
Level 3 | Residential whole loans, at fair value
Assets:
Residential whole loans, at fair value		1,229,664	1,381,583
Liabilities:
Total liabilities carried at fair value		2,959,141
Level 3 | Non-Agency MBS
Assets:
Fair  Value		0	0
Level 3 | Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Assets:
Fair  Value			0
Level 3 | CRT securities
Assets:
Fair  Value		0	0
Level 3 | Term notes backed by MSR-related collateral
Assets:
Term notes backed by MSR related collateral		0	$ 0
Level 3 | Financing agreements with non-mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		1,727,407
Level 3 | Financing agreements with mark-to-market collateral provisions
Liabilities:
Liabilities carried at fair value		1,231,734
Level 3 | Senior secured credit agreement
Liabilities:
Liabilities carried at fair value		$ 0

[1] Includes approximately $568.6 million and $186.4 million of Residential whole loans, at carrying value and $521.2 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.

XML

Fair Value of Financial Instruments (Level 3 Assets) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2019
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Residential whole loans held at fair value for which the closing price of the purchase transaction had not occurred		$ 87,000		$ 87,000	$ 70,600
Recurring basis | Level 3 | Residential Whole Loans, at Fair Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 1,200,981	1,438,827	$ 1,381,583	1,471,263
Purchases and capitalized advances	0	85,855	0	210,030
Changes in fair value recorded in Net gain on residential whole loans measured at fair value through earnings	58,863	13,185	(13,683)	33,312
Cash collections, net of liquidation gains/(losses)	(21,721)	(31,212)	(65,934)	(94,821)
Sales and repurchases	(929)	0	(19,460)	(1,216)
Transfer to REO	(7,530)	(53,486)	(52,842)	(165,399)
Balance at end of period	$ 1,229,664	1,453,169	$ 1,229,664	1,453,169
Recurring basis | Level 3 | Term Notes Backed by MSR-Related Collateral
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period		1,106,026		538,499
Purchases and capitalized advances		0		573,137
Cash collections, net of liquidation gains/(losses)		(3,920)		(12,897)
Changes in unrealized gains		2,024		5,391
Transfer to Level 2		(1,104,130)		(1,104,130)
Balance at end of period		$ 0		$ 0

XML

Fair Value of Financial Instruments (Level 3 Liabilities) (Details) - Level 3 - Recurring basis - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2019
Agreements with Non-mark-to-market Collateral Provisions
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period		$ 0	$ 0
Transfer from Level 2		2,036,597	2,036,597
Payment of principal	$ (312,638)	(312,638)
Changes in unrealized losses		3,448	3,448
Balance at end of period		0	0	$ 1,727,407
Agreements with Mark-to-market Collateral Provisions
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period		0	0
Transfer from Level 2		1,386,592	1,386,592
Payment of principal	$ (156,032)	(156,032)
Changes in unrealized losses		1,174	1,174
Balance at end of period		$ 0	$ 0	$ 1,231,734

XML

Fair Value of Financial Instruments (Fair Value Methodology) (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2020 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Residential whole loans, at fair value		$ 1,229,187		$ 1,381,113
Purchases excluded from level 2 fair value		477		470
Discounted cash flow
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Residential whole loans, at fair value		774,427		829,842
Liquidation model
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Residential whole loans, at fair value		454,760		551,271
Simple average amount		$ 383		$ 365
Residential whole loans, at fair value | Level 3 | Liquidation model | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Annual change in home prices		(0.30%)	2.40%
Liquidation timeline (in years)		1 month 6 days	1 month 6 days
Current value of underlying properties		$ 12	$ 10
Residential whole loans, at fair value | Level 3 | Liquidation model | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Annual change in home prices		5.50%	8.00%
Liquidation timeline (in years)		4 years 9 months 18 days	4 years 6 months
Current value of underlying properties		$ 4,500	$ 4,500
Discount rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.032		0.038
Discount rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.080		0.080
Discount rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.039		0.042
Discount rate | Residential whole loans, at fair value | Level 3 | Liquidation model | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.067		0.065
Discount rate | Residential whole loans, at fair value | Level 3 | Liquidation model | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.500		0.500
Discount rate | Residential whole loans, at fair value | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.081		0.080
Prepayment rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0		0.007
Prepayment rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.093		0.180
Prepayment rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.039		0.045
Prepayment rate | Residential whole loans, at fair value | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Annual change in home prices	3.70%	1.90%
Default rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0		0
Default rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.303		0.230
Default rate | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.062		0.040
Default rate | Residential whole loans, at fair value | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liquidation timeline (in years)	1 year 9 months 18 days	1 year 9 months 18 days
Loss severity | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0		0
Loss severity | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		1.000		1.000
Loss severity | Residential whole loans, at fair value | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.127		0.129
Loss severity | Residential whole loans, at fair value | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Current value of underlying properties	$ 684	$ 734

XML

Fair Value of Financial Instruments (Carrying Value vs Fair Value) (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Financial Assets:
Residential whole loans, carrying value	[1]	$ 4,493,805	$ 6,069,370
Residential whole loans, at fair value	[1]	1,229,664	1,381,583
Fair  Value		152,765	3,983,519
MSR-related assets		252,183	1,217,002
Restricted cash		5,303	64,035
Carrying Value
Financial Assets:
MSR-related assets		252,183	1,217,002
Cash and cash equivalents		884,171	70,629
Restricted cash		5,303	64,035
Financial Liabilities:
Securitized debt		837,683	570,952
Convertible Senior Notes		224,867	223,971
Senior notes		96,900	96,862
Estimated Fair Value
Financial Assets:
MSR-related assets		252,183	1,217,002
Cash and cash equivalents		884,171	70,629
Restricted cash		5,303	64,035
Financial Liabilities:
Securitized debt		839,914	575,353
Convertible Senior Notes		216,919	244,088
Senior notes		94,311	103,231
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Financial Assets:
Fair  Value			1,664,582
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member] | Carrying Value
Financial Assets:
Fair  Value		0	1,664,582
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member] | Estimated Fair Value
Financial Assets:
Fair  Value		0	1,664,582
Non-Agency MBS
Financial Assets:
Fair  Value		56,430	2,063,529
Non-Agency MBS | Carrying Value
Financial Assets:
Fair  Value		56,430	2,063,529
Non-Agency MBS | Estimated Fair Value
Financial Assets:
Fair  Value		56,430	2,063,529
CRT securities
Financial Assets:
Fair  Value		96,335	255,408
CRT securities | Carrying Value
Financial Assets:
Fair  Value		96,335	255,408
CRT securities | Estimated Fair Value
Financial Assets:
Fair  Value		96,335	255,408
Residential whole loans, at fair value
Financial Assets:
Residential whole loans, at fair value		1,229,664	1,381,583
Residential whole loans, at fair value | Carrying Value
Financial Assets:
Residential whole loans, carrying value		4,387,559	6,069,370
Residential whole loans, at fair value		1,229,664	1,381,583
Residential whole loans, at fair value | Estimated Fair Value
Financial Assets:
Residential whole loans, carrying value		4,528,630	6,248,745
Residential whole loans, at fair value		1,229,664	1,381,583
Financing agreements with non-mark-to-market collateral provisions | Carrying Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		1,727,407	0
Financing agreements with non-mark-to-market collateral provisions | Estimated Fair Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		1,727,407	0
Financing agreements with mark-to-market collateral provisions | Carrying Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		1,231,734	4,741,971
Financing agreements with mark-to-market collateral provisions | Estimated Fair Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		1,231,734	4,753,070
Financing agreements with mark-to-market collateral provisions | Carrying Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		258,537	4,397,850
Financing agreements with mark-to-market collateral provisions | Estimated Fair Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		258,537	4,403,139
Senior secured credit agreement | Carrying Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		473,993	0
Senior secured credit agreement | Estimated Fair Value
Financial Liabilities:
Financing agreements with mark-to-market collateral provisions		473,993	0
Level 3 | Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]
Financial Assets:
Fair  Value			0
Level 3 | Non-Agency MBS
Financial Assets:
Fair  Value		0	0
Level 3 | CRT securities
Financial Assets:
Fair  Value		0	0
Level 3 | Residential whole loans, at fair value
Financial Assets:
Residential whole loans, at fair value		1,229,664	1,381,583
Fair Value, Nonrecurring | Carrying Value
Financial Assets:
MSR-related assets		$ 18,100	$ 59,500

[1] Includes approximately $568.6 million and $186.4 million of Residential whole loans, at carrying value and $521.2 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.

XML

Fair Value of Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other real estate, fair value	$ 74.9	$ 193.5

XML

Use of Special Purpose Entities and Variable Interest Entities (Loan Securitization Transaction) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Aggregate fair value	$ 1,681,500	$ 1,681,500		$ 1,290,029
Outstanding amount of Senior Bonds, at carrying value	448,893	448,893		570,952
Outstanding amount of Senior Bonds, at fair value	388,790	388,790		0
Outstanding amount of Senior Bonds, total	837,683	837,683		570,952
Outstanding amount of Senior Bonds	$ 837,700	$ 837,700		$ 571,000
Weighted average interest rate	2.93%	2.93%		3.68%
Weighted average contractual maturity of Senior Bonds		36 years	30 years
Cash received		$ 1,193,969	$ 802,815
Debt issuance cost	$ 2,200	2,200		$ 2,900
Senior notes
Variable Interest Entity [Line Items]
Cash received	372,800	399,800
Senior notes | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Principal amount of Securitized debt	1,202,616	1,202,616		802,817
Proceeds from Senior bond sold with Step up feature		$ 743,900	$ 493,200
Debt instrument, coupon step-up period			36 months
Senior notes | Asset-backed Securities, Securitized Loans and Receivables | Minimum [Member]
Variable Interest Entity [Line Items]
Debt instrument, basis spread on variable rate		1.00%
Senior notes | Asset-backed Securities, Securitized Loans and Receivables | Maximum [Member]
Variable Interest Entity [Line Items]
Debt instrument, basis spread on variable rate		3.00%
Senior Support Certificates | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Principal amount of Securitized debt	$ 266,355	$ 266,355		$ 275,174

XML

Use of Special Purpose Entities and Variable Interest Entities (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
		Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Variable Interest Entity [Line Items]
Residential whole loans, carrying value	[1]	$ 4,493,805	$ 4,493,805		$ 6,069,370
Residential whole loans, at fair value	[1]	1,229,664	1,229,664		1,381,583
Residential whole loans, net		4,387,559	4,387,559		6,066,345
Total residential whole loans		5,600,000	5,600,000		7,400,000
Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Proceeds from issuance of debt			1,193,969	$ 802,815
Residential whole loans, carrying value		568,600	568,600		186,400
Residential whole loans, at fair value		521,200	521,200		567,400
Securitized debt		837,700	837,700		571,000
Asset-backed Securities, Securitized Loans and Receivables | Other Assets
Variable Interest Entity [Line Items]
Real estate owned at fair value		80,300	80,300		$ 137,800
Senior Bonds
Variable Interest Entity [Line Items]
Proceeds from issuance of debt		372,800	399,800
Proceed from debt net of offering expenses and underwriting discount		$ 372,800	$ 391,200

[1] Includes approximately $568.6 million and $186.4 million of Residential whole loans, at carrying value and $521.2 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2020 and December 31, 2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.

XML

Subsequent Events (Narrative) (Details) - USD ($)	Oct. 30, 2020	Oct. 09, 2020	Nov. 05, 2020	Nov. 02, 2020	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2013
Subsequent Event [Line Items]
Financing agreements ($4,080,461 and $0 held at fair value, respectively)					$ 4,851,121,000	$ 10,031,606,000
Stock repurchase program, authorized amount							$ 10,000,000
Number of remaining shares authorized to be repurchased under the Repurchase Program (in shares)					6,616,355
Common stock, shares outstanding (in shares)					453,333,000	452,369,000
Subsequent Event
Subsequent Event [Line Items]
Repayments of debt	$ 81,250,000	$ 400,000,000
Stock repurchase program, authorized amount				$ 250,000,000
Subsequent Event | Non-QM Loans [Member]
Subsequent Event [Line Items]
Financing agreements ($4,080,461 and $0 held at fair value, respectively)			$ 570,000,000
Cash			$ 125,100,000